PMID	title	date	location	doi
21035159	Early gene expression events in ferrets in response to SARS coronavirus infectionversus direct interferon-alpha2b stimulation.	2011 Jan 5	United States	10.1016/j.virol.2010.10.002
21030090	Association of seropositivity for influenza and coronaviruses with history ofmood disorders and suicide attempts.	2011 Apr	Netherlands	10.1016/j.jad.2010.09.029
21028792	Importance of controlling nanotube density for highly sensitive and reliablebiosensors functional in physiological conditions.	2010 Nov 23	United States	10.1021/nn101198u
20980507	Successful vaccination strategies that protect aged mice from lethal challengefrom influenza virus and heterologous severe acute respiratory syndromecoronavirus.	2011 Jan	United States	10.1128/JVI.01805-10
20979304	[Analysis of SARS-coronavirus genome].	2010 Aug	Japan	
20978541	Unique signatures of long noncoding RNA expression in response to virus infectionand altered innate immune signaling.	2010 Oct 26	United States	10.1128/mBio.00206-10
20978536	Autocrine interferon priming in macrophages but not dendritic cells results inenhanced cytokine and chemokine production after coronavirus infection.	2010 Oct 19	United States	10.1128/mBio.00219-10
20976535	SARS-CoV nucleocapsid protein antagonizes IFN-beta response by targeting initialstep of IFN-beta induction pathway, and its C-terminal region is critical for theantagonism.	2011 Feb	United States	10.1007/s11262-010-0544-x
20966275	Morbillivirus infection in a wild siberian tiger in the Russian Far East.	2010 Oct	United States	10.7589/0090-3558-46.4.1252
20960296	Complete genomic sequence of transmissible gastroenteritis virus TS and 3' endsequence characterization following cell culture.	2010 Jun	China	10.1007/s12250-010-3108-2
20960284	Construction of mTNFR1shRNA plasmid and its biological effects on MHV-3 inducedfulminant hepatitis in BALB/cJ mice.	2010 Feb	China	10.1007/s12250-010-3072-x
20960282	Immunogenicity of the spike glycoprotein of bat SARS-like coronavirus.	2010 Feb	China	10.1007/s12250-010-3096-2
20960183	Cxcl16 interact with SARS-CoV N protein in and out cell.	2010 Oct	China	10.1007/s12250-010-3129-x
20960182	Establishment of the eukaryotic cell lines for inducible control of SARS-CoVnucleocapsid gene expression.	2010 Oct	China	10.1007/s12250-010-3124-2
20956884	Small interfering RNA effectively inhibits the expression of SARS coronavirusmembrane gene at two novel targeting sites.	2010 Oct 18	Switzerland	10.3390/molecules15107197
20951182	Construction and immunogenicity of a recombinant fowlpox vaccine coexpressing S1glycoprotein of infectious bronchitis virus and chicken IL-18.	2010 Nov 29	Netherlands	10.1016/j.vaccine.2010.09.106
20951168	Cholesterol is important for a post-adsorption step in the entry process oftransmissible gastroenteritis virus.	2010 Dec	Netherlands	10.1016/j.antiviral.2010.10.002
20949131	Profiling of substrate specificity of SARS-CoV 3CL.	2010 Oct 6	United States	10.1371/journal.pone.0013197
20947359	Synthesis and evaluation of pyrazolone compounds as SARS-coronavirus 3C-likeprotease inhibitors.	2010 Nov 15	England	10.1016/j.bmc.2010.09.050
20943891	Genetic analysis of murine hepatitis virus non-structural protein 16.	2011 Jan	England	10.1099/vir.0.026781-0
20943876	Prevalence of antibodies to four human coronaviruses is lower in nasal secretionsthan in serum.	2010 Dec	United States	10.1128/CVI.00278-10
20942082	[SARS coronavirus].	2010 Jun	Japan	
20942081	[Corona virus].	2010 Jun	Japan	
20938453	Identifying genetic markers of adaptation for surveillance of viral host jumps.	2010 Nov	England	10.1038/nrmicro2440
20934345	Biflavonoids from Torreya nucifera displaying SARS-CoV 3CL(pro) inhibition.	2010 Nov 15	England	10.1016/j.bmc.2010.09.035
20926700	Development, characterization, and application of monoclonal antibodies againstsevere acute respiratory syndrome coronavirus nucleocapsid protein.	2010 Dec	United States	10.1128/CVI.00293-10
20926577	Metagenomic analysis of the viromes of three North American bat species: viraldiversity among different bat species that share a common habitat.	2010 Dec	United States	10.1128/JVI.01255-10
20926566	Efficient activation of the severe acute respiratory syndrome coronavirus spikeprotein by the transmembrane protease TMPRSS2.	2010 Dec	United States	10.1128/JVI.01542-10
20926558	Evolved variants of the membrane protein can partially replace the envelopeprotein in murine coronavirus assembly.	2010 Dec	United States	10.1128/JVI.01850-10
20923611	Evaluation of droplet dispersion during non-invasive ventilation, oxygen therapy,nebuliser treatment and chest physiotherapy in clinical practice: implicationsfor management of pandemic influenza and other airborne infections.	2010 Oct	England	10.3310/hta14460-02
20920119	Respiratory health issues in the Asia-Pacific region: an overview.	2011 Jan	Australia	10.1111/j.1440-1843.2010.01844.x
20919748	Anti-infectious bronchitis virus (IBV) activity of 1,8-cineole: effect onnucleocapsid (N) protein.	2010 Dec	England	10.1080/07391102.2010.10507362
20883165	Immunogenicity and protective efficacy in mice and hamsters of abeta-propiolactone inactivated whole virus SARS-CoV vaccine.	2010 Oct	United States	10.1089/vim.2010.0028
20883160	Porcine reproductive and respiratory syndrome virus-induced immunosuppressionexacerbates the inflammatory response to porcine respiratory coronavirus in pigs.	2010 Oct	United States	10.1089/vim.2010.0051
20883159	Progress towards a SARS vaccine.	2010 Oct	United States	10.1089/vim.2010.ed.23.5
20882317	Development of a porcine epidemic diarrhea virus M protein-based ELISA for virusdetection.	2011 Feb	Netherlands	10.1007/s10529-010-0420-8
20880639	Detection and characterization of bovine-like coronaviruses from four species ofzoo ruminants.	2011 Mar 24	Netherlands	10.1016/j.vetmic.2010.08.035
20864747	Association of a single nucleotide polymorphism in the CD209 (DC-SIGN) promoterwith SARS severity.	2010	China	
20864746	Simultaneous detection of SARS coronavirus and influenza A viruses usingreal-time polymerase chain reaction.	2010	China	
20864745	Immunogenetics in SARS: a case-control study.	2010	China	
20864743	The role of SARS-CoV protein, ORF-6, in the induction of host cell death.	2010	China	
20876353	Enhanced antiviral T cell function in the absence of B7-H1 is insufficient toprevent persistence but exacerbates axonal bystander damage during viralencephalomyelitis.	2010 Nov 1	United States	10.4049/jimmunol.1001984
20863409	Identification of NCAM that interacts with the PHE-CoV spike protein.	2010 Sep 24	England	10.1186/1743-422X-7-254
20861307	The SARS coronavirus E protein interacts with PALS1 and alters tight junctionformation and epithelial morphogenesis.	2010 Nov 15	United States	10.1091/mbc.E10-04-0338
20861244	Proteasome inhibition in vivo promotes survival in a lethal murine model ofsevere acute respiratory syndrome.	2010 Dec	United States	10.1128/JVI.01219-10
20854844	Antiseptic properties of two calix[4]arenes derivatives on the human coronavirus229E.	2010 Dec	Netherlands	10.1016/j.antiviral.2010.09.009
20854299	Application of high-resolution melt curve analysis for classification ofinfectious bronchitis viruses in field specimens.	2010 Oct	England	10.1111/j.1751-0813.2010.00622.x
20850939	Protective immune responses induced by in ovo immunization with recombinantadenoviruses expressing spike (S1) glycoprotein of infectious bronchitis virusfused/co-administered with granulocyte-macrophage colony stimulating factor.	2011 Feb 24	Netherlands	10.1016/j.vetmic.2010.08.003
20844944	Molecular analysis of infectious bronchitis viruses isolated in Slovenia between1990 and 2005: a retrospective study.	2010 Dec	United States	10.1007/s11262-010-0528-x
20844609	Dendritic cell-specific antigen delivery by coronavirus vaccine vectors induceslong-lasting protective antiviral and antitumor immunity.	2010 Sep 14	United States	10.1128/mBio.00171-10
20844028	Novel immunodominant peptide presentation strategy: a featuredHLA-A*2402-restricted cytotoxic T-lymphocyte epitope stabilized by intrachainhydrogen bonds from severe acute respiratory syndrome coronavirus nucleocapsidprotein.	2010 Nov	United States	10.1128/JVI.01464-10
20836389	[The research and application of inhibitory effect of RNA-based strategies onSARS].	2010 Jul	China	
20836383	[Consecutive five-year follow-up analysis of specific IgG antibody of 22 cases ofSARS patients after recovery].	2010 Jul	China	
20833270	A 15-year analysis of molecular epidemiology of avian infectious bronchitiscoronavirus in China.	2011 Jan	Netherlands	10.1016/j.meegid.2010.09.002
20832407	Impaired immune responses following spinal cord injury lead to reduced ability tocontrol viral infection.	2010 Nov	United States	10.1016/j.expneurol.2010.08.036
20831383	The membrane protein of severe acute respiratory syndrome coronavirus acts as adominant immunogen revealed by a clustering region of novel functionally andstructurally defined cytotoxic T-lymphocyte epitopes.	2010 Oct 15	United States	10.1086/656315
20827775	Use of a multiplex PCR/RT-PCR approach to assess the viral causes ofinfluenza-like illnesses in Cambodia during three consecutive dry seasons.	2010 Oct	United States	10.1002/jmv.21891
20827733	Elucidation of the avian nucleolar proteome by quantitative proteomics usingSILAC and changes in cells infected with the coronavirus infectious bronchitisvirus.	2010 Oct	Germany	10.1002/pmic.201000139
20827493	Enhanced cell fusion activity in porcine epidemic diarrhea virus adapted tosuckling mice.	2010 Dec	Austria	10.1007/s00705-010-0790-1
20823091	The many paths to frameshifting: kinetic modelling and analysis of the effects ofdifferent elongation steps on programmed -1 ribosomal frameshifting.	2011 Jan	England	10.1093/nar/gkq761
20822531	VIGOR, an annotation program for small viral genomes.	2010 Sep 7	England	10.1186/1471-2105-11-451
20821824	Antioxidative and antiviral properties of flowering cherry fruits (Prunusserrulata L. var. spontanea).	2010	Singapore	10.1142/S0192415X10008366
20818755	A graphene-based platform for the assay of duplex-DNA unwinding by helicase.	2010 Aug 2	Germany	10.1002/anie.201001332
20809484	Generating stable Chinese hamster ovary cell clones to produce a truncatedSARS-CoV spike protein for vaccine development.	2010 Nov-Dec	United States	10.1002/btpr.480
20801001	Update on SARS research and other possibly zoonotic coronaviruses.	2010 Nov	Netherlands	10.1016/j.ijantimicag.2010.06.016
20800627	SARS-coronavirus protein 6 conformations required to impede protein import intothe nucleus.	2010 Nov	Netherlands	10.1016/j.virusres.2010.08.017
20799985	Detection of swine transmissible gastroenteritis coronavirus using loop-mediatedisothermal amplification.	2010 Aug 29	England	10.1186/1743-422X-7-206
20799142	The American Society for Virology--29th Annual Meeting.	2010 Sep	England	
20798771	Diagnostic methods for feline coronavirus: a review.	2010 Jul 28	United States	10.4061/2010/809480
20739537	Murine coronavirus receptors are differentially expressed in the central nervoussystem and play virus strain-dependent roles in neuronal spread.	2010 Nov	United States	10.1128/JVI.02688-09
20739524	The coronavirus nucleocapsid protein is dynamically associated with thereplication-transcription complexes.	2010 Nov	United States	10.1128/JVI.00569-10
20739481	Rapid detection of respiratory tract viral infections and coinfections inpatients with influenza-like illnesses by use of reverse transcription-PCR DNAmicroarray systems.	2010 Nov	United States	10.1128/JCM.00733-10
20732411	Visual detection of turkey coronavirus RNA in tissues and feces byreverse-transcription loop-mediated isothermal amplification (RT-LAMP) withhydroxynaphthol blue dye.	2010 Dec	England	10.1016/j.mcp.2010.08.003
20727913	Identification of phenanthroindolizines and phenanthroquinolizidines as novelpotent anti-coronaviral agents for porcine enteropathogenic coronavirustransmissible gastroenteritis virus and human severe acute respiratory syndromecoronavirus.	2010 Nov	Netherlands	10.1016/j.antiviral.2010.08.009
20727693	Impact of porcine epidemic diarrhea virus infection at different periods ofpregnancy on subsequent reproductive performance in gilts and sows.	2010 Oct	Netherlands	10.1016/j.anireprosci.2010.07.004
20723564	Multiplex semi-nested RT-PCR with exogenous internal control for simultaneousdetection of bovine coronavirus and group A rotavirus.	2010 Nov	Netherlands	10.1016/j.jviromet.2010.08.008
20720471	Role of human coronavirus NL63 in hospitalized children with croup.	2010 Sep	United States	10.1097/INF.0b013e3181e7c18d
20719951	Culturing the unculturable: human coronavirus HKU1 infects, replicates, andproduces progeny virions in human ciliated airway epithelial cell cultures.	2010 Nov	United States	10.1128/JVI.00947-10
20719948	A conserved domain in the coronavirus membrane protein tail is important forvirus assembly.	2010 Nov	United States	10.1128/JVI.01131-10
20715993	Production and characterization of a monoclonal antibody against spike protein oftransmissible gastroenteritis virus.	2010 Aug	United States	10.1089/hyb.2010.0009
20714750	Cryptosporidium infection in herds with and without calf diarrhoeal problems.	2010 Nov	Germany	10.1007/s00436-010-2020-x
20713325	Microbiological and pathological examination of fatal calf pneumonia casesinduced by bacterial and viral respiratory pathogens.	2010 Sep	Hungary	10.1556/AVet.58.2010.3.7
20712488	Characterization of a variant virus from ascitic fluid of subacute granulomatousserositis in interferon-gamma-deficient C57BL/6 mice persistently infected withmurine coronavirus strain JHM.	2010 Aug	United States	10.1089/vim.2010.0008
20710051	Medicinal herbal extracts of Sophorae radix, Acanthopanacis cortex, Sanguisorbaeradix and Torilis fructus inhibit coronavirus replication in vitro.	2010	England	10.3851/IMP1615
20709084	NMR Structure of the SARS-CoV Nonstructural Protein 7 in Solution at pH 6.5.	2010 Oct 1	England	10.1016/j.jmb.2010.07.043
20709007	CD8+ T cell response in HLA-A*0201 transgenic mice is elicited by epitopes fromSARS-CoV S protein.	2010 Sep 24	Netherlands	10.1016/j.vaccine.2010.08.013
20708597	ORF8a of SARS-CoV forms an ion channel: experiments and molecular dynamicssimulations.	2011 Feb	Netherlands	10.1016/j.bbamem.2010.08.004
20702646	Coexistence of different genotypes in the same bat and serologicalcharacterization of Rousettus bat coronavirus HKU9 belonging to a novelBetacoronavirus subgroup.	2010 Nov	United States	10.1128/JVI.01121-10
20702617	Transcriptomic analysis reveals a mechanism for a prefibrotic phenotype in STAT1knockout mice during severe acute respiratory syndrome coronavirus infection.	2010 Nov	United States	10.1128/JVI.01130-10
20700397	Understanding Human Coronavirus HCoV-NL63.	2010 May 25	United Arab Emirates	10.2174/1874357901004010076
20699222	Molecular mapping of the RNA Cap 2'-O-methyltransferase activation interfacebetween severe acute respiratory syndrome coronavirus nsp10 and nsp16.	2010 Oct 22	United States	10.1074/jbc.M110.120014
20693503	Risk factors for seropositivity to bovine coronavirus and bovine respiratorysyncytial virus in dairy herds.	2010 Aug 7	England	10.1136/vr.c4119
20693502	Epidemiology of canine parvovirus and coronavirus in dogs presented with severediarrhoea to PDSA PetAid hospitals.	2010 Aug 7	England	10.1136/vr.c3095
20691214	Loop-mediated isothermal amplification for rapid detection and differentiation ofwild-type pseudorabies and gene-deleted virus vaccines.	2010 Oct	Netherlands	10.1016/j.jviromet.2010.07.034
20688082	New method for comparing DNA primary sequences based on a discrimination measure.	2010 Oct 21	England	10.1016/j.jtbi.2010.07.040
20686038	Genomic characterization of severe acute respiratory syndrome-related coronavirusin European bats and classification of coronaviruses based on partialRNA-dependent RNA polymerase gene sequences.	2010 Nov	United States	10.1128/JVI.00650-10
20682435	Ferret coronavirus-associated diseases.	2010 Sep	United States	10.1016/j.cvex.2010.05.010
20678314	Bat coronaviruses and experimental infection of bats, the Philippines.	2010 Aug	United States	10.3201/eid1608.100208
20677175	Forsythoside a inhibits the avian infectious bronchitis virus in cell culture.	2011 Mar	England	10.1002/ptr.3260
20674797	Occupation-related respiratory infections revisited.	2010 Sep	United States	10.1016/j.idc.2010.04.013
20674795	Severe acute respiratory syndrome and coronavirus.	2010 Sep	United States	10.1016/j.idc.2010.04.009
21994708	Coronavirus genomics and bioinformatics analysis.	2010 Aug	Switzerland	10.3390/v2081803
20671029	Cooperative translocation enhances the unwinding of duplex DNA by SARScoronavirus helicase nsP13.	2010 Nov	England	10.1093/nar/gkq647
20668092	Papain-like protease 1 from transmissible gastroenteritis virus: crystalstructure and enzymatic activity toward viral and cellular substrates.	2010 Oct	United States	10.1128/JVI.00898-10
20668085	A new cistron in the murine hepatitis virus replicase gene.	2010 Oct	United States	10.1128/JVI.00901-10
20667598	SARS spike protein induces phenotypic conversion of human B cells tomacrophage-like cells.	2010 Oct	England	10.1016/j.molimm.2010.06.014
20664013	Studies of severe acute respiratory syndrome coronavirus pathology in human casesand animal models.	2010 Sep	United States	10.1177/0300985810378760
20663472	Pathogenic characteristics of persistent feline enteric coronavirus infection incats.	2010 Sep-Oct	England	10.1051/vetres/2010043
20663197	Mixed infections with Chlamydia and porcine epidemic diarrhea virus - a new invitro model of chlamydial persistence.	2010 Jul 27	England	10.1186/1471-2180-10-201
20662367	Detection of a respiratory coronavirus from tissues archived during a pneumoniaepizootic in free-ranging Pacific harbor seals Phoca vitulina richardsii.	2010 Jun 11	Germany	10.3354/dao02190
20660183	An interaction between the nucleocapsid protein and a component of thereplicase-transcriptase complex is crucial for the infectivity of coronavirusgenomic RNA.	2010 Oct	United States	10.1128/JVI.01287-10
20652731	Complete genome sequence and recombination analysis of infectious bronchitisvirus attenuated vaccine strain H120.	2010 Dec	United States	10.1007/s11262-010-0517-0
20644980	Sequential nearest-neighbor effects on computed 13Calpha chemical shifts.	2010 Sep	Netherlands	10.1007/s10858-010-9435-7
20643168	Binding characterization of determinants in porcine aminopeptidase N, thecellular receptor for transmissible gastroenteritis virus.	2010 Oct 1	Netherlands	10.1016/j.jbiotec.2010.07.019
20642316	Mutations in the spike glycoprotein of human coronavirus OC43 modulate disease inBALB/c mice from encephalitis to flaccid paralysis and demyelination.	2010 Jul	United States	10.3109/13550284.2010.497806
20637243	Influenza virus variation in susceptibility to inactivation by pomegranatepolyphenols is determined by envelope glycoproteins.	2010 Oct	Netherlands	10.1016/j.antiviral.2010.06.014
20634513	Detection of infectious bronchitis virus strain N1/88 from the oviduct and fecesof experimentally infected vaccinated and unvaccinated hens.	2010 Aug	England	10.3382/ps.2010-00685
20634077	A simple procedure for the derivation of electron density based surfaces ofdrug-receptor complexes from a combination of X-ray data and theoreticalcalculations.	2010 Aug 15	England	10.1016/j.bmc.2010.06.080
20631137	Genetic determinants of mouse hepatitis virus strain 1 pneumovirulence.	2010 Sep	United States	10.1128/JVI.00330-10
20631126	The 7a accessory protein of severe acute respiratory syndrome coronavirus acts asan RNA silencing suppressor.	2010 Oct	United States	10.1128/JVI.00748-10
20629888	Detecting food- and waterborne viruses by surface-enhanced Raman spectroscopy.	2010 Jun	United States	10.1111/j.1750-3841.2010.01619.x
20627924	Detection of respiratory viruses and the associated chemokine responses inserious acute respiratory illness.	2010 Jul	England	10.1136/thx.2009.132480
20627412	Cell replacement therapies to promote remyelination in a viral model ofdemyelination.	2010 Jul 27	Netherlands	10.1016/j.jneuroim.2010.05.013
20623187	Putative probiotic Lactobacillus spp. from porcine gastrointestinal tract inhibittransmissible gastroenteritis coronavirus and enteric bacterial pathogens.	2010 Dec	United States	10.1007/s11250-010-9648-5
20622219	Development of a panel of multiplex real-time polymerase chain reaction assaysfor simultaneous detection of major agents causing calf diarrhea in feces.	2010 Jul	United States	10.1177/104063871002200403
20619189	Bovine respiratory coronavirus.	2010 Jul	United States	10.1016/j.cvfa.2010.04.005
20610717	T cell responses are required for protection from clinical disease and for virusclearance in severe acute respiratory syndrome coronavirus-infected mice.	2010 Sep	United States	10.1128/JVI.01049-10
20609418	Nsp1 proteins of group I and SARS coronaviruses share structural and functionalsimilarities.	2010 Oct	Netherlands	10.1016/j.meegid.2010.05.014
20608535	Molecular epidemiology of avian infectious bronchitis in Brazil from 2007 to 2008in breeders, broilers, and layers.	2010 Jun	United States	10.1637/9218-121709-Reg.1
20608523	Host intraspatial selection of infectious bronchitis virus populations.	2010 Jun	United States	10.1637/9054-090809-Reg.1
20606281	Crystallization and preliminary X-ray diffraction analysis of the N-terminaldomain of human coronavirus OC43 nucleocapsid protein.	2010 Jul 1	England	10.1107/S1744309110017616
20603153	Synergistic antiviral effect of Galanthus nivalis agglutinin and nelfinaviragainst feline coronavirus.	2010 Oct	Netherlands	10.1016/j.antiviral.2010.06.010
20602243	Analysis of Newcastle disease virus quasispecies and factors affecting theemergence of virulent virus.	2010 Oct	Austria	10.1007/s00705-010-0739-4
20600388	Vectored vaccines to protect against PRRSV.	2010 Dec	Netherlands	10.1016/j.virusres.2010.06.017
20599443	Trilogy of ACE2: a peptidase in the renin-angiotensin system, a SARS receptor,and a partner for amino acid transporters.	2010 Oct	England	10.1016/j.pharmthera.2010.06.003
20596532	CXCR2 signaling protects oligodendrocytes and restricts demyelination in a mousemodel of viral-induced demyelination.	2010 Jun 28	United States	10.1371/journal.pone.0011340
20587646	Essential covalent linkage between the chymotrypsin-like domain and the extradomain of the SARS-CoV main protease.	2010 Sep	England	10.1093/jb/mvq071
24031559	Differentiation of bovine coronavirus (bcov) genotypes by a restriction enzymeassay.	2010 Jul	Brazil	10.1590/S1517-83822010000300034
20580052	Palmitoylation of SARS-CoV S protein is necessary for partitioning intodetergent-resistant membranes and cell-cell fusion but not interaction with Mprotein.	2010 Sep 15	United States	10.1016/j.virol.2010.05.031
20578793	A cost-based comparison of quarantine strategies for new emerging diseases.	2010 Jul	United States	10.3934/mbe.2010.7.687
20576142	Light whole genome sequence for SNP discovery across domestic cat breeds.	2010 Jun 24	England	10.1186/1471-2164-11-406
20574643	Naturally occurring recombination between distant strains of infectiousbronchitis virus.	2010 Oct	Austria	10.1007/s00705-010-0731-z
20573835	A single asparagine-linked glycosylation site of the severe acute respiratorysyndrome coronavirus spike glycoprotein facilitates inhibition by mannose-bindinglectin through multiple mechanisms.	2010 Sep	United States	10.1128/JVI.00554-10
20573827	The cellular RNA helicase DDX1 interacts with coronavirus nonstructural protein14 and enhances viral replication.	2010 Sep	United States	10.1128/JVI.00392-10
20570279	Comparative histopathology and immunohistochemistry of QX-like, Massachusetts and793/B serotypes of infectious bronchitis virus infection in chickens.	2010 Nov	England	10.1016/j.jcpa.2010.04.007
20569117	Identifying the probable timing and setting of respiratory virus infections.	2010 Aug	United States	10.1086/655023
20567988	Angiotensin-converting enzyme 2 (ACE2) proteins of different bat species confervariable susceptibility to SARS-CoV entry.	2010 Oct	Austria	10.1007/s00705-010-0729-6
20562343	Subgenomic messenger RNA amplification in coronaviruses.	2010 Jul 6	United States	10.1073/pnas.1000378107
20558599	Alternative splicing of CD200 is regulated by an exonic splicing enhancer andSF2/ASF.	2010 Oct	England	10.1093/nar/gkq554
20558216	Prolonged depletion of circulating CD4+ T lymphocytes and acute monocytosis afterpantropic canine coronavirus infection in dogs.	2010 Sep	Netherlands	10.1016/j.virusres.2010.06.006
20558050	[Bronchiolitis viruses].	2010 Aug	France	10.1016/j.arcped.2010.05.006
20557915	Detection and genotyping of canine coronavirus RNA in diarrheic dogs in Japan.	2011 Apr	England	10.1016/j.rvsc.2010.05.027
20556502	Genetic analysis revealed LX4 genotype strains of avian infectious bronchitisvirus became predominant in recent years in Sichuan area, China.	2010 Oct	United States	10.1007/s11262-010-0500-9
20554960	T cell epitope specificity and pathogenesis of mouse hepatitis virus-1-induceddisease in susceptible and resistant hosts.	2010 Jul 15	United States	10.4049/jimmunol.0902749
20554810	Epidemiology and clinical presentations of the four human coronaviruses 229E,HKU1, NL63, and OC43 detected over 3 years using a novel multiplex real-time PCRmethod.	2010 Aug	United States	10.1128/JCM.00636-10
20544430	Rapid heat-treatment attenuation of infectious bronchitis virus.	2010 Jun	England	10.1080/03079451003801516
20544234	Molecular epidemiology of porcine epidemic diarrhea virus in China.	2010 Sep	Austria	10.1007/s00705-010-0720-2
20542253	Coronaviruses Hijack the LC3-I-positive EDEMosomes, ER-derived vesicles exportingshort-lived ERAD regulators, for replication.	2010 Jun 25	United States	10.1016/j.chom.2010.05.013
20538854	Attachment of mouse hepatitis virus to O-acetylated sialic acid is mediated byhemagglutinin-esterase and not by the spike protein.	2010 Sep	United States	10.1128/JVI.00566-10
20538853	Differential sensitivity of well-differentiated avian respiratory epithelialcells to infection by different strains of infectious bronchitis virus.	2010 Sep	United States	10.1128/JVI.00463-10
20534452	Migration of engrafted neural stem cells is mediated by CXCL12 signaling throughCXCR4 in a viral model of multiple sclerosis.	2010 Jun 15	United States	10.1073/pnas.1006375107
20534109	Proteomic analysis of purified coronavirus infectious bronchitis virus particles.	2010 Jun 9	England	10.1186/1477-5956-8-29
20527968	Severe acute respiratory syndrome coronavirus papain-like novel proteaseinhibitors: design, synthesis, protein-ligand X-ray structure and biologicalevaluation.	2010 Jul 8	United States	10.1021/jm1004489
20525326	The relationship between antibody status to bovine corona virus and bovinerespiratory syncytial virus and disease incidence, reproduction and herdcharacteristics in dairy herds.	2010 Jun 4	England	10.1186/1751-0147-52-37
20519394	Accessory protein 5a is a major antagonist of the antiviral action of interferonagainst murine coronavirus.	2010 Aug	United States	10.1128/JVI.00385-10
20516605	Crystallization and preliminary X-ray diffraction studies of infectiousbronchitis virus nonstructural protein 9.	2010 Jun 1	England	10.1107/S174430911001417X
20516597	Expression, crystallization and preliminary crystallographic study of mousehepatitis virus (MHV) nucleocapsid protein C-terminal domain.	2010 Jun 1	England	10.1107/S1744309110012492
20513097	Viral respiratory infections in hospitalized and community control children inAlaska.	2010 Jul	United States	10.1002/jmv.21790
22319227	The First Case of Feline Infectious Peritonitis-like Pyogranuloma in a FerretInfected by Coronavirus in Japan.	2010 Jun	Japan	10.1293/tox.23.99
20507992	Elastase-mediated activation of the severe acute respiratory syndrome coronavirusspike protein at discrete sites within the S2 domain.	2010 Jul 23	United States	10.1074/jbc.M110.103275
20501927	Viral etiology of severe pneumonia among Kenyan infants and children.	2010 May 26	United States	10.1001/jama.2010.675
20497390	Development of a dose-response model for SARS coronavirus.	2010 Jul	United States	10.1111/j.1539-6924.2010.01427.x
20494577	Synthesis, docking studies, and evaluation of pyrimidines as inhibitors ofSARS-CoV 3CL protease.	2010 Jun 15	England	10.1016/j.bmcl.2010.04.118
20493876	SARS coronavirus unique domain: three-domain molecular architecture in solutionand RNA binding.	2010 Jul 23	England	10.1016/j.jmb.2010.05.027
20492637	Spatial patterns of bovine corona virus and bovine respiratory syncytial virus inthe Swedish beef cattle population.	2010 May 21	England	10.1186/1751-0147-52-33
20489209	Maturation mechanism of severe acute respiratory syndrome (SARS) coronavirus3C-like proteinase.	2010 Sep 3	United States	10.1074/jbc.M109.095851
20488264	Live attenuated Salmonella enterica serovar Typhimurium expressing swineinterferon-alpha has antiviral activity and alleviates clinical signs induced byinfection with transmissible gastroenteritis virus in piglets.	2010 Jul 12	Netherlands	10.1016/j.vaccine.2010.05.013
20484561	Ultrastructural and biochemical analyses of hepatitis C virus-associated hostcell membranes.	2010 Sep	England	10.1099/vir.0.022186-0
20484516	The proteasome inhibitor Velcade enhances rather than reduces disease in mousehepatitis coronavirus-infected mice.	2010 Aug	United States	10.1128/JVI.00486-10
20484511	Feline lectin activity is critical for the cellular entry of feline infectiousperitonitis virus.	2010 Aug	United States	10.1128/JVI.00964-10
20484504	The ubiquitin-proteasome system plays an important role during various stages ofthe coronavirus infection cycle.	2010 Aug	United States	10.1128/JVI.00485-10
20484496	Upregulation of the chemokine (C-C motif) ligand 2 via a severe acute respiratorysyndrome coronavirus spike-ACE2 signaling pathway.	2010 Aug	United States	10.1128/JVI.02560-09
20483547	Characterisation of bubaline coronavirus strains associated with gastroenteritisin water buffalo (Bubalus bubalis) calves.	2010 Oct 26	Netherlands	10.1016/j.vetmic.2010.04.010
20478545	Antiproliferative effect of Toona sinensis leaf extract on non-small-cell lungcancer.	2010 Jun	United States	10.1016/j.trsl.2010.03.002
20478263	Viral proteins function as ion channels.	2011 Feb	Netherlands	10.1016/j.bbamem.2010.05.006
20478089	Detection of a virus related to betacoronaviruses in Italian greater horseshoebats.	2011 Feb	England	10.1017/S0950268810001147
20478047	Interactions of SARS coronavirus nucleocapsid protein with the host cellproteasome subunit p42.	2010 May 17	England	10.1186/1743-422X-7-99
20467043	Quantitative proteomics using stable isotope labeling with amino acids in cellculture reveals changes in the cytoplasmic, nuclear, and nucleolar proteomes inVero cells infected with the coronavirus infectious bronchitis virus.	2010 Sep	United States	10.1074/mcp.M900345-MCP200
20466822	A small-molecule oxocarbazate inhibitor of human cathepsin L blocks severe acuterespiratory syndrome and ebola pseudotype virus infection into human embryonickidney 293T cells.	2010 Aug	United States	10.1124/mol.110.064261
20466573	Survey of infectious and parasitic diseases in stray cats at the LisbonMetropolitan Area, Portugal.	2010 Jun	England	10.1016/j.jfms.2009.11.003
20466438	Anti-TNF-alpha therapy does not ameliorate disease in a model of acutevirus-endotoxin mediated respiratory disease in pigs.	2010 Sep 15	Netherlands	10.1016/j.vetimm.2010.04.003
20463816	Infidelity of SARS-CoV Nsp14-exonuclease mutant virus replication is revealed bycomplete genome sequencing.	2010 May 6	United States	10.1371/journal.ppat.1000896
20462354	Significance of the myxovirus resistance A (MxA) gene -123C>a single-nucleotidepolymorphism in suppressed interferon beta induction of severe acute respiratorysyndrome coronavirus infection.	2010 Jun 15	United States	10.1086/652799
20460833	A novel genotype of avian infectious bronchitis virus isolated in Japan in 2009.	2010 Oct	Japan	10.1292/jvms.10-0080
20458159	Production of specific antibodies against SARS-coronavirus nucleocapsid proteinwithout cross reactivity with human coronaviruses 229E and OC43.	2010 Jun	Korea (South)	10.4142/jvs.2010.11.2.165
20451228	Immune response of AA broilers to IBV H120 vaccine and sodium new houttuyfonate.	2010 Dec	England	10.1016/j.rvsc.2010.04.010
20444893	Functional and genetic studies of the substrate specificity of coronavirusinfectious bronchitis virus 3C-like proteinase.	2010 Jul	United States	10.1128/JVI.02490-09
20439937	Abdominal ultrasonographic findings associated with feline infectiousperitonitis: a retrospective review of 16 cases.	2010 May-Jun	United States	10.5326/0460152
20435659	Upper-respiratory viral infection, biomarkers, and COPD exacerbations.	2010 Oct	United States	10.1378/chest.09-2225
20433759	A multiplex reverse transcription-nested polymerase chain reaction for detectionand differentiation of wild-type and vaccine strains of canine distemper virus.	2010 May 1	England	10.1186/1743-422X-7-86
20427532	Exchange of the coronavirus replicase polyprotein cleavage sites alters proteasespecificity and processing.	2010 Jul	United States	10.1128/JVI.00752-10
20427526	Murine coronavirus induces type I interferon in oligodendrocytes throughrecognition by RIG-I and MDA5.	2010 Jul	United States	10.1128/JVI.00016-10
20421945	In vitro reconstitution of SARS-coronavirus mRNA cap methylation.	2010 Apr 22	United States	10.1371/journal.ppat.1000863
20420403	Mutation of Asn28 disrupts the dimerization and enzymatic activity of SARS3CL(pro) .	2010 May 25	United States	10.1021/bi1002585
20419824	Detection of novel respiratory viruses from influenza-like illness in thePhilippines.	2010 May	United States	10.1002/jmv.21763
20393227	Clinical features and molecular epidemiology of coronavirus-HKU1-associatedcommunity-acquired pneumonia.	2009 Dec	China	
20393222	Prevalence of SARS-CoV antibody in all Hong Kong patient contacts.	2009 Dec	China	
20393221	Comparative host gene transcription by microarray analysis early after infectionof the Huh7 cell line by SARS coronavirus and human coronavirus 229E.	2009 Dec	China	
20393220	Viral loads in clinical specimens and SARS manifestations.	2009 Dec	China	
20393218	Epidemiology of SARS in the 2003 Hong Kong epidemic.	2009 Dec	China	
20393209	Correlation of clinical outcomes and radiographic features in SARS patients.	2009 Dec	China	
20393207	Functional roles of 3a protein in the pathogenesis of SARS.	2009 Dec	China	
20393205	SARS diagnosis, monitoring and prognostication by SARS-coronavirus RNA detection.	2009 Dec	China	
20393204	Immunogenetic studies in SARS: developing a clinical prognostic profile forsevere diseases.	2009 Dec	China	
20414714	Rapid differentiation of vaccine strain and Chinese field strains oftransmissible gastroenteritis virus by restriction fragment length polymorphismof the N gene.	2010 Aug	United States	10.1007/s11262-010-0481-8
20410676	A serological survey of canine respiratory coronavirus and canine influenza virusin Korean dogs.	2010 Sep	Japan	10.1292/jvms.10-0067
20410265	Role of mouse hepatitis virus (MHV) receptor murine CEACAM1 in the resistance ofmice to MHV infection: studies of mice with chimeric mCEACAM1a and mCEACAM1b.	2010 Jul	United States	10.1128/JVI.02680-09
20409735	Lipoteichoic acid from Staphylococcus aureus exacerbates respiratory disease inporcine respiratory coronavirus-infected pigs.	2011 May	England	10.1016/j.tvjl.2010.03.001
20409593	Nitric oxide is elicited and inhibits viral replication in pigs infected withporcine respiratory coronavirus but not porcine reproductive and respiratorysyndrome virus.	2010 Aug 15	Netherlands	10.1016/j.vetimm.2010.03.022
20409569	The envelope protein of severe acute respiratory syndrome coronavirus interactswith the non-structural protein 3 and is ubiquitinated.	2010 Jul 5	United States	10.1016/j.virol.2010.03.015
20408407	A multiplex reverse transcriptase-PCR assay for the genotyping of avianinfectious bronchitis viruses.	2010 Mar	United States	10.1637/8954-060609-Reg.1
20408308	The lessons of SARS in Hong Kong.	2010 Feb	England	10.7861/clinmedicine.10-1-50
20406307	Effect of mucosal and systemic immunization with virus-like particles of severeacute respiratory syndrome coronavirus in mice.	2010 Jun	England	10.1111/j.1365-2567.2010.03231.x
22331307	[Virus detection, clinical signs, and laboratory findings in dogs with acutehemorrhagic diarrhea: a retrospective study of 935 cases].	2010	Germany	
20401893	Mechanistic study of the reaction of thiol-containing enzymes withalpha,beta-unsaturated carbonyl substrates by computation and chemoassays.	2010 Jun 7	Germany	10.1002/cmdc.201000020
20398710	Structural and functional analysis of the hemagglutinin-esterase of infectioussalmon anaemia virus.	2010 Aug	Netherlands	10.1016/j.virusres.2010.03.020
20392858	Quantitative proteomics analysis reveals BAG3 as a potential target to suppresssevere acute respiratory syndrome coronavirus replication.	2010 Jun	United States	10.1128/JVI.00213-10
20390564	Viral respiratory diseases (ILT, aMPV infections, IB): are they ever undercontrol?	2010 Feb	England	10.1080/00071660903541378
20390548	Induction of eggshell apex abnormalities in broiler breeder hens.	2010 Apr	England	10.1080/03079451003657637
20390547	Efficacy of infectious bronchitis virus vaccinations in the field: associationbetween the alpha-IBV IgM response, protection and vaccine applicationparameters.	2010 Apr	England	10.1080/03079451003604639
20390537	Detection and molecular characterization of enteric viruses in breeder turkeys.	2010 Feb	England	10.1080/03079450903490289
20387489	[Characterization of human coronavirus 229E infection among patients withrespiratory symptom in Beijing, Oct-Dec, 2007].	2009 Oct	China	
20386712	SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and IIIinterferon receptor independent mechanism.	2010 Apr 8	United States	10.1371/journal.ppat.1000849
20378004	Identification of SARS-COV spike protein-derived and HLA-A2-restricted human CTLepitopes by using a new muramyl dipeptidederivative adjuvant.	2010 Jan-Mar	England	10.1177/039463201002300115
20375784	Occupational respiratory infections.	2010 May	United States	10.1097/MCP.0b013e328338639b
20374001	A 219-mer CHO-expressing receptor-binding domain of SARS-CoV S protein inducespotent immune responses and protective immunity.	2010 Apr	United States	10.1089/vim.2009.0090
20373999	A novel B-cell epitope of avian infectious bronchitis virus N protein.	2010 Apr	United States	10.1089/vim.2009.0094
20371333	Mutation of Glu-166 blocks the substrate-induced dimerization of SARS coronavirusmain protease.	2010 Apr 7	United States	10.1016/j.bpj.2009.12.4272
20370625	The pathogenesis of murine coronavirus infection of the central nervous system.	2010	United States	10.1615/critrevimmunol.v30.i2.20
20369302	Pathogenesis of murine coronavirus in the central nervous system.	2010 Sep	United States	10.1007/s11481-010-9202-2
20367503	Use of phylogenetics in the molecular epidemiology and evolutionary studies ofviral infections.	2010 Jan-Feb	England	10.3109/10408361003633318
20362494	Human coronaviruses are uncommon in patients with gastrointestinal illness.	2010 Jun	Netherlands	10.1016/j.jcv.2010.03.007
20362004	A protein chip designed to differentiate visually antibodies in chickens whichwere infected by four different viruses.	2010 Aug	Netherlands	10.1016/j.jviromet.2010.03.021
20360268	A novel construction of genome space with biological geometry.	2010 Jun	England	10.1093/dnares/dsq008
20359516	CD209 (DC-SIGN) -336A>G promoter polymorphism and severe acute respiratorysyndrome in Hong Kong Chinese.	2010 Jul	United States	10.1016/j.humimm.2010.03.006
20357099	Murine coronavirus delays expression of a subset of interferon-stimulated genes.	2010 Jun	United States	10.1128/JVI.00211-10
20352075	Is systems biology the key to preventing the next pandemic?	2009 Nov 1	England	10.2217/fvl.09.53
20350196	Coronavirus survival on healthcare personal protective equipment.	2010 May	United States	10.1086/652452
20350162	Respiratory virus pneumonia after hematopoietic cell transplantation (HCT):associations between viral load in bronchoalveolar lavage samples, viral RNAdetection in serum samples, and clinical outcomes of HCT.	2010 May 1	United States	10.1086/651662
20347384	Burden of disease due to human coronavirus NL63 infections and periodicity ofinfection.	2010 Jun	Netherlands	10.1016/j.jcv.2010.02.023
20338784	Evaluation of the sensitivity of PCR methods for the detection of extraneousagents and comparison with in vivo testing.	2010 May	England	10.1016/j.biologicals.2010.01.002
20338429	Associations between bovine coronavirus and bovine respiratory syncytial virusinfections and animal performance in Swedish dairy herds.	2010 Apr	United States	10.3168/jds.2009-2511
20337224	Infectivity of severe acute respiratory syndrome during its incubation period.	2009 Dec	China	10.1016/S0895-3988(10)60008-6
20336714	The route of inoculation determines the tissue tropism of modified vacciniaTiantan expressing the spike glycoprotein of SARS-CoV in mice.	2010 May	United States	10.1002/jmv.21667
20335495	Identification of key amino acid residues required for horseshoe batangiotensin-I converting enzyme 2 to function as a receptor for severe acuterespiratory syndrome coronavirus.	2010 Jul	England	10.1099/vir.0.020172-0
20335250	Lambda interferon renders epithelial cells of the respiratory andgastrointestinal tracts resistant to viral infections.	2010 Jun	United States	10.1128/JVI.00272-10
20331640	Cell permeabilization by poliovirus 2B viroporin triggers bystanderpermeabilization in neighbouring cells through a mechanism involving gapjunctions.	2010 Aug	England	10.1111/j.1462-5822.2010.01460.x
20308420	Understanding stress-induced immunosuppression: exploration of cytokine andchemokine gene profiles in chicken peripheral leukocytes.	2010 Apr	England	10.3382/ps.2009-00483
20307574	Priming with a DNA vaccine and boosting with an inactivated vaccine enhance theimmune response against infectious bronchitis virus.	2010 Jul	Netherlands	10.1016/j.jviromet.2010.03.016
20302715	[Analysis of human coronavirus NL63 in 690 children with acute respiratoryinfection in Shanton].	2010 Jan	China	
20299165	Evolution of infectious bronchitis virus in Taiwan: characterisation of RNArecombination in the nucleocapsid gene.	2010 Aug 26	Netherlands	10.1016/j.vetmic.2010.02.027
20237226	Sites of feline coronavirus persistence in healthy cats.	2010 Jul	England	10.1099/vir.0.020214-0
20233673	Detection of human coronaviruses in children with acute gastroenteritis.	2010 May	Netherlands	10.1016/j.jcv.2010.02.013
20231782	Induction of interferon-gamma-inducible protein 10 by SARS-CoV infection,interferon alfacon 1 and interferon inducer in human bronchial epithelial Calu-3cells and BALB/c mice.	2010 Mar 9	England	10.3851/IMP1477
20229183	Molecular characterization of a Chinese vaccine strain of transmissiblegastroenteritis virus: mutations that may contribute to attenuation.	2010 Jun	United States	10.1007/s11262-010-0467-6
20228108	Effects of air temperature and relative humidity on coronavirus survival onsurfaces.	2010 May	United States	10.1128/AEM.02291-09
20224169	Indirect ELISA and indirect immunofluorescent antibody assay for detecting theantibody against murine norovirus S7 in mice.	2010	Japan	10.1538/expanim.59.47
20224103	An outbreak of canine coronavirus in puppies in a Greek kennel.	2010 Mar	United States	10.1177/104063871002200231
20221421	Murine Coronavirus Cell Type Dependent Interaction with the Type I InterferonResponse.	2009 Dec 1	Switzerland	10.3390/v1030689
20219540	Immunogenicity and protective efficacy of a replication-defective infectiousbronchitis virus vaccine using an adenovirus vector and administered in ovo.	2010 Jun	Netherlands	10.1016/j.jviromet.2010.02.019
20218879	Dual interference with novel genes mfgl2 and mTNFR1 ameliorates murine hepatitisvirus type 3-induced fulminant hepatitis in BALB/cJ mice.	2010 Aug	United States	10.1089/hum.2009.177
20218330	[Cell entry mechanisms of coronaviruses].	2009 Dec	Japan	10.2222/jsv.59.215
20217155	Identification of SARS-like coronaviruses in horseshoe bats (Rhinolophushipposideros) in Slovenia.	2010 Apr	Austria	10.1007/s00705-010-0612-5
20217154	Trypsin-induced hemagglutination activity of porcine epidemic diarrhea virus.	2010 Apr	Austria	10.1007/s00705-010-0620-5
20215723	Prevalence of antibodies against transmissible gastroenteritis virus and porcinerespiratory coronavirus among pigs in six regions in Japan.	2010 Jul	Japan	10.1292/jvms.09-0377
20215721	A simple and rapid strip test for detection of antibodies to avian infectiousbronchitis virus.	2010 Jul	Japan	10.1292/jvms.09-0528
20208000	Regulatory T cells inhibit T cell proliferation and decrease demyelination inmice chronically infected with a coronavirus.	2010 Apr 15	United States	10.4049/jimmunol.0903918
20205658	Study on the influences of palindromes in protein coding sequences on the foldingrates of peptide chains.	2010 Jul	Netherlands	10.2174/092986610791306652
20202661	Group-specific structural features of the 5'-proximal sequences of coronavirusgenomic RNAs.	2010 May 25	United States	10.1016/j.virol.2010.02.007
20201616	Analysis of the gene 3 region sequences of Chinese field strains of Transmissiblegastroenteritis virus.	2010	Slovakia	10.4149/av_2010_01_61
20196933	Detection of coronaviruses in children with acute gastroenteritis in Maddina,Saudi Arabia.	2010	England	10.1179/146532810X12637745451997
20195741	Genomic characterization of a proventriculitis-associated infectious bronchitiscoronavirus.	2010 Jun	United States	10.1007/s11262-010-0461-z
20194425	Structural considerations in the fitness landscape of a virus.	2010 Aug	United States	10.1093/molbev/msq056
22371728	Human bocavirus infections in hospitalized Greek children.	2010 Mar 1	Poland	10.5114/aoms.2010.13515
20586931	Telbivudine preserves T-helper 1 cytokine production and downregulates programmeddeath ligand 1 in a mouse model of viral hepatitis.	2010 Mar	England	10.1111/j.1365-2893.2010.01268.x
20181861	Swine intestine antimicrobial peptides inhibit infectious bronchitis virusinfectivity in chick embryos.	2010 Mar	England	10.3382/ps.2009-00461
20181858	Identification of intertypic recombinant infectious bronchitis viruses fromslaughtered chickens.	2010 Mar	England	10.3382/ps.2009-00322
20181693	Deubiquitinating and interferon antagonism activities of coronavirus papain-likeproteases.	2010 May	United States	10.1128/JVI.02406-09
20181357	An investigation of the pathology and pathogens associated with porcinerespiratory disease complex in Denmark.	2010 Aug-Oct	England	10.1016/j.jcpa.2010.01.012
20180212	Feline infectious peritonitis.	2009 Oct	United States	
20171552	Severe acute respiratory syndrome (SARS).	2010 Mar	United States	10.1016/j.idc.2009.10.005
20170679	Multiplex nested RT-PCR for the detection of porcine enteric viruses.	2010 May	Netherlands	10.1016/j.jviromet.2010.02.010
20168090	Neutralizing epitopes of the SARS-CoV S-protein cluster independent ofrepertoire, antigen structure or mAb technology.	2010 Jan-Feb	United States	10.4161/mabs.2.1.10788
20167482	SARS-CoV 3CLpro inhibitory effects of quinone-methide triterpenes fromTripterygium regelii.	2010 Mar 15	England	10.1016/j.bmcl.2010.01.152
20166951	Recent advances in targeting viral proteases for the discovery of novelantivirals.	2010	United Arab Emirates	10.2174/156802610790725470
20164235	Achieving a golden mean: mechanisms by which coronaviruses ensure synthesis ofthe correct stoichiometric ratios of viral proteins.	2010 May	United States	10.1128/JVI.02480-09
20163804	Pathology and tissue distribution of turkey coronavirus in experimentallyinfected chicks and turkey poults.	2010 Jul	England	10.1016/j.jcpa.2009.12.012
20158498	Induced, selective proteolysis of MLK3 negatively regulates MLK3/JNK signalling.	2010 Apr 14	England	10.1042/BJ20091077
20154085	Self-assembly of severe acute respiratory syndrome coronavirus membrane protein.	2010 Apr 23	United States	10.1074/jbc.M109.030270
20153350	Characterization of a novel live attenuated infectious bronchitis virus vaccinecandidate derived from a Korean nephropathogenic strain.	2010 Apr 1	Netherlands	10.1016/j.vaccine.2010.01.062
20148749	Quantitative evaluation of infection control models in the prevention ofnosocomial transmission of SARS virus to healthcare workers: implication tonosocomial viral infection control for healthcare workers.	2010 Jul	England	10.3109/00365540903582400
20144233	SARS coronavirus protein 7a interacts with human Ap4A-hydrolase.	2010 Feb 9	England	10.1186/1743-422X-7-31
20144042	Escape from human monoclonal antibody neutralization affects in vitro and in vivofitness of severe acute respiratory syndrome coronavirus.	2010 Mar 15	United States	10.1086/651022
20140198	Exacerbated innate host response to SARS-CoV in aged non-human primates.	2010 Feb 5	United States	10.1371/journal.ppat.1000756
20140073	Automated detection of conformational epitopes using phage display Peptidesequences.	2009 Jul 1	United States	10.4137/bbi.s2745
20134095	Angiotensin-converting enzyme 2 (ACE2) in disease pathogenesis.	2010 Mar	Japan	10.1253/circj.cj-10-0045
20132850	Heterogeneity in spike protein genes of porcine epidemic diarrhea virusesisolated in Korea.	2010 May	Netherlands	10.1016/j.virusres.2010.01.015
20129637	Identification of N-linked carbohydrates from severe acute respiratory syndrome(SARS) spike glycoprotein.	2010 Apr 10	United States	10.1016/j.virol.2009.12.020
20117547	Bovine coronavirus associated syndromes.	2010 Mar	United States	10.1016/j.cvfa.2009.10.003
20113545	Effects of coronavirus infections in children.	2010 Feb	United States	10.3201/eid1602.090469
20110095	Immunization with an attenuated severe acute respiratory syndrome coronavirusdeleted in E protein protects against lethal respiratory disease.	2010 Mar 30	United States	10.1016/j.virol.2010.01.004
20106914	The N-terminal region of severe acute respiratory syndrome coronavirus protein 6induces membrane rearrangement and enhances virus replication.	2010 Apr	United States	10.1128/JVI.02570-09
20106541	Lactic acid bacteria efficiently protect human and animal intestinal epithelialand immune cells from enteric virus infection.	2010 Jul 31	Netherlands	10.1016/j.ijfoodmicro.2009.12.024
20104945	Discrete epidemic models.	2010 Jan	United States	10.3934/mbe.2010.7.1
20103835	Anti-SARS coronavirus 3C-like protease effects of Rheum palmatum L. extracts.	2009 Aug	Japan	
20096315	Avian coronavirus infectious bronchitis virus susceptibility to botanicaloleoresins and essential oils in vitro and in vivo.	2010 Apr	Netherlands	10.1016/j.virusres.2010.01.006
20093802	Classification of IBV S1 genotypes by direct reverse transcriptase-polymerasechain reaction (RT-PCR) and relationship between serotypes and genotypes ofstrains isolated between 1998 and 2008 in Japan.	2010 Jun	Japan	10.1292/jvms.09-0130
20093692	Identification of a novel coronavirus possibly associated with acute respiratorysyndrome in alpacas (Vicugna pacos) in California, 2007.	2010 Jan	United States	10.1177/104063871002200118
20090954	Dynamic innate immune responses of human bronchial epithelial cells to severeacute respiratory syndrome-associated coronavirus infection.	2010 Jan 15	United States	10.1371/journal.pone.0008729
20088951	Qualitative and quantitative ultrastructural analysis of the membranerearrangements induced by coronavirus.	2010 Jun	England	10.1111/j.1462-5822.2010.01437.x
20087179	Epidemic viral pneumonia.	2010 Apr	United States	10.1097/QCO.0b013e328336eaae
20080134	Inhibition of porcine transmissible gastroenteritis virus (TGEV) replication inmini-pigs by shRNA.	2010 Apr	Netherlands	10.1016/j.virusres.2009.12.012
20079964	Construction of an implicit membrane environment for the lattice Monte Carlosimulation of transmembrane protein.	2010 Mar	Netherlands	10.1016/j.bpc.2009.12.008
20079778	Comparative sequence analysis of the distal one-third of the genomes of asystemic and an enteric ferret coronavirus.	2010 Apr	Netherlands	10.1016/j.virusres.2009.12.011
20078868	Human coronavirus NL63 open reading frame 3 encodes a virion-incorporatedN-glycosylated membrane protein.	2010 Jan 15	England	10.1186/1743-422X-7-6
20075787	A prospective molecular surveillance study evaluating the clinical impact ofcommunity-acquired respiratory viruses in lung transplant recipients.	2010 Apr 27	United States	10.1097/TP.0b013e3181d05a71
20075272	Detection and molecular characterization of enteric viruses from poult enteritissyndrome in turkeys.	2010 Feb	England	10.3382/ps.2009-00424
20074871	Contribution of the porcine aminopeptidase N (CD13) receptor density to porcineepidemic diarrhea virus infection.	2010 Jul 29	Netherlands	10.1016/j.vetmic.2009.12.024
20071579	Ecoepidemiology and complete genome comparison of different strains of severeacute respiratory syndrome-related Rhinolophus bat coronavirus in China revealbats as a reservoir for acute, self-limiting infection that allows recombinationevents.	2010 Mar	United States	10.1128/JVI.02219-09
20055576	Circulation of group 2 coronaviruses in a bat species common to urban areas inWestern Europe.	2010 Oct	United States	10.1089/vbz.2009.0173
20054988	Data mining pathogen genomes using GeneOrder and CoreGenes and CGUG: gene order,synteny and in silico proteomes.	2009	England	10.1504/ijcbdd.2009.027586
20053278	Descriptive distribution and phylogenetic analysis of feline infectiousperitonitis virus isolates of Malaysia.	2010 Jan 6	England	10.1186/1751-0147-52-1
20051016	Cytopathy of an infiltrating monocyte lineage during the early phase of infectionwith murinecoronavirus in the brain.	2010 Aug	Australia	10.1111/j.1440-1789.2009.01082.x
20046025	Multivalent DNA vaccine enhanced protection efficacy against infectiousbronchitis virus in chickens.	2009 Dec	Japan	10.1292/jvms.001585
20042728	Human rhinovirus and coronavirus detection among allogeneic hematopoietic stemcell transplantation recipients.	2010 Mar 11	United States	10.1182/blood-2009-09-244152
20042510	Gamma interferon signaling in oligodendrocytes is critical for protection fromneurotropic coronavirus infection.	2010 Mar	United States	10.1128/JVI.02373-09
20041855	Engineering a novel endopeptidase based on SARS 3CL(pro).	2009 Dec	England	10.2144/000113303
20035861	Tempol ameliorates murine viral encephalomyelitis by preserving the blood-brainbarrier, reducing viral load, and lessening inflammation.	2010 Mar 1	United States	10.1016/j.freeradbiomed.2009.12.013
20034394	Mutagenesis of the transmembrane domain of the SARS coronavirus spikeglycoprotein: refinement of the requirements for SARS coronavirus cell entry.	2009 Dec 24	England	10.1186/1743-422X-6-230
20032190	Broad-spectrum in vitro activity and in vivo efficacy of the antiviral proteingriffithsin against emerging viruses of the family Coronaviridae.	2010 Mar	United States	10.1128/JVI.02322-09
20031041	Recombinant canine coronaviruses in dogs, Europe.	2010 Jan	United States	10.3201/eid1601.090726
20023282	Prevalence of eight bovine viruses in sika deer (Cervus nippon yesoensis) inJapan.	2009 Dec 26	England	
20022714	Isolation and genetic analysis revealed no predominant new strains of avianinfectious bronchitis virus circulating in South China during 2004-2008.	2010 Jul 14	Netherlands	10.1016/j.vetmic.2009.11.022
20022075	Emergence of a group 3 coronavirus through recombination.	2010 Mar 1	United States	10.1016/j.virol.2009.11.044
20021285	Picornaviral 3C protease inhibitors and the dual 3C protease/coronaviral 3C-likeprotease inhibitors.	2010 Jan	England	10.1517/13543770903460323
20020050	The SARS Coronavirus 3a protein causes endoplasmic reticulum stress and inducesligand-independent downregulation of the type 1 interferon receptor.	2009 Dec 17	United States	10.1371/journal.pone.0008342
20016037	Intraspecies diversity of SARS-like coronaviruses in Rhinolophus sinicus and itsimplications for the origin of SARS coronaviruses in humans.	2010 Apr	England	10.1099/vir.0.016378-0
20015551	Annexin A2 on lung epithelial cell surface is recognized by severe acuterespiratory syndrome-associated coronavirus spike domain 2 antibodies.	2010 Feb	England	10.1016/j.molimm.2009.11.019
20011515	Establishment, immortalisation and characterisation of pteropid bat cell lines.	2009 Dec 11	United States	10.1371/journal.pone.0008266
20007459	Neuronal degeneration in a viral model of multiple sclerosis.	2009 Dec 9	United States	10.1523/JNEUROSCI.5198-09.2009
20007284	The murine coronavirus nucleocapsid gene is a determinant of virulence.	2010 Feb	United States	10.1128/JVI.01758-09
20007283	A single tyrosine in the severe acute respiratory syndrome coronavirus membraneprotein cytoplasmic tail is important for efficient interaction with spikeprotein.	2010 Feb	United States	10.1128/JVI.02458-09
20007278	Dynamics of coronavirus replication-transcription complexes.	2010 Feb	United States	10.1128/JVI.01716-09
20005142	Prevalence of coronavirus.	2010 Apr	England	10.1016/j.jfms.2009.11.002
20003652	Update on viral pathogenesis in BRD.	2009 Dec	England	10.1017/S146625230999020X
20003649	Bovine respiratory disease research (1983-2009).	2009 Dec	England	10.1017/S146625230999017X
19996694	Effect of recombinant lactobacillus expressing canine GM-CSF on immune functionin dogs.	2009 Nov	Korea (South)	10.4014/jmb.0904.4010
19995578	TACE antagonists blocking ACE2 shedding caused by the spike protein of SARS-CoVare candidate antiviral compounds.	2010 Mar	Netherlands	10.1016/j.antiviral.2009.12.001
19966415	Structure of the X (ADRP) domain of nsp3 from feline coronavirus.	2009 Dec	United States	10.1107/S0907444909040074
19959386	Association of Bartonella species, feline calicivirus, and feline herpesvirus 1infection with gingivostomatitis in cats.	2010 Apr	England	10.1016/j.jfms.2009.10.007
19958537	Identification of a novel conserved HLA-A*0201-restricted epitope from the spikeprotein of SARS-CoV.	2009 Dec 3	England	10.1186/1471-2172-10-61
19955814	Comprehensive detection and identification of seven animal coronaviruses andhuman respiratory coronavirus 229E with a microarray hybridization assay.	2010	Switzerland	10.1159/000264199
19955325	Seroprevalences to viral pathogens in free-ranging and captive cheetahs (Acinonyxjubatus) on Namibian Farmland.	2010 Feb	United States	10.1128/CVI.00345-09
19955314	Coronavirus nucleocapsid protein facilitates template switching and is requiredfor efficient transcription.	2010 Feb	United States	10.1128/JVI.02011-09
19951178	Protein transfer enhances cellular immune responses to DNA vaccination againstSARS-CoV.	2009 Dec	United States	10.1089/vim.2009.0048
19951177	Antibody binding site mapping of SARS-CoV spike protein receptor-binding domainby a combination of yeast surface display and phage peptide library screening.	2009 Dec	United States	10.1089/vim.2009.0046
19946572	The Biology of Persistent Infection: Inflammation and Demyelination followingMurine Coronavirus Infection of the Central Nervous System.	2009 May 4	United Arab Emirates	10.2174/157339509789504005
19939462	Characterization of the cytokine and maturation responses of pure populations ofporcine plasmacytoid dendritic cells to porcine viruses and toll-like receptoragonists.	2010 May 15	Netherlands	10.1016/j.vetimm.2009.10.026
19937534	Comparison of the pathogenicity of QX-like, M41 and 793/B infectious bronchitisstrains from different pathological conditions.	2009 Dec	England	10.1080/03079450903349196
19937520	Effect of a live Mycoplasma synoviae vaccine on the production of eggshell apexabnormalities induced by a M. synoviae infection preceded by an infection withinfectious bronchitis virus D1466.	2009 Oct	England	10.1080/03079450903183652
19937512	Infection with a pathogenic turkey coronavirus isolate negatively affects growthperformance and intestinal morphology of young turkey poults in Canada.	2009 Aug	England	10.1080/03079450903055389
19934604	Pathogenicity and antigenicity of a new variant of Korean nephropathogenicinfectious bronchitis virus.	2009 Dec	Korea (South)	10.4142/jvs.2009.10.4.357
19932978	Western European epidemiological survey for parvovirus and coronavirus infectionsin dogs.	2011 Feb	England	10.1016/j.tvjl.2009.10.027
19931188	Expression of beta-defensins in the canine respiratory tract and antimicrobialactivity against Bordetella bronchiseptica.	2010 May 15	Netherlands	10.1016/j.vetimm.2009.10.025
19924243	Cleavage of the SARS coronavirus spike glycoprotein by airway proteases enhancesvirus entry into human bronchial epithelial cells in vitro.	2009 Nov 17	United States	10.1371/journal.pone.0007870
19917315	Specific real-time reverse transcription-polymerase chain reaction for detectionand quantitation of turkey coronavirus RNA in tissues and feces from turkeysinfected with turkey coronavirus.	2010 Feb	Netherlands	10.1016/j.jviromet.2009.11.012
19915717	MicroRNome analysis unravels the molecular basis of SARS infection inbronchoalveolar stem cells.	2009 Nov 13	United States	10.1371/journal.pone.0007837
19913371	Serosurvey of selected viruses in captive giant pandas (Ailuropoda melanoleuca)in China.	2010 May 19	Netherlands	10.1016/j.vetmic.2009.09.062
19801717	Identification of human cell line model of persistent SARS coronavirus infectionand studies of the response to cytokines and chemokines.	2009 Oct	China	
19801713	The macrophage in the pathogenesis of severe acute respiratory syndromecoronavirus infection.	2009 Oct	China	
19801711	Determination of the functions of the putative metal-binding domain of the SCVhelicase.	2009 Oct	China	
19906932	Recombination, reservoirs, and the modular spike: mechanisms of coronaviruscross-species transmission.	2010 Apr	United States	10.1128/JVI.01394-09
19906920	Cellular immune responses to severe acute respiratory syndrome coronavirus(SARS-CoV) infection in senescent BALB/c mice: CD4+ T cells are important incontrol of SARS-CoV infection.	2010 Feb	United States	10.1128/JVI.01281-09
19906918	Chimeric feline coronaviruses that encode type II spike protein on type I geneticbackground display accelerated viral growth and altered receptor usage.	2010 Feb	United States	10.1128/JVI.01568-09
19901342	Improved health and survival of FIV-infected cats is associated with the presenceof autoantibodies to the primary receptor, CD134.	2009 Nov 24	United States	10.1073/pnas.0911307106
19901337	Crystal structure of NL63 respiratory coronavirus receptor-binding domaincomplexed with its human receptor.	2009 Nov 24	United States	10.1073/pnas.0908837106
19893623	A protective role for ELR+ chemokines during acute viral encephalomyelitis.	2009 Nov	United States	10.1371/journal.ppat.1000648
19892230	Recently discovered human coronaviruses.	2009 Dec	United States	10.1016/j.cll.2009.07.007
19889934	Feline infectious peritonitis: insights into feline coronavirus pathobiogenesisand epidemiology based on genetic analysis of the viral 3c gene.	2010 Feb	England	10.1099/vir.0.016485-0
19889777	Integrity of the early secretory pathway promotes, but is not required for,severe acute respiratory syndrome coronavirus RNA synthesis and virus-inducedremodeling of endoplasmic reticulum membranes.	2010 Jan	United States	10.1128/JVI.01826-09
19889773	The open reading frame 3a protein of severe acute respiratory syndrome-associatedcoronavirus promotes membrane rearrangement and cell death.	2010 Jan	United States	10.1128/JVI.01662-09
19887130	Immunity after natural exposure to enteric canine coronavirus does not providecomplete protection against infection with the new pantropic CB/05 strain.	2010 Jan 8	Netherlands	10.1016/j.vaccine.2009.10.077
19885368	Unraveling the complexities of the interferon response during SARS-CoV infection.	2009 Jan 1	England	10.2217/17460794.4.1.71
19883356	Otitis media: viruses, bacteria, biofilms and vaccines.	2009 Nov 2	Australia	
19878695	An ELISA based on recombinant spike protein S for the detection of antibodies totransmissible gastroenteritis virus of swine-like canine coronaviruses.	2010 Feb	Netherlands	10.1016/j.jviromet.2009.10.015
19875857	Evaluating protein similarity from coarse structures.	2009 Oct-Dec	United States	10.1109/TCBB.2007.70250
19875418	The RNA polymerase activity of SARS-coronavirus nsp12 is primer dependent.	2010 Jan	England	10.1093/nar/gkp904
19864379	Differential downregulation of ACE2 by the spike proteins of severe acuterespiratory syndrome coronavirus and human coronavirus NL63.	2010 Jan	United States	10.1128/JVI.01248-09
19861118	Antibody-mediated synergy and interference in the neutralization of SARS-CoV atan epitope cluster on the spike protein.	2009 Dec 18	United States	10.1016/j.bbrc.2009.10.115
19855817	The application of genomics to emerging zoonotic viral diseases.	2009 Oct	United States	10.1371/journal.ppat.1000557
19853613	Identification of a new region of SARS-CoV S protein critical for viral entry.	2009 Dec 11	England	10.1016/j.jmb.2009.10.032
19853271	A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviralagents in vitro and in vivo.	2009 Dec 20	United States	10.1016/j.virol.2009.09.023
19851732	Identification of a novel linear B-cell epitope in the M protein of avianinfectious bronchitis coronaviruses.	2009 Oct	Korea (South)	10.1007/s12275-009-0104-z
19851468	Evasion by stealth: inefficient immune activation underlies poor T cell responseand severe disease in SARS-CoV-infected mice.	2009 Oct	United States	10.1371/journal.ppat.1000636
19848084	Characterization of new variants of avian infectious bronchitis virus in Tunisia.	2009 Sep	United States	10.1637/8666-022609-Reg.1
19848072	Detection and molecular characterization of gene 3 and 5 of turkey coronavirusfrom turkeys with severe enteritis in Brazil.	2009 Sep	United States	10.1637/8507-103108-Reg.1
19846526	Murine hepatitis virus nonstructural protein 4 regulates virus-induced membranemodifications and replication complex function.	2010 Jan	United States	10.1128/JVI.01772-09
19846189	A human coronavirus OC43 variant harboring persistence-associated mutations inthe S glycoprotein differentially induces the unfolded protein response in humanneurons as compared to wild-type virus.	2009 Dec 20	United States	10.1016/j.virol.2009.09.026
19838190	A two-pronged strategy to suppress host protein synthesis by SARS coronavirusNsp1 protein.	2009 Nov	United States	10.1038/nsmb.1680
19835950	Reverse transcription loop-mediated isothermal amplification for the rapiddetection of infectious bronchitis virus in infected chicken tissues.	2010 Apr	England	10.1016/j.mcp.2009.10.001
19828744	Enhanced viral etiological diagnosis of respiratory system infection outbreaks byuse of a multitarget nucleic acid amplification assay.	2009 Dec	United States	10.1128/JCM.01469-09
19828617	Nuclear magnetic resonance structure of the nucleic acid-binding domain of severeacute respiratory syndrome coronavirus nonstructural protein 3.	2009 Dec	United States	10.1128/JVI.01253-09
19827980	Virologic survey of dogs with naturally acquired idiopathic conjunctivitis.	2009 Oct 15	United States	10.2460/javma.235.8.954
19822538	Respiratory syncytial virus, human bocavirus and rhinovirus bronchiolitis ininfants.	2010 Jan	England	10.1136/adc.2008.153361
19820731	Fatal lower respiratory tract disease with human corona virus NL63 in an adulthaematopoietic cell transplant recipient.	2010 Jun	England	10.1038/bmt.2009.292
19819574	Prevalence, prediction and risk factors of enteropathogens in normal andnon-normal faeces of young Dutch dairy calves.	2010 Feb 1	Netherlands	10.1016/j.prevetmed.2009.09.020
19819173	Dynamics of SARS-coronavirus HR2 domain in the prefusion and transition states.	2009 Dec	United States	10.1016/j.jmr.2009.09.012
19819086	Genetic analysis of canine group 2 coronavirus in Korean dogs.	2010 Feb 24	Netherlands	10.1016/j.vetmic.2009.09.002
19818660	Prevalence of feline coronavirus in two cat populations in Malaysia.	2009 Dec	England	10.1016/j.jfms.2009.08.005
19816578	The replicase gene of avian coronavirus infectious bronchitis virus is adeterminant of pathogenicity.	2009 Oct 9	United States	10.1371/journal.pone.0007384
19811085	Fine specificity of autoantibodies induced by mouse hepatitis virus A59.	2009 Oct	United States	10.1089/vim.2009.0019
19802044	The seroprevalence of canine respiratory coronavirus and canine influenza virusin dogs in New Zealand.	2009 Oct	England	10.1080/00480169.2009.58624
19801669	Role of spike protein endodomains in regulating coronavirus entry.	2009 Nov 20	United States	10.1074/jbc.M109.043547
19800091	Dual effect of nitric oxide on SARS-CoV replication: viral RNA production andpalmitoylation of the S protein are affected.	2009 Dec 5	United States	10.1016/j.virol.2009.09.007
19800030	Phylogenetic perspectives on the epidemiology and origins of SARS and SARS-likecoronaviruses.	2009 Dec	Netherlands	10.1016/j.meegid.2009.09.015
19798426	RNase L mediated protection from virus induced demyelination.	2009 Oct	United States	10.1371/journal.ppat.1000602
19794894	Vaccine efficacy against Ontario isolates of infectious bronchitis virus.	2009 Jul	Canada	
19793537	The infection of primary avian tracheal epithelial cells with infectiousbronchitis virus.	2010 Jan-Feb	England	10.1051/vetres/2009054
19788813	Genetics and pathogenesis of feline infectious peritonitis virus.	2009 Sep	United States	10.3201/eid1509.081573
19788804	Distant relatives of severe acute respiratory syndrome coronavirus and closerelatives of human coronavirus 229E in bats, Ghana.	2009 Sep	United States	10.3201/eid1509.090224
19786545	De novo recruitment of antigen-experienced and naive T cells contributes to thelong-term maintenance of antiviral T cell populations in the persistentlyinfected central nervous system.	2009 Oct 15	United States	10.4049/jimmunol.0902164
19786144	Protection of chickens against infectious bronchitis by a recombinant fowlpoxvirus co-expressing IBV-S1 and chicken IFNgamma.	2009 Nov 23	Netherlands	10.1016/j.vaccine.2009.09.065
19782089	Coronavirus N protein N-terminal domain (NTD) specifically binds thetranscriptional regulatory sequence (TRS) and melts TRS-cTRS RNA duplexes.	2009 Dec 4	England	10.1016/j.jmb.2009.09.040
19781871	Bid cleavage, cytochrome c release and caspase activation in caninecoronavirus-induced apoptosis.	2010 Feb 24	Netherlands	10.1016/j.vetmic.2009.09.001
19781572	Development of a real-time TaqMan RT-PCR assay for the detection of infectiousbronchitis virus in chickens, and comparison of RT-PCR and virus isolation.	2010 Feb	Netherlands	10.1016/j.jviromet.2009.09.014
19777806	[Induction of immune response after oral inoculation of mice with Lactobacilluscasei surface-displayed porcine epidemic diarrhea viral N protein].	2009 Jun	China	
19776135	Inhibition of protein kinase R activation and upregulation of GADD34 expressionplay a synergistic role in facilitating coronavirus replication by maintaining denovo protein synthesis in virus-infected cells.	2009 Dec	United States	10.1128/JVI.01546-09
19776127	Regulation of proinflammatory cytokine expression in primary mouse astrocytes bycoronavirus infection.	2009 Dec	United States	10.1128/JVI.01103-09
19775957	Signal from noise?	2009 Sep-Oct	United States	10.1109/MEMB.2009.934250
19740316	A synergistic interferon-gamma production is induced by mouse hepatitis virus ininterleukin-12 (IL-12)/IL-18-activated natural killer cells and modulated bycarcinoembryonic antigen-related cell adhesion molecules (CEACAM) 1a receptor.	2009 Sep	England	10.1111/j.1365-2567.2008.03030.x
19740307	Macrophage interleukin-6 and tumour necrosis factor-alpha are induced bycoronavirus fixation to Toll-like receptor 2/heparan sulphate receptors but notcarcinoembryonic cell adhesion antigen 1a.	2009 Sep	England	10.1111/j.1365-2567.2008.02946.x
19774678	Just like SARS.	2009 Oct	United States	10.1002/ppul.21085
19774076	Inducible bronchus-associated lymphoid tissue elicited by a protein cagenanoparticle enhances protection in mice against diverse respiratory viruses.	2009 Sep 23	United States	10.1371/journal.pone.0007142
19769160	[The cloning, expression and structural analysis of putative unknown protein Orf9b in SARS-CoV].	2009 Jul	China	
19258634	An oral mucosal DNA vaccine for SARS coronavirus infections.	2009 Feb	China	
19258633	Roles of spike protein in the pathogenesis of SARS coronavirus.	2009 Feb	China	
19258632	Mouse studies of SARS coronavirus-specific immune responses to recombinantreplication-defective adenovirus expressing SARS coronavirus N protein.	2009 Feb	China	
19762832	Respiratory infections in Norwegian dairy calves.	2009 Oct	United States	10.3168/jds.2009-2224
19762824	Enteropathogens and risk factors for diarrhea in Norwegian dairy calves.	2009 Oct	United States	10.3168/jds.2009-2080
19759228	Epidemiology and clinical presentations of human coronavirus NL63 infections inhong kong children.	2009 Nov	United States	10.1128/JCM.00832-09
19759148	Mouse hepatitis virus stem-loop 2 adopts a uYNMG(U)a-like tetraloop structurethat is highly functionally tolerant of base substitutions.	2009 Dec	United States	10.1128/JVI.00915-09
19748648	Human monoclonal antibodies to SARS-coronavirus inhibit infection by differentmechanisms.	2009 Nov 10	United States	10.1016/j.virol.2009.07.028
19748524	Efficient induction of cytotoxic T lymphocytes specific for severe acuterespiratory syndrome (SARS)-associated coronavirus by immunization withsurface-linked liposomal peptides derived from a non-structural polyprotein 1a.	2009 Nov	Netherlands	10.1016/j.antiviral.2009.09.004
19741068	Rat respiratory coronavirus infection: replication in airway and alveolarepithelial cells and the innate immune response.	2009 Dec	England	10.1099/vir.0.014282-0
19737757	Detection and differentiation of four poultry diseases using asymmetric reversetranscription polymerase chain reaction in combination with oligonucleotidemicroarrays.	2009 Sep	United States	10.1177/104063870902100506
19737754	Antigen-capture blocking enzyme-linked immunosorbent assay based on a baculovirusrecombinant antigen to differentiate Transmissible gastroenteritis virus fromPorcine respiratory coronavirus antibodies.	2009 Sep	United States	10.1177/104063870902100503
19737459	[Study on interaction between SARS-CoV N and MAP19].	2009 Sep	China	
19736875	Commentary on the feature article.	2009 Summer	United States	10.1016/S0840-4704(10)60454-1
19729635	American Chemical Society fall meeting, 16-20 August, Washington, D.C. SugaryAchilles' heel raises hope for broad-acting antiviral drugs.	2009 Sep 4	United States	10.1126/science.325_1200a
19729039	A real-time TaqMan RT-PCR assay with an internal amplification control for rapiddetection of transmissible gastroenteritis virus in swine fecal samples.	2009 Dec	Netherlands	10.1016/j.jviromet.2009.08.016
19727132	Immune responses to T-cell epitopes of SARS CoV-N protein are enhanced by Nimmunization with a chimera of lysosome-associated membrane protein.	2009 Nov	England	10.1038/gt.2009.92
19721004	Structural basis for ligand and substrate recognition by torovirus hemagglutininesterases.	2009 Sep 15	United States	10.1073/pnas.0904266106
19720244	Absence of antibody-dependent, complement-mediated lysis of feline infectiousperitonitis virus-infected cells.	2009 Sep	Netherlands	10.1016/j.virusres.2009.03.017
19717178	SARS-coronavirus spike S2 domain flanked by cysteine residues C822 and C833 isimportant for activation of membrane fusion.	2009 Oct 25	United States	10.1016/j.virol.2009.07.038
21994544	Significance of coronavirus mutants in feces and diseased tissues of catssuffering from feline infectious peritonitis.	2009 Sep	Switzerland	10.3390/v1020166
21089580	[Progress in structural studies of larger proteins by the SAIL-NMR method].	2009 Sep	Japan	
19710653	Population context determines cell-to-cell variability in endocytosis and virusinfection.	2009 Sep 24	England	10.1038/nature08282
19710146	Rhesus theta-defensin prevents death in a mouse model of severe acute respiratorysyndrome coronavirus pulmonary disease.	2009 Nov	United States	10.1128/JVI.01363-09
19706706	Two-step conformational changes in a coronavirus envelope glycoprotein mediatedby receptor binding and proteolysis.	2009 Nov	United States	10.1128/JVI.00959-09
19698190	Reverse genetic characterization of the natural genomic deletion inSARS-Coronavirus strain Frankfurt-1 open reading frame 7b reveals an attenuatingfunction of the 7b protein in-vitro and in-vivo.	2009 Aug 24	England	10.1186/1743-422X-6-131
19696879	Temporal variability and social heterogeneity in disease transmission: the caseof SARS in Hong Kong.	2009 Aug	United States	10.1371/journal.pcbi.1000471
19692601	Mechanisms of primary axonal damage in a viral model of multiple sclerosis.	2009 Aug 19	United States	10.1523/JNEUROSCI.1975-09.2009
19692148	The antiviral action of common household disinfectants and antiseptics againstmurine hepatitis virus, a potential surrogate for SARS coronavirus.	2009 Oct	United States	10.1016/j.ajic.2009.03.012
19691129	Elucidation of the stability and functional regions of the human coronavirus OC43nucleocapsid protein.	2009 Nov	United States	10.1002/pro.225
19687628	Isolation and identification of a canine coronavirus strain from giant pandas(Ailuropoda melanoleuca).	2009 Sep	Korea (South)	10.4142/jvs.2009.10.3.261
19687622	Detection and molecular characterization of infectious bronchitis virus isolatedfrom recent outbreaks in broiler flocks in Thailand.	2009 Sep	Korea (South)	10.4142/jvs.2009.10.3.219
19687041	Avian influenza virus, Streptococcus suis serotype 2, severe acute respiratorysyndrome-coronavirus and beyond: molecular epidemiology, ecology and thesituation in China.	2009 Sep 27	England	10.1098/rstb.2009.0093
19685004	Potential enhancement of osteoclastogenesis by severe acute respiratory syndromecoronavirus 3a/X1 protein.	2009	Austria	10.1007/s00705-009-0472-z
19684916	RNA aptamer-based sensitive detection of SARS coronavirus nucleocapsid protein.	2009 Sep	England	10.1039/b906788d
19683779	Recombinant receptor-binding domain of SARS-CoV spike protein expressed inmammalian, insect and E. coli cells elicits potent neutralizing antibody andprotective immunity.	2009 Oct 10	United States	10.1016/j.virol.2009.07.018
19669794	Large Arf1 guanine nucleotide exchange factors: evolution, domain structure, androles in membrane trafficking and human disease.	2009 Oct	Germany	10.1007/s00438-009-0473-3
19665859	Shuffling multivariate adaptive regression splines and adaptive neuro-fuzzyinference system as tools for QSAR study of SARS inhibitors.	2009 Dec 5	England	10.1016/j.jpba.2009.07.009
19651389	The year in review.	2009 Jun	England	10.1016/S1526-0542(09)70003-X
19660929	Detection of severe acute respiratory syndrome (SARS) coronavirus nucleocapsidprotein in human serum using a localized surface plasmon coupled fluorescencefiber-optic biosensor.	2009 Oct 15	England	10.1016/j.bios.2009.07.012
19657879	Lack of evidence of avian adenovirus infection among turkey workers.	2009	England	10.1080/10599240903041737
19656969	Porcine reproductive and respiratory syndrome virus modifies innate immunity andalters disease outcome in pigs subsequently infected with porcine respiratorycoronavirus: implications for respiratory viral co-infections.	2009 Nov	England	10.1099/vir.0.014001-0
19652475	Serological studies of infectious bronchitis vaccines against Japanese fieldisolates of homologous and heterologous genotypes.	2009 Jul	Japan	10.1292/jvms.71.891
19652340	Expression, crystallization and preliminary X-ray diffraction analysis of theN-terminal domain of nsp2 from avian infectious bronchitis virus.	2009 Aug 1	England	10.1107/S1744309109024749
19651159	Evaluation of the Cepheid respiratory syncytial virus and influenza virus A/Breal-time PCR analyte specific reagent.	2009 Dec	Netherlands	10.1016/j.jviromet.2009.07.020
19650917	Type I interferon receptor-independent and -dependent host transcriptionalresponses to mouse hepatitis coronavirus infection in vivo.	2009 Aug 3	England	10.1186/1471-2164-10-350
19647379	Prevalence of canine enteric coronavirus in a cross-sectional survey of dogspresenting at veterinary practices.	2010 Jan 6	Netherlands	10.1016/j.vetmic.2009.07.012
19645480	Structure-based design, synthesis, and biological evaluation of a series of noveland reversible inhibitors for the severe acute respiratory syndrome-coronaviruspapain-like protease.	2009 Aug 27	United States	10.1021/jm900611t
19641854	Mesodynamics in the SARS nucleocapsid measured by NMR field cycling.	2009 Sep	Netherlands	10.1007/s10858-009-9347-6
19640993	Severe acute respiratory syndrome coronavirus nonstructural protein 2 interactswith a host protein complex involved in mitochondrial biogenesis andintracellular signaling.	2009 Oct	United States	10.1128/JVI.00842-09
19638499	Host-pathogen interactions during coronavirus infection of primary alveolarepithelial cells.	2009 Nov	United States	10.1189/jlb.0209078
19638288	Simultaneous detection of respiratory viruses in children with acute respiratoryinfection using two different multiplex reverse transcription-PCR assays.	2009 Dec	Netherlands	10.1016/j.jviromet.2009.07.004
19636888	NMR assignment of the nonstructural protein nsp3(1066-1181) from SARS-CoV.	2008 Dec	Netherlands	10.1007/s12104-008-9104-x
19634766	[Porcine aminopeptidase N is a functional receptor for the PEDV coronavirus].	2009 May	China	
19633513	The pediatric burden of human coronaviruses evaluated for twenty years.	2009 Aug	United States	10.1097/INF.0b013e31819d0d27
19630234	CpG oligodeoxynucleotides activate innate immune response that suppressesinfectious bronchitis virus replication in chicken embryos.	2009 Jun	United States	10.1637/8560-121808-Reg.1
19630221	Infectious bronchitis virus field vaccination coverage and persistence ofArkansas-type viruses in commercial broilers.	2009 Jun	United States	10.1637/8465-090308-Reg.1
19629668	Oral immunization of mice with recombinant Lactococcus lactis expressing porcinetransmissible gastroenteritis virus spike glycoprotein.	2009 Oct	United States	10.1007/s11262-009-0390-x
19626607	Detection of four human coronaviruses in respiratory infections in children: aone-year study in Colorado.	2009 Sep	United States	10.1002/jmv.21541
19626487	CXCL10 and trafficking of virus-specific T cells during coronavirus-induceddemyelination.	2009 Sep	England	10.1080/08916930902810708
19625463	Characterization of a new genotype and serotype of infectious bronchitis virus inWestern Africa.	2009 Nov	England	10.1099/vir.0.012476-0
19625462	Angiotensin-converting enzyme 2 (ACE2) from raccoon dog can serve as an efficientreceptor for the spike protein of severe acute respiratory syndrome coronavirus.	2009 Nov	England	10.1099/vir.0.013490-0
19625461	Interferon priming enables cells to partially overturn the SARScoronavirus-induced block in innate immune activation.	2009 Nov	England	10.1099/vir.0.013599-0
19625187	Investigation of the pharmacophore space of Severe Acute Respiratory Syndromecoronavirus (SARS-CoV) NTPase/helicase by dihydroxychromone derivatives.	2009 Aug 15	England	10.1016/j.bmcl.2009.07.009
19624933	Chinese-like strain of porcine epidemic diarrhea virus, Thailand.	2009 Jul	United States	10.3201/eid1507.081256
19624927	Genetically diverse coronaviruses in wild bird populations of northern England.	2009 Jul	United States	10.3201/eid1507.090067
19623666	Experimental infection of Mongolian gerbils by a genotype 4 strain of swinehepatitis E virus.	2009 Sep	United States	10.1002/jmv.21573
19622868	Structure of the C-terminal domain of nsp4 from feline coronavirus.	2009 Aug	United States	10.1107/S0907444909018253
19608458	Persistence pays: how viruses promote host group survival.	2009 Aug	England	10.1016/j.mib.2009.06.014
19595990	Immunogenicity difference between the SARS coronavirus and the bat SARS-likecoronavirus spike (S) proteins.	2009 Sep 18	United States	10.1016/j.bbrc.2009.07.025
19593433	Crystal structure of the C-terminal cytoplasmic domain of non-structural protein4 from mouse hepatitis virus A59.	2009 Jul 10	United States	10.1371/journal.pone.0006217
19593379	Structure and inhibition of the SARS coronavirus envelope protein ion channel.	2009 Jul	United States	10.1371/journal.ppat.1000511
19590927	Candidate genes associated with susceptibility for SARS-coronavirus.	2010 Jan	United States	10.1007/s11538-009-9440-8
19590226	Molecular characterization and pathogenicity of infectious bronchitiscoronaviruses: complicated evolution and epidemiology in china caused bycocirculation of multiple types of infectious bronchitis coronaviruses.	2009	Switzerland	10.1159/000227134
19584555	The protective immune response against infectious bronchitis virus induced bymulti-epitope based peptide vaccines.	2009 Jul	England	10.1271/bbb.80864
19581895	Multifunctional nanoarchitectures from DNA-based ABC monomers.	2009 Jul	England	10.1038/nnano.2009.93
19580983	Host cell proteins interacting with the 3' end of TGEV coronavirus genomeinfluence virus replication.	2009 Sep 1	United States	10.1016/j.virol.2009.06.006
19579009	Enhancing immune responses against SARS-CoV nucleocapsid DNA vaccine byco-inoculating interleukin-2 expressing vector in mice.	2009 Nov	Netherlands	10.1007/s10529-009-0061-y
19573642	Intragastric administration of attenuated Salmonella typhimurium harbouringtransmissible gastroenteritis virus (TGEV) DNA vaccine induced specific antibodyproduction.	2009 Aug 13	Netherlands	10.1016/j.vaccine.2009.06.050
19572016	Acquisition of cell-cell fusion activity by amino acid substitutions in spikeprotein determines the infectivity of a coronavirus in cultured cells.	2009 Jul 2	United States	10.1371/journal.pone.0006130
19570864	Protective and pathologic roles of the immune response to mouse hepatitis virustype 1: implications for severe acute respiratory syndrome.	2009 Sep	United States	10.1128/JVI.00355-09
19570858	The spike protein of murine coronavirus regulates viral genome transport from thecell surface to the endoplasmic reticulum during infection.	2009 Oct	United States	10.1128/JVI.00956-09
19569487	Survey of feline leukemia virus and feline coronaviruses in captive neotropicalwild felids from Southern Brazil.	2009 Jun	United States	10.1638/2008-0067.1
19564494	Lung pathology and infectious agents in fatal feedlot pneumonias and relationshipwith mortality, disease onset, and treatments.	2009 Jul	United States	10.1177/104063870902100407
19561398	Comparative study of synonymous codon usage variations between the nucleocapsidand spike genes of coronavirus, and C-type lectin domain genes of human andmouse.	2009 Oct 31	United States	10.3858/emm.2009.41.10.081
19560387	Prevalence of feline coronavirus antibodies in cats in Bursa province, Turkey, byan enzyme-linked immunosorbent assay.	2009 Oct	England	10.1016/j.jfms.2009.02.008
19555507	Distribution and seasonality of rhinovirus and other respiratory viruses in across-section of asthmatic children in Trinidad, West Indies.	2009 Jun 25	England	10.1186/1824-7288-35-16
19555207	Simultaneous detection of five biothreat agents in powder samples by amultiplexed suspension array.	2009	England	10.1080/08923970902740837
19555169	Synthesis and evaluation of in vitro antiviral activity of 2-[3-(substitutedphenyl)-4,5-dihydro-1H-5-pyrazolyl]benzofuran-3-yl chloride derivatives.	2009 Aug	England	10.1080/14756360802560677
19553337	Toll-like receptor 4 deficiency increases disease and mortality after mousehepatitis virus type 1 infection of susceptible C3H mice.	2009 Sep	United States	10.1128/JVI.01857-08
19553314	Proteolytic activation of the spike protein at a novel RRRR/S motif is implicatedin furin-dependent entry, syncytium formation, and infectivity of coronavirusinfectious bronchitis virus in cultured cells.	2009 Sep	United States	10.1128/JVI.00613-09
19509435	Development of interfering RNA agents to inhibit SARS-associated coronavirusinfection and replication.	2009 Jun	China	
19509431	Occult respiratory viral infections in coronial autopsies: a pilot project.	2009 Jun	China	
19548531	[Synthesis in Escherichia coli cells and characterization of the activeexoribonuclease of severe acute respiratory syndrome coronavirus].	2009 May-Jun	Russia (Federation)	
19546349	Coronavirus diversity, phylogeny and interspecies jumping.	2009 Oct	England	10.3181/0903-MR-94
19544636	[Effect on mRNA and secretion levels of proinflammatory cytokines in DC infectedby SARS-CoV N gene recombinant adenovirus].	2008 Dec	China	
19543689	Coadministration of chicken GM-CSF with a DNA vaccine expressing infectiousbronchitis virus (IBV) S1 glycoprotein enhances the specific immune response andprotects against IBV infection.	2009	Austria	10.1007/s00705-009-0424-7
19538115	SARS vaccines: where are we?	2009 Jul	England	10.1586/erv.09.43
19537912	Analysis of putative recombination hot sites in the S gene of caninecoronaviruses.	2009	Slovakia	10.4149/av_2009_02_111
19534833	Studies on membrane topology, N-glycosylation and functionality of SARS-CoVmembrane protein.	2009 Jun 18	England	10.1186/1743-422X-6-79
19533385	Recent and future developments in the epidemiology of the infectious diseases.	2009	Netherlands	10.1007/s10654-009-9361-8
19526193	Characterization of SARS-CoV-specific memory T cells from recovered individuals 4years after infection.	2009	Austria	10.1007/s00705-009-0409-6
19523911	Boosted expression of the SARS-CoV nucleocapsid protein in tobacco and itsimmunogenicity in mice.	2009 Aug 6	Netherlands	10.1016/j.vaccine.2009.05.073
19523910	Altered pathogenicity, immunogenicity, tissue tropism and 3'-7kb region sequenceof an avian infectious bronchitis coronavirus strain after serial passage inembryos.	2009 Jul 23	Netherlands	10.1016/j.vaccine.2009.05.072
19515609	Multiplex PCR tests sentinel the appearance of pandemic influenza virusesincluding H1N1 swine influenza.	2009 Jul	Netherlands	10.1016/j.jcv.2009.05.031
19513614	Construction of plasmids expressing Sars-CoV encoding proteins and their effectson transcription of hfgl2 prothrombinase.	2009 Jun	China	10.1007/s11596-009-0311-1
19506054	Antiviral activity of chloroquine against human coronavirus OC43 infection innewborn mice.	2009 Aug	United States	10.1128/AAC.01509-08
19505311	Toll-like receptors, chemokine receptors and death receptor ligands responses inSARS coronavirus infected human monocyte derived dendritic cells.	2009 Jun 8	England	10.1186/1471-2172-10-35
19504744	Kawasaki disease lacks association with human coronavirus NL63 and humanbocavirus.	2009 Jun	United States	10.1097/inf.0b013e31819f41b6
19504730	Respiratory pathogens in respiratory tract illnesses during the first year oflife: a birth cohort study.	2009 Jun	United States	10.1097/inf.0b013e318195e26e
19501378	Comparison of enzyme-linked immunosorbent assay and RT-PCR for the detection ofporcine epidemic diarrhoea virus.	2010 Feb	England	10.1016/j.rvsc.2009.05.009
19498285	Propagation of swine hemagglutinating encephalomyelitis virus and pseudorabiesvirus in dorsal root ganglia cells.	2009 May	Japan	10.1292/jvms.71.595
19498283	Genetic analysis of the S1 gene of 4/91 type infectious bronchitis virus isolatedin Japan.	2009 May	Japan	10.1292/jvms.71.583
19497090	Bats and emerging zoonoses: henipaviruses and SARS.	2009 Aug	Germany	10.1111/j.1863-2378.2008.01218.x
19494700	Recombinant S-layer proteins of Lactobacillus brevis mediating antibody adhesionto calf intestine alleviated neonatal diarrhea syndrome.	2009 May	Korea (South)	10.4014/jmb.0805.325
19491313	Coronavirus immunoreactivity in individuals with a recent onset of psychoticsymptoms.	2011 Jan	United States	10.1093/schbul/sbp052
19490987	Synthetic peptides coupled to the surface of liposomes effectively induce SARScoronavirus-specific cytotoxic T lymphocytes and viral clearance in HLA-A*0201transgenic mice.	2009 Jun 12	Netherlands	10.1016/j.vaccine.2009.04.001
19490977	A new Sephadex-based method for removing microbicidal and cytotoxic residues whentesting antiseptics against viruses: Experiments with a human coronavirus as amodel.	2009 Aug	Netherlands	10.1016/j.jviromet.2009.03.023
19482534	Effect of Polyprenyl Immunostimulant on the survival times of three cats with thedry form of feline infectious peritonitis.	2009 Aug	England	10.1016/j.jfms.2008.12.002
19481039	Feline infectious peritonitis. ABCD guidelines on prevention and management.	2009 Jul	England	10.1016/j.jfms.2009.05.008
21994538	More and More Coronaviruses: Human Coronavirus HKU1.	2009 Jun	Switzerland	10.3390/v1010057
19479732	Using Gaussian model to improve biological sequence comparison.	2010 Jan 30	United States	10.1002/jcc.21322
19477025	Endogenous remyelination is induced by transplant rejection in a viral model ofmultiple sclerosis.	2009 Jul 25	Netherlands	10.1016/j.jneuroim.2009.05.002
19475608	Characterization of cytotoxic T-lymphocyte epitopes and immune responses to SARScoronavirus spike DNA vaccine expressing the RGD-integrin-binding motif.	2009 Jul	United States	10.1002/jmv.21571
19474208	Rapid pulmonary fibrosis induced by acute lung injury via a lipopolysaccharidethree-hit regimen.	2009 Jun	United States	10.1177/1753425908101509
19468938	Comparative analysis of the effect of glycyrrhizin diammonium and lithiumchloride on infectious bronchitis virus infection in vitro.	2009 Jun	England	10.1080/03079450902912184
19462619	[An update on viral diseases of the dog and cat].	2009 Apr 15	Netherlands	
19461490	Community-acquired respiratory viral infections in lung transplant recipients: asingle season cohort study.	2009 May 27	United States	10.1097/TP.0b013e3181a4857d
19459405	[Porcine epidemic diarrhea].	2009 Mar-Apr	Russia (Federation)	
19453650	SARS-coronavirus modulation of myocardial ACE2 expression and inflammation inpatients with SARS.	2009 Jul	England	10.1111/j.1365-2362.2009.02153.x
19453465	Human coronavirus NL63 infections in infants hospitalised with acute respiratorytract infections in South Africa.	2008 Jul	England	10.1111/j.1750-2659.2008.00049.x
19449500	Therapies for coronaviruses. Part I of II -- viral entry inhibitors.	2009 Mar	England	10.1517/13543770802609384
19444037	Review of new and newly discovered respiratory tract viruses in children.	2009 May	United States	10.1097/PEC.0b013e3181a3497e
19442544	Intestinal mucosal immune response in ducklings following oral immunisation withan attenuated Duck enteritis virus vaccine.	2010 Aug	England	10.1016/j.tvjl.2009.04.011
19441924	Therapies for coronaviruses. Part 2: Inhibitors of intracellular life cycle.	2009 Apr	England	10.1517/13543770802600698
19439480	Characterization of a highly conserved domain within the severe acute respiratorysyndrome coronavirus spike protein S2 domain with characteristics of a viralfusion peptide.	2009 Aug	United States	10.1128/JVI.00079-09
19439466	Coronavirus genetically redirected to the epidermal growth factor receptorexhibits effective antitumor activity against a malignant glioblastoma.	2009 Aug	United States	10.1128/JVI.00495-09
19439011	Elevated plasma surfactant protein D (SP-D) levels and a direct correlation withanti-severe acute respiratory syndrome coronavirus-specific IgG antibody in SARSpatients.	2009 Jun	England	10.1111/j.1365-3083.2009.02245.x
19436709	The SARS-unique domain (SUD) of SARS coronavirus contains two macrodomains thatbind G-quadruplexes.	2009 May	United States	10.1371/journal.ppat.1000428
19436584	Total sialic acid: an acute phase reactant in cats with a possible role in felinecoronavirus infection.	2009 Apr	Canada	
19435434	Toward better clinical data in emerging infectious diseases.	2009 Jun 15	United States	10.1086/599032
19432014	Massachusetts live vaccination protects against a novel infectious bronchitisvirus S1 genotype DMV/5642/06.	2009 Mar	United States	10.1637/8454-082108-ResNote.1
19430490	Coronaviruses post-SARS: update on replication and pathogenesis.	2009 Jun	England	10.1038/nrmicro2147
19428826	Escherichia coli expressing single-chain Fv on the cell surface as a potentialprophylactic of porcine epidemic diarrhea virus.	2009 Mar 23	Netherlands	10.1016/j.vaccine.2009.01.130
19428736	Expression and functional analysis of porcine aminopeptidase N produced inprokaryotic expression system.	2009 Apr 20	Netherlands	10.1016/j.jbiotec.2009.02.005
19428598	Procyanidins and butanol extract of Cinnamomi Cortex inhibit SARS-CoV infection.	2009 Apr	Netherlands	10.1016/j.antiviral.2009.02.001
19423547	Severe acute respiratory syndrome coronavirus nucleocapsid protein does notmodulate transcription of the human FGL2 gene.	2009 Sep	England	10.1099/vir.0.009209-0
19422787	Antigenicity and immunogenicity of SARS-CoV S protein receptor-binding domainstably expressed in CHO cells.	2009 Jul 10	United States	10.1016/j.bbrc.2009.05.003
19422193	Label-free, electrical detection of the SARS virus N-protein with nanowirebiosensors utilizing antibody mimics as capture probes.	2009 May 26	United States	10.1021/nn900086c
19420961	Development of a chimeric DNA-RNA hammerhead ribozyme targeting SARS virus.	2009	Switzerland	10.1159/000215946
19420847	Analysis of the properties of neutralizing monoclonal antibodies against thehemagglutinating encephalomyelitis virus and inhibition of HEV infection byspecific MAb.	2009 Apr	Japan	10.1292/jvms.71.447
19420084	Early upregulation of acute respiratory distress syndrome-associated cytokinespromotes lethal disease in an aged-mouse model of severe acute respiratorysyndrome coronavirus infection.	2009 Jul	United States	10.1128/JVI.00127-09
19420077	Identification of in vivo-interacting domains of the murine coronavirusnucleocapsid protein.	2009 Jul	United States	10.1128/JVI.00440-09
19419742	Molecular screening and risk factors of enterotoxigenic Escherichia coli andSalmonella spp. in diarrheic neonatal calves in Egypt.	2009 Dec	England	10.1016/j.rvsc.2009.04.006
19414227	Use of recombinant S1 spike polypeptide to develop a TCoV-specific antibodyELISA.	2009 Sep 18	Netherlands	10.1016/j.vetmic.2009.04.010
19412834	Interaction of a peptide corresponding to the loop domain of the S2 SARS-CoVvirus protein with model membranes.	2009 May	England	10.1080/09687680902926203
19411314	Ectodomain shedding of angiotensin converting enzyme 2 in human airway epithelia.	2009 Jul	United States	10.1152/ajplung.00071.2009
19409595	Two adjacent mutations on the dimer interface of SARS coronavirus 3C-likeprotease cause different conformational changes in crystal structure.	2009 Jun 5	United States	10.1016/j.virol.2009.03.034
19409420	Towards construction of viral vectors based on avian coronavirus infectiousbronchitis virus for gene delivery and vaccine development.	2009 Sep	Netherlands	10.1016/j.jviromet.2009.04.023
19407394	Expression, crystallization and preliminary crystallographic study of humancoronavirus HKU1 nonstructural protein 9.	2009 May 1	England	10.1107/S1744309109014055
19406168	Broadly targeted multiprobe QPCR for detection of coronaviruses: Coronavirus iscommon among mallard ducks (Anas platyrhynchos).	2009 Aug	Netherlands	10.1016/j.jviromet.2009.04.022
19405982	Lack of association between polymorphisms of MASP2 and susceptibility to SARScoronavirus infection.	2009 May 1	England	10.1186/1471-2334-9-51
19404494	MAVS-mediated apoptosis and its inhibition by viral proteins.	2009	United States	10.1371/journal.pone.0005466
19403678	Molecular determinants for subcellular localization of the severe acuterespiratory syndrome coronavirus open reading frame 3b protein.	2009 Jul	United States	10.1128/JVI.00367-09
19401822	Plant production of veterinary vaccines and therapeutics.	2009	Germany	10.1007/978-3-540-70868-1_5
19400136	Expression and characterization of recombinant S2 subunit of SARS-coronavirus Sfusion protein.	2009	United States	10.1007/978-0-387-73657-0_69
19398035	The ion channel activity of the SARS-coronavirus 3a protein is linked to itspro-apoptotic function.	2009 Nov	Netherlands	10.1016/j.biocel.2009.04.019
19394707	Viral nanoparticles associate with regions of inflammation and blood brainbarrier disruption during CNS infection.	2009 Jun 25	Netherlands	10.1016/j.jneuroim.2009.03.015
19394665	Severe acute respiratory syndrome coronavirus accessory protein 9b is avirion-associated protein.	2009 Jun 5	United States	10.1016/j.virol.2009.03.032
19393959	Incubation periods of acute respiratory viral infections: a systematic review.	2009 May	United States	10.1016/S1473-3099(09)70069-6
19386712	Detection of nonstructural protein 6 in murine coronavirus-infected cells andanalysis of the transmembrane topology by using bioinformatics and molecularapproaches.	2009 Jul	United States	10.1128/JVI.00254-09
19385704	Alignment-free comparison of protein sequences based on reduced amino acidalphabets.	2009 Jun	England	10.1080/07391102.2009.10507288
19382676	A candidate modified-live bovine coronavirus vaccine: safety and immunogenicityevaluation.	2009 Jan	Italy	
19380790	Target-dependent B7-H1 regulation contributes to clearance of central nervoussystem infection and dampens morbidity.	2009 May 1	United States	10.4049/jimmunol.0803557
19380580	Severe acute respiratory syndrome coronavirus M protein inhibits type Iinterferon production by impeding the formation of TRAF3.TANK.TBK1/IKKepsiloncomplex.	2009 Jun 12	United States	10.1074/jbc.M109.008227
19378126	Use of GFP to investigate expression of plant-derived vaccines.	2009	United States	10.1007/978-1-59745-559-6_19
19374142	Thiopurine analogue inhibitors of severe acute respiratory syndrome-coronaviruspapain-like protease, a deubiquitinating and deISGylating enzyme.	2009	England	10.1177/095632020901900402
19373660	Detection of respiratory viruses with a multiplex polymerase chain reaction assay(MultiCode-PLx Respiratory Virus Panel) in patients with hematologicmalignancies.	2009 Apr	United States	10.1080/10428190902777665
19370396	Frequency of BCoV detection by a semi-nested PCR assay in faeces of calves fromBrazilian cattle herds.	2009 Oct	United States	10.1007/s11250-009-9347-2
19370068	The SR-rich motif in SARS-CoV nucleocapsid protein is important for virusreplication.	2009 Mar	Canada	10.1139/w08-139
19369340	Severe acute respiratory syndrome coronavirus papain-like protease ubiquitin-likedomain and catalytic domain regulate antagonism of IRF3 and NF-kappaB signaling.	2009 Jul	United States	10.1128/JVI.02220-08
19369173	Human coronaviruses 229E and NL63: close yet still so far.	2009 Apr	Singapore	10.1016/S0929-6646(09)60066-8
19364769	mRNA display design of fibronectin-based intrabodies that detect and inhibitsevere acute respiratory syndrome coronavirus nucleocapsid protein.	2009 Jun 26	United States	10.1074/jbc.M901547200
19363699	Translational control of the subgenomic RNAs of severe acute respiratory syndromecoronavirus.	2009 Aug	United States	10.1007/s11262-009-0357-y
19362479	New developments for the design, synthesis and biological evaluation of potentSARS-CoV 3CL(pro) inhibitors.	2009 May 15	England	10.1016/j.bmcl.2009.03.118
19358828	Expression of newly identified secretory CEACAM1(a) isoforms in the intestinalepithelium.	2009 Jun 5	United States	10.1016/j.bbrc.2009.04.008
19357225	Detection of polyoma and corona viruses in bats of Canada.	2009 Aug	England	10.1099/vir.0.010694-0
19357173	Bovine coronavirus nonstructural protein 1 (p28) is an RNA binding protein thatbinds terminal genomic cis-replication elements.	2009 Jun	United States	10.1128/JVI.00160-09
19346695	Genetic diversity of avian infectious bronchitis viruses in Japan based onanalysis of s2 glycoprotein gene.	2009 Mar	Japan	10.1292/jvms.71.287
19345973	APOBEC3G cytidine deaminase association with coronavirus nucleocapsid protein.	2009 May 25	United States	10.1016/j.virol.2009.03.010
19343474	Neutrophil survival factors (TNF-alpha, GM-CSF, and G-CSF) produced bymacrophages in cats infected with feline infectious peritonitis virus contributeto the pathogenesis of granulomatous lesions.	2009	Austria	10.1007/s00705-009-0371-3
19342289	Examination of seroprevalence of coronavirus HKU1 infection with S protein-basedELISA and neutralization assay against viral spike pseudotyped virus.	2009 May	Netherlands	10.1016/j.jcv.2009.02.011
19342183	Genetic diversity and phylogenetic analysis of Feline Coronavirus sequences fromPortugal.	2009 Jul 2	Netherlands	10.1016/j.vetmic.2009.03.009
19339350	Interleukin-12 (IL-12), but not IL-23, deficiency ameliorates viral encephalitiswithout affecting viral control.	2009 Jun	United States	10.1128/JVI.00315-09
19337618	Infectious bronchitis virus in Jordanian chickens: seroprevalence and detection.	2009 Jan	Canada	
19335979	[Role of CD4-CD8- T cells in the murine hepatitis virus type 3 induced chronicviral hepatitis].	2009 Mar	China	
19333547	Binding of SARS coronavirus to its receptor damages islets and causes acutediabetes.	2010 Sep	Germany	10.1007/s00592-009-0109-4
24031353	Epidemiological aspects of astrovirus and coronavirus in poults in the SouthEastern Region of Brazil.	2009 Apr	Brazil	10.1590/S1517-83822009000200008
19324051	Structural insights into immune recognition of the severe acute respiratorysyndrome coronavirus S protein receptor binding domain.	2009 May 15	England	10.1016/j.jmb.2009.03.042
19322719	Virus shedding and serum antibody responses during experimental turkeycoronavirus infections in young turkey poults.	2009 Apr	England	10.1080/03079450902751863
19322714	Molecular characterization of avian infectious bronchitis virus strains fromoutbreaks in Argentina (2001-2008).	2009 Apr	England	10.1080/03079450902737821
19322648	Expression and membrane integration of SARS-CoV E protein and its interactionwith M protein.	2009 Jun	United States	10.1007/s11262-009-0341-6
19321428	Activation of the SARS coronavirus spike protein via sequential proteolyticcleavage at two distinct sites.	2009 Apr 7	United States	10.1073/pnas.0809524106
19319948	Coronavirus infection and hospitalizations for acute respiratory illness in youngchildren.	2009 May	United States	10.1002/jmv.21443
19319935	C-terminal domain of SARS-CoV main protease can form a 3D domain-swapped dimer.	2009 Apr	United States	10.1002/pro.76
19308801	An outbreak of human metapneumovirus infection in hospitalized psychiatric adultpatients in Taiwan.	2009	England	10.1080/00365540902849375
19304506	[Prokaryotic expression of S2 extracellular domain of SARS coronavirus spikeprotein and its fusion with Hela cell membrane].	2009 Mar	China	
19304306	The 8ab protein of SARS-CoV is a luminal ER membrane-associated protein andinduces the activation of ATF6.	2009 May 10	United States	10.1016/j.virol.2009.02.021
19303123	Intestinal mucosal immune response against virulent duck enteritis virusinfection in ducklings.	2009 Oct	England	10.1016/j.rvsc.2009.02.009
19301093	Rapid detection and non-subjective characterisation of infectious bronchitisvirus isolates using high-resolution melt curve analysis and a mathematicalmodel.	2009	Austria	10.1007/s00705-009-0357-1
19299698	Recombinant Ov-ASP-1, a Th1-biased protein adjuvant derived from the helminthOnchocerca volvulus, can directly bind and activate antigen-presenting cells.	2009 Apr 1	United States	10.4049/jimmunol.0800531
19297500	Biochemical characterization of arterivirus nonstructural protein 11 reveals thenidovirus-wide conservation of a replicative endoribonuclease.	2009 Jun	United States	10.1128/JVI.00261-09
19297479	Differential virological and immunological outcome of severe acute respiratorysyndrome coronavirus infection in susceptible and resistant transgenic miceexpressing human angiotensin-converting enzyme 2.	2009 Jun	United States	10.1128/JVI.02272-08
19291090	Neutralizing antibody against severe acute respiratory syndrome(SARS)-coronavirus spike is highly effective for the protection of mice in themurine SARS model.	2009 Feb	Australia	10.1111/j.1348-0421.2008.00097.x
19289133	Timely identification of optimal control strategies for emerging infectiousdiseases.	2009 Jul 7	England	10.1016/j.jtbi.2009.03.006
19287830	A coronavirus detected in the vampire bat Desmodus rotundus.	2008 Dec	Brazil	10.1590/s1413-86702008000600003
19287488	Interaction of the coronavirus infectious bronchitis virus membrane protein withbeta-actin and its implication in virion assembly and budding.	2009	United States	10.1371/journal.pone.0004908
19275708	Drug targets in severe acute respiratory syndrome (SARS) virus and othercoronavirus infections.	2009 Apr	United Arab Emirates	10.2174/187152609787847659
19264783	Suppression of host gene expression by nsp1 proteins of group 2 batcoronaviruses.	2009 May	United States	10.1128/JVI.02485-08
19264610	Comparison of vesicular stomatitis virus pseudotyped with the S proteins from aporcine and a human coronavirus.	2009 Jul	England	10.1099/vir.0.009704-0
19261195	Differential stepwise evolution of SARS coronavirus functional proteins indifferent host species.	2009 Mar 5	England	10.1186/1471-2148-9-52
19258054	The autoimmune response induced by mouse hepatitis virus A59 is expanded by ahepatotoxic agent.	2009 May	Netherlands	10.1016/j.intimp.2009.02.006
19254859	A review of feline infectious peritonitis virus infection: 1963-2008.	2009 Apr	England	10.1016/j.jfms.2008.09.008
19254548	Thermostability of the N-terminal RNA-binding domain of the SARS-CoV nucleocapsidprotein: experiments and numerical simulations.	2009 Mar 4	United States	10.1016/j.bpj.2008.10.045
19252844	Antibody fragment expression and purification.	2009	United States	10.1007/978-1-59745-554-1_25
19246070	Survival of surrogate coronaviruses in water.	2009 Apr	England	10.1016/j.watres.2009.02.002
19208150	A computational analysis of SARS cysteine proteinase-octapeptide substrateinteraction: implication for structure and active site binding mechanism.	2009 Jan 30	England	10.1186/1471-2105-10-S1-S48
19242786	Sequence and phylogenetic analysis of S1, S2, M, and N genes of infectiousbronchitis virus isolates from Malaysia.	2009 Jun	United States	10.1007/s11262-009-0337-2
19239771	Detection of novel SARS-like and other coronaviruses in bats from Kenya.	2009 Mar	United States	10.3201/eid1503.081013
19239338	Human coronavirus and acute respiratory illness in older adults with chronicobstructive pulmonary disease.	2009 Mar 15	United States	10.1086/597122
19239038	[Expression, purification and antibody preparation of recombinat SARS-CoV X5protein].	2008 Nov	China	
19235872	Epidemiological and clinical study of viral respiratory tract infections inchildren from Italy.	2009 Apr	United States	10.1002/jmv.21457
19234811	Differential characteristics of the early stage of lung inflammation induced bySARS-CoV Nucleocapsid protein related to age in the mouse.	2009 Jun	Switzerland	10.1007/s00011-009-8062-9
19233643	Aryl diketoacids (ADK) selectively inhibit duplex DNA-unwinding activity of SARScoronavirus NTPase/helicase.	2009 Mar 15	England	10.1016/j.bmcl.2009.02.010
19224332	Interaction between SARS-CoV helicase and a multifunctional cellular protein(Ddx5) revealed by yeast and mammalian cell two-hybrid systems.	2009	Austria	10.1007/s00705-009-0323-y
19219965	Case definitions for the 4 diseases requiring notification to WHO in allcircumstances under the IHR (2005).	2009 Feb 13	Switzerland	
19219402	Identification of sequence changes responsible for the attenuation of avianinfectious bronchitis virus strain Arkansas DPI.	2009	Austria	10.1007/s00705-009-0325-9
19216624	Potent human monoclonal antibodies against SARS CoV, Nipah and Hendra viruses.	2009 Mar	England	10.1517/14712590902763755
19215224	Non-invasive imaging of mouse hepatitis coronavirus infection revealsdeterminants of viral replication and spread in vivo.	2009 May	England	10.1111/j.1462-5822.2009.01298.x
19210229	SARS-CoV spike proteins expressed by the vaccinia virus Tiantan strain: secretedsq protein induces robust neutralization antibody in mice.	2009 Feb	United States	10.1089/vim.2008.0064
19208801	Functional screen reveals SARS coronavirus nonstructural protein nsp14 as a novelcap N7 methyltransferase.	2009 Mar 3	United States	10.1073/pnas.0808790106
19203466	Molecular targets for diagnostics and therapeutics of severe acute respiratorysyndrome (SARS-CoV).	2008 Apr 19	Canada	10.18433/j3j019
19199189	Healthcare-associated atypical pneumonia.	2009 Feb	United States	10.1055/s-0028-1119811
19198616	The spike protein of SARS-CoV--a target for vaccine and therapeutic development.	2009 Mar	England	10.1038/nrmicro2090
19196466	Immunohistochemistry for detection of avian infectious bronchitis virus strainM41 in the proventriculus and nervous system of experimentally infected chickenembryos.	2009 Feb 5	England	10.1186/1743-422X-6-15
19195443	[Application of molecular methods in the diagnosis and epidemiological study ofviral respiratory infections].	2008 Jul	Spain	10.1016/s0213-005x(08)76537-6
19194080	Phylogenetic studies of bovine coronaviruses isolated in Japan.	2009 Jan	Japan	10.1292/jvms.71.83
19186202	Comparative analysis of the immunogenicity of SARS-CoV nucleocapsid DNA vaccineadministrated with different routes in mouse model.	2009 Mar 10	Netherlands	10.1016/j.vaccine.2009.01.021
19185596	SARS coronavirus spike protein-induced innate immune response occurs viaactivation of the NF-kappaB pathway in human monocyte macrophages in vitro.	2009 Jun	Netherlands	10.1016/j.virusres.2009.01.005
19177346	Crystal structures of the X-domains of a Group-1 and a Group-3 coronavirus revealthat ADP-ribose-binding may not be a conserved property.	2009 Jan	United States	10.1002/pro.15
19177333	Demonstration of passive protection in neonatal calves against colibacillosisfollowing immunization of pregnant heifers at 3 months of gestation.	2008 Winter	United States	
19176619	Organ-specific attenuation of murine hepatitis virus strain A59 by replacement ofcatalytic residues in the putative viral cyclic phosphodiesterase ns2.	2009 Apr	United States	10.1128/JVI.02203-08
19174281	Pathophysiology of diarrhea in calves.	2009 Mar	United States	10.1016/j.cvfa.2008.10.013
19174178	Effects of infectious bronchitis virus vaccine on the oviduct of hens.	2009 Mar 4	Netherlands	10.1016/j.vaccine.2009.01.012
19168110	Delivery to the lower respiratory tract is required for effective immunizationwith Newcastle disease virus-vectored vaccines intended for humans.	2009 Mar 4	Netherlands	10.1016/j.vaccine.2009.01.009
19166843	Individual and common inhibitors of coronavirus and picornavirus main proteases.	2009 Feb 4	England	10.1016/j.febslet.2008.12.059
19166052	Isolation of 4/91 type of infectious bronchitis virus as a new variant in Japanand efficacy of vaccination against 4/91 type field isolate.	2008 Dec	United States	10.1637/8359-051408-Reg.1
19164471	The identification of a calmodulin-binding domain within the cytoplasmic tail ofangiotensin-converting enzyme-2.	2009 May	United States	10.1210/en.2008-1274
19162099	Sequence analysis of divergent canine coronavirus strains present in a UK dogpopulation.	2009 Apr	Netherlands	10.1016/j.virusres.2008.12.009
19162098	Molecular characterization of a canine respiratory coronavirus strain detected inItaly.	2009 Apr	Netherlands	10.1016/j.virusres.2008.12.011
19159014	A novel replication-competent vaccinia vector MVTT is superior to MVA forinducing high levels of neutralizing antibody via mucosal vaccination.	2009	United States	10.1371/journal.pone.0004180
19156578	Comparative analysis of the sialic acid binding activity and the tropism for therespiratory epithelium of four different strains of avian infectious bronchitisvirus.	2009 Feb	England	10.1080/03079450802632049
19153302	Rate of concurrent otitis media in upper respiratory tract infections withspecific viruses.	2009 Jan	United States	10.1001/archotol.135.1.17
19153232	Severe acute respiratory syndrome coronavirus nsp9 dimerization is essential forefficient viral growth.	2009 Apr	United States	10.1128/JVI.01505-08
19152635	Peptide nanoparticles as novel immunogens: design and analysis of a prototypicsevere acute respiratory syndrome vaccine.	2009 Jan	England	10.1111/j.1747-0285.2008.00746.x
19144641	Structural basis of inhibition specificities of 3C and 3C-like proteases byzinc-coordinating and peptidomimetic compounds.	2009 Mar 20	United States	10.1074/jbc.M807947200
19141454	Production of protective gamma interferon by natural killer cells during earlymouse hepatitis virus infection.	2009 Feb	England	10.1099/vir.0.005876-0
19141357	Role of regulatory T cells in coronavirus-induced acute encephalitis.	2009 Mar 15	United States	10.1016/j.virol.2008.12.014
19129753	Crossing barriers: infections of the lung and the gut.	2009 Mar	United States	10.1038/mi.2008.79
19125153	Inhibition of IRF3-dependent antiviral responses by cellular and viral proteins.	2009 Jan	England	10.1038/cr.2009.1
19124777	Cryo-electron tomography of mouse hepatitis virus: Insights into the structure ofthe coronavirion.	2009 Jan 13	United States	10.1073/pnas.0805270106
19124753	Type I IFN-mediated protection of macrophages and dendritic cells secures controlof murine coronavirus infection.	2009 Jan 15	United States	10.4049/jimmunol.182.2.1099
19122402	Existence of avian infectious bronchitis virus with a European-prevalent 4/91genotype in Japan.	2008 Dec	Japan	10.1292/jvms.70.1341
19122397	Antibody-dependent enhancement occurs upon re-infection with the identicalserotype virus in feline infectious peritonitis virus infection.	2008 Dec	Japan	10.1292/jvms.70.1315
19120977	Analysis of severe acute respiratory syndrome coronavirus structural proteins invirus-like particle assembly.	2008 Dec	Australia	10.1111/j.1348-0421.2008.00079.x
19117866	Severe acute respiratory syndrome-associated coronavirus infection in Torontochildren: a second look.	2009 Jan	United States	10.1542/peds.2007-3745
19117699	Genetic diversity and correlation with feline infectious peritonitis of felinecoronavirus type I and II: a 5-year study in Taiwan.	2009 May 12	Netherlands	10.1016/j.vetmic.2008.11.010
20707223	[Avian infectious bronchitis disease in Tunisia: seroprevalence, pathogenicityand compatibility studies of vaccine-field isolates].	2009	Tunisia	
19112100	SARS-CoV proteins decrease levels and activity of human ENaC via activation ofdistinct PKC isoforms.	2009 Mar	United States	10.1152/ajplung.90437.2008
19111020	The pathogen receptor liver and lymph node sinusoidal endotelial cell C-typelectin is expressed in human Kupffer cells and regulated by PU.1.	2009 Jan	United States	10.1002/hep.22678
19109397	Severe acute respiratory syndrome coronavirus triggers apoptosis via proteinkinase R but is resistant to its antiviral activity.	2009 Mar	United States	10.1128/JVI.01245-08
19106108	Glycogen synthase kinase-3 regulates the phosphorylation of severe acuterespiratory syndrome coronavirus nucleocapsid protein and viral replication.	2009 Feb 20	United States	10.1074/jbc.M805747200
19106006	IL-15 independent maintenance of virus-specific CD8(+) T cells in the CNS duringchronic infection.	2009 Feb 15	Netherlands	10.1016/j.jneuroim.2008.11.005
19103225	Characterization of a continuous feline mammary epithelial cell line susceptibleto feline epitheliotropic viruses.	2009 Apr	Netherlands	10.1016/j.jviromet.2008.11.018
19102764	Complete genomic sequence analysis of infectious bronchitis virus Ark DPI strainand its evolution by recombination.	2008 Dec 22	England	10.1186/1743-422X-5-157
19100792	Identification of Taiwan and China-like recombinant avian infectious bronchitisviruses in Taiwan.	2009 Mar	Netherlands	10.1016/j.virusres.2008.11.012
19091867	Severe acute respiratory syndrome coronavirus protein 6 is required for optimalreplication.	2009 Mar	United States	10.1128/JVI.02371-08
19089556	Comprehensive detection of causative pathogens using real-time PCR to diagnosepediatric community-acquired pneumonia.	2008 Dec	Netherlands	10.1007/s10156-008-0648-6
19086372	Pathogenicity of infectious bronchitis virus isolates from Ontario chickens.	2008 Oct	Canada	
19085958	The novel CD4+CD25+ regulatory T cell effector molecule fibrinogen-like protein 2contributes to the outcome of murine fulminant viral hepatitis.	2009 Feb	United States	10.1002/hep.22684
19079579	MyD88 is required for protection from lethal infection with a mouse-adaptedSARS-CoV.	2008 Dec	United States	10.1371/journal.ppat.1000240
19073197	A Poisson model of sequence comparison and its application to coronavirusphylogeny.	2009 Feb	United States	10.1016/j.mbs.2008.11.006
19070879	Infectious Bronchitis Virus induces acute interferon-gamma production throughpolyclonal stimulation of chicken leukocytes.	2009 Mar 1	United States	10.1016/j.virol.2008.11.021
18708675	An evaluation of SARS and droplet infection control practices in acute andrehabilitation hospitals in Hong Kong.	2008 Aug	China	
18708674	Studies of SARS virus vaccines.	2008 Aug	China	
18708673	Helicases as antiviral drug targets.	2008 Aug	China	
18708672	Role of polymorphisms of the inflammatory response genes and DC-SIGNR in geneticsusceptibility to SARS and other infections.	2008 Aug	China	
18708671	Investigation of immunogenic T-cell epitopes in SARS virus nucleocapsid proteinand their role in the prevention and treatment of SARS infection.	2008 Aug	China	
18708670	Mechanisms of lymphocyte loss in SARS coronavirus infection.	2008 Aug	China	
18708669	Risk-stratified seroprevalence of SARS coronavirus in children residing in adistrict with point-source outbreak compared to a low-risk area.	2008 Aug	China	
18708668	Molecular and genetic characterisation of the SARS coronavirus auxiliary proteinX1 in Drosophila.	2008 Aug	China	
18708667	SARS coronavirus and apoptosis.	2008 Aug	China	
18708666	Expression and functional characterisation of the putative SARS coronavirusnon-structural proteins X1-X5.	2008 Aug	China	
19068525	SARS- and other coronaviruses.	2008	United States	10.1007/978-1-59745-181-9
19066576	Titration of human coronaviruses using an immunoperoxidase assay.	2008 Apr 28	United States	10.3791/751
19065798	SCHOOL model and new targeting strategies.	2008	United States	10.1007/978-0-387-09789-3_20
19063921	Rapid detection and identification of 12 respiratory viruses using a dual primingoligonucleotide system-based multiplex PCR assay.	2009 Mar	Netherlands	10.1016/j.jviromet.2008.11.007
19059617	IFN-gamma-mediated suppression of coronavirus replication in glial-committedprogenitor cells.	2009 Feb 5	United States	10.1016/j.virol.2008.10.036
19058829	Activation of p38 MAPK by feline infectious peritonitis virus regulatespro-inflammatory cytokine production in primary blood-derived feline mononuclearcells.	2009 Feb 5	United States	10.1016/j.virol.2008.11.006
19057882	A pancoronavirus RT-PCR assay for detection of all known coronaviruses.	2008	United States	10.1007/978-1-59745-181-9_1
19057881	Isolation and propagation of coronaviruses in embryonated eggs.	2008	United States	10.1007/978-1-59745-181-9_10
19057880	Large-scale preparation of UV-inactivated SARS coronavirus virions for vaccineantigen.	2008	United States	10.1007/978-1-59745-181-9_11
19057879	Purification and electron cryomicroscopy of coronavirus particles.	2008	United States	10.1007/978-1-59745-181-9_12
19057878	Production of coronavirus nonstructural proteins in soluble form forcrystallization.	2008	United States	10.1007/978-1-59745-181-9_13
19057877	Generating antibodies to the gene 3 proteins of infectious bronchitis virus.	2008	United States	10.1007/978-1-59745-181-9_14
19057876	Establishment and characterization of monoclonal antibodies against SARScoronavirus.	2008	United States	10.1007/978-1-59745-181-9_15
19057874	Manipulation of the coronavirus genome using targeted RNA recombination withinterspecies chimeric coronaviruses.	2008	United States	10.1007/978-1-59745-181-9_17
19057873	Generation of recombinant coronaviruses using vaccinia virus as the cloningvector and stable cell lines containing coronaviral replicon RNAs.	2008	United States	10.1007/978-1-59745-181-9_18
19057872	Transient dominant selection for the modification and generation of recombinantinfectious bronchitis coronaviruses.	2008	United States	10.1007/978-1-59745-181-9_19
19057871	Detection of group 1 coronaviruses in bats using universal coronavirus reversetranscription polymerase chain reactions.	2008	United States	10.1007/978-1-59745-181-9_2
19057870	Engineering infectious cDNAs of coronavirus as bacterial artificial chromosomes.	2008	United States	10.1007/978-1-59745-181-9_20
19057869	Systematic assembly and genetic manipulation of the mouse hepatitis virus A59genome.	2008	United States	10.1007/978-1-59745-181-9_21
19057868	Identification of sugar residues involved in the binding of TGEV to porcine brushborder membranes.	2008	United States	10.1007/978-1-59745-181-9_22
19057867	Pseudotyped vesicular stomatitis virus for analysis of virus entry mediated bySARS coronavirus spike proteins.	2008	United States	10.1007/978-1-59745-181-9_23
19057866	Detection and sequence characterization of the 3'-end of coronavirus genomesharboring the highly conserved RNA motif s2m.	2008	United States	10.1007/978-1-59745-181-9_3
19057865	RT-PCR detection of avian coronaviruses of galliform birds (chicken, turkey,pheasant) and in a parrot.	2008	United States	10.1007/978-1-59745-181-9_4
19057864	Detection of group 2a coronaviruses with emphasis on bovine and wild ruminantstrains. Virus isolation and detection of antibody, antigen, and nucleic acid.	2008	United States	10.1007/978-1-59745-181-9_5
19057863	Detection of SARS coronavirus in humans and animals by conventional andquantitative (real time) reverse transcription polymerase chain reactions.	2008	United States	10.1007/978-1-59745-181-9_6
19057862	Detection of new viruses by VIDISCA. Virus discovery based on cDNA-amplifiedfragment length polymorphism.	2008	United States	10.1007/978-1-59745-181-9_7
19057861	Titration of human coronaviruses, HcoV-229E and HCoV-OC43, by an indirectimmunoperoxidase assay.	2008	United States	10.1007/978-1-59745-181-9_8
19057860	The preparation of chicken tracheal organ cultures for virus isolation,propagation, and titration.	2008	United States	10.1007/978-1-59745-181-9_9
19056023	Characteristic features and outcomes of severe acute respiratory syndrome foundin severe acute respiratory syndrome intensive care unit patients.	2008 Dec	United States	10.1016/j.jcrc.2007.05.004
19052324	Mechanisms of severe acute respiratory syndrome pathogenesis and innateimmunomodulation.	2008 Dec	United States	10.1128/MMBR.00015-08
19052087	Novel influenza virus NS1 antagonists block replication and restore innate immunefunction.	2009 Feb	United States	10.1128/JVI.01805-08
19052085	Nuclear magnetic resonance structure shows that the severe acute respiratorysyndrome coronavirus-unique domain contains a macrodomain fold.	2009 Feb	United States	10.1128/JVI.01781-08
19052082	Multiple nucleic acid binding sites and intrinsic disorder of severe acuterespiratory syndrome coronavirus nucleocapsid protein: implications forribonucleocapsid protein packaging.	2009 Mar	United States	10.1128/JVI.02001-08
19050106	Searching immunodominant epitopes prior to epidemic: HLA class II-restrictedSARS-CoV spike protein epitopes in unexposed individuals.	2009 Jan	England	10.1093/intimm/dxn124
19049248	The use of cross-foster rederivation to eliminate murine norovirus, Helicobacterspp., and murine hepatitis virus from a mouse colony.	2008 Nov	United States	
19048198	Viral protease inhibitors.	2009	Germany	10.1007/978-3-540-79086-0_4
19046513	Detection and phylogenetic analysis of group 1 coronaviruses in South Americanbats.	2008 Dec	United States	10.3201/eid1412.080642
19043660	B-cell activation in cats with feline infectious peritonitis (FIP) byFIP-virus-induced B-cell differentiation/survival factors.	2009	Austria	10.1007/s00705-008-0265-9
19041346	Comparison of four nasal sampling methods for the detection of viral pathogens byRT-PCR-A GA(2)LEN project.	2009 Mar	Netherlands	10.1016/j.jviromet.2008.10.027
19038782	Development of an enzyme-linked immunosorbent assay-based test with a cocktail ofnucleocapsid and spike proteins for detection of severe acute respiratorysyndrome-associated coronavirus-specific antibody.	2009 Feb	United States	10.1128/CVI.00252-08
19038059	The expression and antigenicity of a truncated spike-nucleocapsid fusion proteinof severe acute respiratory syndrome-associated coronavirus.	2008 Nov 28	England	10.1186/1471-2180-8-207
19036930	Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cellsand in mice.	2008 Dec 16	United States	10.1073/pnas.0808116105
19036814	Recombinant canine coronaviruses related to transmissible gastroenteritis virusof Swine are circulating in dogs.	2009 Feb	United States	10.1128/JVI.01937-08
19035325	[Isolation and genomic sequence analysis of porcine transmissible gastroenteritisvirus].	2008 Sep	China	
19033999	Emerging viruses in transplantation: there is more to infection after transplantthan CMV and EBV.	2008 Nov 27	United States	10.1097/TP.0b013e31818b6548
19031443	Identification of viral and atypical bacterial pathogens in children hospitalizedwith acute respiratory infections in Hong Kong by multiplex PCR assays.	2009 Jan	United States	10.1002/jmv.21364
19031435	Differential inhibitory activities and stabilisation of DNA aptamers against theSARS coronavirus helicase.	2008 Dec 15	Germany	10.1002/cbic.200800491
19027037	Human airway epithelial cell culture to identify new respiratory viruses:coronavirus NL63 as a model.	2009 Mar	Netherlands	10.1016/j.jviromet.2008.10.022
19023218	Turkey coronavirus non-structure protein NSP15--an endoribonuclease.	2008	Switzerland	10.1159/000175837
19022466	Formation of stable homodimer via the C-terminal alpha-helical domain ofcoronavirus nonstructural protein 9 is critical for its function in viralreplication.	2009 Jan 20	United States	10.1016/j.virol.2008.10.032
19022319	Vaccine-induced enhancement of viral infections.	2009 Jan 22	Netherlands	10.1016/j.vaccine.2008.10.087
19014487	Plaque assay for human coronavirus NL63 using human colon carcinoma cells.	2008 Nov 12	England	10.1186/1743-422X-5-138
19013196	Development of a quantitative real-time PCR for the detection of caninerespiratory coronavirus.	2009 Feb	Netherlands	10.1016/j.jviromet.2008.10.008
19013091	Field strain feline coronaviruses with small deletions in ORF7b associated withboth enteric infection and feline infectious peritonitis.	2009 Jun	England	10.1016/j.jfms.2008.09.004
19011250	QX genotypes of infectious bronchitis virus circulating in Europe.	2008 Nov 15	England	10.1136/vr.163.20.606-d
19004938	Severe acute respiratory syndrome (SARS) coronavirus-induced lung epithelialcytokines exacerbate SARS pathogenesis by modulating intrinsic functions ofmonocyte-derived macrophages and dendritic cells.	2009 Apr	United States	10.1128/JVI.01792-08
19004507	Progression of lesions in the respiratory tract of broilers after singleinfection with Escherichia coli compared to superinfection with E. coli afterinfection with infectious bronchitis virus.	2009 Jan 15	Netherlands	10.1016/j.vetimm.2008.09.019
18992773	Antiviral activity of quercetin 7-rhamnoside against porcine epidemic diarrheavirus.	2009 Jan	Netherlands	10.1016/j.antiviral.2008.10.002
18991761	Structural and biochemical investigation of heptad repeat derived peptides ofhuman SARS corona virus (hSARS-CoV) spike protein.	2008	Netherlands	10.2174/092986608785849173
18989460	Broadening of neutralization activity to directly block a dominantantibody-driven SARS-coronavirus evolution pathway.	2008 Nov	United States	10.1371/journal.ppat.1000197
18987166	Simple tests for rapid detection of canine parvovirus antigen and canineparvovirus-specific antibodies.	2009 Jan	United States	10.1128/CVI.00304-08
18987164	Humoral and cellular immune responses induced by 3a DNA vaccines against severeacute respiratory syndrome (SARS) or SARS-like coronavirus in mice.	2009 Jan	United States	10.1128/CVI.00261-08
18987156	Crystal structures of two coronavirus ADP-ribose-1''-monophosphatases and theircomplexes with ADP-Ribose: a systematic structural analysis of the viral ADRPdomain.	2009 Jan	United States	10.1128/JVI.01862-08
18987136	Identification of major histocompatibility complex class I C molecule as anattachment factor that facilitates coronavirus HKU1 spike-mediated infection.	2009 Jan	United States	10.1128/JVI.01387-08
18986662	Conserved amino acids W423 and N424 in receptor-binding domain of SARS-CoV arepotential targets for therapeutic monoclonal antibody.	2009 Jan 5	United States	10.1016/j.virol.2008.09.029
18983873	Identification of a minimal peptide derived from heptad repeat (HR) 2 of spikeprotein of SARS-CoV and combination of HR1-derived peptides as fusion inhibitors.	2009 Jan	Netherlands	10.1016/j.antiviral.2008.10.001
18983849	Differential activities of cellular and viral macro domain proteins in binding ofADP-ribose metabolites.	2009 Jan 9	England	10.1016/j.jmb.2008.10.045
18977539	Quantification of mRNA encoding cytokines and chemokines and assessment ofciliary function in canine tracheal epithelium during infection with caninerespiratory coronavirus (CRCoV).	2009 Jan 15	Netherlands	10.1016/j.vetimm.2008.09.017
18976820	Course of infection and immune responses in the respiratory tract of IBV infectedbroilers after superinfection with E. coli.	2009 Jan 15	Netherlands	10.1016/j.vetimm.2008.09.016
18973912	Insertion of the CXC chemokine ligand 9 (CXCL9) into the mouse hepatitis virusgenome results in protection from viral-induced encephalitis and hepatitis.	2008 Dec 20	United States	10.1016/j.virol.2008.09.032
18971306	Seroprevalence of turkey coronavirus in North American turkeys determined by anewly developed enzyme-linked immunosorbent assay based on recombinant antigen.	2008 Dec	United States	10.1128/CVI.00319-08
18971277	Comparative analysis of complete genome sequences of three avian coronavirusesreveals a novel group 3c coronavirus.	2009 Jan	United States	10.1128/JVI.01977-08
18971274	Protease-mediated entry via the endosome of human coronavirus 229E.	2009 Jan	United States	10.1128/JVI.01933-08
18971158	Seroprevalence of SARS Coronavirus Among Residents Near a Hospital with aNosocomial Outbreak.	2008 Nov	Singapore	10.1016/S0929-6646(08)60205-3
18958613	Expression of SARS-coronavirus spike glycoprotein in Pichia pastoris.	2009 Feb	United States	10.1007/s11262-008-0292-3
18957937	PLP2, a potent deubiquitinase from murine hepatitis virus, strongly inhibitscellular type I interferon production.	2008 Nov	England	10.1038/cr.2008.294
18955825	Detection of antibodies against SARS-Coronavirus using recombinant truncatednucleocapsid proteins by ELISA.	2008 Oct	Korea (South)	
18955085	LNA probe-based real-time RT-PCR for the detection of infectious bronchitis virusfrom the oviduct of unvaccinated and vaccinated laying hens.	2009 Jan	Netherlands	10.1016/j.jviromet.2008.09.028
18954762	Emerging and zoonotic infections in women.	2008 Dec	United States	10.1016/j.idc.2008.05.007
18949029	Prevention of cytotoxic T cell escape using a heteroclitic subdominant viral Tcell determinant.	2008 Oct	United States	10.1371/journal.ppat.1000186
18945884	Development of a nucleocapsid-based human coronavirus immunoassay and estimatesof individuals exposed to coronavirus in a U.S. metropolitan population.	2008 Dec	United States	10.1128/CVI.00124-08
18941225	Prior immunization with severe acute respiratory syndrome (SARS)-associatedcoronavirus (SARS-CoV) nucleocapsid protein causes severe pneumonia in miceinfected with SARS-CoV.	2008 Nov 1	United States	10.4049/jimmunol.181.9.6337
18939636	Transmissibility of infectious bronchitis virus H120 vaccine strain amongbroilers under experimental conditions.	2008 Sep	United States	10.1637/8204-010708-Reg.1
18939499	[SARS vaccines].	2008 Oct	Japan	
18820582	New respiratory viruses of humans.	2008 Oct	United States	10.1097/INF.0b013e3181684d7c
18936097	The tumor marker human placental protein 11 is an endoribonuclease.	2008 Dec 12	United States	10.1074/jbc.M805759200
18931070	Interaction of severe acute respiratory syndrome-coronavirus and NL63 coronavirusspike proteins with angiotensin converting enzyme-2.	2008 Nov	England	10.1099/vir.0.2008/003962-0
18931069	Surface-expressed viral proteins in feline infectious peritonitis virus-infectedmonocytes are internalized through a clathrin- and caveolae-independent pathway.	2008 Nov	England	10.1099/vir.0.2008/002212-0
18927951	Papular cutaneous lesions in a cat associated with feline infectious peritonitis.	2008 Oct	England	10.1111/j.1365-3164.2008.00684.x
18926799	SARS coronavirus: unusual lability of the nucleocapsid protein.	2008 Dec 12	United States	10.1016/j.bbrc.2008.09.153
18922871	Mouse hepatitis virus liver pathology is dependent on ADP-ribose-1''-phosphatase,a viral function conserved in the alpha-like supergroup.	2008 Dec	United States	10.1128/JVI.02082-08
18852458	A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARSvirus replication.	2008 Oct 21	United States	10.1073/pnas.0805240105
18849544	Spike protein, S, of human coronavirus HKU1: role in viral life cycle andapplication in antibody detection.	2008 Dec	England	10.3181/0806-RM-197
18845442	Evaluation of peptide-aldehyde inhibitors using R188I mutant of SARS 3CL proteaseas a proteolysis-resistant mutant.	2008 Nov 1	England	10.1016/j.bmc.2008.09.057
18842892	Neuroprotective effect of apolipoprotein D against human coronavirus OC43-inducedencephalitis in mice.	2008 Oct 8	United States	10.1523/JNEUROSCI.2644-08.2008
18842722	Bovine-like coronaviruses isolated from four species of captive wild ruminantsare homologous to bovine coronaviruses, based on complete genomic sequences.	2008 Dec	United States	10.1128/JVI.01586-08
18842712	Memory CD4+ T-cell-mediated protection from lethal coronavirus encephalomyelitis.	2008 Dec	United States	10.1128/JVI.01267-08
18842706	Topology and membrane anchoring of the coronavirus replication complex: not allhydrophobic domains of nsp3 and nsp6 are membrane spanning.	2008 Dec	United States	10.1128/JVI.01219-08
18840974	Serosurveillance of viral diseases in Korean native goats (Capra hircus).	2008 Sep	Japan	10.1292/jvms.70.977
18840967	Virological and serological studies of porcine respiratory coronavirus infectionon a Japanese farm.	2008 Sep	Japan	10.1292/jvms.70.929
18840402	The immunoreactivity of a chimeric multi-epitope DNA vaccine against IBV inchickens.	2008 Dec 5	United States	10.1016/j.bbrc.2008.09.125
18835795	Reduced likelihood of bovine coronavirus and bovine respiratory syncytial virusinfection on organic compared to conventional dairy farms.	2009 Dec	England	10.1016/j.tvjl.2008.08.010
18832706	T cell responses to whole SARS coronavirus in humans.	2008 Oct 15	United States	10.4049/jimmunol.181.8.5490
18827877	Genome-wide analysis of protein-protein interactions and involvement of viralproteins in SARS-CoV replication.	2008 Oct 1	United States	10.1371/journal.pone.0003299
18827378	Design and synthesis of cinanserin analogs as severe acute respiratory syndromecoronavirus 3CL protease inhibitors.	2008 Oct	Japan	10.1248/cpb.56.1400
18824060	A SARS DNA vaccine induces neutralizing antibody and cellular immune responses inhealthy adults in a Phase I clinical trial.	2008 Nov 25	Netherlands	10.1016/j.vaccine.2008.09.026
18823911	Respiratory pathogens in children with and without respiratory symptoms.	2009 Mar	United States	10.1016/j.jpeds.2008.08.036
18822205	[The functions of liver natural killer cells in murine fulminant hepatitisinduced by murine hepatitis virus strain 3].	2008 Sep	China	
18821175	Detection of respiratory viruses and Legionella spp. by real-time polymerasechain reaction in patients with community acquired pneumonia.	2009	England	10.1080/00365540802448799
18818423	Inhibition of the interaction between the SARS-CoV spike protein and its cellularreceptor by anti-histo-blood group antibodies.	2008 Dec	England	10.1093/glycob/cwn093
18818320	Systematic assembly of a full-length infectious clone of human coronavirus NL63.	2008 Dec	United States	10.1128/JVI.01804-08
18815297	Murine coronaviruses encoding nsp2 at different genomic loci have alteredreplication, protein expression, and localization.	2008 Dec	United States	10.1128/JVI.01126-07
18814896	Importance of cholesterol-rich membrane microdomains in the interaction of the Sprotein of SARS-coronavirus with the cellular receptor angiotensin-convertingenzyme 2.	2008 Nov 25	United States	10.1016/j.virol.2008.08.026
18806349	Risk factors for SARS infection within hospitals in Hanoi, Vietnam.	2008 Sep	Japan	
18806283	Prevalence of antibodies to canine respiratory coronavirus in some dogpopulations in Japan.	2008 Sep 20	England	10.1136/vr.163.12.368
18806281	Prevalence of four enteropathogens in the faeces of young diarrhoeic dairy calvesin Switzerland.	2008 Sep 20	England	10.1136/vr.163.12.362
18805454	A prime-boost vaccination protocol optimizes immune responses against thenucleocapsid protein of the SARS coronavirus.	2008 Dec 2	Netherlands	10.1016/j.vaccine.2008.09.006
18801550	Rhesus angiotensin converting enzyme 2 supports entry of severe acute respiratorysyndrome coronavirus in Chinese macaques.	2008 Nov 10	United States	10.1016/j.virol.2008.08.016
18800235	Impairment of germline transmission after blastocyst injection with murineembryonic stem cells cultured with mouse hepatitis virus and mouse minute virus.	2009 Feb	Netherlands	10.1007/s11248-008-9216-1
18799586	Utilization of DC-SIGN for entry of feline coronaviruses into host cells.	2008 Dec	United States	10.1128/JVI.01094-08
18798692	SARS-coronavirus replication is supported by a reticulovesicular network ofmodified endoplasmic reticulum.	2008 Sep 16	United States	10.1371/journal.pbio.0060226
18798022	Pathogenicity of a QX strain of infectious bronchitis virus in specific pathogenfree and commercial broiler chickens, and evaluation of protection induced by avaccination programme based on the Ma5 and 4/91 serotypes.	2008 Oct	England	10.1080/03079450802356938
18796655	What are the risks--hypothetical and observed--of recombination involving livevaccines and vaccine vectors based on nonsegmented negative-strain RNA viruses?	2008 Oct	United States	10.1128/JVI.01336-08
18796354	Design, synthesis and antiviral efficacy of a series of potent chloropyridylester-derived SARS-CoV 3CLpro inhibitors.	2008 Oct 15	England	10.1016/j.bmcl.2008.08.082
18792806	Interactions between M protein and other structural proteins of severe, acuterespiratory syndrome-associated coronavirus.	2008 Nov	England	10.1007/s11373-008-9278-3
18792774	Characterization and membrane gene-based phylogenetic analysis of avianinfectious bronchitis virus Chinese strain HH06.	2009 Feb	United States	10.1007/s11262-008-0280-7
18786990	Entry from the cell surface of severe acute respiratory syndrome coronavirus withcleaved S protein as revealed by pseudotype virus bearing cleaved S protein.	2008 Dec	United States	10.1128/JVI.01412-08
18785966	Multiple viral respiratory pathogens in children with bronchiolitis.	2009 Jan	Norway	10.1111/j.1651-2227.2008.01023.x
18784843	Lentivirus display: stable expression of human antibodies on the surface of humancells and virus particles.	2008 Sep 11	United States	10.1371/journal.pone.0003181
18783789	Spinal cryptococcoma in an immunocompetent cat.	2008 Nov	England	10.1016/j.jcpa.2008.06.007
18783027	Detection of respiratory pathogens in air samples from acutely infected pigs.	2008 Jul	Canada	
18781076	Severe acute respiratory syndrome coronavirus elicits a weak interferon responsecompared to traditional interferon-inducing viruses.	2008	Switzerland	10.1159/000154258
18780635	[Development and comparison of real-time and conventional RT-PCR assay fordetection of human coronavirus NL63 and HKU1].	2008 Jul	China	
18778958	Evaluation of rapid assays for the detection of bovine coronavirus, rotavirus Aand Cryptosporidium parvum in faecal samples of calves.	2009 Dec	England	10.1016/j.tvjl.2008.07.016
18776180	Parrot proventricular dilation disease.	2008 Sep 6	England	10.1136/vr.163.10.310-b
18775548	Viral nucleolar localisation signals determine dynamic trafficking within thenucleolus.	2008 Oct 25	United States	10.1016/j.virol.2008.05.032
18771515	The studies on the aetiology of diarrhoea in neonatal calves and determination ofvirulence gene markers of Escherichia coli strains by multiplex PCR.	2009 Mar	Germany	10.1111/j.1863-2378.2008.01156.x
18770015	Complete genome sequence analysis of a predominant infectious bronchitis virus(IBV) strain in China.	2009 Feb	United States	10.1007/s11262-008-0282-5
18766276	[New respiratory viruses in children 2 months to 3 years old with recurrentwheeze].	2008 Aug	Argentina	10.1590/S0325-00752008000400005
18765908	Purification, crystallization and preliminary crystallographic analysis of avianinfectious bronchitis virus nsp3 ADRP domain.	2008 Sep 1	England	10.1107/S1744309108024391
18764691	Evaluation of antibodies against feline coronavirus 7b protein for diagnosis offeline infectious peritonitis in cats.	2008 Sep	United States	10.2460/ajvr.69.9.1179
18762235	Toona sinensis Roem tender leaf extract inhibits SARS coronavirus replication.	2008 Oct 30	Ireland	10.1016/j.jep.2008.07.048
18760437	An immunosuppressed Syrian golden hamster model for SARS-CoV infection.	2008 Oct 25	United States	10.1016/j.virol.2008.07.026
18757967	Steroid-induced osteonecrosis: the number of lesions is related to the dosage.	2008 Sep	England	10.1302/0301-620X.90B9.20056
18756809	[Antiviral activity of arbidol and its derivatives against the pathogen of severeacute respiratory syndrome in the cell cultures].	2008 Jul-Aug	Russia (Federation)	
18753224	Clathrin- and caveolae-independent entry of feline infectious peritonitis virusin monocytes depends on dynamin.	2008 Sep	England	10.1099/vir.0.2008/001602-0
18753223	Severe acute respiratory syndrome vaccine efficacy in ferrets: whole killed virusand adenovirus-vectored vaccines.	2008 Sep	England	10.1099/vir.0.2008/001891-0
18753196	The M, E, and N structural proteins of the severe acute respiratory syndromecoronavirus are required for efficient assembly, trafficking, and release ofvirus-like particles.	2008 Nov	United States	10.1128/JVI.01052-08
18727942	Importance of cholesterol for infection of cells by transmissible gastroenteritisvirus.	2008 Nov	Netherlands	10.1016/j.virusres.2008.07.023
18724064	Development of human single-chain antibodies against SARS-associated coronavirus.	2008	Switzerland	10.1159/000151530
18721794	Membrane insertion of the three main membranotropic sequences from SARS-CoV S2glycoprotein.	2008 Dec	Netherlands	10.1016/j.bbamem.2008.07.021
18716008	Detection of an antigenic group 2 coronavirus in an adult alpaca with enteritis.	2008 Oct	United States	10.1128/CVI.00232-08
18712847	First report on fatal myocarditis associated with adenovirus infection in Cuba.	2008 Oct	United States	10.1002/jmv.21274
18712837	Acute respiratory infection and influenza-like illness viral etiologies inBrazilian adults.	2008 Oct	United States	10.1002/jmv.21295
18712588	Sequence analysis of the gene coding for the S1 glycoprotein of infectiousbronchitis virus (IBV) strains from New Zealand.	2008 Dec	United States	10.1007/s11262-008-0273-6
18708124	A SARS-CoV protein, ORF-6, induces caspase-3 mediated, ER stress andJNK-dependent apoptosis.	2008 Dec	Netherlands	10.1016/j.bbagen.2008.07.009
18707025	Baculovirus up-regulates antiviral systems and induces protection againstinfectious bronchitis virus challenge in neonatal chicken.	2008 Dec 10	Netherlands	10.1016/j.intimp.2008.07.004
18706430	Molecular dynamic simulations analysis of ritonavir and lopinavir as SARS-CoV3CL(pro) inhibitors.	2008 Oct 21	England	10.1016/j.jtbi.2008.07.030
18703211	Dissection and identification of regions required to form pseudoparticles by theinteraction between the nucleocapsid (N) and membrane (M) proteins of SARScoronavirus.	2008 Oct 10	United States	10.1016/j.virol.2008.07.012
18701332	Association between faecal shedding of feline coronavirus and serum alpha1-acidglycoprotein sialylation.	2008 Oct	England	10.1016/j.jfms.2008.04.004
18699780	Internalization of cystatin C in human cell lines.	2008 Sep	England	10.1111/j.1742-4658.2008.06600.x
18697825	Polymorphisms in the C-type lectin genes cluster in chromosome 19 andpredisposition to severe acute respiratory syndrome coronavirus (SARS-CoV)infection.	2008 Nov	England	10.1136/jmg.2008.058966
18694760	Variable oligomerization modes in coronavirus non-structural protein 9.	2008 Nov 28	England	10.1016/j.jmb.2008.07.071
18694314	Signal amplification on a DNA-tile-based biosensor with enhanced sensitivity.	2008 Aug	England	10.2217/17435889.3.4.521
18694075	Genomic analysis and geographic visualization of H5N1 and SARS-CoV.	2007 Oct 11	United States	
18689592	Viral infection in adults hospitalized with community-acquired pneumonia:prevalence, pathogens, and presentation.	2008 Dec	United States	10.1378/chest.08-0888
18678384	Proteolytic processing of polyproteins 1a and 1ab between non-structural proteins10 and 11/12 of Coronavirus infectious bronchitis virus is dispensable for viralreplication in cultured cells.	2008 Sep 30	United States	10.1016/j.virol.2008.06.038
18671826	Bench-to-bedside review: rare and common viral infections in the intensive careunit--linking pathophysiology to clinical presentation.	2008	England	10.1186/cc6917
18667517	Gain, preservation, and loss of a group 1a coronavirus accessory glycoprotein.	2008 Oct	United States	10.1128/JVI.01031-08
18667505	Murine coronavirus mouse hepatitis virus is recognized by MDA5 and induces type Iinterferon in brain macrophages/microglia.	2008 Oct	United States	10.1128/JVI.01199-08
18658207	Structural flexibility of the pentameric SARS coronavirus envelope protein ionchannel.	2008 Sep 15	United States	10.1529/biophysj.108.133041
18646466	Genetic diversity of avian infectious bronchitis virus isolates in Korea between2003 and 2006.	2008 Jun	United States	10.1637/8117-092707-ResNote.1
18646462	Identification of a newly isolated avian infectious bronchitis coronavirusvariant in China exhibiting affinity for the respiratory tract.	2008 Jun	United States	10.1637/8110-091307-ResNote.1
18646452	Enteric viruses detected by molecular methods in commercial chicken and turkeyflocks in the United States between 2005 and 2006.	2008 Jun	United States	10.1637/8174-111507-Reg.1
18646448	Electron microscopic identification of viruses associated with poult enteritis inturkeys grown in California 1993-2003.	2008 Jun	United States	10.1637/8106-090607-Reg.1
18635322	An update on canine coronaviruses: viral evolution and pathobiology.	2008 Dec 10	Netherlands	10.1016/j.vetmic.2008.06.007
18632968	Severe acute respiratory syndrome coronavirus 3a protein activates themitochondrial death pathway through p38 MAP kinase activation.	2008 Aug	England	10.1099/vir.0.83665-0
18632870	Genomic analysis reveals age-dependent innate immune responses to severe acuterespiratory syndrome coronavirus.	2008 Oct	United States	10.1128/JVI.00489-08
18632859	The transmembrane domain of the severe acute respiratory syndrome coronavirusORF7b protein is necessary and sufficient for its retention in the Golgi complex.	2008 Oct	United States	10.1128/JVI.00784-08
18631359	Phosphorylation of the arginine/serine dipeptide-rich motif of the severe acuterespiratory syndrome coronavirus nucleocapsid protein modulates itsmultimerization, translation inhibitory activity and cellular localization.	2008 Aug	England	10.1111/j.1742-4658.2008.06564.x
18628832	Virus-like particles of SARS-like coronavirus formed by membrane proteins fromdifferent origins demonstrate stimulating activity in human dendritic cells.	2008 Jul 16	United States	10.1371/journal.pone.0002685
18628596	Etiologic study of upper respiratory infections of household dogs.	2008 Jun	Japan	10.1292/jvms.70.563
18620761	A rapid point of care immunoswab assay for SARS-CoV detection.	2008 Sep	Netherlands	10.1016/j.jviromet.2008.05.023
18619943	Construction of a non-infectious SARS coronavirus replicon for application indrug screening and analysis of viral protein function.	2008 Sep 12	United States	10.1016/j.bbrc.2008.06.129
18616295	A second SARS-CoV S2 glycoprotein internal membrane-active peptide. Biophysicalcharacterization and membrane interaction.	2008 Aug 5	United States	10.1021/bi800814q
18611220	Development of broad-spectrum halomethyl ketone inhibitors against coronavirusmain protease 3CL(pro).	2008 Jul	England	10.1111/j.1747-0285.2008.00679.x
18606506	Differential role for low pH and cathepsin-mediated cleavage of the viral spikeprotein during entry of serotype II feline coronaviruses.	2008 Dec 10	Netherlands	10.1016/j.vetmic.2008.05.019
18606245	A single amino acid substitution in the S1 and S2 Spike protein domainsdetermines the neutralization escape phenotype of SARS-CoV.	2008 Jul	France	10.1016/j.micinf.2008.05.009
18602337	Phylogenetic analysis of human coronavirus NL63 circulating in Italy.	2008 Sep	Netherlands	10.1016/j.jcv.2008.04.015
18593570	DC-SIGN mediates avian H5N1 influenza virus infection in cis and in trans.	2008 Sep 5	United States	10.1016/j.bbrc.2008.06.078
18592403	Severe acute respiratory syndrome coronavirus nucleocapsid protein confersability to efficiently produce virus-like particles when substituted for thehuman immunodeficiency virus nucleocapsid domain.	2008 Nov	England	10.1007/s11373-008-9265-8
18590747	WSE, a new sequence distance measure based on word frequencies.	2008 Sep	United States	10.1016/j.mbs.2008.06.001
18587105	Pathology of experimental SARS coronavirus infection in cats and ferrets.	2008 Jul	United States	10.1354/vp.45-4-551
18584889	High-throughput assay using a GFP-expressing replicon for SARS-CoV drugdiscovery.	2008 Nov	Netherlands	10.1016/j.antiviral.2008.05.005
18579604	Pathways of cross-species transmission of synthetically reconstructed zoonoticsevere acute respiratory syndrome coronavirus.	2008 Sep	United States	10.1128/JVI.00818-08
18579591	Experimental optic neuritis induced by a demyelinating strain of mouse hepatitisvirus.	2008 Sep	United States	10.1128/JVI.00920-08
18579223	Detection of bovine coronavirus using a TaqMan-based real-time RT-PCR assay.	2008 Aug	Netherlands	10.1016/j.jviromet.2008.05.016
18577614	Validation of an immunohistochemistry assay to detect turkey coronavirus: a rapidand simple screening tool for limited resource settings.	2008 Jul	England	10.3382/ps.2008-00042
18572754	Distinct signature type I interferon responses are determined by the infectingvirus and the target cell.	2008	England	
18570589	Generation of a protective T-cell response following coronavirus infection of thecentral nervous system is not dependent on IL-12/23 signaling.	2008 Jun	United States	10.1089/vim.2008.0014
18568656	Rapid selection in chickens of subpopulations within ArkDPI-derived infectiousbronchitis virus vaccines.	2008 Jun	England	10.1080/03079450802043783
18568650	A reverse transcriptase-polymerase chain reaction survey of infectious bronchitisvirus genotypes in Western Europe from 2002 to 2006.	2008 Jun	England	10.1080/03079450801986529
18567519	QM/QM studies for Michael reaction in coronavirus main protease (3CL Pro).	2008 Oct	United States	10.1016/j.jmgm.2008.05.002
18565970	The management of coronavirus infections with particular reference to SARS.	2008 Sep	England	10.1093/jac/dkn243
18565762	Peptides from the SARS-associated coronavirus as tags for protein expression andpurification.	2008 Oct	United States	10.1016/j.pep.2008.04.011
18562531	Structure of the main protease from a global infectious human coronavirus,HCoV-HKU1.	2008 Sep	United States	10.1128/JVI.00298-08
18562523	Cathepsin L functionally cleaves the severe acute respiratory syndromecoronavirus class I fusion protein upstream of rather than adjacent to the fusionpeptide.	2008 Sep	United States	10.1128/JVI.00415-08
18561946	Solution structure of the c-terminal dimerization domain of SARS coronavirusnucleocapsid protein solved by the SAIL-NMR method.	2008 Jul 18	England	10.1016/j.jmb.2007.11.093
18560223	Potent in vitro activity of the albumin fusion type 1 interferons(albumin-interferon-alpha and albumin-interferon-beta) against RNA viral agentsof bioterrorism and the severe acute respiratory syndrome (SARS) virus.	2008	Switzerland	10.1159/000140361
18559270	A structural view of the inactivation of the SARS coronavirus main proteinase bybenzotriazole esters.	2008 Jun	United States	10.1016/j.chembiol.2008.04.011
18558940	Role of respiratory pathogens in infants hospitalized for a first episode ofwheezing and their impact on recurrences.	2008 Jul	England	10.1111/j.1469-0691.2008.02016.x
18557966	Long-term care facilities: a cornucopia of viral pathogens.	2008 Jul	United States	10.1111/j.1532-5415.2008.01775.x
18557357	[Detection of coronavirus in experimental pneumocystic pneumonia].	2008 Apr-Jun	Russia (Federation)	
18554741	Endocytosis of the receptor-binding domain of SARS-CoV spike protein togetherwith virus receptor ACE2.	2008 Sep	Netherlands	10.1016/j.virusres.2008.03.004
18551169	Mouse hepatitis coronavirus RNA replication depends on GBF1-mediated ARF1activation.	2008 Jun 13	United States	10.1371/journal.ppat.1000088
18550812	Structure of coronavirus hemagglutinin-esterase offers insight into corona andinfluenza virus evolution.	2008 Jul 1	United States	10.1073/pnas.0800502105
18550663	Mouse hepatitis virus type 2 enters cells through a clathrin-mediated endocyticpathway independent of Eps15.	2008 Aug	United States	10.1128/JVI.00837-08
18541340	Stability of human metapneumovirus and human coronavirus NL63 on medicalinstruments and in the patient environment.	2008 Aug	England	10.1016/j.jhin.2008.04.017
18540634	Characterization of the prefusion and transition states of severe acuterespiratory syndrome coronavirus S2-HR2.	2008 Jul 1	United States	10.1021/bi800622t
18540051	Structure of a SARS coronavirus-derived peptide bound to the human majorhistocompatibility complex class I molecule HLA-B*1501.	2008 Jun 1	England	10.1107/S1744309108012396
18538629	Upper respiratory virus detection without parent-reported illness in children isvirus-specific.	2008 Sep	Netherlands	10.1016/j.jcv.2008.04.008
18538604	Pathogenesis of feline enteric coronavirus infection.	2008 Dec	England	10.1016/j.jfms.2008.02.006
18536105	[Evaluation of the protection conferred by several avian infectious bronchitisattenuated vaccines against the field strain CK/CH/LDL/97 I in China].	2008 Jun	China	
18533344	[Genetic variation of S1 gene hypervariable region I of infectious bronchitisviruses isolated in different periods in Guangxi].	2008 Jun	China	
18533276	A chimeric multi-epitope DNA vaccine elicited specific antibody response againstsevere acute respiratory syndrome-associated coronavirus which attenuated thevirulence of SARS-CoV in vitro.	2008 Aug 15	Netherlands	10.1016/j.imlet.2008.04.005
18514348	Complete nucleotide sequence of polyprotein gene 1 and genome organization ofturkey coronavirus.	2008 Sep	Netherlands	10.1016/j.virusres.2008.04.015
18512821	Serum-free transient protein production system based on adenoviral vector andPER.C6 technology: high yield and preserved bioactivity.	2008 Jun 1	United States	10.1002/bit.21757
18510050	[SARS-CoV infection and pregnancy].	2008 Jan	Poland	
18508552	The role of programmed-1 ribosomal frameshifting in coronavirus propagation.	2008 May 1	United States	10.2741/3046
18508518	Mouse hepatitis virus infection of the CNS: a model for defense, disease, andrepair.	2008 May 1	United States	10.2741/3012
18507931	Coronavirus antibodies in bat biologists.	2008 Jun	United States	10.3201/eid1406.070964
18506062	Old enemies, still with us after all these years.	2008	England	10.1093/ilar.49.3.291
18504193	[Development of a SPA-ELISA method for detecting anti-coronavirus IgG antibodiesin serum samples from fulvous fruit bats].	2008 May	China	
18501701	H5N1 influenza marker vaccine for serological differentiation between vaccinatedand infected chickens.	2008 Jul 25	United States	10.1016/j.bbrc.2008.05.057
18501280	Canine respiratory coronavirus: an emerging pathogen in the canine infectiousrespiratory disease complex.	2008 Jul	United States	10.1016/j.cvsm.2008.02.008
18496882	Predicting linear B-cell epitopes using string kernels.	2008 Jul-Aug	England	10.1002/jmr.893
18495857	Human coronavirus NL63 and 229E seroconversion in children.	2008 Jul	United States	10.1128/JCM.00533-08
18495771	Severe acute respiratory syndrome coronavirus infection causes neuronal death inthe absence of encephalitis in mice transgenic for human ACE2.	2008 Aug	United States	10.1128/JVI.00737-08
18490652	Modulation of TNF-alpha-converting enzyme by the spike protein of SARS-CoV andACE2 induces TNF-alpha production and facilitates viral entry.	2008 Jun 3	United States	10.1073/pnas.0711241105
18490264	Coronavirus phylogeny based on base-base correlation.	2008	Switzerland	10.1504/IJBRA.2008.018347
18489147	Structural and dynamic characterization of the interaction of the putative fusionpeptide of the S2 SARS-CoV virus protein with lipid membranes.	2008 Jun 12	United States	10.1021/jp7118229
18480090	Rapid discovery and optimization of therapeutic antibodies against emerginginfectious diseases.	2008 Aug	England	10.1093/protein/gzn027
18479853	Immunomodulatory and anti-SARS activities of Houttuynia cordata.	2008 Jun 19	Ireland	10.1016/j.jep.2008.03.018
18479515	Improved microarray gene expression profiling of virus-infected cells afterremoval of viral RNA.	2008 May 14	England	10.1186/1471-2164-9-221
18479078	[Emerging viral infections in Belgium and abroad].	2008 Mar	Belgium	
18468711	Complete genomic sequence of turkey coronavirus.	2008 Aug	Netherlands	10.1016/j.virusres.2008.03.020
18468073	Combination of functionalized nanoparticles and polymerase chain reaction-basedmethod for SARS-CoV gene detection.	2008 Jan	United States	
18467696	Mouse-passaged severe acute respiratory syndrome-associated coronavirus leads tolethal pulmonary edema and diffuse alveolar damage in adult but not young mice.	2008 Jun	United States	10.2353/ajpath.2008.071060
18466680	Human LINE1 endonuclease domain as a putative target of SARS-associatedautoantibodies involved in the pathogenesis of severe acute respiratory syndrome.	2008 Apr 5	China	
18465270	A novel strategy for analyzing RNA-protein interactions by surface plasmonresonance biosensor.	2008 Sep	United States	10.1007/s12033-008-9066-3
18463152	A live attenuated severe acute respiratory syndrome coronavirus is immunogenicand efficacious in golden Syrian hamsters.	2008 Aug	United States	10.1128/JVI.00304-08
18460521	Acute febrile respiratory illness in the ICU: reducing disease transmission.	2008 May	United States	10.1378/chest.07-0778
18458712	Severe acute respiratory syndrome: clinical and laboratory manifestations.	2004 May	Australia	
18458711	The laboratory diagnosis of severe acute respiratory syndrome: emerginglaboratory tests for an emerging pathogen.	2004 May	Australia	
18458710	Molecular epidemiology of the coronavirus associated with severe acuterespiratory syndrome: a review of data from the Chinese University of Hong Kong.	2004 May	Australia	
18458506	[Evaluation of Seeplex RV detection kit for detecting rhinovirus, humanmetapneumovirus, and coronavirus].	2008 Apr	Korea (South)	10.3343/kjlm.2008.28.2.109
18456429	[Human coronaviruses].	2009 Mar	France	10.1016/j.patbio.2008.02.018
18452964	Pathogenicity of severe acute respiratory coronavirus deletion mutants in hACE-2transgenic mice.	2008 Jul 5	United States	10.1016/j.virol.2008.03.005
18451981	SARS-coronavirus replication/transcription complexes are membrane-protected andneed a host factor for activity in vitro.	2008 May 2	United States	10.1371/journal.ppat.1000054
18449585	siRNA silencing of angiotensin-converting enzyme 2 reduced severe acuterespiratory syndrome-associated coronavirus replications in Vero E6 cells.	2008 Aug	Germany	10.1007/s10096-008-0495-5
18448662	The discovery of angiotensin-converting enzyme 2 and its role in acute lunginjury in mice.	2008 May	England	10.1113/expphysiol.2007.040048
18448527	Structural analysis of major species barriers between humans and palm civets forsevere acute respiratory syndrome coronavirus infections.	2008 Jul	United States	10.1128/JVI.00442-08
18448520	Severe acute respiratory syndrome coronavirus protein 6 accelerates murinehepatitis virus infections by more than one mechanism.	2008 Jul	United States	10.1128/JVI.02406-07
18448518	The nucleocapsid protein of severe acute respiratory syndrome coronavirusinhibits cell cytokinesis and proliferation by interacting with translationelongation factor 1alpha.	2008 Jul	United States	10.1128/JVI.00133-08
18448259	What caused lymphopenia in SARS and how reliable is the lymphokine status inglucocorticoid-treated patients?	2008 Aug	United States	10.1016/j.mehy.2008.03.019
18447621	Evaluation of cotton rats as a model for severe acute respiratory syndrome.	2008 Jun	United States	10.1089/vbz.2007.0210
18442051	Fusion core structure of the severe acute respiratory syndrome coronavirus(SARS-CoV): in search of potent SARS-CoV entry inhibitors.	2008 Aug 15	United States	10.1002/jcb.21790
18440652	Search for potential target site of nucleocapsid gene for the design of anepitope-based SARS DNA vaccine.	2008 Jun 15	Netherlands	10.1016/j.imlet.2008.03.003
18433331	Identification of a novel transcriptional repressor (HEPIS) that interacts withnsp-10 of SARS coronavirus.	2008 Jun	United States	10.1089/vim.2007.0108
18427249	Recent antiviral strategies against human coronavirus-related respiratoryillnesses.	2008 May	United States	10.1097/MCP.0b013e3282f7646f
18427248	Clinical features, pathogenesis and immunobiology of severe acute respiratorysyndrome.	2008 May	United States	10.1097/MCP.0b013e3282fb81b2
18424841	Clinicopathologic features of a systemic coronavirus-associated diseaseresembling feline infectious peritonitis in the domestic ferret (Mustelaputorius).	2008 Mar	United States	10.1354/vp.45-2-236
18424826	Detection of antigenic heterogeneity in feline coronavirus nucleocapsid in felinepyogranulomatous meningoencephalitis.	2008 Mar	United States	10.1354/vp.45-2-140
18424514	Characterization of ubiquitin and ubiquitin-like-protein isopeptidase activities.	2008 Jun	United States	10.1110/ps.083450408
18424264	Importance of SARS-CoV spike protein Trp-rich region in viral infectivity.	2008 Jul 4	United States	10.1016/j.bbrc.2008.04.044
18423639	Is the anti-psychotic, 10-(3-(dimethylamino)propyl)phenothiazine (promazine), apotential drug with which to treat SARS infections? Lack of efficacy of promazineon SARS-CoV replication in a mouse model.	2008 Aug	Netherlands	10.1016/j.antiviral.2007.12.005
18423191	A TRIFfic perspective on acute lung injury.	2008 Apr 18	United States	10.1016/j.cell.2008.04.006
18420807	Genomic characterizations of bat coronaviruses (1A, 1B and HKU8) and evidence forco-infections in Miniopterus bats.	2008 May	England	10.1099/vir.0.83605-0
18417581	Priming of CD8+ T cells during central nervous system infection with a murinecoronavirus is strain dependent.	2008 Jul	United States	10.1128/JVI.00106-08
18417574	Coronavirus nonstructural protein 16 is a cap-0 binding enzyme possessing(nucleoside-2'O)-methyltransferase activity.	2008 Aug	United States	10.1128/JVI.00407-08
18413134	Pre-validation study for testing of avian viral vaccines for extraneous agents byPCR.	2007 Dec	France	
18410770	Respiratory viruses in laryngeal croup of young children.	2008 May	United States	10.1016/j.jpeds.2007.10.043
18407505	Heteroaromatic ester inhibitors of hepatitis A virus 3C proteinase: Evaluation ofmode of action.	2008 May 15	England	10.1016/j.bmc.2008.03.059
18406664	Emerging respiratory agents: new viruses for old diseases?	2008 Jul	Netherlands	10.1016/j.jcv.2008.03.002
18406642	Interferon-gamma in the serum and effusions of cats with feline coronavirusinfection.	2009 Jun	England	10.1016/j.tvjl.2008.02.028
18406349	Interferon alfacon 1 inhibits SARS-CoV infection in human bronchial epithelialCalu-3 cells.	2008 Jun 20	United States	10.1016/j.bbrc.2008.04.006
18400867	Cleavage of group 1 coronavirus spike proteins: how furin cleavage is traded offagainst heparan sulfate binding upon cell culture adaptation.	2008 Jun	United States	10.1128/JVI.00074-08
18400422	Identification of two novel B cell epitopes on porcine epidemic diarrhea virusspike protein.	2008 Sep 18	Netherlands	10.1016/j.vetmic.2008.02.022
18400147	Detection and prevalence patterns of group I coronaviruses in bats, northernGermany.	2008 Apr	United States	10.3201/eid1404.071439
18398701	Expression and membrane integration of SARS-CoV M protein.	2008 May	England	10.1007/s11373-008-9235-1
18396435	Infection of the tracheal epithelium by infectious bronchitis virus is sialicacid dependent.	2008 Apr	France	10.1016/j.micinf.2007.12.009
18396306	SARS vaccine based on a replication-defective recombinant vesicular stomatitisvirus is more potent than one based on a replication-competent vector.	2008 Jun 20	United States	10.1016/j.virol.2008.03.002
18395804	The use of Armored RNA as a multi-purpose internal control for RT-PCR.	2008 Jun	Netherlands	10.1016/j.jviromet.2008.02.007
18395801	Treatment of cats with feline infectious peritonitis.	2008 May 15	Netherlands	10.1016/j.vetimm.2008.01.026
18392449	Molecular analysis of the bovine coronavirus S1 gene by direct sequencing ofdiarrheic fecal specimens.	2008 Apr	Brazil	10.1590/s0100-879x2008000400004
18390877	The nucleocapsid protein of SARS-CoV induces transcription of hfgl2prothrombinase gene dependent on C/EBP alpha.	2008 Jul	England	10.1093/jb/mvn042
18389721	The viral bronchiolites diagnosis in children by PCR multiplex.	2006 Jul-Dec	Romania	
18385249	Demyelinating and nondemyelinating strains of mouse hepatitis virus differ intheir neural cell tropism.	2008 Jun	United States	10.1128/JVI.01488-07
18385240	A novel mutation in murine hepatitis virus nsp5, the viral 3C-like proteinase,causes temperature-sensitive defects in viral growth and protein processing.	2008 Jun	United States	10.1128/JVI.00203-08
18383098	Design, synthesis and screening of antisense peptide based combinatorial peptidelibraries towards an aromatic region of SARS-CoV.	2008 Mar-Apr	England	10.1002/jmr.880
18382647	An Outbreak of Human Coronavirus OC43 Infection and Serological Cross-reactivitywith SARS Coronavirus.	2006 Nov	Egypt	10.1155/2006/152612
18380809	Co-infection of respiratory bacterium with severe acute respiratory syndromecoronavirus induces an exacerbated pneumonia in mice.	2008 Feb	Australia	10.1111/j.1348-0421.2008.00011.x
18380153	Characterization and epitope mapping of monoclonal antibodies to the nucleocapsidprotein of severe acute respiratory syndrome coronavirus.	2008 Feb	Japan	
18377725	2-D graphical representation of protein sequences and its application tocoronavirus phylogeny.	2008 Mar 31	Korea (South)	10.5483/bmbrep.2008.41.3.217
18373106	Materno-fetal transmission of human coronaviruses: a prospective pilot study.	2008 Sep	Germany	10.1007/s10096-008-0505-7
18370280	Analysis of cell-to-cell and long-distance movement of apple latent sphericalvirus in infected plants using green, cyan, and yellow fluorescent proteins.	2008	United States	10.1007/978-1-59745-102-4_37
18369784	Application of siRNA against SARS in the rhesus macaque model.	2008	United States	10.1007/978-1-59745-191-8_11
18367782	Predicting ribosomal frameshifting efficiency.	2008 Mar 11	England	10.1088/1478-3975/5/1/016002
18367528	Persistent replication of severe acute respiratory syndrome coronavirus in humantubular kidney cells selects for adaptive mutations in the membrane protein.	2008 Jun	United States	10.1128/JVI.00096-08
18367524	Proteomics analysis unravels the functional repertoire of coronavirusnonstructural protein 3.	2008 Jun	United States	10.1128/JVI.02631-07
18362400	Reduced incorporation of SARS-CoV spike protein into viral particles due to aminoacid substitutions within the receptor binding domain.	2008 Mar	Japan	
18360904	Role of human metapneumovirus, human coronavirus NL63 and human bocavirus ininfants and young children with acute wheezing.	2008 May	United States	10.1002/jmv.21135
18359708	[Detection of the mRNA expression of human angiotensin-converting enzyme 2 as aSARS coronavirus functional receptor in human femoral head].	2008 Mar	China	
18359518	The role of phagocytic cells in enhanced susceptibility of broilers tocolibacillosis after Infectious Bronchitis Virus infection.	2008 Jun 15	Netherlands	10.1016/j.vetimm.2008.02.003
18357554	Phytochemical analysis and in vitro antiviral activities of the essential oils ofseven Lebanon species.	2008 Mar	Switzerland	10.1002/cbdv.200890045
18356599	Respiratory viruses in HIV-infected patients with suspected respiratoryopportunistic infection.	2008 Mar 30	England	10.1097/QAD.0b013e3282f470ac
18355120	Effects of different immunization protocols and adjuvant on antibody responses toinactivated SARS-CoV vaccine.	2008 Mar	United States	10.1089/vim.2007.0079
18353961	Identification of a novel coronavirus from a beluga whale by using a panviralmicroarray.	2008 May	United States	10.1128/JVI.02722-07
18348770	A survey of rodent-borne pathogens carried by wild-caught Norway rats: apotential threat to laboratory rodent colonies.	2008 Jan	England	10.1258/la.2007.06015e
18348134	Sensitized detection of inhibitory fragments and iterative development ofnon-peptidic protease inhibitors by dynamic ligation screening.	2008	Germany	10.1002/anie.200704594
18346823	Induction of neutralising antibodies and cellular immune responses against SARScoronavirus by recombinant measles viruses.	2008 Apr 16	Netherlands	10.1016/j.vaccine.2008.01.057
18343845	Analysis of the mechanism of antibody-dependent enhancement of feline infectiousperitonitis virus infection: aminopeptidase N is not important and a process ofacidification of the endosome is necessary.	2008 Apr	England	10.1099/vir.0.83558-0
18343844	Identification of residues in the receptor-binding domain (RBD) of the spikeprotein of human coronavirus NL63 that are critical for the RBD-ACE2 receptorinteraction.	2008 Apr	England	10.1099/vir.0.83331-0
18343398	Pathological changes in masked palm civets experimentally infected by severeacute respiratory syndrome (SARS) coronavirus.	2008 May	England	10.1016/j.jcpa.2007.12.005
18343121	Structure-based virtual screening against SARS-3CL(pro) to identify novelnon-peptidic hits.	2008 Apr 1	England	10.1016/j.bmc.2008.01.011
18340998	[Lessons from SARS: a new potential therapy for acute respiratory distresssyndrome (ARDS) with angiotensin converting enzyme 2 (ACE2)].	2008 Mar	Japan	
18339986	Molecular subtype of infectious bronchitis virus in broiler flocks in Jordan.	2008 Apr	England	10.3382/ps.2007-00509
18336588	Intrahepatic endothelial and Kupffer cells involved in immunosuppressivecytokines and natural killer (NK)/NK T cell disorders in viral acute hepatitis.	2008 May	England	10.1111/j.1365-2249.2008.03628.x
18335238	Outbreaks of human coronavirus in a pediatric and neonatal intensive care unit.	2008 Dec	Germany	10.1007/s00431-008-0687-0
18329272	Design, synthesis, and evaluation of trifluoromethyl ketones as inhibitors ofSARS-CoV 3CL protease.	2008 Apr 15	England	10.1016/j.bmc.2008.02.040
18329109	Enhancement of the immunogenicity of an infectious bronchitis virus DNA vaccineby a bicistronic plasmid encoding nucleocapsid protein and interleukin-2.	2008 Apr	Netherlands	10.1016/j.jviromet.2008.01.017
18326842	Epidemic of diarrhoea caused by porcine epidemic diarrhoea virus in Italy.	2008 Mar 8	England	10.1136/vr.162.10.307
18325268	Hemagglutinating encephalomyelitis coronavirus infection in pigs, Argentina.	2008 Mar	United States	10.3201/eid1403.070825
18322201	Structural and biological basis of CTL escape in coronavirus-infected mice.	2008 Mar 15	United States	10.4049/jimmunol.180.6.3926
18321765	Interferon and cytokine responses to SARS-coronavirus infection.	2008 Apr	England	10.1016/j.cytogfr.2008.01.001
18320019	Peptide mimicrying between SARS coronavirus spike protein and human proteinsreacts with SARS patient serum.	2008	United States	10.1155/2008/326464
18314540	Amiodarone alters late endosomes and inhibits SARS coronavirus infection at apost-endosomal level.	2008 Aug	United States	10.1165/rcmb.2007-0217OC
18314161	Thrombopoietin levels increased in patients with severe acute respiratorysyndrome.	2008	United States	10.1016/j.thromres.2007.12.021
18313035	Thiopurine analogues inhibit papain-like protease of severe acute respiratorysyndrome coronavirus.	2008 Apr 15	England	10.1016/j.bcp.2008.01.005
18312678	Roles of TNF-alpha gene polymorphisms in the occurrence and progress of SARS-Covinfection: a case-control study.	2008 Feb 29	England	10.1186/1471-2334-8-27
21603094	Management of upper respiratory tract infections in children.	2008 Mar	South Africa	10.1080/20786204.2008.10873685
18306032	Molecular characterization of the 9.36 kb C-terminal region of canine coronavirus1-71 strain.	2008 Jun	United States	10.1007/s11262-008-0214-4
18305135	RNase-resistant virus-like particles containing long chimeric RNA sequencesproduced by two-plasmid coexpression system.	2008 May	United States	10.1128/JCM.02248-07
18305050	Severe acute respiratory syndrome coronavirus nsp1 suppresses host geneexpression, including that of type I interferon, in infected cells.	2008 May	United States	10.1128/JVI.02472-07
18305043	Without its N-finger, the main protease of severe acute respiratory syndromecoronavirus can form a novel dimer through its C-terminal domain.	2008 May	United States	10.1128/JVI.02612-07
18305036	Coronavirus infection modulates the unfolded protein response and mediatessustained translational repression.	2008 May	United States	10.1128/JVI.00017-08
18305031	Mechanism for controlling the dimer-monomer switch and coupling dimerization tocatalysis of the severe acute respiratory syndrome coronavirus 3C-like protease.	2008 May	United States	10.1128/JVI.02680-07
18303415	Viral infections in patients with chronic obstructive pulmonary disease.	2008 Mar	United States	10.1097/MCP.0b013e3282f4a99f
18301805	Development of subunit vaccines against severe acute respiratory syndrome.	2008 Jan	Spain	10.1358/dot.2008.44.1.1131830
18300071	Chemokine expression during mouse-hepatitis-virus-induced encephalitis:contributions of the spike and background genes.	2008 Jan	United States	10.1080/13550280701750635
18297694	Two-year prospective study of single infections and co-infections by respiratorysyncytial virus and viruses identified recently in infants with acute respiratorydisease.	2008 Apr	United States	10.1002/jmv.21108
18295820	Aryl methylene ketones and fluorinated methylene ketones as reversible inhibitorsfor severe acute respiratory syndrome (SARS) 3C-like proteinase.	2008 Oct	United States	10.1016/j.bioorg.2008.01.001
18295413	Identification of the avian infectious bronchitis coronaviruses with mutations ingene 3.	2008 Apr 15	Netherlands	10.1016/j.gene.2008.01.004
18295294	Mutation in murine coronavirus replication protein nsp4 alters assembly of doublemembrane vesicles.	2008 May 25	United States	10.1016/j.virol.2008.01.018
18293623	Serological evidence of coronavirus infection in mithuns (Bos frontalis) fromIndia.	2007 Dec	France	
18289745	Priming with rAAV encoding RBD of SARS-CoV S protein and boosting withRBD-specific peptides for T cell epitopes elevated humoral and cellular immuneresponses against SARS-CoV infection.	2008 Mar 20	Netherlands	10.1016/j.vaccine.2008.01.025
18289557	Structural lability in stem-loop 1 drives a 5' UTR-3' UTR interaction incoronavirus replication.	2008 Mar 28	England	10.1016/j.jmb.2008.01.068
18289290	Infectious diseases of dogs and cats on Isabela Island, Galapagos.	2008 Jan-Feb	United States	10.1111/j.1939-1676.2007.0034.x
18287230	Cytokine responses in porcine respiratory coronavirus-infected pigs treated withcorticosteroids as a model for severe acute respiratory syndrome.	2008 May	United States	10.1128/JVI.02190-07
18279660	Lipid rafts are involved in SARS-CoV entry into Vero E6 cells.	2008 May 2	United States	10.1016/j.bbrc.2008.02.023
18279042	Viral upper respiratory tract infection and otitis media complication in youngchildren.	2008 Mar 15	United States	10.1086/528685
18275836	Correlation between dissociation and catalysis of SARS-CoV main protease.	2008 Apr 1	United States	10.1016/j.abb.2008.01.023
18272586	Identification of a coronavirus transcription enhancer.	2008 Apr	United States	10.1128/JVI.02622-07
18271263	[Potent immune responses elicited by a bicistronic IBV DNA vaccine expressing S1and IL-2 gene].	2007 Dec	China	
18269318	Glucose-6-phosphate dehydrogenase deficiency enhances human coronavirus 229Einfection.	2008 Mar 15	United States	10.1086/528377
18263918	Clinical aspects of systemic granulomatous inflammatory syndrome in ferrets(Mustela putorius furo).	2008 Feb 9	England	10.1136/vr.162.6.180
18262691	Avian coronavirus infectious bronchitis attenuated live vaccines undergoselection of subpopulations and mutations following vaccination.	2008 Mar 4	Netherlands	10.1016/j.vaccine.2008.01.006
18258500	Sequential affinity purification of peroxidase tagged bispecific anti-SARS-CoVantibodies on phenylboronic acid agarose.	2008 Mar 1	Netherlands	10.1016/j.jchromb.2008.01.003
18258415	Modulation of signaling pathways by RNA virus capsid proteins.	2008 Jul	England	10.1016/j.cellsig.2007.12.018
18258008	Duration of antibody responses after severe acute respiratory syndrome.	2007 Oct	United States	10.3201/eid1310.070576
18258002	Evolutionary relationships between bat coronaviruses and their hosts.	2007 Oct	United States	10.3201/eid1310.070448
18257204	[SARS corona virus--a new dilemma].	2005 Jan-Feb	Serbia	10.2298/mpns0502043k
18256230	RespiFinder: a new multiparameter test to differentially identify fifteenrespiratory viruses.	2008 Apr	United States	10.1128/JCM.02294-07
18255185	The SARS-Coronavirus PLnc domain of nsp3 as a replication/transcriptionscaffolding protein.	2008 May	Netherlands	10.1016/j.virusres.2007.11.017
18252111	Coronavirus antibodies in African bat species.	2007 Sep	United States	10.3201/eid1309.070342
18252098	Detection of group 1 coronaviruses in bats in North America.	2007 Sep	United States	10.3201/eid1309.070491
18251411	Molecular characterization of infectious bronchitis virus strains isolated fromthe enteric contents of Brazilian laying hens and broilers.	2007 Dec	United States	10.1637/7983-041307.1
18251404	Evaluating viral interference between infectious bronchitis virus and Newcastledisease virus vaccine strains using quantitative reverse transcription-polymerasechain reaction.	2007 Dec	United States	10.1637/7930-020807-REGR.1
18251400	Orchitis in roosters with reduced fertility associated with avian infectiousbronchitis virus and avian metapneumovirus infections.	2007 Dec	United States	10.1637/7815-121306-REGR4.1
18247102	Coinfection of avian influenza virus (H9N2 subtype) with infectious bronchitislive vaccine.	2008	Austria	10.1007/s00705-008-0033-x
18245437	Human metapneumovirus and human coronavirus NL63.	2008 Feb	United States	10.1542/peds.2007-3356
18243744	Evaluation of real-time RT-PCR for the quantification of FCoV shedding in thefaeces of domestic cats.	2008 Apr	England	10.1016/j.jfms.2007.10.010
18243587	Equine coronavirus induces apoptosis in cultured cells.	2008 Jun 22	Netherlands	10.1016/j.vetmic.2007.11.034
18243139	The nucleocapsid protein of SARS-associated coronavirus inhibits B23phosphorylation.	2008 May 2	United States	10.1016/j.bbrc.2008.01.096
18237196	Steady-state and pre-steady-state kinetic evaluation of severe acute respiratorysyndrome coronavirus (SARS-CoV) 3CLpro cysteine protease: development of anion-pair model for catalysis.	2008 Feb 26	United States	10.1021/bi702107v
18236362	Microbiology and management of neonatal necrotizing enterocolitis.	2008 Feb	United States	10.1055/s-2008-1040346
18234270	The SARS-CoV ferret model in an infection-challenge study.	2008 Apr 25	United States	10.1016/j.virol.2007.12.032
18231581	Coronavirus spike protein inhibits host cell translation by interaction witheIF3f.	2008 Jan 30	United States	10.1371/journal.pone.0001494
18229861	Serosurvey of ex situ giant pandas (Ailuropoda melanoleuca) and red pandas(Ailurus fulgens) in China with implications for species conservation.	2007 Dec	United States	10.1638/2006-0008R.1
18227861	SARS coronavirus entry into host cells through a novel clathrin- andcaveolae-independent endocytic pathway.	2008 Feb	England	10.1038/cr.2008.15
18221160	Recent patents on treatment of severe acute respiratory syndrome (SARS).	2007 Jan	Netherlands	10.2174/157489107779561698
18221155	SARS coronavirus anti-infectives.	2006 Nov	Netherlands	10.2174/157489106778777637
18220240	Application of ProteinChip array profiling in serum biomarker discovery forpatients suffering from severe acute respiratory syndrome.	2007	United States	10.1007/978-1-59745-304-2_20
18215734	Molecular epidemiology and evolution of avian infectious bronchitis virus inSpain over a fourteen-year period.	2008 Apr 25	United States	10.1016/j.virol.2007.12.020
18214664	Molecular characterization and phylogenetic analysis of membrane protein genes ofporcine epidemic diarrhea virus isolates in China.	2008 Apr	United States	10.1007/s11262-007-0196-7
18207382	DNA hybridization biosensors using polylysine modified SPCEs.	2008 Apr 15	England	10.1016/j.bios.2007.12.001
18205173	Induction of class I antigen processing components in oligodendroglia andmicroglia during viral encephalomyelitis.	2008 Mar	United States	10.1002/glia.20625
18204039	Chinese QX strain of infectious bronchitis virus isolated in the UK.	2008 Jan 19	England	10.1136/vr.162.3.99
18199653	Aromatic amino acids in the juxtamembrane domain of severe acute respiratorysyndrome coronavirus spike glycoprotein are important for receptor-dependentvirus entry and cell-cell fusion.	2008 Mar	United States	10.1128/JVI.01805-07
18199643	Expression of transgenes from newcastle disease virus with a segmented genome.	2008 Mar	United States	10.1128/JVI.02341-07
18199635	Structural basis for potent cross-neutralizing human monoclonal antibodyprotection against lethal human and zoonotic severe acute respiratory syndromecoronavirus challenge.	2008 Apr	United States	10.1128/JVI.02377-07
18197734	Inhibition of gene expression directed by small interfering RNAs in infectiousbronchitis virus.	2007	Slovakia	
18196725	Effect of feline interferon-omega on the survival time and quality of life ofcats with feline infectious peritonitis.	2007 Nov-Dec	United States	10.1892/06-302.1
18196455	Influenza C virus and bovine coronavirus esterase reveal a similar catalyticmechanism: new insights for drug discovery.	2008 Jul	United States	10.1007/s10719-007-9094-4
18191362	A line immunoassay utilizing recombinant nucleocapsid proteins for detection ofantibodies to human coronaviruses.	2008 May	United States	10.1016/j.diagmicrobio.2007.12.002
18191140	Determination and application of immunodominant regions of SARS coronavirus spikeand nucleocapsid proteins recognized by sera from different animal species.	2008 Feb 29	Netherlands	10.1016/j.jim.2007.11.009
18191004	Chimeric coronavirus-like particles carrying severe acute respiratory syndromecoronavirus (SCoV) S protein protect mice against challenge with SCoV.	2008 Feb 6	Netherlands	10.1016/j.vaccine.2007.11.092
18186801	Lack of association between HLA-A, -B and -DRB1 alleles and the development ofSARS: a cohort of 95 SARS-recovered individuals in a population of Guangdong,southern China.	2008 Feb	England	10.1111/j.1744-313X.2007.00741.x
18184706	Envelope protein palmitoylations are crucial for murine coronavirus assembly.	2008 Mar	United States	10.1128/JVI.01906-07
18184703	Importance of conserved cysteine residues in the coronavirus envelope protein.	2008 Mar	United States	10.1128/JVI.01914-07
18182507	Comparison of serologic techniques for the detection of antibodies against felinecoronaviruses.	2008 Jan	United States	10.1177/104063870802000108
18182504	Respiratory disease associated with bovine coronavirus infection in cattle herdsin Southern Italy.	2008 Jan	United States	10.1177/104063870802000105
18182387	Residues on the dimer interface of SARS coronavirus 3C-like protease: dimerstability characterization and enzyme catalytic activity analysis.	2008 Apr	England	10.1093/jb/mvm246
18178835	Intranasal vaccination of recombinant adeno-associated virus encodingreceptor-binding domain of severe acute respiratory syndrome coronavirus(SARS-CoV) spike protein induces strong mucosal immune responses and provideslong-term protection against SARS-CoV infection.	2008 Jan 15	United States	10.4049/jimmunol.180.2.948
18174876	Viral etiology of acute respiratory infections with cough in infancy: acommunity-based birth cohort study.	2008 Feb	United States	10.1097/INF.0b013e31815922c8
18173859	Severe febrile respiratory illnesses as a cause of mass critical care.	2008 Jan	United States	
18172751	Sequence analysis of the ORF 7 region of transmissible gastroenteritis virusesisolated in Korea.	2008 Feb	United States	10.1007/s11262-007-0191-z
18167201	Comparison of effectiveness of whole viral, N and N199 proteins by ELISA for therapid diagnosis of severe acute respiratory syndrome coronavirus.	2007 Dec 20	China	
21847845	Stigmatized ethnicity, public health, and globalization.	2008	Canada	10.1353/ces.2008.0002
19844604	Morphogenesis of Coronavirus HCoV-NL63 in Cell Culture: A Transmission ElectronMicroscopic Study.	2008 Jan 1	Netherlands	10.2174/1874279300802010052
18160832	Detection of 12 respiratory viruses with two-set multiplex reversetranscriptase-PCR assay using a dual priming oligonucleotide system.	2007 Dec	Korea (South)	10.3343/kjlm.2007.27.6.420
18160451	Preparation of armored RNA as a control for multiplex real-time reversetranscription-PCR detection of influenza virus and severe acute respiratorysyndrome coronavirus.	2008 Mar	United States	10.1128/JCM.01904-07
18158733	CCR1 deficiency increases susceptibility to fatal coronavirus infection of thecentral nervous system.	2007 Dec	United States	10.1089/vim.2007.0056
18158730	Mannan-binding lectin (MBL) serum concentration in relation to propagation ofinfectious bronchitis virus (IBV) in chickens.	2007 Dec	United States	10.1089/vim.2007.0036
18156685	The search for a structural basis for therapeutic intervention against the SARScoronavirus.	2008 Jan	United States	10.1107/S0108767307054426
18155731	Cell type-specific cleavage of nucleocapsid protein by effector caspases duringSARS coronavirus infection.	2008 Feb 8	England	10.1016/j.jmb.2007.11.081
18095623	[Techniques used for the diagnostic of upper and lower respiratory tract viralinfections].	2007 Nov 15	France	
18094188	Mechanisms of zoonotic severe acute respiratory syndrome coronavirus host rangeexpansion in human airway epithelium.	2008 Mar	United States	10.1128/JVI.02041-07
18094171	CD4 T cells contribute to virus control and pathology following central nervoussystem infection with neurotropic mouse hepatitis virus.	2008 Mar	United States	10.1128/JVI.01762-07
18094157	Evidence for differential roles for NKG2D receptor signaling in innate hostdefense against coronavirus-induced neurological and liver disease.	2008 Mar	United States	10.1128/JVI.02032-07
18094153	The spike protein of infectious bronchitis virus is retained intracellularly by atyrosine motif.	2008 Mar	United States	10.1128/JVI.02064-07
18094151	Structures of two coronavirus main proteases: implications for substrate bindingand antiviral drug design.	2008 Mar	United States	10.1128/JVI.02114-07
18092718	[Epidemiology of acute upper and lower respiratory tract infections in children].	2007 Oct 31	France	
18092680	[Development and application of a safe SARS-CoV neutralization assay based onlentiviral vectors pseudotyped with SARS-CoV spike protein].	2007 Nov	China	
18086157	Comparison of the prevalence of enteric viruses in healthy dogs and those withacute haemorrhagic diarrhoea by electron microscopy.	2008 Feb	England	10.1111/j.1748-5827.2007.00470.x
18082623	Isolation of inhibitory RNA aptamers against severe acute respiratory syndrome(SARS) coronavirus NTPase/Helicase.	2008 Feb 15	United States	10.1016/j.bbrc.2007.12.020
18082272	Role of IFN-gamma responsiveness in CD8 T-cell-mediated viral clearance anddemyelination in coronavirus-infected mice.	2008 Feb	Netherlands	10.1016/j.jneuroim.2007.10.030
18077725	Difference in receptor usage between severe acute respiratory syndrome (SARS)coronavirus and SARS-like coronavirus of bat origin.	2008 Feb	United States	10.1128/JVI.01085-07
18077720	Genome organization and reverse genetic analysis of a type I feline coronavirus.	2008 Feb	United States	10.1128/JVI.02339-07
18077706	Coronavirus escape from heptad repeat 2 (HR2)-derived peptide entry inhibition asa result of mutations in the HR1 domain of the spike fusion protein.	2008 Mar	United States	10.1128/JVI.02287-07
18076307	Intratracheal inoculation of severe acute respiratory syndrome coronavirus inmonkeys Macaca rhesus.	2007	Slovakia	
18076304	Spike protein region (aa 636789) of porcine epidemic diarrhea virus is essentialfor induction of neutralizing antibodies.	2007	Slovakia	
18074094	Tumor necrosis factor alpha is not a pathogenic determinant in acute lethalencephalitis induced by a highly neurovirulent strain of mouse hepatitis virus.	2008	Austria	10.1007/s00705-007-0006-5
18070603	Calmodulin interacts with angiotensin-converting enzyme-2 (ACE2) and inhibitsshedding of its ectodomain.	2008 Jan 23	England	10.1016/j.febslet.2007.11.085
18069252	Heterologous expression of SARS-CoV ORF10 and X5 genes in E. coli andStreptomyces lividans TK24.	2007 Sep-Oct	Germany	10.1515/znc-2007-9-1021
18067984	The GPRLQPY motif located at the carboxy-terminal of the spike protein inducesantibodies that neutralize Porcine epidemic diarrhea virus.	2008 Mar	Netherlands	10.1016/j.virusres.2007.10.015
18067916	Identification of group 1 coronavirus antigen in multisystemic granulomatouslesions in ferrets (Mustela putorius furo).	2008 Jan	England	10.1016/j.jcpa.2007.10.002
18063358	Human monoclonal antibodies by immortalization of memory B cells.	2007 Dec	England	10.1016/j.copbio.2007.10.011
18060630	Differential gene expression profiles in acute hepatic failure model in miceinfected with MHV-3 virus intervened by anti-hepatic failure compound.	2007 Oct	China	10.1007/s11596-007-0516-0
18057240	Evidence of the recombinant origin of a bat severe acute respiratory syndrome(SARS)-like coronavirus and its implications on the direct ancestor of SARScoronavirus.	2008 Feb	United States	10.1128/JVI.01926-07
18055455	Severe acute respiratory syndrome-associated coronavirus nucleocapsid proteininteracts with Smad3 and modulates transforming growth factor-beta signaling.	2008 Feb 8	United States	10.1074/jbc.M708033200
18055026	Inhibition of human coronavirus 229E infection in human epithelial lung cells(L132) by chloroquine: involvement of p38 MAPK and ERK.	2008 Feb	Netherlands	10.1016/j.antiviral.2007.10.011
18054413	Surface-displayed porcine epidemic diarrhea viral (PEDV) antigens on lactic acidbacteria.	2007 Dec 21	Netherlands	10.1016/j.vaccine.2007.10.065
18054092	International research networks in viral structural proteomics: again, lessonsfrom SARS.	2008 Apr	Netherlands	10.1016/j.antiviral.2007.09.007
18050746	[Optimization of expression condition of SARS-CoV PUPs genes in E. coli].	2007 Sep	China	
19636862	NMR assignment of the domain 513-651 from the SARS-CoV nonstructural proteinnsp3.	2007 Dec	Netherlands	10.1007/s12104-007-9052-x
18045937	Infectious bronchitis viruses with a novel genomic organization.	2008 Feb	United States	10.1128/JVI.01694-07
18045871	Structural and functional analyses of the severe acute respiratory syndromecoronavirus endoribonuclease Nsp15.	2008 Feb 8	United States	10.1074/jbc.M708375200
18045721	SARS coronavirus accessory proteins.	2008 Apr	Netherlands	10.1016/j.virusres.2007.10.009
18041997	Discontinued drugs in 2006: anti-infectives.	2007 Dec	England	10.1517/13543784.16.12.1867
18041044	Molecular epidemiology and disease severity of respiratory syncytial virus inrelation to other potential pathogens in children hospitalized with acuterespiratory infection in Jordan.	2008 Jan	United States	10.1002/jmv.21067
18039277	Pathology and virus dispersion in cynomolgus monkeys experimentally infected withsevere acute respiratory syndrome coronavirus via different inoculation routes.	2007 Dec	England	10.1111/j.1365-2613.2007.00567.x
18037505	Experimental coronavirus retinopathy (ECOR): retinal degeneration susceptiblemice have an augmented interferon and chemokine (CXCL9, CXCL10) response earlyafter virus infection.	2008 Jan	Netherlands	10.1016/j.jneuroim.2007.09.032
18036985	Theoretically estimated risk of severe acute respiratory syndrome transmissionthrough blood transfusion during an epidemic in Shenzhen, Guangdong, China in2003.	2007 Dec	England	10.1016/j.transci.2007.09.004
18036887	In vitro inhibition of coronavirus replications by the traditionally usedmedicinal herbal extracts, Cimicifuga rhizoma, Meliae cortex, Coptidis rhizoma,and Phellodendron cortex.	2008 Feb	Netherlands	10.1016/j.jcv.2007.10.011
18035977	Action of disinfectants on canine coronavirus replication in vitro.	2007	Germany	10.1111/j.1863-2378.2007.01079.x
18032917	Are nidoviruses hijacking the autophagy machinery?	2008 Apr	United States	10.4161/auto.5241
18032831	Effects of several virucidal agents on inactivation of influenza, Newcastledisease, and avian infectious bronchitis viruses in the allantoic fluid ofchicken eggs.	2007 Nov	Japan	
18032623	Sensitive and specific enzyme-linked immunosorbent assay using chemiluminescencefor detection of severe acute respiratory syndrome viral infection.	2008 Jan	United States	10.1128/JCM.01006-07
18032506	Genetic interactions between an essential 3' cis-acting RNA pseudoknot, replicasegene products, and the extreme 3' end of the mouse coronavirus genome.	2008 Feb	United States	10.1128/JVI.01690-07
18032498	Amino acid substitutions in the S2 subunit of mouse hepatitis virus variant V51encode determinants of host range expansion.	2008 Feb	United States	10.1128/JVI.01674-07
18031959	Experimental infection of dogs with a novel strain of canine coronavirus causingsystemic disease and lymphopenia.	2008 Apr 30	Netherlands	10.1016/j.vetmic.2007.10.008
18029798	Immunopotentiating effects of four Chinese herbal polysaccharides administered atvaccination in chickens.	2007 Dec	England	10.3382/ps.2007-00076
18022664	SARS-CoV replicates in primary human alveolar type II cell cultures but not intype I-like cells.	2008 Mar 1	United States	10.1016/j.virol.2007.09.045
18022332	Coinfection of pigs with porcine respiratory coronavirus and Bordetellabronchiseptica.	2008 Apr 1	Netherlands	10.1016/j.vetmic.2007.09.025
18021801	Characterization of the mechanical unfolding of RNA pseudoknots.	2008 Jan 11	England	10.1016/j.jmb.2007.05.058
18020324	Interaction of a peptide from the pre-transmembrane domain of the severe acuterespiratory syndrome coronavirus spike protein with phospholipid membranes.	2007 Dec 13	United States	10.1021/jp073675y
18018769	Safety and immunogenicity from a phase I trial of inactivated severe acuterespiratory syndrome coronavirus vaccine.	2007	England	
18006061	Cloning, expression and characterization of ferret CXCL10.	2008 Mar	England	10.1016/j.molimm.2007.09.018
18003729	The spike glycoprotein of murine coronavirus MHV-JHM mediatesreceptor-independent infection and spread in the central nervous systems ofCeacam1a-/- Mice.	2008 Jan	United States	10.1128/JVI.01851-07
17999671	Human (non-severe acute respiratory syndrome) coronavirus infections inhospitalised children in France.	2008 Apr	Australia	10.1111/j.1440-1754.2007.01246.x
17996696	Evaluation of the safety, immunogenicity and pharmacokinetics of equineanti-SARS-CoV F(ab')(2) in macaque.	2007 Dec 15	Netherlands	10.1016/j.intimp.2007.09.011
17993755	Sequence analysis of the S1 glycoprotein gene of infectious bronchitis viruses:identification of a novel phylogenetic group in Korea.	2007 Dec	Korea (South)	10.4142/jvs.2007.8.4.401
17992938	Pathogenesis of infectious bronchitis virus in vaccinated chickens of twodifferent major histocompatibility B complex genotypes.	2007 Sep	United States	10.1637/0005-2086(2007)51[758:POIBVI]2.0.CO;2
17992925	Periodic monitoring of commercial turkeys for enteric viruses indicatescontinuous presence of astrovirus and rotavirus on the farms.	2007 Sep	United States	10.1637/0005-2086(2007)51[674:PMOCTF]2.0.CO;2
17988578	[Preparation and characterization of the epitopes of SARS coronavirus spikeprotein].	2007 Nov	China	
17985603	[Bad bats?].	2007 Oct 10	Switzerland	
17983666	Molecular mechanisms of primary and secondary mucosal immunity using avianinfectious bronchitis virus as a model system.	2008 Feb 15	Netherlands	10.1016/j.vetimm.2007.09.016
17983135	Solving the mystery of SARS.	2003 Apr 14	United States	
17981158	Structural basis of mercury- and zinc-conjugated complexes as SARS-CoV 3C-likeprotease inhibitors.	2007 Nov 27	England	10.1016/j.febslet.2007.10.048
17977841	Mutation of Gly-11 on the dimer interface results in the completecrystallographic dimer dissociation of severe acute respiratory syndromecoronavirus 3C-like protease: crystal structure with molecular dynamicssimulations.	2008 Jan 4	United States	10.1074/jbc.M705240200
17976532	"The ""SARS-unique domain"" (SUD) of SARS coronavirus is an oligo(G)-bindingprotein."	2007 Dec 28	United States	10.1016/j.bbrc.2007.10.081
17974127	Mice transgenic for human angiotensin-converting enzyme 2 provide a model forSARS coronavirus infection.	2007 Oct	United States	
17966113	An efficient RNA-cleaving DNA enzyme can specifically target the 5'-untranslatedregion of severe acute respiratory syndrome associated coronavirus (SARS-CoV).	2007 Dec	England	10.1002/jgm.1111
17966037	DRAK2 regulates memory T cell responses following murine coronavirus infection.	2007 Nov	England	10.1080/08916930701651139
17964088	A possible role for Clostridium difficile in the etiology of calf enteritis.	2008 Mar 18	Netherlands	10.1016/j.vetmic.2007.09.002
17961624	Transcriptional profiling of Vero E6 cells over-expressing SARS-CoV S2 subunit:insights on viral regulation of apoptosis and proliferation.	2008 Feb 5	United States	10.1016/j.virol.2007.09.016
17959675	Intracellular restriction of a productive noncytopathic coronavirus infection.	2008 Jan	United States	10.1128/JVI.01251-07
17957304	Inhibition of SARS coronavirus helicase by bismuth complexes.	2007 Nov 14	England	10.1039/b709515e
17957264	Conformational reorganization of the SARS coronavirus spike following receptorbinding: implications for membrane fusion.	2007 Oct 24	United States	10.1371/journal.pone.0001082
17952734	Vaccination against the avian infectious bronchitis virus affects spermconcentration, sperm quality and blood testosterone concentrations in cockerels.	2007 Oct	England	10.1080/00071660701592375
17950647	Priapism in a castrated cat associated with feline infectious peritonitis.	2008 Apr	England	10.1016/j.jfms.2007.08.006
17947532	Severe acute respiratory syndrome coronavirus Orf3a protein interacts withcaveolin.	2007 Nov	England	10.1099/vir.0.82856-0
17944272	Human coronaviruses: what do they cause?	2007	England	
17944271	Severe acute respiratory syndrome coronavirus entry as a target of antiviraltherapies.	2007	England	
17942563	Altered pathogenesis of porcine respiratory coronavirus in pigs due toimmunosuppressive effects of dexamethasone: implications for corticosteroid usein treatment of severe acute respiratory syndrome coronavirus.	2007 Dec	United States	10.1128/JVI.01702-07
17942557	Heptad repeat-derived peptides block protease-mediated direct entry from the cellsurface of severe acute respiratory syndrome coronavirus but not entry via theendosomal pathway.	2008 Jan	United States	10.1128/JVI.01697-07
17936066	Co-circulation of human metapneumovirus and SARS-associated coronavirus during amajor nosocomial SARS outbreak in Hong Kong.	2007 Dec	Netherlands	10.1016/j.jcv.2007.08.015
17936045	Evaluation of the protection conferred by commercial vaccines and attenuatedheterologous isolates in China against the CK/CH/LDL/97I strain of infectiousbronchitis coronavirus.	2009 Jan	England	10.1016/j.tvjl.2007.08.018
17935605	Maturation and localization of macrophages and microglia during infection with aneurotropic murine coronavirus.	2008 Jan	Switzerland	10.1111/j.1750-3639.2007.00098.x
17934078	Severe acute respiratory syndrome coronavirus as an agent of emerging andreemerging infection.	2007 Oct	United States	10.1128/CMR.00023-07
17932736	Cloning and further sequence analysis of the ORF3 gene of wild- andattenuated-type porcine epidemic diarrhea viruses.	2008 Feb	United States	10.1007/s11262-007-0164-2
17931870	Molecular docking identifies the binding of 3-chloropyridine moietiesspecifically to the S1 pocket of SARS-CoV Mpro.	2008 Jan 1	England	10.1016/j.bmc.2007.09.034
17931676	Role of phosphorylation clusters in the biology of the coronavirus infectiousbronchitis virus nucleocapsid protein.	2008 Jan 20	United States	10.1016/j.virol.2007.08.016
17931120	Protection from infection with severe acute respiratory syndrome coronavirus in aChinese hamster model by equine neutralizing F(ab')2.	2007 Sep	United States	10.1089/vim.2007.0038
17931118	Interleukin-6 expression after infectious bronchitis virus infection in chickens.	2007 Sep	United States	10.1089/vim.2006.0109
17928347	The 29-nucleotide deletion present in human but not in animal severe acuterespiratory syndrome coronaviruses disrupts the functional expression of openreading frame 8.	2007 Dec	United States	10.1128/JVI.01631-07
17928334	Type I interferons are essential in controlling neurotropic coronavirus infectionirrespective of functional CD8 T cells.	2008 Jan	United States	10.1128/JVI.01794-07
17927896	Biochemical characterization of exoribonuclease encoded by SARS coronavirus.	2007 Sep 30	Korea (South)	10.5483/bmbrep.2007.40.5.649
17924722	The utility of preemptive mass influenza vaccination in controlling a sarsoutbreak during flu season.	2007 Oct	United States	10.3934/mbe.2007.4.739
17923501	A novel subset of putative stem/progenitor CD34+Oct-4+ cells is the major targetfor SARS coronavirus in human lung.	2007 Oct 29	United States	10.1084/jem.20070462
17922397	Severe acute respiratory syndrome coronavirus infection in vaccinated ferrets.	2007 Nov 1	United States	10.1086/522431
17922396	Human coronavirus infections in rural Thailand: a comprehensive study usingreal-time reverse-transcription polymerase chain reaction assays.	2007 Nov 1	United States	10.1086/521308
17917382	Fatal winter dysentery with severe anemia in an adult cow.	2007 Sep	Japan	10.1292/jvms.69.957
17917063	Pathogenesis of acute and chronic central nervous system infection with variantsof mouse hepatitis virus, strain JHM.	2007	United States	10.1007/s12026-007-0079-y
17916374	Biological and genetic analysis of a bovine-like coronavirus isolated from waterbuffalo (Bubalus bubalis) calves.	2008 Jan 5	United States	10.1016/j.virol.2007.08.031
17913858	High prevalence of the CD14-159CC genotype in patients infected with severe acuterespiratory syndrome-associated coronavirus.	2007 Dec	United States	10.1128/CVI.00100-07
17913802	Antiviral antibodies are necessary to prevent cytotoxic T-lymphocyte escape inmice infected with a coronavirus.	2007 Dec	United States	10.1128/JVI.01580-07
17913799	Two-way antigenic cross-reactivity between severe acute respiratory syndromecoronavirus (SARS-CoV) and group 1 animal CoVs is mediated through an antigenicsite in the N-terminal region of the SARS-CoV nucleoprotein.	2007 Dec	United States	10.1128/JVI.01169-07
17913743	CoVDB: a comprehensive database for comparative analysis of coronavirus genes andgenomes.	2008 Jan	England	10.1093/nar/gkm754
17905435	Vaccination of mice with recombinant baculovirus expressing spike or nucleocapsidprotein of SARS-like coronavirus generates humoral and cellular immune responses.	2008 Feb	England	10.1016/j.molimm.2007.08.010
17899966	Lymphopenia in severe acute respiratory syndrome: a summary on its frequency.	2007 Jun	Nepal	
17898055	Biochemical and genetic analyses of murine hepatitis virus Nsp15endoribonuclease.	2007 Dec	United States	10.1128/JVI.00547-07
17896716	Tracking SARS.	2003 Apr 28	United States	
17895966	Identification of upper respiratory tract pathogens using electrochemicaldetection on an oligonucleotide microarray.	2007 Sep 26	United States	10.1371/journal.pone.0000924
17894233	[Genetic variations of membrane gene of infectious bronchitis virus strainsisolated in China between 1995 and 2004].	2007 Jul	China	
17894231	[Expression of recombinant spike protein of SARS-coronavirus in vaccinia virusand analysis of its immunogenicity].	2007 Jul	China	
17894224	[Sequence analysis for genes encoding nucleoprotein and envelope protein of a newhuman coronavirus NL63 identified from a pediatric patient in Beijing bybioinformatics].	2007 Jul	China	
17889596	Seroepidemiology of group I human coronaviruses in children.	2007 Nov	Netherlands	10.1016/j.jcv.2007.08.007
17889450	[Vertical transmission of human coronavirus. Prospective pilot study].	2007 Dec	France	10.1016/j.patbio.2007.07.013
17886224	Antiviral effects of Glycyrrhiza species.	2008 Feb	England	10.1002/ptr.2295
17884305	Comments to the predecessor of human SARS coronavirus in 2003-2004 epidemic.	2008 Jan 25	Netherlands	10.1016/j.vetmic.2007.08.014
17881505	Use of antibody avidity assays for diagnosis of severe acute respiratory syndromecoronavirus infection.	2007 Nov	United States	10.1128/CVI.00056-07
17881296	The SARS-CoV nucleocapsid protein: a protein with multifarious activities.	2008 Jul	Netherlands	10.1016/j.meegid.2007.07.004
17881030	Cytosine deamination and selection of CpG suppressed clones are the two majorindependent biological forces that shape codon usage bias in coronaviruses.	2007 Dec 20	United States	10.1016/j.virol.2007.08.010
17877547	High-cell-passage canine coronavirus vaccine providing sterilising immunity.	2007 Oct	England	10.1111/j.1748-5827.2007.00416.x
17875651	Community epidemiology of human metapneumovirus, human coronavirus NL63, andother respiratory viruses in healthy preschool-aged children usingparent-collected specimens.	2007 Oct	United States	10.1542/peds.2006-3703
17872528	Comparative analysis of innate immune responses following infection of newborncalves with bovine rotavirus and bovine coronavirus.	2007 Oct	England	10.1099/vir.0.82861-0
17872527	Persistent memory CD4+ and CD8+ T-cell responses in recovered severe acuterespiratory syndrome (SARS) patients to SARS coronavirus M antigen.	2007 Oct	England	10.1099/vir.0.82839-0
17872515	Discovery of herpesviruses in bats.	2007 Oct	England	10.1099/vir.0.83045-0
17868443	DetectiV: visualization, normalization and significance testing forpathogen-detection microarray data.	2007	England	10.1186/gb-2007-8-9-r190
17855683	Disappearance of antibodies to SARS-associated coronavirus after recovery.	2007 Sep 13	United States	10.1056/NEJMc070348
17855548	Genetic analysis of Murine hepatitis virus nsp4 in virus replication.	2007 Nov	United States	10.1128/JVI.01257-07
17855519	Localization and membrane topology of coronavirus nonstructural protein 4:involvement of the early secretory pathway in replication.	2007 Nov	United States	10.1128/JVI.01506-07
17855091	Structure-based design, synthesis, and biological evaluation of peptidomimeticSARS-CoV 3CLpro inhibitors.	2007 Nov 1	England	10.1016/j.bmcl.2007.08.031
17848893	Coronavirus-associated pneumonia in previously healthy children.	2007 Aug	United States	10.1097/INF.0b013e318054e31b
17848889	Newly identified respiratory viruses.	2007 Aug	United States	10.1097/INF.0b013e3181376428
17848070	Bats, civets and the emergence of SARS.	2007	Germany	10.1007/978-3-540-70962-6_13
17827535	A pseudoknot improves selection efficiency in ribosome display.	2007 May	United States	10.1007/s12033-007-0017-1
17825937	Pathogenetic mechanisms of severe acute respiratory syndrome.	2008 Apr	Netherlands	10.1016/j.virusres.2007.01.022
17824323	The emergence of porcine circovirus 2b genotype (PCV-2b) in swine in Canada.	2007 Aug	Canada	
17824221	[Three-dimensional structure prediction of the viral protein in the developmentof anti SARS drugs].	2007 Aug	Japan	
17822117	Effect of ultraviolet germicidal irradiation on viral aerosols.	2007 Aug 1	United States	10.1021/es070056u
17804659	Rapid multiplex nested PCR for detection of respiratory viruses.	2007 Nov	United States	10.1128/JCM.00280-07
17804504	High fidelity of murine hepatitis virus replication is decreased in nsp14exoribonuclease mutants.	2007 Nov	United States	10.1128/JVI.01296-07
17804032	Rat coronaviruses infect rat alveolar type I epithelial cells and induceexpression of CXC chemokines.	2007 Dec 20	United States	10.1016/j.virol.2007.07.030
17803510	Detection and molecular characterization of calf diarrhoea bovine coronavirusescirculating in South Korea during 2004-2005.	2007	Germany	10.1111/j.1863-2378.2007.01045.x
17802926	Prevention and control of emerging infections: a challenge for the 3rdmillennium.	2007 Jul	Italy	
17767596	Viral epizootic reveals inbreeding depression in a habitually inbreeding mammal.	2007 Sep	United States	10.1111/j.1558-5646.2007.00177.x
17766393	Conductance and amantadine binding of a pore formed by a lysine-flankedtransmembrane domain of SARS coronavirus envelope protein.	2007 Sep	United States	10.1110/ps.062730007
17766156	Evaluation of the association of Bartonella species, feline herpesvirus 1, felinecalicivirus, feline leukemia virus and feline immunodeficiency virus with chronicfeline gingivostomatitis.	2008 Feb	England	10.1016/j.jfms.2007.05.007
17766124	5'-O-masked 2'-deoxyadenosine analogues as lead compounds for hepatitis C virus(HCV) therapeutic agents.	2007 Nov 15	England	10.1016/j.bmc.2007.08.025
17763318	Clinical and molecular epidemiology of human bocavirus in respiratory and fecalsamples from children in Hong Kong.	2007 Oct 1	United States	10.1086/521310
17763311	[Immunisation strategies for the management of severe acute respiratory syndrome(SARS)].	2007 Oct	Germany	10.1055/s-2007-980107
17761676	Regulation of IRF-3-dependent innate immunity by the papain-like protease domainof the severe acute respiratory syndrome coronavirus.	2007 Nov 2	United States	10.1074/jbc.M704870200
17728234	Nuclear magnetic resonance structure of the N-terminal domain of nonstructuralprotein 3 from the severe acute respiratory syndrome coronavirus.	2007 Nov	United States	10.1128/JVI.00969-07
17728163	Genetic differentiation of the nucleocapsid protein of Korean isolates of porcineepidemic diarrhoea virus by RT-PCR based restriction fragment length polymorphismanalysis.	2008 Oct	England	10.1016/j.tvjl.2007.07.007
17727905	Impact of porcine group A rotavirus co-infection on porcine epidemic diarrheavirus pathogenicity in piglets.	2008 Jun	England	10.1016/j.rvsc.2007.07.004
17722610	[Bovine coronavirus reproduction in the continuous cell cultures at a temperatureof 34 degrees C].	2007 Jul-Aug	Russia (Federation)	
17722121	Structure-based design and synthesis of highly potent SARS-CoV 3CL proteaseinhibitors.	2007 Sep 24	Germany	10.1002/cbic.200700254
17715238	Specific asparagine-linked glycosylation sites are critical for DC-SIGN- andL-SIGN-mediated severe acute respiratory syndrome coronavirus entry.	2007 Nov	United States	10.1128/JVI.00315-07
17715225	Severe acute respiratory syndrome coronavirus evades antiviral signaling: role ofnsp1 and rational design of an attenuated strain.	2007 Nov	United States	10.1128/JVI.00702-07
17714515	Regulation of cell death during infection by the severe acute respiratorysyndrome coronavirus and other coronaviruses.	2007 Nov	England	10.1111/j.1462-5822.2007.01034.x
17709464	Novel small-molecule inhibitors of transmissible gastroenteritis virus.	2007 Nov	United States	10.1128/AAC.00408-07
17709158	Priming with SARS CoV S DNA and boosting with SARS CoV S epitopes specific forCD4+ and CD8+ T cells promote cellular immune responses.	2007 Sep 28	Netherlands	10.1016/j.vaccine.2007.06.047
17706262	Genomic characterization of equine coronavirus.	2007 Dec 5	United States	10.1016/j.virol.2007.06.035
17705188	The membrane protein of SARS-CoV suppresses NF-kappaB activation.	2007 Oct	United States	10.1002/jmv.20953
17704516	The carbohydrate-binding plant lectins and the non-peptidic antibiotic pradimicinA target the glycans of the coronavirus envelope glycoproteins.	2007 Oct	England	10.1093/jac/dkm301
17704379	Ultrastructural observations on effects of infectious bronchitis virus ineggshell-forming regions of the oviduct of the commercial laying hen.	2007 Sep	England	10.1093/ps/86.9.1915
17703411	Pan-viral screening of respiratory tract infections in adults with and withoutasthma reveals unexpected human coronavirus and human rhinovirus diversity.	2007 Sep 15	United States	10.1086/520816
17700057	Coronavirus replication does not require the autophagy gene ATG5.	2007 Nov-Dec	United States	10.4161/auto.4782
17698663	Attachment and internalization of feline infectious peritonitis virus in felineblood monocytes and Crandell feline kidney cells.	2007 Sep	England	10.1099/vir.0.82991-0
17697717	Multiplex real-time RT-PCR for the simultaneous detection and quantification oftransmissible gastroenteritis virus and porcine epidemic diarrhea virus.	2007 Dec	Netherlands	10.1016/j.jviromet.2007.06.021
17696769	Paper of the Year 2006: award to Pamela Hamill.	2007 Sep	Germany	10.1515/BC.2007.116
17696609	Functional genomics highlights differential induction of antiviral pathways inthe lungs of SARS-CoV-infected macaques.	2007 Aug 10	United States	10.1371/journal.ppat.0030112
17696607	Coronavirus non-structural protein 1 is a major pathogenicity factor:implications for the rational design of coronavirus vaccines.	2007 Aug 10	United States	10.1371/journal.ppat.0030109
17692883	Absence of E protein arrests transmissible gastroenteritis coronavirus maturationin the secretory pathway.	2007 Nov 25	United States	10.1016/j.virol.2007.05.032
17692881	Human CD4(+) memory T-lymphocyte responses to SARS coronavirus infection.	2007 Nov 25	United States	10.1016/j.virol.2007.07.015
17692355	Heparan sulfate is a binding molecule but not a receptor for CEACAM1-independentinfection of murine coronavirus.	2007 Sep 15	United States	10.1016/j.virol.2007.06.034
17692280	Selectivity in ISG15 and ubiquitin recognition by the SARS coronaviruspapain-like protease.	2007 Oct 1	United States	10.1016/j.abb.2007.07.006
17689145	Newly discovered respiratory viruses: significance and implications.	2007 Oct	England	10.1016/j.coph.2007.07.004
17686858	Severe acute respiratory syndrome coronavirus gene 7 products contribute tovirus-induced apoptosis.	2007 Oct	United States	10.1128/JVI.01266-07
17680799	Immune responses against severe acute respiratory syndrome coronavirus induced byvirus-like particles in mice.	2007 Dec	England	10.1111/j.1365-2567.2007.02676.x
17680348	Structural proteomics of the SARS coronavirus: a model response to emerginginfectious diseases.	2007 Sep	Netherlands	10.1007/s10969-007-9024-5
17676941	Characteristic distribution of L-tuple for DNA primary sequence.	2007 Aug	England	10.1080/07391102.2007.10507158
17675636	Aetiological role of viruses in puppies with diarrhoea.	2007 Aug 4	England	10.1136/vr.161.5.169
17672145	[New infections: myths and reality].	2007 May-Jun	Russia (Federation)	
17670839	The coronavirus spike protein induces endoplasmic reticulum stress andupregulation of intracellular chemokine mRNA concentrations.	2007 Oct	United States	10.1128/JVI.01033-07
17670827	Enhancement of murine coronavirus replication by severe acute respiratorysyndrome coronavirus protein 6 requires the N-terminal hydrophobic region but notC-terminal sorting motifs.	2007 Oct	United States	10.1128/JVI.01308-07
17669602	Severe outbreak of bovine coronavirus infection in dairy cattle during the warmerseason.	2008 Jan 1	Netherlands	10.1016/j.vetmic.2007.06.024
17669539	Activation of human monocytes after infection by human coronavirus 229E.	2007 Dec	Netherlands	10.1016/j.virusres.2007.06.016
17665998	Optimization of a DNA vaccine against SARS.	2007 Oct	United States	10.1089/dna.2007.0616
17663539	Specific plant terpenoids and lignoids possess potent antiviral activitiesagainst severe acute respiratory syndrome coronavirus.	2007 Aug 23	United States	10.1021/jm070295s
17658563	Expression of feline angiotensin converting enzyme 2 and its interaction withSARS-CoV S1 protein.	2008 Jun	England	10.1016/j.rvsc.2007.05.011
17652785	Expression of a synthetic neutralizing epitope of porcine epidemic diarrhea virusfused with synthetic B subunit of Escherichia coli heat labile enterotoxin inrice endosperm.	2007 Mar	United States	10.1007/bf02686007
17652383	Amino acid substitutions in the s2 region enhance severe acute respiratorysyndrome coronavirus infectivity in rat angiotensin-converting enzyme2-expressing cells.	2007 Oct	United States	10.1128/JVI.01143-07
17645546	Expression, post-translational modification and biochemical characterization ofproteins encoded by subgenomic mRNA8 of the severe acute respiratory syndromecoronavirus.	2007 Aug	England	10.1111/j.1742-4658.2007.05947.x
17645269	Bismuth complexes inhibit the SARS coronavirus.	2007	Germany	10.1002/anie.200701021
17643500	Chicken single-chain variable fragments against the SARS-CoV spike protein.	2007 Dec	Netherlands	10.1016/j.jviromet.2007.06.010
17643010	Severe acute respiratory syndrome.	2003 Jul-Sep	India	
17641827	The immunity induced by recombinant spike proteins of SARS coronavirus in Balb/cmice.	2007 Jun	China	10.1007/s11596-007-0301-0
17640780	Intranasal Protollin-formulated recombinant SARS S-protein elicits respiratoryand serum neutralizing antibodies and protection in mice.	2007 Aug 21	Netherlands	10.1016/j.vaccine.2007.06.017
17640731	Towards our understanding of SARS-CoV, an emerging and devastating but quicklyconquered virus.	2007 Sep	England	10.1016/j.cimid.2007.05.009
17635157	Cell-penetrating peptide-morpholino conjugates alter pre-mRNA splicing of DMD(Duchenne muscular dystrophy) and inhibit murine coronavirus replication in vivo.	2007 Aug	England	10.1042/BST0350826
17634238	Processing of open reading frame 1a replicase proteins nsp7 to nsp10 in murinehepatitis virus strain A59 replication.	2007 Oct	United States	10.1128/JVI.00017-07
17632570	Targeting the glycans of glycoproteins: a novel paradigm for antiviral therapy.	2007 Aug	England	10.1038/nrmicro1707
17631932	The S proteins of human coronavirus NL63 and severe acute respiratory syndromecoronavirus bind overlapping regions of ACE2.	2007 Oct 25	United States	10.1016/j.virol.2007.04.035
17629993	A Massachusetts prototype like coronavirus isolated from wild peafowls ispathogenic to chickens.	2007 Dec	Netherlands	10.1016/j.virusres.2007.06.003
17629360	Induction of T-cell response by a DNA vaccine encoding a novel HLA-A*0201 severeacute respiratory syndrome coronavirus epitope.	2007 Aug 10	Netherlands	10.1016/j.vaccine.2007.05.025
17626812	Intratracheally administered pathogen-associated molecular patterns affectantibody responses of poultry.	2007 Aug	England	10.1093/ps/86.8.1667
17626490	The efficacy of an avian metapneumovirus vaccine applied simultaneously withinfectious bronchitis and Newcastle disease virus vaccines tospecific-pathogen-free chickens.	2007 Jun	United States	10.1637/0005-2086(2007)51[594:TEOAAM]2.0.CO;2
17626488	Evaluation of the effectiveness of two infectious bronchitis virus vaccineprograms for preventing disease caused by a California IBV field isolate.	2007 Jun	United States	10.1637/0005-2086(2007)51[584:EOTEOT]2.0.CO;2
17626478	Molecular and serologic characterization, pathogenicity, and protection studieswith infectious bronchitis virus field isolates from California.	2007 Jun	United States	10.1637/0005-2086(2007)51[527:MASCPA]2.0.CO;2
17626088	Role of endocytosis and low pH in murine hepatitis virus strain A59 cell entry.	2007 Oct	United States	10.1128/JVI.00725-07
17620608	Potent cross-reactive neutralization of SARS coronavirus isolates by humanmonoclonal antibodies.	2007 Jul 17	United States	10.1073/pnas.0701000104
17620171	Infection of HeLa cells by avian infectious bronchitis virus is dependent on cellstatus.	2007 Aug	England	10.1080/03079450701447291
17618660	Systemic fatal type II coronavirus infection in a dog: pathological findings andimmunohistochemistry.	2008 Apr	England	10.1016/j.rvsc.2007.05.004
17617609	Expression of CXC chemokine ligand 10 from the mouse hepatitis virus genomeresults in protection from viral-induced neurological and liver disease.	2007 Jul 15	United States	10.4049/jimmunol.179.2.1155
17617433	Complete genome sequence of bat coronavirus HKU2 from Chinese horseshoe batsrevealed a much smaller spike gene with a different evolutionary lineage from therest of the genome.	2007 Oct 25	United States	10.1016/j.virol.2007.06.009
17607787	Quantitative temporal-spatial distribution of severe acute respiratorysyndrome-associated coronavirus (SARS-CoV) in post-mortem tissues.	2007 Sep	United States	10.1002/jmv.20873
17605471	Substrate specificity profiling and identification of a new class of inhibitorfor the major protease of the SARS coronavirus.	2007 Jul 31	United States	10.1021/bi0621415
17602767	Calf-level risk factors for neonatal diarrhea and shedding of Cryptosporidiumparvum in Ontario dairy calves.	2007 Nov 15	Netherlands	10.1016/j.prevetmed.2007.05.003
17600339	Distinct regulation of MHC molecule expression on astrocytes and microglia duringviral encephalomyelitis.	2007 Aug 15	United States	10.1002/glia.20538
17599357	A mechanistic view of enzyme inhibition and peptide hydrolysis in the active siteof the SARS-CoV 3C-like peptidase.	2007 Aug 24	England	10.1016/j.jmb.2007.06.001
17597972	Pharmacologic treatment of SARS: current knowledge and recommendations.	2007 Jun	Singapore	
17597481	Detection of viruses identified recently in children with acute wheezing.	2007 Aug	United States	10.1002/jmv.20926
17597455	Open reading frame 8a of the human severe acute respiratory syndrome coronavirusnot only promotes viral replication but also induces apoptosis.	2007 Aug 1	United States	10.1086/519166
17596427	Type IVB pilus operon promoter controlling expression of the severe acuterespiratory syndrome-associated coronavirus nucleocapsid gene in Salmonellaenterica Serovar Typhi elicits full immune response by intranasal vaccination.	2007 Aug	United States	10.1128/CVI.00076-07
17596360	Development of a respiratory virus panel test for detection of twenty humanrespiratory viruses by use of multiplex PCR and a fluid microbead-based assay.	2007 Sep	United States	10.1128/JCM.02436-06
17596301	Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function bysequestering nuclear import factors on the rough endoplasmic reticulum/Golgimembrane.	2007 Sep	United States	10.1128/JVI.01012-07
17590445	siRNAs targeting terminal sequences of the SARS-associated coronavirus membranegene inhibit M protein expression through degradation of M mRNA.	2007 Nov	Netherlands	10.1016/j.jviromet.2007.05.017
17585465	Infectious bronchitis virus replication in the chicken embryo related cell line.	2003 Aug	England	10.1080/0307945031000121167
17582907	European Hedgehogs as Hosts for Borrelia spp., Germany.	2007 Jun	United States	10.3201/eid1306.070224
17582904	Coronaviruses in children, Greece.	2007 Jun	United States	10.3201/eid1306.061353
17581748	Heterologous MVA-S prime Ad5-S boost regimen induces high and persistent levelsof neutralizing antibody response against SARS coronavirus.	2007 Oct	Germany	10.1007/s00253-007-1073-y
17580675	[Ligand screening in affinity chromatography and its applications].	2007 Mar	China	
17577826	Estimating incubation period with multiple contact days.	2007	England	10.1080/00365540601113719
17576016	Application of a focus formation assay for detection and titration of porcineepidemic diarrhea virus.	2007 Oct	Netherlands	10.1016/j.jviromet.2007.05.012
17575179	Detection and seroprevalence of infectious bronchitis virus strains in commercialpoultry in Pakistan.	2007 Jul	England	10.1093/ps/86.7.1329
17574457	Effects of epidermal growth factor on atrophic enteritis in piglets induced byexperimental porcine epidemic diarrhoea virus.	2008 Aug	England	10.1016/j.tvjl.2007.04.018
17573516	Viral etiology of acute exacerbations of COPD in Hong Kong.	2007 Sep	United States	10.1378/chest.07-0530
17570115	Association of ICAM3 genetic variant with severe acute respiratory syndrome.	2007 Jul 15	United States	10.1086/518892
17568476	Effectiveness of control measures during the SARS epidemic in Beijing: acomparison of the Rt curve and the epidemic curve.	2008 Apr	England	10.1017/S0950268807008722
17567770	First isolation of cytopathogenic bovine torovirus in cell culture from a calfwith diarrhea.	2007 Aug	United States	10.1128/CVI.00475-06
17567241	Cell entry by enveloped viruses: redox considerations for HIV andSARS-coronavirus.	2007 Aug	United States	10.1089/ars.2007.1639
17566670	A Saccharomyces cerevisiae autoselection system for optimised recombinant proteinexpression.	2007 Sep 15	Netherlands	10.1016/j.gene.2007.05.001
17565868	[Expression of severe acute respiratory syndrome coronavirus receptors, ACE2 andCD209L in different organ derived microvascular endothelial cells].	2007 Mar 27	China	
17564760	Dual enteric and respiratory tropisms of winter dysentery bovine coronavirus incalves.	2007	Austria	10.1007/s00705-007-1005-2
17559989	Adenovirus-based vaccine prevents pneumonia in ferrets challenged with the SARScoronavirus and stimulates robust immune responses in macaques.	2007 Jul 9	Netherlands	10.1016/j.vaccine.2007.04.065
17558469	Angiotensin-converting enzyme 2 in acute respiratory distress syndrome.	2007 Aug	Switzerland	10.1007/s00018-007-6228-6
17555580	Cyclooxygenase activity is important for efficient replication of mouse hepatitisvirus at an early stage of infection.	2007 Jun 7	England	10.1186/1743-422X-4-55
17553448	The use of hepatitis C virus NS3/4A and secreted alkaline phosphatase toquantitate cell-cell membrane fusion mediated by severe acute respiratorysyndrome coronavirus S protein and the receptor angiotensin-converting enzyme 2.	2007 Jul 15	United States	10.1016/j.ab.2007.04.031
17552246	[Construction of recombinant Lactococcus lactis expressing porcine transmissiblegastroenteritis spike glycoprotein and analysis of immunogenicity].	2007 Apr	China	
17552243	[Construction of recombinant BCG bearing S1 glycoprotein of nephropathogenic IBVand study on its immunogenicity on chickens].	2007 Apr	China	
17551411	Human coronavirus OC43 pneumonia in a pediatric cancer patient with down syndromeand acute lymphoblastic leukemia.	2007 Jun	United States	10.1097/MPH.0b013e31806451c1
17551218	Detection of bovine torovirus in fecal specimens of calves with diarrhea inJapan.	2007 May	Japan	10.1292/jvms.69.471
17548223	Isolation and identification of an scFv antibody against nucleocapsid protein ofSARS-CoV.	2007 Jul	France	10.1016/j.micinf.2007.04.008
17543480	Differentiation of feline coronavirus type I and II infections by virusneutralization test.	2007 Oct 6	Netherlands	10.1016/j.vetmic.2007.04.031
17540042	The association of RANTES polymorphism with severe acute respiratory syndrome inHong Kong and Beijing Chinese.	2007 Jun 1	England	10.1186/1471-2334-7-50
17537928	High-throughput, sensitive, and accurate multiplex PCR-microsphere flow cytometrysystem for large-scale comprehensive detection of respiratory viruses.	2007 Aug	United States	10.1128/JCM.02501-06
17537850	De novo initiation of RNA synthesis by the arterivirus RNA-dependent RNApolymerase.	2007 Aug	United States	10.1128/JVI.00564-07
17536623	Spontaneous exocrine pancreas hypoplasia in specific pathogen-free C3HeB/FeJ and101/H mouse pups causes steatorrhea and runting.	2007 Apr	United States	
17535926	Newcastle disease virus, a host range-restricted virus, as a vaccine vector forintranasal immunization against emerging pathogens.	2007 Jun 5	United States	10.1073/pnas.0703584104
17534355	Lack of support for an association between CLEC4M homozygosity and protectionagainst SARS coronavirus infection.	2007 Jun	United States	10.1038/ng0607-692
17534354	Lack of support for an association between CLEC4M homozygosity and protectionagainst SARS coronavirus infection.	2007 Jun	United States	10.1038/ng0607-691
17533554	Characterization of divergent and atypical canine coronaviruses from Sweden.	2007	Austria	10.1007/s00705-007-0986-1
17533109	Cleavage of spike protein of SARS coronavirus by protease factor Xa is associatedwith viral infectivity.	2007 Jul 20	United States	10.1016/j.bbrc.2007.05.092
17532082	Up-regulation of IL-6 and TNF-alpha induced by SARS-coronavirus spike protein inmurine macrophages via NF-kappaB pathway.	2007 Sep	Netherlands	10.1016/j.virusres.2007.02.007
17532081	Immune response induced by spike protein from transmissible gastroenteritiscoronavirus expressed in mouse mammary cells.	2007 Sep	Netherlands	10.1016/j.virusres.2007.04.004
17532020	The nonstructural protein 8 (nsp8) of the SARS coronavirus interacts with itsORF6 accessory protein.	2007 Sep 30	United States	10.1016/j.virol.2007.04.029
17530462	Coronavirus envelope protein: a small membrane protein with multiple functions.	2007 Aug	Switzerland	10.1007/s00018-007-7103-1
17526201	[Severe acute respiratory syndrome].	2007	Russia (Federation)	
17524366	Trafficking motifs in the SARS-coronavirus nucleocapsid protein.	2007 Jul 13	United States	10.1016/j.bbrc.2007.05.036
17522231	Clathrin-dependent entry of severe acute respiratory syndrome coronavirus intotarget cells expressing ACE2 with the cytoplasmic tail deleted.	2007 Aug	United States	10.1128/JVI.00253-07
17520018	Analysis of intraviral protein-protein interactions of the SARS coronavirusORFeome.	2007 May 23	United States	10.1371/journal.pone.0000459
17518614	Human immunodeficiency viral vector pseudotyped with the spike envelope of severeacute respiratory syndrome coronavirus transduces human airway epithelial cellsand dendritic cells.	2007 May	United States	10.1089/hum.2006.194
17517191	A retrospective serological study of severe acute respiratory syndrome cases inGuangdong province, China.	2007 Apr 20	China	
17515642	Formalin-treated UV-inactivated SARS coronavirus vaccine retains itsimmunogenicity and promotes Th2-type immune responses.	2007 May	Japan	
17513145	Canine coronavirus inactivation with physical and chemical agents.	2008 Jul	England	10.1016/j.tvjl.2007.03.019
17511240	[Loop-mediated isothermal amplification].	2007 May	Japan	
17507510	Simultaneous detection and high-throughput identification of a panel of RNAviruses causing respiratory tract infections.	2007 Jul	United States	10.1128/JCM.00210-07
17507479	Synthetic reconstruction of zoonotic and early human severe acute respiratorysyndrome coronavirus isolates that produce fatal disease in aged mice.	2007 Jul	United States	10.1128/JVI.00505-07
17507478	GxxxG motif of severe acute respiratory syndrome coronavirus spike glycoproteintransmembrane domain is not involved in trimerization and is not important forentry.	2007 Aug	United States	10.1128/JVI.00014-07
17507310	Two cases of severe obstructive pneumonia associated with an HKU1-likecoronavirus.	2007 Mar 26	England	
17504232	The two fACEs of the tissue renin-angiotensin systems: implication incardiovascular diseases.	2007	United Arab Emirates	10.2174/138161207780618911
17502675	Expression, glycosylation, and modification of the spike (S) glycoprotein of SARSCoV.	2007	United States	10.1007/978-1-59745-393-6_9
17502669	Expression of the severe acute respiratory syndrome coronavirus 3a protein andthe assembly of coronavirus-like particles in the baculovirus expression system.	2007	United States	10.1007/978-1-59745-393-6_3
17502668	Interaction between respiratory syncytial virus and glycosaminoglycans, includingheparan sulfate.	2007	United States	10.1007/978-1-59745-393-6_2
17502293	Epidemic modeling in complex realities.	2007 Apr	France	10.1016/j.crvi.2007.02.014
17499378	Animal models and vaccines for SARS-CoV infection.	2008 Apr	Netherlands	10.1016/j.virusres.2007.03.025
17499376	Antigenic characterization of severe acute respiratory syndrome-coronavirusnucleocapsid protein expressed in insect cells: The effect of phosphorylation onimmunoreactivity and specificity.	2007 Jul	Netherlands	10.1016/j.virusres.2007.03.019
17497340	Coronavirus associated with an enteric syndrome on a quail farm.	2007 Jun	England	10.1080/03079450701344738
17497337	S1 gene sequence heterogeneity of a pathogenic infectious bronchitis virus strainand its embryo-passaged, attenuated derivatives.	2007 Jun	England	10.1080/03079450701338730
17494640	Induction of specific immune responses by severe acute respiratory syndromecoronavirus spike DNA vaccine with or without interleukin-2 immunization usingdifferent vaccination routes in mice.	2007 Jul	United States	10.1128/CVI.00019-07
17493653	Cell cycle arrest and apoptosis induced by the coronavirus infectious bronchitisvirus in the absence of p53.	2007 Sep 1	United States	10.1016/j.virol.2007.04.015
17493140	Detection of viral agents in fecal specimens of monkeys with diarrhea.	2007 Apr	Denmark	10.1111/j.1600-0684.2006.00167.x
17490702	Nucleocapsid protein of SARS-CoV activates interleukin-6 expression throughcellular transcription factor NF-kappaB.	2007 Sep 1	United States	10.1016/j.virol.2007.04.009
17490409	Mouse hepatitis coronavirus replication induces host translational shutoff andmRNA decay, with concomitant formation of stress granules and processing bodies.	2007 Sep	England	10.1111/j.1462-5822.2007.00951.x
17488094	The 3a accessory protein of SARS coronavirus specifically interacts with the5'UTR of its genomic RNA, Using a unique 75 amino acid interaction domain.	2007 Jun 5	United States	10.1021/bi062057p
17485536	Type I feline coronavirus spike glycoprotein fails to recognize aminopeptidase Nas a functional receptor on feline cell lines.	2007 Jun	England	10.1099/vir.0.82666-0
17479370	Lithium chloride inhibits the coronavirus infectious bronchitis virus in cellculture.	2007 Apr	England	10.1080/03079450601156083
17478116	The detection of feline coronaviruses in blood samples from cats by mRNA RT-PCR.	2007 Oct	England	10.1016/j.jfms.2007.03.002
17475765	Comparison of immunoglobulin G responses to the spike and nucleocapsid proteinsof severe acute respiratory syndrome (SARS) coronavirus in patients with SARS.	2007 Jul	United States	10.1128/CVI.00432-06
17475638	An RNA stem-loop within the bovine coronavirus nsp1 coding region is a cis-actingelement in defective interfering RNA replication.	2007 Jul	United States	10.1128/JVI.00549-07
17475420	High-level prokaryotic expression of envelope exterior of membrane protein ofporcine epidemic diarrhea virus.	2007 Jul 20	Netherlands	10.1016/j.vetmic.2007.03.027
17471479	A fluorogenic peptide containing the processing site of human SARS corona virusS-protein: kinetic evaluation and NMR structure elucidation.	2007 Jun 18	Germany	10.1002/cbic.200700007
17470913	Signal transduction in SARS-CoV-infected cells.	2007 Apr	United States	10.1196/annals.1408.006
17470909	The molecular biology of SARS coronavirus.	2007 Apr	United States	10.1196/annals.1408.002
17470907	Proceedings of a meeting entitled Emerging Viral Infectious Diseases, April 4-5,2005, Hanoi, Vietnam.	2007 Apr	United States	10.1196/annals.1408.011
17469274	Serosurvey of infectious disease agents of carnivores in captive red pandas(Ailurus fulgens) in China.	2007 Mar	United States	10.1638/06-048.1
17467837	SARS-CoV: lessons for global health.	2008 Apr	Netherlands	10.1016/j.virusres.2007.03.024
17467767	Porcine aminopeptidase N is a functional receptor for the PEDV coronavirus.	2007 Aug 15	United States	10.1016/j.virol.2007.03.031
17466472	Molecular epidemiology of bovine noroviruses in South Korea.	2007 Sep 20	Netherlands	10.1016/j.vetmic.2007.03.010
17464936	The emerging role of ACE2 in physiology and disease.	2007 May	England	10.1002/path.2162
17461975	In silico prediction of SARS protease inhibitors by virtual high throughputscreening.	2007 Apr	England	10.1111/j.1747-0285.2007.00475.x
17461266	Heparan sulfate is a selective attachment factor for the avian coronavirusinfectious bronchitis virus Beaudette.	2007 Mar	United States	10.1637/0005-2086(2007)051[0045:HSIASA]2.0.CO;2
17460117	Seroprevalence of selected infectious agents in a free-ranging, low-density lionpopulation in the Central Kalahari Game Reserves in Botswana.	2007 Jun	United States	10.1128/CVI.00307-06
17459938	Detection of a novel and highly divergent coronavirus from asian leopard cats andChinese ferret badgers in Southern China.	2007 Jul	United States	10.1128/JVI.00299-07
17459917	Inhibition of the alpha/beta interferon response by mouse hepatitis virus atmultiple levels.	2007 Jul	United States	10.1128/JVI.00013-07
17459855	Critical assessment of the diagnostic value of feline alpha1-acid glycoproteinfor feline infectious peritonitis using the likelihood ratios approach.	2007 May	United States	10.1177/104063870701900306
17459444	Analysis of the genome sequence of an alpaca coronavirus.	2007 Aug 15	United States	10.1016/j.virol.2007.03.035
17458774	Severe acute respiratory syndrome (SARS) coronavirus.	2007 Apr	United States	10.1055/s-2007-976492
17458772	Rhinovirus and coronavirus infections.	2007 Apr	United States	10.1055/s-2007-976490
17453707	SARS-CoV nucleocapsid protein induced apoptosis of COS-1 mediated by themitochondrial pathway.	2007	England	10.1080/10731190601188422
17451830	A review of studies on animal reservoirs of the SARS coronavirus.	2008 Apr	Netherlands	10.1016/j.virusres.2007.03.012
17451829	SARS-CoV replication and pathogenesis in an in vitro model of the humanconducting airway epithelium.	2008 Apr	Netherlands	10.1016/j.virusres.2007.03.013
17451827	SARS coronavirus and innate immunity.	2008 Apr	Netherlands	10.1016/j.virusres.2007.03.015
17450553	Peptide reagent design based on physical and chemical properties of amino acidresidues.	2007 Sep	United States	10.1002/jcc.20732
17448727	Long-term human coronavirus-myelin cross-reactive T-cell clones derived frommultiple sclerosis patients.	2007 Jun	United States	10.1016/j.clim.2007.02.002
17448558	Intracellular localization of the SARS coronavirus protein 9b: evidence of activeexport from the nucleus.	2007 Jul	Netherlands	10.1016/j.virusres.2007.03.011
17447647	Identification of antibody against porcine coronavirus in human milk.	2007	Germany	
17446665	[Cell entry mechanism of coronaviruses: implication in their pathogenesis].	2006 Dec	Japan	10.2222/jsv.56.165
17436639	[Immunogenicity of S1 gene DNA vaccine of mouse hepatitis virus delivered byattenuated Salmonella typhimurium].	2007 Feb	China	
17436070	Sequence analysis of the partial spike glycoprotein gene of porcine epidemicdiarrhea viruses isolated in Korea.	2007 Oct	United States	10.1007/s11262-007-0096-x
17434558	Quasispecies of bovine enteric and respiratory coronaviruses based on completegenome sequences and genetic changes after tissue culture adaptation.	2007 Jun 20	United States	10.1016/j.virol.2007.03.018
17431755	Different genotypes of nephropathogenic infectious bronchitis virusesco-circulating in chicken population in China.	2007 Oct	United States	10.1007/s11262-007-0100-5
17428870	Analysis of murine hepatitis virus strain A59 temperature-sensitive mutant TS-LA6suggests that nsp10 plays a critical role in polyprotein processing.	2007 Jul	United States	10.1128/JVI.00049-07
17428862	Induction of apoptosis by the severe acute respiratory syndrome coronavirus 7aprotein is dependent on its interaction with the Bcl-XL protein.	2007 Jun	United States	10.1128/JVI.00090-07
17428856	New structure model for the packaging signal in the genome of group IIacoronaviruses.	2007 Jun	United States	10.1128/JVI.02231-06
17428553	Plant lectins are potent inhibitors of coronaviruses by interfering with twotargets in the viral replication cycle.	2007 Sep	Netherlands	10.1016/j.antiviral.2007.03.003
17426449	Cell cycle dependent nucleolar localization of the coronavirus nucleocapsidprotein.	2007 Apr 1	United States	10.4161/cc.6.7.4032
17425434	Inhibition of severe acute respiratory syndrome-associated coronavirus infectionby equine neutralizing antibody in golden Syrian hamsters.	2007 Spring	United States	10.1089/vim.2006.0064
17419026	[Emerging viral diseases in pulmonary medicine].	2007 Jun	France	10.1016/j.arcped.2007.02.073
17416443	Manipulation of the infectious bronchitis coronavirus genome for vaccinedevelopment and analysis of the accessory proteins.	2007 Jul 26	Netherlands	10.1016/j.vaccine.2007.02.046
17416434	Vaccines to prevent severe acute respiratory syndrome coronavirus-induceddisease.	2008 Apr	Netherlands	10.1016/j.virusres.2007.01.021
17414123	Community acquired pneumonia in the tropics.	2007 May	United States	10.1097/MCP.0b013e3280ebb5dc
17413032	G1 phase cell cycle arrest induced by SARS-CoV 3a protein via the cyclin D3/pRbpathway.	2007 Jul	United States	10.1165/rcmb.2005-0345RC
17412287	The SARS coronavirus spike glycoprotein is selectively recognized by lungsurfactant protein D and activates macrophages.	2007	Netherlands	10.1016/j.imbio.2006.12.001
17409649	The infectivity and pathogenicity of a group 2 bovine coronavirus in pups.	2007 Mar	Japan	10.1292/jvms.69.301
17409150	Crystal structure of a monomeric form of severe acute respiratory syndromecoronavirus endonuclease nsp15 suggests a role for hexamerization as anallosteric switch.	2007 Jun	United States	10.1128/JVI.02817-06
17407183	Proteomic analysis of up-regulated proteins in human promonocyte cells expressingsevere acute respiratory syndrome coronavirus 3C-like protease.	2007 May	Germany	10.1002/pmic.200600459
17405470	Knowledge of and attitudes toward severe acute respiratory syndrome among acohort of dental patients in Hong Kong following a major local outbreak.	2007 Mar	England	
17402839	Identification of new human coronaviruses.	2007 Apr	England	10.1586/14787210.5.2.245
17402612	Serological prevalence of canine respiratory coronavirus in southern Italy andepidemiological relationship with canine enteric coronavirus.	2007 Mar	United States	10.1177/104063870701900206
17402195	[Study on the dynamic prevalence of serum antibody against severe acuterespiratory syndrome coronavirus in employees from wild animal market inGuangzhou].	2006 Nov	China	
17397959	SARS coronavirus replicase proteins in pathogenesis.	2008 Apr	Netherlands	10.1016/j.virusres.2007.02.017
17397958	Evaluating the 3C-like protease activity of SARS-Coronavirus: recommendations forstandardized assays for drug discovery.	2008 Apr	Netherlands	10.1016/j.virusres.2007.02.015
17392374	Identification and characterization of dominant helper T-cell epitopes in thenucleocapsid protein of severe acute respiratory syndrome coronavirus.	2007 Jun	United States	10.1128/JVI.02568-06
17392370	Proteolytic processing and deubiquitinating activity of papain-like proteases ofhuman coronavirus NL63.	2007 Jun	United States	10.1128/JVI.02747-06
17392363	Murine hepatitis virus replicase protein nsp10 is a critical regulator of viralRNA synthesis.	2007 Jun	United States	10.1128/JVI.02805-06
17392154	Pathology and pathogenesis of severe acute respiratory syndrome.	2007 Apr	United States	10.2353/ajpath.2007.061088
17390754	New and emerging infectious diseases.	2007 Jan-Feb	United States	10.2500/aap.2007.28.2870
17386116	Using patient-collected clinical samples and sera to detect and quantify thesevere acute respiratory syndrome coronavirus (SARS-CoV).	2007 Mar 27	England	10.1186/1743-422X-4-32
17382365	TNF-alpha, produced by feline infectious peritonitis virus (FIPV)-infectedmacrophages, upregulates expression of type II FIPV receptor felineaminopeptidase N in feline macrophages.	2007 Jul 20	United States	10.1016/j.virol.2007.02.006
17381079	Design, synthesis, and evaluation of inhibitors for severe acute respiratorysyndrome 3C-like protease based on phthalhydrazide ketones or heteroaromaticesters.	2007 Apr 19	United States	10.1021/jm061425k
17379242	Structure of the SARS coronavirus nucleocapsid protein RNA-binding dimerizationdomain suggests a mechanism for helical packaging of viral RNA.	2007 May 11	England	10.1016/j.jmb.2007.02.069
17374765	Molecular analysis of the S glycoprotein gene of bovine coronaviruses isolated inJapan from 1999 to 2006.	2007 Apr	England	10.1099/vir.0.82635-0
17374510	Computational characterization and design of SARS coronavirus receptorrecognition and antibody neutralization.	2007 Apr	England	10.1016/j.compbiolchem.2007.02.005
17374415	Human immunopathogenesis of severe acute respiratory syndrome (SARS).	2008 Apr	Netherlands	10.1016/j.virusres.2007.02.014
17368968	Development and evaluation of enzyme-linked immunosorbent assay based onrecombinant nucleocapsid protein for detection of porcine epidemic diarrhea(PEDV) antibodies.	2007 Jul 20	Netherlands	10.1016/j.vetmic.2007.02.014
17368948	[Emerging viral infectious diseases and pregnancy].	2007 Apr	France	10.1016/j.gyobfe.2007.02.020
17368104	Computational simulation of interactions between SARS coronavirus spike mutantsand host species-specific receptors.	2007 Apr	England	10.1016/j.compbiolchem.2007.02.006
17367888	Identification of mouse hepatitis coronavirus A59 nucleocapsid proteinphosphorylation sites.	2007 Jun	Netherlands	10.1016/j.virusres.2007.02.008
17366033	Positive rate of serum SARS-CoV immunoglobulin G antibody among healthcareworkers.	2007	England	10.1080/00365540600951226
17365191	Bioactive coumarins from Boenninghausenia sessilicarpa.	2007 Jan-Feb	England	10.1080/10286020500382397
17364511	Sequence changes of infectious bronchitis virus isolates in the 3' 7.3 kb of thegenome after attenuating passage in embryonated eggs.	2007 Feb	England	10.1080/03079450601110015
17364507	Detection of turkey coronavirus in commercial turkey poults in Brazil.	2007 Feb	England	10.1080/03079450601102939
17364498	Anti-viral effector T cell responses and trafficking are not dependent upon DRAK2signaling following viral infection of the central nervous system.	2007 Feb	England	10.1080/08916930600996700
17363313	Genomic RNA sequence of feline coronavirus strain FCoV C1Je.	2007 Jun	England	10.1016/j.jfms.2006.12.002
17363184	Why G3139 works poorly in cancer trials but might work well against HIV.	2007	United States	10.1016/j.mehy.2007.01.044
17361062	Wildlife, environment and (re)-emerging zoonoses, with special reference tosylvatic tick-borne zoonoses in North-Western Italy.	2006	Italy	
17360045	A dominant antigenic epitope on SARS-CoV spike protein identified by an aviansingle-chain variable fragment (scFv)-expressing phage.	2007 May 15	Netherlands	10.1016/j.vetimm.2007.02.001
17359980	Characterisation of cyclin D1 down-regulation in coronavirus infected cells.	2007 Apr 3	England	10.1016/j.febslet.2007.02.039
17354647	Carbohydrate-binding agents: a potential future cornerstone for the chemotherapyof enveloped viruses?	2007	England	10.1177/095632020701800101
17353353	A U-turn motif-containing stem-loop in the coronavirus 5' untranslated regionplays a functional role in replication.	2007 May	United States	10.1261/rna.261807
17352399	Acute life threatening event (ALTE) in an infant with human coronavirus HCoV-229Einfection.	2007 Apr	United States	10.1002/ppul.20595
17348910	Production and characterization of monoclonal antibodies to (poly100)S1 proteinof avian infectious bronchitis virus.	2007	Germany	10.1111/j.1863-2378.2007.01030.x
17348296	Reliability of soiled bedding transfer for detection of mouse parvovirus andmouse hepatitis virus.	2007 Feb	United States	
17346212	Antiviral strategies against human coronaviruses.	2007 Mar	United Arab Emirates	10.2174/187152607780090757
17346209	Recent developments in the virology and antiviral research of severe acuterespiratory syndrome coronavirus.	2007 Mar	United Arab Emirates	10.2174/187152607780090739
17344287	Antiviral effects of antisense morpholino oligomers in murine coronavirusinfection models.	2007 Jun	United States	10.1128/JVI.02360-06
17344286	Severe acute respiratory syndrome coronavirus accessory protein 6 is avirion-associated protein and is released from 6 protein-expressing cells.	2007 May	United States	10.1128/JVI.02307-06
17344285	Biologic, antigenic, and full-length genomic characterization of a bovine-likecoronavirus isolated from a giraffe.	2007 May	United States	10.1128/JVI.02361-06
17344083	Serum alpha1-acid glycoprotein (AGP) concentration in non-symptomatic cats withfeline coronavirus (FCoV) infection.	2007 Aug	England	10.1016/j.jfms.2007.01.002
17339770	Strong antiviral activity of heated and hydrated dolomite--preliminaryinvestigation.	2007 Feb	Japan	10.1292/jvms.69.217
17336519	Synthesis and biological evaluation of nucleoside analogues having 6-chloropurineas anti-SARS-CoV agents.	2007 May 1	England	10.1016/j.bmcl.2007.02.026
17333886	[Further analysis and study based on a visualized method for SARS RNA sequences].	2007 Feb	China	
17331558	Heterologous viral RNA export elements improve expression of severe acuterespiratory syndrome (SARS) coronavirus spike protein and protective efficacy ofDNA vaccines against SARS.	2007 Jul 5	United States	10.1016/j.virol.2007.01.012
17331291	Three men, a paint brush and a coronavirus.	2007 Feb	England	10.1258/095646207779949600
17330875	Myelin transcription factor 1 (Myt1) expression in demyelinated lesions of rodentand human CNS.	2007 May	United States	10.1002/glia.20492
17329345	Importance of the penultimate positive charge in mouse hepatitis coronavirus A59membrane protein.	2007 May	United States	10.1128/JVI.02427-06
17327210	SARS molecular epidemiology: a Chinese fairy tale of controlling an emergingzoonotic disease in the genomics era.	2007 Jun 29	England	10.1098/rstb.2007.2034
17326946	Long-term psychological and occupational effects of providing hospital healthcareduring SARS outbreak.	2006 Dec	United States	10.3201/eid1212.060584
17326933	Review of bats and SARS.	2006 Dec	United States	10.3201/eid1212.060401
17326030	Challenges faced by hospital healthcare workers in using a syndrome-basedsurveillance system during the 2003 outbreak of severe acute respiratory syndromein Taiwan.	2007 Mar	United States	10.1086/508835
17324273	Feline aminopeptidase N is not a functional receptor for avian infectiousbronchitis virus.	2007 Feb 26	England	10.1186/1743-422X-4-20
17324010	Ranpirnase: amphibian ribonuclease A, P-30 protein-alfacell.	2007	New Zealand	10.2165/00126839-200708020-00007
17323903	[Anticancer coronaviruses].	2007 Feb 1	Netherlands	
17323558	Exposure of free-ranging maned wolves (Chrysocyon brachyurus) to infectious andparasitic disease agents in the Noel Kempff Mercado National Park, Bolivia.	2005 Jun	United States	10.1638/04-076.1
17321700	Ultrastructural study of infectious bronchitis virus infection in infundibulumand magnum of commercial laying hens.	2007 Jun 21	Netherlands	10.1016/j.vetmic.2007.01.021
17320791	Coronavirus HKU1 in an Italian pre-term infant with bronchiolitis.	2007 Mar	Netherlands	10.1016/j.jcv.2006.11.014
17319269	Severe acute respiratory syndrome--retrospect and lessons of 2004 outbreak inChina.	2006 Dec	China	
17316733	Group 2 coronaviruses prevent immediate early interferon induction by protectionof viral RNA from host cell recognition.	2007 Apr 25	United States	10.1016/j.virol.2007.01.020
17315469	Serologic survey of domestic felids in the Peten region of Guatemala.	2005 Mar	United States	10.1638/03-059
17314167	Natural mutations in the receptor binding domain of spike glycoprotein determinethe reactivity of cross-neutralization between palm civet coronavirus and severeacute respiratory syndrome coronavirus.	2007 May	United States	10.1128/JVI.02389-06
17313874	[A follow up study of total IgM, IgG, nucleoprotein and spike protein antibodiesagainst severe acute respiratory syndrome (SARS) coronavirus in patients withSARS].	2006 Nov	China	
17311326	Detection and typing by molecular techniques of respiratory viruses in childrenhospitalized for acute respiratory infection in Rome, Italy.	2007 Apr	United States	10.1002/jmv.20832
17309733	An antibody derivative expressed from viral vectors passively immunizes pigsagainst transmissible gastroenteritis virus infection when supplied orally incrude plant extracts.	2006 Nov	England	10.1111/j.1467-7652.2006.00206.x
17306213	The SARS-Coronavirus Membrane protein induces apoptosis through modulating theAkt survival pathway.	2007 Mar 15	United States	10.1016/j.abb.2007.01.012
17302372	Indomethacin has a potent antiviral activity against SARS coronavirus.	2006	England	
17302155	[Construction of genomic full-length cDNA of SARS coronavirus BJ01 strain andidentification of its biological characteristics].	2006 Dec	China	
17298911	The potential of targeted antibody prophylaxis in SARS outbreak control: amathematic analysis.	2007 Mar	Netherlands	10.1016/j.tmaid.2006.01.007
17297612	Clinical manifestations of human coronavirus NL63 infection in children inTaiwan.	2008 Jan	Germany	10.1007/s00431-007-0429-8
17296157	Coronavirus avian infectious bronchitis virus.	2007 Mar-Apr	England	10.1051/vetres:2006055
17289305	Isolation and identification of four infectious bronchitis virus strains in Chinaand analyses of their S1 glycoprotein gene.	2007 May 16	Netherlands	10.1016/j.vetmic.2007.01.006
17289225	Development of vaccines and passive immunotherapy against SARS corona virus usingSCID-PBL/hu mouse models.	2007 Apr 20	Netherlands	10.1016/j.vaccine.2007.01.032
17287288	Dual priming oligonucleotide system for the multiplex detection of respiratoryviruses and SNP genotyping of CYP2C19 gene.	2007	England	10.1093/nar/gkm051
17287033	Effective inhibition of porcine transmissible gastroenteritis virus replicationin ST cells by shRNAs targeting RNA-dependent RNA polymerase gene.	2007 Apr	Netherlands	10.1016/j.antiviral.2006.12.007
17286901	[Expression of predicted B cell epitope peptide in S2 subunit of SARS coronavirusspike protein in E.coli and identification of its mimic antigenicity].	2007 Feb	China	
17282011	The 3a Protein of SARS-coronavirus Induces Apoptosis in Vero E6 Cells.	2005	United States	10.1109/IEMBS.2005.1616242
17278385	Pathogenesis of avian flu H5N1 and SARS.	2006	England	
17277901	Enhancement of cytotoxicity against Vero E6 cells persistently infected withSARS-CoV by Mycoplasma fermentans.	2007	Austria	10.1007/s00705-006-0924-7
17277621	Identification of viruses in patients with postviral olfactory dysfunction.	2007 Feb	United States	10.1097/01.mlg.0000249922.37381.1e
17276898	Inhibition of infection caused by severe acute respiratory syndrome-associatedcoronavirus by equine neutralizing antibody in aged mice.	2007 Mar	Netherlands	10.1016/j.intimp.2006.10.009
17275120	Molecular characterisation of the virulent canine coronavirus CB/05 strain.	2007 Apr	Netherlands	10.1016/j.virusres.2006.12.006
17274299	Epididymal stone formation and decreased sperm production in roosters vaccinatedwith a killed strain of avian infectious bronchitis virus.	2006 Dec	United States	10.1637/7654-052506R.1
17274284	Molecular analysis of Brazilian infectious bronchitis field isolates by reversetranscription-polymerase chain reaction, restriction fragment lengthpolymorphism, and partial sequencing of the N gene.	2006 Dec	United States	10.1637/7525-030706R.1
17267506	Evolutionary insights into the ecology of coronaviruses.	2007 Apr	United States	10.1128/JVI.02605-06
17267381	Spike protein of SARS-CoV stimulates cyclooxygenase-2 expression via bothcalcium-dependent and calcium-independent protein kinase C pathways.	2007 May	United States	10.1096/fj.06-6589com
17267057	Specific and quantitative detection of PCR products from Clostridium piliforme,Helicobacter bilis, H. hepaticus, and mouse hepatitis virus infected mousesamples using a newly developed electrochemical DNA chip.	2007 Apr	Netherlands	10.1016/j.mimet.2006.12.009
17266617	"Inhibitor design for SARS coronavirus main protease based on ""distorted keytheory""."	2007 Jan	Netherlands	10.2174/157340607779317616
17264247	Children's vaccines do not induce cross reactivity against SARS-CoV.	2007 Feb	England	10.1136/jcp.2006.038893
17263585	Therapeutic and prophylactic potential of small interfering RNAs against severeacute respiratory syndrome: progress to date.	2007	New Zealand	10.2165/00063030-200721010-00002
17263584	Trends in the development and approval of monoclonal antibodies for viralinfections.	2007	New Zealand	10.2165/00063030-200721010-00001
19649165	Progress in Anti-SARS Coronavirus Chemistry, Biology and Chemotherapy.	2007 Feb 1	United States	10.1016/S0065-7743(06)41011-3
17262907	RNAi therapeutics: can siRNAs conquer SARS?	2006 Jun	England	10.1038/sj.gt.3302682
17261372	Establishment of a reference panel for the detection of anti-SARS-CoV antibodies.	2007 Jun	England	10.1016/j.biologicals.2006.11.001
17258782	Exosomal vaccines containing the S protein of the SARS coronavirus induce highlevels of neutralizing antibodies.	2007 May 25	United States	10.1016/j.virol.2006.12.011
17258678	[Lessons from SARS].	2007 Feb	France	10.1016/j.lpm.2006.12.005
17258318	Association of bovine respiratory disease with clinical status and acute phaseproteins in calves.	2007 May	England	10.1016/j.cimid.2006.11.004
17257500	Comparative immunization in BALB/c mice with recombinant replication-defectiveadenovirus vector and DNA plasmid expressing a SARS-CoV nucleocapsid proteingene.	2006 Dec	China	
17256630	[First detection of human metapneumovirus in a child with respiratory syndrome inHungary].	2006 Dec 3	Hungary	
17255322	Molecular pathology in the lungs of severe acute respiratory syndrome patients.	2007 Feb	United States	10.2353/ajpath.2007.060469
17254720	Canine coronavirus induces apoptosis in cultured cells.	2007 Mar 31	Netherlands	10.1016/j.vetmic.2006.12.016
17253209	[Avian influenza and the Severe Acute Respiratory Syndrome (SARS) - experiencesand perspectives].	2007 Jan	Germany	10.1055/s-2006-955002
17251282	Human coronavirus 229E papain-like proteases have overlapping specificities butdistinct functions in viral replication.	2007 Apr	United States	10.1128/JVI.02091-06
17244370	GraphDNA: a Java program for graphical display of DNA composition analyses.	2007 Jan 23	England	10.1186/1471-2105-8-21
17243893	The Immunobiology of SARS*.	2007	United States	10.1146/annurev.immunol.25.022106.141706
17240906	Development of a method for bacteria and virus recovery from heating,ventilation, and air conditioning (HVAC) filters.	2006 Oct	England	10.1039/b606132j
17237979	Characterization of the cleavage of signal peptide at the C-terminus of hepatitisC virus core protein by signal peptide peptidase.	2007 Jan	England	10.1007/s11373-006-9127-1
17230423	Evidence for quasi species in severe acute respiratory syndrome-associatedcoronavirus deletion mutants.	2007 Feb 15	United States	10.1086/510917
17230391	Impact of severe acute respiratory syndrome care on the general health status ofhealthcare workers in taiwan.	2007 Jan	United States	10.1086/508824
17229882	Recombinant protein-based assays for detection of antibodies to severe acuterespiratory syndrome coronavirus spike and nucleocapsid proteins.	2007 Mar	United States	10.1128/CVI.00351-06
17229859	Generic detection of coronaviruses and differentiation at the prototype strainlevel by reverse transcription-PCR and nonfluorescent low-density microarray.	2007 Mar	United States	10.1128/JCM.02426-06
17229702	5'-proximal hot spot for an inducible positive-to-negative-strand template switchby coronavirus RNA-dependent RNA polymerase.	2007 Apr	United States	10.1128/JVI.01817-06
17229691	Ribonucleocapsid formation of severe acute respiratory syndrome coronavirusthrough molecular action of the N-terminal domain of N protein.	2007 Apr	United States	10.1128/JVI.02236-06
17229680	Role of the coronavirus E viroporin protein transmembrane domain in virusassembly.	2007 Apr	United States	10.1128/JVI.01472-06
17227689	Utility of the aged BALB/c mouse model to demonstrate prevention and controlstrategies for severe acute respiratory syndrome coronavirus (SARS-CoV).	2007 Mar 8	Netherlands	10.1016/j.vaccine.2006.11.055
17224665	New developments in the search for the etiologic agent of Kawasaki disease.	2007 Feb	United States	10.1097/MOP.0b013e328012720f
17223751	Use of anti-coronavirus antibody testing of cerebrospinal fluid for diagnosis offeline infectious peritonitis involving the central nervous system in cats.	2007 Jan 15	United States	10.2460/javma.230.2.199
17222884	Membrane topology of murine coronavirus replicase nonstructural protein 3.	2007 May 10	United States	10.1016/j.virol.2006.12.009
17222582	Human respiratory coronavirus HKU1 versus other coronavirus infections in Italianhospitalised patients.	2007 Mar	Netherlands	10.1016/j.jcv.2006.12.008
17222058	A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice.	2007 Jan	United States	10.1371/journal.ppat.0030005
17219094	Features discriminating SARS from other severe viral respiratory tractinfections.	2007 Feb	Germany	10.1007/s10096-006-0246-4
17215093	Serological and molecular evidence that canine respiratory coronavirus iscirculating in Italy.	2007 Apr 15	Netherlands	10.1016/j.vetmic.2006.12.001
17210170	The intracellular sites of early replication and budding of SARS-coronavirus.	2007 May 10	United States	10.1016/j.virol.2006.11.027
17207625	Unique SARS-CoV protein nsp1: bioinformatics, biochemistry and potential effectson virulence.	2007 Feb	England	10.1016/j.tim.2006.12.005
17202310	Recombinant truncated nucleocapsid protein as antigen in a novel immunoglobulin Mcapture enzyme-linked immunosorbent assay for diagnosis of severe acuterespiratory syndrome coronavirus infection.	2007 Feb	United States	10.1128/CVI.00360-06
17202223	Characterization of the nuclear export signal in the coronavirus infectiousbronchitis virus nucleocapsid protein.	2007 Apr	United States	10.1128/JVI.02239-06
17202208	Novel beta-barrel fold in the nuclear magnetic resonance structure of thereplicase nonstructural protein 1 from the severe acute respiratory syndromecoronavirus.	2007 Apr	United States	10.1128/JVI.01939-06
17201672	Transcriptome of local innate and adaptive immunity during early phase ofinfectious bronchitis viral infection.	2006 Winter	United States	10.1089/vim.2006.19.768
17200104	Development and validation of a high-throughput screen for inhibitors of SARS CoVand its application in screening of a 100,000-compound library.	2007 Feb	United States	10.1177/1087057106296688
17197003	"Infectious canine hepatitis: an ""old"" disease reemerging in Italy."	2007 Oct	England	10.1016/j.rvsc.2006.11.009
17196984	Crystal structures reveal an induced-fit binding of a substrate-like Aza-peptideepoxide to SARS coronavirus main peptidase.	2007 Feb 23	England	10.1016/j.jmb.2006.11.078
17195709	Severe acute respiratory syndrome in children.	2007 Jan	United States	10.1097/01.inf.0000247136.28950.41
17194611	Lipid rafts play an important role in the early stage of severe acute respiratorysyndrome-coronavirus life cycle.	2007 Jan	France	10.1016/j.micinf.2006.10.015
17194306	Human coronavirus 229E encodes a single ORF4 protein between the spike and theenvelope genes.	2006 Dec 28	England	10.1186/1743-422X-3-106
17194199	Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearingepidemic and zoonotic spike variants.	2006 Dec	United States	10.1371/journal.pmed.0030525
17192307	Aurintricarboxylic acid inhibits the early stage of vaccinia virus replication bytargeting both cellular and viral factors.	2007 Mar	United States	10.1128/JVI.02531-06
17191018	The synergistic interaction of interferon types I and II leads to markedreduction in severe acute respiratory syndrome-associated coronavirus replicationand increase in the expression of mRNAs for interferon-induced proteins.	2007	Switzerland	10.1159/000098242
17189639	Production of authentic SARS-CoV M(pro) with enhanced activity: application as anovel tag-cleavage endopeptidase for protein overproduction.	2007 Feb 23	England	10.1016/j.jmb.2006.11.073
17188823	Absence of surface expression of feline infectious peritonitis virus (FIPV)antigens on infected cells isolated from cats with FIP.	2007 Mar 31	Netherlands	10.1016/j.vetmic.2006.11.026
17187987	Expression, purification and characterization of recombinant severe acuterespiratory syndrome coronavirus non-structural protein 1.	2007 Apr	United States	10.1016/j.pep.2006.11.005
17187565	Public health awareness of emerging zoonotic viruses of bats: a Europeanperspective.	2006 Winter	United States	10.1089/vbz.2006.6.315
17184168	Baculovirus surface display of SARS coronavirus (SARS-CoV) spike protein andimmunogenicity of the displayed protein in mice models.	2006 Dec	United States	10.1089/dna.2006.25.668
17183651	Long-term persistence of robust antibody and cytotoxic T cell responses inrecovered patients infected with SARS coronavirus.	2006 Dec 20	United States	10.1371/journal.pone.0000024
17183167	Preliminary crystallographic analysis of avian infectious bronchitis virus mainprotease.	2007 Jan 1	England	10.1107/S1744309106052341
17183035	The psychological effect of severe acute respiratory syndrome on emergencydepartment staff.	2007 Jan	England	10.1136/emj.2006.035089
17182690	Exceptional flexibility in the sequence requirements for coronavirus smallenvelope protein function.	2007 Mar	United States	10.1128/JVI.01577-06
17182678	Mouse hepatitis coronavirus A59 nucleocapsid protein is a type I interferonantagonist.	2007 Mar	United States	10.1128/JVI.01634-06
17179416	Histopathology of two serotypes of infectious bronchitis virus in laying hensvaccinated in the rearing phase.	2007 Jan	England	10.1093/ps/86.1.59
17179415	Comparative histopathology of two serotypes of infectious bronchitis virus (T andn1/88) in laying hens and cockerels.	2007 Jan	England	10.1093/ps/86.1.50
17177440	Coupling molecular beacons to barcoded metal nanowires for multiplexed, sealedchamber DNA bioassays.	2006 Dec 27	United States	10.1021/ja0658261
17176633	Antiviral activity of nucleoside analogues against SARS-coronavirus (SARS-coV).	2006	England	10.1177/095632020601700506
17176632	Evaluation of immunomodulators, interferons and known in vitro SARS-coVinhibitors for inhibition of SARS-coV replication in BALB/c mice.	2006	England	10.1177/095632020601700505
17176042	Core structure of S2 from the human coronavirus NL63 spike glycoprotein.	2006 Dec 26	United States	10.1021/bi061686w
17171319	[Severe acute respiratory syndrome (SARS)].	2006 Dec 15	Germany	10.1007/s00063-006-1127-4
17170451	Recombinant dimeric small immunoproteins neutralize transmissible gastroenteritisvirus infectivity efficiently in vitro and confer passive immunity in vivo.	2007 Jan	England	10.1099/vir.0.82192-0
17169467	Comparison of a fimbrial versus an autotransporter display system for viralepitopes on an attenuated Salmonella vaccine vector.	2007 Feb 19	Netherlands	10.1016/j.vaccine.2006.11.006
17168850	Progress in computational approach to drug development against SARS.	2006	United Arab Emirates	10.2174/092986706778773077
17168763	Drug design targeting the main protease, the Achilles' heel of coronaviruses.	2006	United Arab Emirates	10.2174/138161206779010369
17168762	Bioinformatics research on the SARS coronavirus (SARS_CoV) in China.	2006	United Arab Emirates	10.2174/138161206779010404
17168761	Quaternary structure, substrate selectivity and inhibitor design for SARS 3C-likeproteinase.	2006	United Arab Emirates	10.2174/138161206779010396
17168760	An overall picture of SARS coronavirus (SARS-CoV) genome-encoded major proteins:structures, functions and drug development.	2006	United Arab Emirates	10.2174/138161206779010459
17166901	The cytoplasmic tail of the severe acute respiratory syndrome coronavirus spikeprotein contains a novel endoplasmic reticulum retrieval signal that binds COPIand promotes interaction with membrane protein.	2007 Mar	United States	10.1128/JVI.02146-06
17163583	Symptom combinations associated with outcome and therapeutic effects in a cohortof cases with SARS.	2006	Singapore	10.1142/S0192415X06004417
17163582	The lesson of supplementary treatment with Chinese medicine on severelaboratory-confirmed SARS patients.	2006	Singapore	10.1142/S0192415X06004405
17163178	[Severe acute respiratory syndrome].	2006 Sep	Poland	
17162377	Towards a coronavirus-based HIV multigene vaccine.	2006 Jun-Dec	Egypt	10.1080/17402520600579168
17161858	Generation and characterization of human monoclonal neutralizing antibodies withdistinct binding and sequence features against SARS coronavirus using XenoMouse.	2007 Apr 25	United States	10.1016/j.virol.2006.09.029
17161477	Infectious bronchitis virus serotypes in poultry flocks in Jordan.	2007 Mar 17	Netherlands	10.1016/j.prevetmed.2006.11.004
17158198	Microarray-in-a-tube for detection of multiple viruses.	2007 Feb	England	10.1373/clinchem.2006.071720
17156812	Murine coronavirus-induced oligodendrocyte apoptosis is mediated through theactivation of the Fas signaling pathway.	2007 Apr 10	United States	10.1016/j.virol.2006.10.044
17154528	Long-range cooperative interactions modulate dimerization in SARS 3CLpro.	2006 Dec 19	United States	10.1021/bi0616302
17151094	Participation of both host and virus factors in induction of severe acuterespiratory syndrome (SARS) in F344 rats infected with SARS coronavirus.	2007 Feb	United States	10.1128/JVI.01967-06
17150843	Anti-SARS-CoV activity of nucleoside analogs having 6-chloropurine as anucleobase.	2006	England	10.1093/nass/nrl056
17149875	Progressive docking: a hybrid QSAR/docking approach for accelerating in silicohigh throughput screening.	2006 Dec 14	United States	10.1021/jm060961+
17144656	SARS CoV main proteinase: The monomer-dimer equilibrium dissociation constant.	2006 Dec 12	United States	10.1021/bi061746y
17142734	T cell antiviral effector function is not dependent on CXCL10 following murinecoronavirus infection.	2006 Dec 15	United States	10.4049/jimmunol.177.12.8372
17142288	Reversible unfolding of the severe acute respiratory syndrome coronavirus mainprotease in guanidinium chloride.	2007 Feb 15	United States	10.1529/biophysj.106.091736
17142081	Molecular pathogenesis of severe acute respiratory syndrome.	2007 Jan	France	10.1016/j.micinf.2006.06.012
17141432	Genetic distance of SARS coronavirus from the recent natural case.	2007 Feb 25	Netherlands	10.1016/j.vetmic.2006.10.022
17141229	Augmentation of chemokine production by severe acute respiratory syndromecoronavirus 3a/X1 and 7a/X4 proteins through NF-kappaB activation.	2006 Dec 22	England	10.1016/j.febslet.2006.11.046
17140648	Prevalence of viral respiratory tract infections in children with asthma.	2007 Feb	United States	10.1016/j.jaci.2006.08.041
17139182	Human coronavirus infection among children with acute lower respiratory tractinfection in Thailand.	2007	Switzerland	10.1159/000097392
17139181	Inhibition of SARS-CoV gene expression by adenovirus-delivered small hairpin RNA.	2007	Switzerland	10.1159/000097391
17137835	Human Coronavirus-NL63 infections in Korean children, 2004-2006.	2007 Jan	Netherlands	10.1016/j.jcv.2006.10.009
17137053	Diseases of indigenous chickens in Bokaa village, Kgatleng district, Botswana.	2006 Sep	South Africa	10.4102/jsava.v77i3.360
17135519	Generating vesicular stomatitis virus pseudotype bearing the severe acuterespiratory syndrome coronavirus spike envelope glycoprotein for rapid and safeneutralization test or cell-entry assay.	2006 Oct	United States	10.1196/annals.1373.030
17135502	Porcine innate and adaptative immune responses to influenza and coronavirusinfections.	2006 Oct	United States	10.1196/annals.1373.014
17134730	Palmitoylation of the cysteine-rich endodomain of the SARS-coronavirus spikeglycoprotein is important for spike-mediated cell fusion.	2007 Apr 10	United States	10.1016/j.virol.2006.10.034
17131942	The possible origin of recent human SARS coronavirus isolate from China.	2006	Slovakia	
17131690	"[""New"" coronaviruses are the cause of respiratory diseases]."	2006 Nov	Germany	
17130280	Clinical disease in children associated with newly described coronavirussubtypes.	2007 Jan	United States	10.1542/peds.2006-1406
17129463	[The possible mechanism of lung injury induced by severe acute respiratorysyndrome coronavirus spike glycoprotein].	2006 Sep	China	
17128290	Structural studies of algal lectins with anti-HIV activity.	2006	Poland	
17123424	First detection of canine parvovirus type 2c in pups with haemorrhagic enteritisin Spain.	2006 Dec	Germany	10.1111/j.1439-0450.2006.00974.x
17121802	Comparative analysis of twelve genomes of three novel group 2c and group 2dcoronaviruses reveals unique group and subgroup features.	2007 Feb	United States	10.1128/JVI.02182-06
17121734	Epidemiological and experimental evidence for immunodeficiency affecting avianinfectious bronchitis.	2006 Dec	England	10.1080/03079450601028811
17121628	Public health implications of using various case definitions in The Netherlandsduring the worldwide SARS outbreak.	2006 Dec	England	10.1111/j.1469-0691.2006.01552.x
17112780	Characterizing 56 complete SARS-CoV S-gene sequences from Hong Kong.	2007 Jan	Netherlands	10.1016/j.jcv.2006.10.001
17112601	Inhibition of SARS-CoV replication cycle by small interference RNAs silencingspecific SARS proteins, 7a/7b, 3a/3b and S.	2007 Mar	Netherlands	10.1016/j.antiviral.2006.10.008
17110851	Radiology of severe acute respiratory syndrome (SARS): the emergingpathologic-radiologic correlates of an emerging disease.	2006 Nov	United States	10.1097/01.rti.0000213581.14225.f1
17109341	Blinded case-control study of the relationship between human coronavirus NL63 andKawasaki syndrome.	2006 Dec 15	United States	10.1086/509509
17109334	Finding the cause of Kawasaki disease: a pediatric infectious diseases researchpriority.	2006 Dec 15	United States	10.1086/509514
17109267	[Pharmacotherapy of severe acute respiratory syndrome (SARS)].	2006 Nov	Germany	10.1055/s-2006-944278
17108287	Naturally occurring anti-Escherichia coli protein antibodies in the sera ofhealthy humans cause analytical interference in a recombinant nucleocapsidprotein-based enzyme-linked immunosorbent assay for serodiagnosis of severe acuterespiratory syndrome.	2007 Jan	United States	10.1128/CVI.00136-06
17108045	Severe acute respiratory syndrome coronavirus protein 6 accelerates murinecoronavirus infections.	2007 Feb	United States	10.1128/JVI.01515-06
17108030	A severe acute respiratory syndrome coronavirus that lacks the E gene isattenuated in vitro and in vivo.	2007 Feb	United States	10.1128/JVI.01467-06
17108024	Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6,and nucleocapsid proteins function as interferon antagonists.	2007 Jan	United States	10.1128/JVI.01782-06
17108019	Severe acute respiratory syndrome coronavirus infection of mice transgenic forthe human Angiotensin-converting enzyme 2 virus receptor.	2007 Feb	United States	10.1128/JVI.01702-06
17102613	Novel SARS unique AdoMet-dependent methyltransferase.	2006 Oct	United States	10.4161/cc.5.20.3361
17098272	Derivation of a novel SARS-coronavirus replicon cell line and its application foranti-SARS drug screening.	2007 Mar 30	United States	10.1016/j.virol.2006.10.016
17098187	Lysine methylation as a routine rescue strategy for protein crystallization.	2006 Nov	United States	10.1016/j.str.2006.09.005
17093194	A hypervariable region within the 3' cis-acting element of the murine coronavirusgenome is nonessential for RNA synthesis but affects pathogenesis.	2007 Feb	United States	10.1128/JVI.00803-06
17093189	Mutational analysis of aminopeptidase N, a receptor for several group 1coronaviruses, identifies key determinants of viral host range.	2007 Feb	United States	10.1128/JVI.01510-06
17092912	Discovering severe acute respiratory syndrome coronavirus 3CL proteaseinhibitors: virtual screening, surface plasmon resonance, and fluorescenceresonance energy transfer assays.	2006 Dec	United States	10.1177/1087057106293295
17092900	A serosurvey of viral infections in lions (Panthera leo), from Queen ElizabethNational Park, Uganda.	2006 Jul	United States	10.7589/0090-3558-42.3.667
17092891	Factors associated with pathogen seroprevalence and infection in Rocky Mountaincougars.	2006 Jul	United States	10.7589/0090-3558-42.3.606
17092615	Receptor-binding domain of SARS-CoV spike protein induces long-term protectiveimmunity in an animal model.	2007 Apr 12	Netherlands	10.1016/j.vaccine.2006.10.031
17092595	Isolation and sequence analysis of canine respiratory coronavirus.	2007 Mar	Netherlands	10.1016/j.virusres.2006.10.004
17090960	Diffuse alveolar lesion in BALB/c mice induced with human reovirus BYD1 strainand its potential relation with SARS.	2006 Oct	Japan	10.1538/expanim.55.439
17083088	Insight into the activity of SARS main protease: Molecular dynamics study ofdimeric and monomeric form of enzyme.	2007 Feb 1	United States	10.1002/prot.21160
17082754	Nucleocapsid amino acids 211 to 254, in particular, tetrad glutamines, areessential for the interaction between the nucleocapsid and membrane proteins ofSARS-associated coronavirus.	2006 Oct	Korea (South)	
17082583	Quantification of repertoire diversity of influenza-specific epitopes withpredominant public or private TCR usage.	2006 Nov 15	United States	10.4049/jimmunol.177.10.6705
17081731	The peptide specificities of the autoantibodies elicited by mouse hepatitis virusA59.	2006 Nov	England	10.1016/j.jaut.2006.09.003
17080396	Analysis of costs attributable to an outbreak of severe acute respiratorysyndrome at a French hospital.	2006 Nov	United States	10.1086/508846
17079328	Suppression of coronavirus replication by inhibition of the MEK signalingpathway.	2007 Jan	United States	10.1128/JVI.01705-06
17079323	The novel human coronaviruses NL63 and HKU1.	2007 Apr	United States	10.1128/JVI.01466-06
17079322	The ORF7b protein of severe acute respiratory syndrome coronavirus (SARS-CoV) isexpressed in virus-infected cells and incorporated into SARS-CoV particles.	2007 Jan	United States	10.1128/JVI.01691-06
17079315	Lethal infection of K18-hACE2 mice infected with severe acute respiratorysyndrome coronavirus.	2007 Jan	United States	10.1128/JVI.02012-06
17079305	Mouse hepatitis virus does not induce Beta interferon synthesis and does notinhibit its induction by double-stranded RNA.	2007 Jan	United States	10.1128/JVI.01512-06
17079303	Replicase genes of murine coronavirus strains A59 and JHM are interchangeable:differences in pathogenesis map to the 3' one-third of the genome.	2007 Jan	United States	10.1128/JVI.01944-06
17079026	Baculovirus expression of HCoV-OC43 nucleocapsid protein and development of aWestern blot assay for detection of human antibodies against HCoV-OC43.	2007 Feb	Netherlands	10.1016/j.jviromet.2006.09.024
17077967	Role of laboratory variables in differentiating SARS-coronavirus from othercauses of community-acquired pneumonia within the first 72 h of hospitalization.	2006 Dec	Germany	10.1007/s10096-006-0222-z
17077309	The spleen as a target in severe acute respiratory syndrome.	2006 Nov	United States	10.1096/fj.06-6324com
17072758	Cloning and further sequence analysis of the spike gene of attenuated porcineepidemic diarrhea virus DR13.	2007 Aug	United States	10.1007/s11262-006-0036-1
17072335	Diminished lifespan and acute stress-induced death in DNA-PKcs-deficient micewith limiting telomeres.	2007 May 3	England	10.1038/sj.onc.1210099
17063525	Impact of human coronavirus infections in otherwise healthy children who attendedan emergency department.	2006 Dec	United States	10.1002/jmv.20745
17063504	Evaluation of a novel vesicular stomatitis virus pseudotype-based assay fordetection of neutralizing antibody responses to SARS-CoV.	2006 Dec	United States	10.1002/jmv.20732
17060979	SARS: an emerging global microbial threat.	2004	United States	
17058491	SARS/avian coronaviruses.	2006	Switzerland	
17055591	Capillary zone electrophoresis method for fingerprint of allantoic fluid innormal and infected SPF embryonated chicken eggs.	2007 Jan	Netherlands	10.1016/j.jviromet.2006.08.009
17055551	A study on antigenicity and receptor-binding ability of fragment 450-650 of thespike protein of SARS coronavirus.	2007 Mar 15	United States	10.1016/j.virol.2006.09.022
17055022	Selection of SARS-coronavirus-specific B cell epitopes by phage peptide libraryscreening and evaluation of the immunological effect of epitope-based peptides onmice.	2007 Mar 15	United States	10.1016/j.virol.2006.09.016
17054987	Mosaic structure of human coronavirus NL63, one thousand years of evolution.	2006 Dec 15	England	10.1016/j.jmb.2006.09.074
17054529	Societal responses to familiar versus unfamiliar risk: comparisons of influenzaand SARS in Korea.	2006 Oct	United States	10.1111/j.1539-6924.2006.00812.x
17052713	Characterisation of the RNA binding properties of the coronavirus infectiousbronchitis virus nucleocapsid protein amino-terminal region.	2006 Oct 30	England	10.1016/j.febslet.2006.09.052
17049691	Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoVchallenge despite their capacity to mediate FcgammaRII-dependent entry into Bcells in vitro.	2007 Jan 8	Netherlands	10.1016/j.vaccine.2006.08.011
17049610	Studies on the interactions of Ti-containing polyoxometalates (POMs) withSARS-CoV 3CLpro by molecular modeling.	2007 Jan	United States	10.1016/j.jinorgbio.2006.08.013
17046271	Binding interaction of quercetin-3-beta-galactoside and its synthetic derivativeswith SARS-CoV 3CL(pro): structure-activity relationship studies reveal salientpharmacophore features.	2006 Dec 15	England	10.1016/j.bmc.2006.09.014
17045921	Association between nitric oxide synthesis and vaccination-acquired resistance tomurine hepatitis virus by spf mice.	2006 Nov 15	United States	10.1016/j.freeradbiomed.2006.08.011
17043759	Phylogenetic analysis of partial S1 and N gene sequences of infectious bronchitisvirus isolates from Italy revealed genetic diversity and recombination.	2007 Aug	United States	10.1007/s11262-006-0037-0
17042030	Bats as a continuing source of emerging infections in humans.	2007 Mar-Apr	England	10.1002/rmv.520
17041219	Murine hepatitis virus strain 1 produces a clinically relevant model of severeacute respiratory syndrome in A/J mice.	2006 Nov	United States	10.1128/JVI.00747-06
17041212	Identifying epitopes responsible for neutralizing antibody and DC-SIGN binding onthe spike glycoprotein of the severe acute respiratory syndrome coronavirus.	2006 Nov	United States	10.1128/JVI.01138-06
17041137	Emerging respiratory viruses: challenges and vaccine strategies.	2006 Oct	United States	10.1128/CMR.00005-06
17040245	Zoonotic viral diseases and the frontier of early diagnosis, control andprevention.	2006 Nov	England	10.1111/j.1365-2796.2006.01711.x
17039827	The relationship of severe acute respiratory syndrome coronavirus with avian andother coronaviruses.	2006 Sep	United States	10.1637/7612-042006R.1
17039233	Antibody-mediated targeting of viral vectors to the Fc receptor expressed onacute myeloid leukemia cells.	2006 Dec	England	10.1038/sj.leu.2404422
17037921	Protein nanopatterns and biosensors using gold binding polypeptide as a fusionpartner.	2006 Oct 15	United States	10.1021/ac060976f
17037607	Identification and evaluation of coronavirus replicase inhibitors using areplicon cell line.	2006	United States	10.1007/978-0-387-33012-9_111
17037605	Virucidal effect of a newly developed nickel alloy on mouse coronavirus.	2006	United States	10.1007/978-0-387-33012-9_109
17037604	Renilla luciferase as a reporter to assess SARS-CoV mRNA transcription regulationand efficacy of anti-SARS-CoV agents.	2006	United States	10.1007/978-0-387-33012-9_108
17037603	Highly attenuated vaccinia virus DIs as a potential SARS vaccine.	2006	United States	10.1007/978-0-387-33012-9_107
17037602	Structure and dynamics of SARS coronavirus main proteinase (Mpro).	2006	United States	10.1007/978-0-387-33012-9_106
17037601	Identification of essential genes as a strategy to select a SARS candidatevaccine using a SARS-CoV infectious cDNA.	2006	United States	
17037600	Validation of coronavirus E proteins ion channels as targets for antiviral drugs.	2006	United States	10.1007/978-0-387-33012-9_104
17037599	Inhibition and escape of SARS-CoV treated with antisense morpholino oligomers.	2006	United States	10.1007/978-0-387-33012-9_103
17037598	Development of vaccines and passive immunotherapy against SARS coronavirus usingmouse and SCID-PBL/hu mouse models.	2006	United States	10.1007/978-0-387-33012-9_102
17037597	SARS coronavirus vaccine development.	2006	United States	10.1007/978-0-387-33012-9_101
17037596	"Resurrection of an ""extinct"" SARS-CoV isolate GD03 from late 2003."	2006	United States	10.1007/978-0-387-33012-9_100
17037595	Glia expression of MHC during CNS infection by neurotropic coronavirus.	2006	United States	10.1007/978-0-387-33012-9_99
17037594	Immunogenicity of SARS-CoV: the receptor-binding domain of S protein is a majortarget of neutralizing antibodies.	2006	United States	10.1007/978-0-387-33012-9_98
17037593	SARS CoV replication and pathogenesis in human airway epithelial cultures.	2006	United States	10.1007/978-0-387-33012-9_97
17037592	HCoV-OC43-induced encephalitis is in part immune-mediated.	2006	United States	10.1007/978-0-387-33012-9_96
17037591	Toward the development of an infectious cDNA clone of a human entericcoronavirus.	2006	United States	10.1007/978-0-387-33012-9_95
17037590	Human coronavirus-NL63 infection is not associated with acute Kawasaki disease.	2006	United States	10.1007/978-0-387-33012-9_94
17037589	Identification of ferret ACE2 and its receptor function for SARS-coronavirus.	2006	United States	10.1007/978-0-387-33012-9_93
17037588	Pathological and virological analyses of severe acute respiratorysyndrome-associated coronavirus infections in experimental animals.	2006	United States	10.1007/978-0-387-33012-9_92
17037587	HCoV-229E infects and activates monocytes.	2006	United States	10.1007/978-0-387-33012-9_91
17037586	Mustela vison ACE2 functions as a receptor for SARS-coronavirus.	2006	United States	10.1007/978-0-387-33012-9_90
17037585	Synergistic inhibition of SARS-coronavirus replication by type I and type II IFN.	2006	United States	10.1007/978-0-387-33012-9_89
17037584	Genetic evolution of human coronavirus OC43 in neural cell culture.	2006	United States	10.1007/978-0-387-33012-9_88
17037583	A SARS-CoV-specific protein enhances virulence of an attenuated strain of mousehepatitis virus.	2006	United States	10.1007/978-0-387-33012-9_87
17037582	Human coronavirus NL63 infection is associated with croup.	2006	United States	10.1007/978-0-387-33012-9_86
17037581	Infection of human airway epithelia by SARS coronavirus is associated with ACE2expression and localization.	2006	United States	10.1007/978-0-387-33012-9_85
17037580	HCoV-OC43-induced apoptosis of murine neuronal cells.	2006	United States	10.1007/978-0-387-33012-9_84
17037578	SARS and other coronaviruses in humans and animals.	2006	United States	10.1007/978-0-387-33012-9_82
17037572	Identification of the receptor for FGL2 and implications for susceptibility tomouse hepatitis virus (MHV-3)-induced fulminant hepatitis.	2006	United States	10.1007/978-0-387-33012-9_76
17037571	Role of the replicase gene of murine coronavirus JHM strain in hepatitis.	2006	United States	10.1007/978-0-387-33012-9_75
17037570	Preferential infection of mature dendritic cells by the JHM strain of mousehepatitis virus.	2006	United States	10.1007/978-0-387-33012-9_74
17037569	Differential induction of proinflammatory cytokines in primary mouse astrocytesand microglia by coronavirus infection.	2006	United States	10.1007/978-0-387-33012-9_73
17037568	Analysis of the N protein in feline coronavirus strains in Italy.	2006	United States	10.1007/978-0-387-33012-9_72
17037567	Autoantibodies exacerbate the severity of MHV-induced encephalitis.	2006	United States	10.1007/978-0-387-33012-9_71
17037566	Developing bioinformatic resources for coronaviruses.	2006	United States	10.1007/978-0-387-33012-9_70
17037565	Antibody-mediated virus clearance from neurons of rats infected withhemagglutinating encephalomyelitis virus.	2006	United States	10.1007/978-0-387-33012-9_69
17037564	CD8+ T-cell priming during a central nervous system infection with mousehepatitis virus.	2006	United States	10.1007/978-0-387-33012-9_68
17037563	Persistent coronavirus infection of progenitor oligodendrocytes.	2006	United States	10.1007/978-0-387-33012-9_67
17037562	Murine hepatitis virus strain 1 as a model for severe acute respiratory distresssyndrome (SARS).	2006	United States	10.1007/978-0-387-33012-9_66
17037561	NKG2D signaling and host defense after mouse hepatitis virus infection of thecentral nervous system.	2006	United States	10.1007/978-0-387-33012-9_65
17037560	Genes 3 and 5 of infectious bronchitis virus are accessory protein genes.	2006	United States	10.1007/978-0-387-33012-9_64
17037559	Infectious bronchitis coronavirus induces cell-cycle perturbations.	2006	United States	10.1007/978-0-387-33012-9_63
17037558	Rat coronavirus infection of primary rat alveolar epithelial cells.	2006	United States	10.1007/978-0-387-33012-9_62
17037557	Coronavirus immunity: from T cells to B cells.	2006	United States	10.1007/978-0-387-33012-9_61
17037556	SARS-CoV, but not HCoV-NL63, utilizes cathepsins to infect cells: viral entry.	2006	United States	10.1007/978-0-387-33012-9_60
17037555	Receptor-independent infection of mouse hepatitis virus: analysis byspinoculation.	2006	United States	10.1007/978-0-387-33012-9_59
17037554	Receptor-independent spread of a neurotropic murine coronavirus MHV-JHMV in mixedneural culture.	2006	United States	10.1007/978-0-387-33012-9_58
17037553	Characterization of persistent SARS-CoV infection in Vero E6 cells.	2006	United States	10.1007/978-0-387-33012-9_57
17037552	Dissection of the fusion machine of SARS-coronavirus.	2006	United States	10.1007/978-0-387-33012-9_56
17037551	Three-dimensional reconstruction of the nucleolus using meta-confocal microscopyin cells expressing the coronavirus nucleoprotein.	2006	United States	10.1007/978-0-387-33012-9_55
17037550	Avian infectious bronchitis virus enters cells via the endocytic pathway.	2006	United States	10.1007/978-0-387-33012-9_54
17037549	Virion-liposome interactions identify a cholesterol-independent coronavirus entrystage.	2006	United States	10.1007/978-0-387-33012-9_53
17037548	Spike gene determinants of mouse hepatitis virus host range expansion.	2006	United States	10.1007/978-0-387-33012-9_52
17037547	Subcellular localization of SARS-CoV structural proteins.	2006	United States	10.1007/978-0-387-33012-9_51
17037546	Pseudotyped vesicular stomatitis virus for functional analysis of SARScoronavirus spike protein.	2006	United States	10.1007/978-0-387-33012-9_50
17037545	Molecular interactions of group 1 coronaviruses with feline APN.	2006	United States	10.1007/978-0-387-33012-9_49
17037544	Human angiotensin-converting enzyme 2 (ACE2) is a receptor for human respiratorycoronavirus NL63.	2006	United States	10.1007/978-0-387-33012-9_48
17037543	Interaction between the spike protein of human coronavirus NL63 and its cellularreceptor ACE2.	2006	United States	10.1007/978-0-387-33012-9_47
17037542	Analysis of SARS-CoV receptor activity of ACE2 orthologs.	2006	United States	10.1007/978-0-387-33012-9_46
17037541	Intracellular transport of the S proteins of coronaviruses.	2006	United States	10.1007/978-0-387-33012-9_45
17037540	Human coronavirus 229E can use CD209L (L-SIGN) to enter cells.	2006	United States	10.1007/978-0-387-33012-9_44
17037539	Increased viral titers and subtle changes in plaque morphology upon passage ofSARS-CoV in cells from different species.	2006	United States	10.1007/978-0-387-33012-9_43
17037538	Enhancement of SARS-CoV infection by proteases.	2006	United States	10.1007/978-0-387-33012-9_42
17037536	Fluorescence dequenching assays of coronavirus fusion.	2006	United States	10.1007/978-0-387-33012-9_40
17037535	Proteolysis of SARS-associated coronavirus spike glycoprotein.	2006	United States	10.1007/978-0-387-33012-9_39
17037534	Interactions between SARS coronavirus and its receptor.	2006	United States	10.1007/978-0-387-33012-9_38
17037533	Attachment factor and receptor engagement of SARS coronavirus and humancoronavirus NL63.	2006	United States	10.1007/978-0-387-33012-9_37
17037532	Insights from the association of SARS-CoV S-protein with its receptor, ACE2.	2006	United States	10.1007/978-0-387-33012-9_36
17037531	Efficient transduction of dendritic cells using coronavirus-based vectors.	2006	United States	10.1007/978-0-387-33012-9_35
17037530	Viroporin activity of SARS-CoV E protein.	2006	United States	10.1007/978-0-387-33012-9_34
17037529	The transmembrane domain of the infectious bronchitis virus E protein is requiredfor efficient virus release.	2006	United States	10.1007/978-0-387-33012-9_33
17037528	Role of mouse hepatitis coronavirus envelope protein transmembrane domain.	2006	United States	10.1007/978-0-387-33012-9_32
17037527	Ultrastructure of SARS-CoV, FIPV, and MHV revealed by electron cryomicroscopy.	2006	United States	10.1007/978-0-387-33012-9_31
17037525	Genetic and molecular biological analysis of protein-protein interactions incoronavirus assembly.	2006	United States	10.1007/978-0-387-33012-9_29
17037524	Mouse hepatitis coronavirus nucleocapsid phosphorylation.	2006	United States	10.1007/978-0-387-33012-9_28
17037523	Production and characterization of monoclonal antibodies against the nucleocapsidprotein of SARS-CoV.	2006	United States	10.1007/978-0-387-33012-9_27
17037522	SARS coronavirus accessory ORFs encode luxury functions.	2006	United States	10.1007/978-0-387-33012-9_26
17037520	Mouse hepatitis virus infection activates the Ire1/XBP1 pathway of the unfoldedprotein response.	2006	United States	10.1007/978-0-387-33012-9_24
17037519	Expression and structural analysis of infectious bronchitis virus nucleoprotein.	2006	United States	10.1007/978-0-387-33012-9_23
17037518	Importance of MHV-CoV A59 nucleocapsid protein COOH-terminal negative charges.	2006	United States	10.1007/978-0-387-33012-9_22
17037517	Sumoylation of the nucleocapsid protein of severe acute respiratory syndromecoronavirus by interaction with Ubc9.	2006	United States	10.1007/978-0-387-33012-9_21
17037516	Structure, expression, and intracellular localization of the SARS-CoV accessoryproteins 7a and 7b.	2006	United States	10.1007/978-0-387-33012-9_20
17037515	Transcriptional regulation of RNA3 of infectious bronchitis virus.	2006	United States	10.1007/978-0-387-33012-9_19
17037514	Stem-loop 1 in the 5' UTR of the SARS coronavirus can substitute for itscounterpart in mouse hepatitis virus.	2006	United States	10.1007/978-0-387-33012-9_18
17037513	MHV-A59 ORF1a replicase protein nsp7-nsp10 processing in replication.	2006	United States	10.1007/978-0-387-33012-9_17
17037512	Nonstructural proteins of human coronavirus NL63.	2006	United States	10.1007/978-0-387-33012-9_16
17037511	"ADP-ribose-1""-phosphatase activities of the human coronavirus 229E and SARScoronavirus X domains."	2006	United States	10.1007/978-0-387-33012-9_15
17037510	Identification and characterization of a unique ribosomal frameshifting signal inSARS-CoV ORF3a.	2006	United States	10.1007/978-0-387-33012-9_14
17037509	Identification and characterization of severe acute respiratory syndromecoronavirus subgenomic RNAs.	2006	United States	10.1007/978-0-387-33012-9_13
17037508	Differential role of N-terminal polyprotein processing in coronavirus genomereplication and minigenome amplification.	2006	United States	10.1007/978-0-387-33012-9_12
17037506	The nsp2 proteins of mouse hepatitis virus and SARS coronavirus are dispensablefor viral replication.	2006	United States	10.1007/978-0-387-33012-9_10
17037505	Mutational analysis of MHV-A59 replicase protein-nsp10.	2006	United States	10.1007/978-0-387-33012-9_9
17037504	Effects of mutagenesis of murine hepatitis virus nsp1 and nsp14 on replication inculture.	2006	United States	10.1007/978-0-387-33012-9_8
17037503	Non structural proteins 8 and 9 of human coronavirus 229E.	2006	United States	10.1007/978-0-387-33012-9_7
17037502	Nucleocapsid protein expression facilitates coronavirus replication.	2006	United States	10.1007/978-0-387-33012-9_6
17037501	Deubiquitinating activity of the SARS-CoV papain-like protease.	2006	United States	10.1007/978-0-387-33012-9_5
17037500	Regulation of coronavirus transcription: viral and cellular proteins interactingwith transcription-regulating sequences.	2006	United States	10.1007/978-0-387-33012-9_4
17037499	A previously unrecognized UNR stem-loop structure in the coronavirus 5'untranslated region plays a functional role in replication.	2006	United States	10.1007/978-0-387-33012-9_3
17037498	Biochemical aspects of coronavirus replication.	2006	United States	10.1007/978-0-387-33012-9_2
17037497	The coronavirus replicase: insights into a sophisticated enzyme machinery.	2006	United States	10.1007/978-0-387-33012-9_1
17037189	[Identification of mimotope peptides which bind to the SARS-CoV spike proteinspecific monoclonal antibody 2C5 with phage-displayed peptides library].	2006 Sep	China	10.1016/s1872-2075(06)60051-4
17035307	Role for nonstructural protein 1 of severe acute respiratory syndrome coronavirusin chemokine dysregulation.	2007 Jan	United States	10.1128/JVI.02336-05
17031779	Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infectedACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesisof SARS.	2006 Nov	England	10.1002/path.2067
17031699	Genotypes and subtypes of Cryptosporidium spp. in neonatal calves in NorthernIreland.	2007 Feb	Germany	10.1007/s00436-006-0305-x
17030870	Full-length genome sequences of two SARS-like coronaviruses in horseshoe bats andgenetic variation analysis.	2006 Nov	England	10.1099/vir.0.82220-0
17030869	Inter- and intra-variant genetic heterogeneity of human coronavirus OC43 strainsin France.	2006 Nov	England	10.1099/vir.0.82065-0
17030066	Real-time RT-PCR detection of Bovine Viral Diarrhoea virus in whole blood usingan external RNA reference.	2006 Dec	Netherlands	10.1016/j.jviromet.2006.08.008
17027618	The cell biology of acute childhood respiratory disease: therapeuticimplications.	2006 Oct	United States	10.1016/j.pcl.2006.08.004
17024815	[Molecular biology investigation of respiratory viruses as a factor of infectiouscomplications in hemoblastosis and myelodepression].	2006	Russia (Federation)	
17024565	Upregulation of mitochondrial gene expression in PBMC from convalescent SARSpatients.	2006 Nov	Netherlands	10.1007/s10875-006-9046-y
17024178	A second, non-canonical RNA-dependent RNA polymerase in SARS coronavirus.	2006 Oct 18	England	10.1038/sj.emboj.7601368
17023013	Complete genomic sequences, a key residue in the spike protein and deletions innonstructural protein 3b of US strains of the virulent and attenuatedcoronaviruses, transmissible gastroenteritis virus and porcine respiratorycoronavirus.	2007 Feb 20	United States	10.1016/j.virol.2006.08.051
17021342	Transmission of mouse minute virus (MMV) but not mouse hepatitis virus (MHV)following embryo transfer with experimentally exposed in vivo-derived embryos.	2007 Feb	United States	10.1095/biolreprod.106.056135
17021082	Preparation of His-tagged armored RNA phage particles as a control for real-timereverse transcription-PCR detection of severe acute respiratory syndromecoronavirus.	2006 Oct	United States	10.1128/JCM.00713-06
17020602	Adaptive evolution of the spike gene of SARS coronavirus: changes in positivelyselected sites in different epidemic groups.	2006 Oct 4	England	10.1186/1471-2180-6-88
17019591	Viral ion channel proteins in model membranes: a comparative study by X-rayreflectivity.	2006 Dec	Germany	10.1007/s00249-006-0099-x
17011679	SARS-CoV spike protein-expressing recombinant vaccinia virus efficiently inducesneutralizing antibodies in rabbits pre-immunized with vaccinia virus.	2007 Jan 8	Netherlands	10.1016/j.vaccine.2006.08.039
24980529	Techniques used for the discovery of therapeutic compounds: The case of SARS.	2006 Autumn	England	10.1016/j.ddtec.2006.09.005
17004304	Use of virus vectors for the expression in plants of active full-length andsingle chain anti-coronavirus antibodies.	2006 Oct	Germany	10.1002/biot.200600143
17002634	Evaluation of inactivation methods for severe acute respiratory syndromecoronavirus in noncellular blood products.	2006 Oct	United States	10.1111/j.1537-2995.2006.00976.x
17002608	Detection of human coronavirus NL63, human metapneumovirus and respiratorysyncytial virus in children with respiratory tract infections in south-westSweden.	2006 Nov	England	10.1111/j.1469-0691.2006.01506.x
17002511	Are nonhuman primates good models for SARS?	2006 Sep	United States	10.1371/journal.pmed.0030411
17002283	Carboxyl terminus of severe acute respiratory syndrome coronavirus nucleocapsidprotein: self-association analysis and nucleic acid binding characterization.	2006 Oct 3	United States	10.1021/bi0609319
17002096	[A new method for visual SARS DNA sequences analysis].	2006 Aug	China	
16998894	Comparison of multiplex PCR assays and conventional techniques for the diagnosticof respiratory virus infections in children admitted to hospital with an acuterespiratory illness.	2006 Nov	United States	10.1002/jmv.20725
16998888	SARS-CoV nucleocapsid protein binds to hUbc9, a ubiquitin conjugating enzyme ofthe sumoylation system.	2006 Nov	United States	10.1002/jmv.20707
16996569	Pathology of the thyroid in severe acute respiratory syndrome.	2007 Jan	United States	10.1016/j.humpath.2006.06.011
16991004	Modification of SARS-CoV S1 gene render expression in Pichia pastoris.	2006 Dec	United States	10.1007/s11262-006-0072-x
16991002	Amino acids 1 to 422 of the spike protein of SARS associated coronavirus arerequired for induction of cyclooxygenase-2.	2006 Dec	United States	10.1007/s11262-005-0070-4
16990149	Infectious bronchitis virus: S1 gene characteristics of vaccines used in Chinaand efficacy of vaccination against heterologous strains from China.	2006 Oct	England	10.1080/03079450600920984
16990148	Molecular epizootiology of avian infectious bronchitis in Russia.	2006 Oct	England	10.1080/03079450600921008
16989815	Quantitative comparison of the efficiency of antibodies against S1 and S2 subunitof SARS coronavirus spike protein in virus neutralization and blocking ofreceptor binding: implications for the functional roles of S2 subunit.	2006 Oct 16	England	10.1016/j.febslet.2006.08.085
16988814	Lessons from SARS: control of acute lung failure by the SARS receptor ACE2.	2006 Oct	Germany	10.1007/s00109-006-0094-9
16987966	Characterization of White bream virus reveals a novel genetic cluster ofnidoviruses.	2006 Dec	United States	10.1128/JVI.01758-06
16987422	S1 gene sequence analysis of a nephropathogenic strain of avian infectiousbronchitis virus in Egypt.	2006 Sep 20	England	10.1186/1743-422X-3-78
16987125	Risk of severe acute respiratory syndrome-associated coronavirus transmissionaboard commercial aircraft.	2006 Sep-Oct	England	10.1111/j.1708-8305.2006.00048.x
16987069	Immunization of mice with a DNA vaccine based on severe acute respiratorysyndrome coronavirus spike protein fragment 1.	2006 Summer	United States	10.1089/vim.2006.19.518
16985170	Control of coronavirus infection through plasmacytoid dendritic-cell-derived typeI interferon.	2007 Feb 1	United States	10.1182/blood-2006-05-023770
16983613	A prospective hospital-based study of the clinical impact of non-severe acuterespiratory syndrome (Non-SARS)-related human coronavirus infection.	2006 Oct 15	United States	10.1086/507898
16981695	A trimerizing GxxxG motif is uniquely inserted in the severe acute respiratorysyndrome (SARS) coronavirus spike protein transmembrane domain.	2006 Sep 26	United States	10.1021/bi060953v
16980289	ANN-based mapping of febrile subjects in mass thermogram screening: facts andmyths.	2006 Sep-Oct	England	10.1080/03091900500225136
16979681	An arginine-to-proline mutation in a domain with undefined functions within thehelicase protein (Nsp13) is lethal to the coronavirus infectious bronchitis virusin cultured cells.	2007 Feb 5	United States	10.1016/j.virol.2006.08.020
16979208	Coronavirus nucleocapsid protein is an RNA chaperone.	2007 Jan 20	United States	10.1016/j.virol.2006.07.046
16972168	Three dimensional model of severe acute respiratory syndrome coronavirus helicaseATPase catalytic domain and molecular design of severe acute respiratory syndromecoronavirus helicase inhibitors.	2006 May	Netherlands	10.1007/s10822-006-9057-z
16972037	Cloning and sequence analysis of the N gene of porcine epidemic diarrhea virusLJB/03.	2006 Oct	United States	10.1007/s11262-005-0059-z
16972028	Identification of a B-cell antigenic epitope at the N-terminus of SARS-CoV Mprotein and characterization of monoclonal antibody against the protein.	2006 Oct	United States	10.1007/s11262-005-0050-8
16971454	Amino acid residues critical for RNA-binding in the N-terminal domain of thenucleocapsid protein are essential determinants for the infectivity ofcoronavirus in cultured cells.	2006	England	10.1093/nar/gkl650
16971444	Cross-protection against a human enteric coronavirus and a virulent bovineenteric coronavirus in gnotobiotic calves.	2006 Dec	United States	10.1128/JVI.00402-06
16971428	Replication of murine hepatitis virus is regulated by papain-like proteinase 1processing of nonstructural proteins 1, 2, and 3.	2006 Dec	United States	10.1128/JVI.01428-06
16968120	SARS: systematic review of treatment effects.	2006 Sep	United States	10.1371/journal.pmed.0030343
16967296	Acute otitis media and respiratory viruses.	2007 Mar	Germany	10.1007/s00431-006-0233-x
16965829	Over-expression of severe acute respiratory syndrome coronavirus 3b proteininduces both apoptosis and necrosis in Vero E6 cells.	2006 Dec	Netherlands	10.1016/j.virusres.2006.06.005
16963681	Airflows around oxygen masks: A potential source of infection?	2006 Sep	United States	10.1378/chest.130.3.822
16962670	Identification of cell lines permissive for human coronavirus NL63.	2006 Dec	Netherlands	10.1016/j.jviromet.2006.07.023
16956938	Cooperative involvement of the S1 and S2 subunits of the murine coronavirus spikeprotein in receptor binding and extended host range.	2006 Nov	United States	10.1128/JVI.00950-06
16954245	Detection and characterization of bovine coronaviruses in fecal specimens ofadult cattle with diarrhea during the warmer seasons.	2006 Sep	United States	10.1128/JCM.02667-05
16954221	Structural basis of neutralization by a human anti-severe acute respiratorysyndrome spike protein antibody, 80R.	2006 Nov 10	United States	10.1074/jbc.M603275200
16950494	Phage-displayed peptides having antigenic similarities with porcine epidemicdiarrhea virus (PEDV) neutralizing epitopes.	2006 Oct 10	United States	10.1016/j.virol.2006.04.027
16948604	Isolation and characterization of a coronavirus from pigeons with pancreatitis.	2006 Sep	United States	10.2460/ajvr.67.9.1575
16948478	Molecular modeling studies of peptide drug candidates against SARS.	2006 May	Netherlands	10.2174/157340606776930736
16946403	Accumulation of recombinant SARS-CoV spike protein in plant cytosol andchloroplasts indicate potential for development of plant-derived oral vaccines.	2006 Sep	England	10.1177/153537020623100808
16946315	New genotype of infectious bronchitis virus in chickens in Scotland.	2006 Aug 26	England	10.1136/vr.159.9.291-b
16944772	Waste water disinfection during SARS epidemic for microbiological andtoxicological control.	2006 Jun	China	
16943352	Detection of severe acute respiratory syndrome coronavirus in stool specimens bycommercially available real-time reverse transcriptase PCR assays.	2006 Nov	United States	10.1128/JCM.01202-06
16942813	Preparation and characterization of a novel monoclonal antibody specific tosevere acute respiratory syndrome-coronavirus nucleocapsid protein.	2006 Dec	Netherlands	10.1016/j.virusres.2006.07.004
16941348	The large 386-nt deletion in SARS-associated coronavirus: evidence forquasispecies?	2006 Sep 15	United States	10.1086/507044
16941059	SYBR Green real-time reverse transcription-polymerase chain reaction assay forthe generic detection of coronaviruses.	2007 Jan	Austria	10.1007/s00705-006-0840-x
16940861	Infectious diseases emerging from Chinese wet-markets: zoonotic origins of severerespiratory viral infections.	2006 Oct	United States	10.1097/01.qco.0000244043.08264.fc
16940539	Modulation of the unfolded protein response by the severe acute respiratorysyndrome coronavirus spike protein.	2006 Sep	United States	10.1128/JVI.00659-06
16940504	Extremely low exposure of a community to severe acute respiratory syndromecoronavirus: false seropositivity due to use of bacterially derived antigens.	2006 Sep	United States	10.1128/JVI.00649-06
16934878	Development and evaluation of a real-time Taqman RT-PCR assay for the detectionof infectious bronchitis virus from infected chickens.	2006 Dec	Netherlands	10.1016/j.jviromet.2006.07.018
16931402	Experience of a global laboratory network in responding to infectious diseaseepidemics.	2006 Sep	United States	10.1016/S1473-3099(06)70556-4
16930781	Animal models and antibody assays for evaluating candidate SARS vaccines: summaryof a technical meeting 25-26 August 2005, London, UK.	2006 Nov 30	Netherlands	10.1016/j.vaccine.2006.07.009
16928755	A contemporary view of coronavirus transcription.	2007 Jan	United States	10.1128/JVI.01358-06
16928748	Construction of a severe acute respiratory syndrome coronavirus infectious cDNAclone and a replicon to study coronavirus RNA synthesis.	2006 Nov	United States	10.1128/JVI.00385-06
16927130	Genotypic and phenotypic characterization of the California 99 (Cal99) variant ofinfectious bronchitis virus.	2007 Jun	United States	10.1007/s11262-006-0014-7
16920822	Putative cis-acting stem-loops in the 5' untranslated region of the severe acuterespiratory syndrome coronavirus can substitute for their mouse hepatitis viruscounterparts.	2006 Nov	United States	10.1128/JVI.00455-06
16920216	Antigenic and cellular localisation analysis of the severe acute respiratorysyndrome coronavirus nucleocapsid protein using monoclonal antibodies.	2006 Dec	Netherlands	10.1016/j.virusres.2006.07.005
16919855	Immunogenicity of a receptor-binding domain of SARS coronavirus spike protein inmice: implications for a subunit vaccine.	2007 Jan 2	Netherlands	10.1016/j.vaccine.2006.06.084
16916786	A convenient cell fusion assay for the study of SARS-CoV entry and inhibition.	2006 Aug	England	10.1080/15216540600820974
16916263	Genomic sequencing of the severe acute respiratory syndrome-coronavirus.	2006	United States	10.1385/1-59745-074-X:177
16916262	Molecular diagnosis of severe acute respiratory syndrome.	2006	United States	10.1385/1-59745-074-X:163
16913834	Structural aspects of recently discovered viral deubiquitinating activities.	2006 Jul	Germany	10.1515/BC.2006.108
16913704	Structure-based drug design and structural biology study of novel nonpeptideinhibitors of severe acute respiratory syndrome coronavirus main protease.	2006 Aug 24	United States	10.1021/jm060207o
16912951	Acute respiratory distress syndrome and pneumonia: a comprehensive review ofclinical data.	2006 Sep 15	United States	10.1086/506430
16912312	Highly conserved regions within the spike proteins of human coronaviruses 229Eand NL63 determine recognition of their respective cellular receptors.	2006 Sep	United States	10.1128/JVI.00560-06
16912299	Structural and functional basis for ADP-ribose and poly(ADP-ribose) binding byviral macro domains.	2006 Sep	United States	10.1128/JVI.00713-06
16912115	Severe acute respiratory syndrome coronavirus nsp1 protein suppresses host geneexpression by promoting host mRNA degradation.	2006 Aug 22	United States	10.1073/pnas.0603144103
16911043	Human coronavirus NL63, a new respiratory virus.	2006 Sep	England	10.1111/j.1574-6976.2006.00032.x
16908043	Induction of transcription factor Egr-1 gene expression in astrocytoma cells byMurine coronavirus infection.	2006 Nov 25	United States	10.1016/j.virol.2006.07.012
16907978	Factors associated with nosocomial SARS-CoV transmission among healthcare workersin Hanoi, Vietnam, 2003.	2006 Aug 14	England	10.1186/1471-2458-6-207
16904198	Copious production of SARS-CoV nucleocapsid protein employing codon optimizedsynthetic gene.	2006 Nov	Netherlands	10.1016/j.jviromet.2006.06.029
16904134	Congruent epidemic models for unstructured and structured populations: analyticalreconstruction of a 2003 SARS outbreak.	2006 Oct	United States	10.1016/j.mbs.2006.05.004
16903465	Maternal antibody transfer from dams to their egg yolks, egg whites, and chicksin meat lines of chickens.	2006 Aug	England	10.1093/ps/85.8.1364
16895992	The structure of the endoribonuclease XendoU: From small nucleolar RNA processingto severe acute respiratory syndrome coronavirus replication.	2006 Aug 15	United States	10.1073/pnas.0602426103
16895476	Development of a red-shifted fluorescence-based assay for SARS-coronavirus 3CLprotease: identification of a novel class of anti-SARS agents from the tropicalmarine sponge Axinella corrugata.	2006 Aug	Germany	10.1515/BC.2006.131
16894183	Coronaviruses in bent-winged bats (Miniopterus spp.).	2006 Sep	England	10.1099/vir.0.82203-0
16894145	Severe acute respiratory syndrome-associated coronavirus 3a protein forms an ionchannel and modulates virus release.	2006 Aug 15	United States	10.1073/pnas.0605402103
16893997	Human neutralizing Fab molecules against severe acute respiratory syndromecoronavirus generated by phage display.	2006 Aug	United States	10.1128/CVI.00037-06
16891478	Multicenter comparison of nucleic acid extraction methods for detection of severeacute respiratory syndrome coronavirus RNA in stool specimens.	2006 Aug	United States	10.1128/JCM.02460-05
16891424	M gene analysis of atypical strains of feline and canine coronavirus circulatingin an Austrian animal shelter.	2006 Aug 5	England	10.1136/vr.159.6.170
16891412	Rewiring the severe acute respiratory syndrome coronavirus (SARS-CoV)transcription circuit: engineering a recombination-resistant genome.	2006 Aug 15	United States	10.1073/pnas.0605438103
16889606	Living donor renal transplantation using alemtuzumab induction and tacrolimusmonotherapy.	2006 Oct	United States	10.1111/j.1600-6143.2006.01495.x
16888922	Observations and immunohistochemical detection of Coronavirus, Cryptosporidiumparvum and Giardia intestinalis in neonatal diarrhoea in lambs and kids.	2006 Jul	Switzerland	10.1024/0036-7281.148.7.357
16887973	Screening and identification of severe acute respiratory syndrome-associatedcoronavirus-specific CTL epitopes.	2006 Aug 15	United States	10.4049/jimmunol.177.4.2138
16886150	The association of newly identified respiratory viruses with lower respiratorytract infections in Korean children, 2000-2005.	2006 Sep 1	United States	10.1086/506350
16884338	Can herbal medicine assist against avian flu? Learning from the experience ofusing supplementary treatment with Chinese medicine on SARS or SARS-likeinfectious disease in 2003.	2006 Jul-Aug	United States	10.1089/acm.2006.12.505
16884309	Synthesis, crystal structure, structure-activity relationships, and antiviralactivity of a potent SARS coronavirus 3CL protease inhibitor.	2006 Aug 10	United States	10.1021/jm0603926
16884179	Use of human nasal cannulas during bronchoscopy procedures as a simple method formaintaining adequate oxygen saturation in pigtailed macaques (Macaca nemestrina).	2006 Jul	United States	
16882730	Crystal structure and mechanistic determinants of SARS coronavirus nonstructuralprotein 15 define an endoribonuclease family.	2006 Aug 8	United States	10.1073/pnas.0601708103
16881855	Transmission of bovine coronavirus and serologic responses in feedlot calvesunder field conditions.	2006 Aug	United States	10.2460/ajvr.67.8.1412
16877062	The molecular biology of coronaviruses.	2006	United States	10.1016/S0065-3527(06)66005-3
16876844	The human severe acute respiratory syndrome coronavirus (SARS-CoV) 8b protein isdistinct from its counterpart in animal SARS-CoV and down-regulates theexpression of the envelope protein in infected cells.	2006 Oct 10	United States	10.1016/j.virol.2006.06.026
16875760	Synthesis of stilbene derivatives with inhibition of SARS coronavirusreplication.	2006 Sep	France	10.1016/j.ejmech.2006.03.024
16873249	Supramolecular architecture of severe acute respiratory syndrome coronavirusrevealed by electron cryomicroscopy.	2006 Aug	United States	10.1128/JVI.00645-06
16873248	New antiviral target revealed by the hexameric structure of mouse hepatitis virusnonstructural protein nsp15.	2006 Aug	United States	10.1128/JVI.00525-06
16873247	Dodecamer structure of severe acute respiratory syndrome coronavirusnonstructural protein nsp10.	2006 Aug	United States	10.1128/JVI.00483-06
16873246	Crystal structure of nonstructural protein 10 from the severe acute respiratorysyndrome coronavirus reveals a novel fold with two zinc-binding motifs.	2006 Aug	United States	10.1128/JVI.00467-06
16870878	First evidence of feline herpesvirus, calicivirus, parvovirus, and Ehrlichiaexposure in Brazilian free-ranging felids.	2006 Apr	United States	10.7589/0090-3558-42.2.470
16870029	SARS transmission in Vietnam outside of the health-care setting.	2007 Apr	England	10.1017/S0950268806006996
16864084	[An epidemiological investigation of bats carrying SARS-CoV in Guangzhou and itsvicinity].	2006 Jul	China	
16863085	Detection of Massachusetts and Arkansas serotypes of infectious bronchitis virusin broilers.	2006 Jun	United States	10.1637/7458-101805R.1
16863071	Seroprevalence of avian influenza virus, infectious bronchitis virus, reovirus,avian pneumovirus, infectious laryngotracheitis virus, and avian leukosis virusin Nigerian poultry.	2006 Jun	United States	10.1637/7412-071505R.1
16862327	Respiratory viruses in children younger than five years old with acuterespiratory disease from 2001 to 2004 in Uberlandia, MG, Brazil.	2006 May	Brazil	10.1590/s0074-02762006000300014
16860835	Interferon-gamma and interleukin-4 downregulate expression of the SARScoronavirus receptor ACE2 in Vero E6 cells.	2006 Sep 30	United States	10.1016/j.virol.2006.06.011
16860445	Safety and efficacy of an infectious bronchitis virus used for chicken embryovaccination.	2006 Nov 17	Netherlands	10.1016/j.vaccine.2006.06.040
16850939	Infection with Porcine reproductive and respiratory syndrome virus stimulates anearly gamma interferon response in the serum of pigs.	2006 Jul	Canada	
16847968	Frequent detection of human rhinoviruses, paramyxoviruses, coronaviruses, andbocavirus during acute respiratory tract infections.	2006 Sep	United States	10.1002/jmv.20689
16845612	M and N proteins of SARS coronavirus induce apoptosis in HPF cells.	2006 Sep	Netherlands	10.1007/s10565-006-0077-1
16845391	Architecture of the SARS coronavirus prefusion spike.	2006 Aug	United States	10.1038/nsmb1123
16845046	siVirus: web-based antiviral siRNA design software for highly divergent viralsequences.	2006 Jul 1	England	10.1093/nar/gkl214
16844400	Human memory T cell responses to SARS-CoV E protein.	2006 Aug	France	10.1016/j.micinf.2006.05.008
16843897	The crystal structure of ORF-9b, a lipid binding protein from the SARScoronavirus.	2006 Jul	United States	10.1016/j.str.2006.05.012
16843894	Domain-swapped structure of the potent antiviral protein griffithsin and its modeof carbohydrate binding.	2006 Jul	United States	10.1016/j.str.2006.05.017
16843888	Common scaffolds, diverse recognition profiles.	2006 Jul	United States	10.1016/j.str.2006.06.001
16843832	Microwave-assisted tissue processing for same-day EM-diagnosis of potentialbioterrorism and clinical samples.	2006	England	10.1016/j.micron.2005.11.015
16842982	Peptides derived from HIV-1, HIV-2, Ebola virus, SARS coronavirus and coronavirus229E exhibit high affinity binding to the formyl peptide receptor.	2006 Jul	Netherlands	10.1016/j.bbadis.2006.05.008
16842194	Antiviral drug discovery against SARS-CoV.	2006	United Arab Emirates	10.2174/092986706777584988
16840328	Prevalence and genetic diversity of coronaviruses in bats from China.	2006 Aug	United States	10.1128/JVI.00697-06
16840309	Severe acute respiratory syndrome coronavirus 7a accessory protein is a viralstructural protein.	2006 Aug	United States	10.1128/JVI.00414-06
16837072	Coronaviruses and their therapy.	2006 Sep	Netherlands	10.1016/j.antiviral.2006.05.019
16836564	Photochemical treatment of plasma with amotosalen and long-wavelength ultravioletlight inactivates pathogens while retaining coagulation function.	2006 Jul	United States	10.1111/j.1537-2995.2006.00867.x
16836185	[My greatest concern was decontaminating my family].	2006	Switzerland	
16830004	Laboratory containment of SARS virus.	2006 May	Singapore	
16830001	Radiographic features of SARS in paediatric patients: a review of cases inSingapore.	2006 May	Singapore	
16830000	Clinical and laboratory findings of SARS in Singapore.	2006 May	Singapore	
16829999	SARS in Singapore--predictors of disease severity.	2006 May	Singapore	
16828802	RNA recognition and cleavage by the SARS coronavirus endoribonuclease.	2006 Aug 11	England	10.1016/j.jmb.2006.06.021
16828088	The non-structural protein Nsp10 of mouse hepatitis virus binds zinc ions andnucleic acids.	2006 Jul 24	England	10.1016/j.febslet.2006.06.061
16826344	Substantial differences in preparedness for emergency infection control measuresamong major hospitals in Japan: lessons from SARS.	2006 Jun	Netherlands	10.1007/s10156-006-0436-0
16825396	Survey of dogs in Japan for group 2 canine coronavirus infection.	2006 Jul	United States	10.1128/JCM.02397-05
16824203	Association of SARS susceptibility with single nucleic acid polymorphisms of OAS1and MxA genes: a case-control study.	2006 Jul 6	England	10.1186/1471-2334-6-106
16821128	NMR assignment of the SARS-CoV protein nsp1.	2006	Netherlands	10.1007/s10858-006-9018-9
16820226	Understanding the accessory viral proteins unique to the severe acute respiratorysyndrome (SARS) coronavirus.	2006 Nov	Netherlands	10.1016/j.antiviral.2006.05.010
16819967	Changes in nucleolar morphology and proteins during infection with thecoronavirus infectious bronchitis virus.	2006 Jul	England	10.1111/j.1462-5822.2006.00698.x
16816874	[Follow up study on viruses associated with SARS among the SARS patients].	2006 Jun	China	
16816854	[Establishment of molecular differential diagnostic (MDD) technology fordetection of common respiratory viruses].	2006 Jun	China	
16816374	Pathogenic role for virus-specific CD4 T cells in mice with coronavirus-inducedacute encephalitis.	2006 Jul	United States	10.2353/ajpath.2006.051308
16815524	Hexamethylene amiloride blocks E protein ion channels and inhibits coronavirusreplication.	2006 Sep 30	United States	10.1016/j.virol.2006.05.028
16809936	Enhanced induction of SARS-CoV nucleocapsid protein-specific immune responseusing DNA vaccination followed by adenovirus boosting in BALB/c mice.	2006	Switzerland	10.1159/000094247
16809333	Evolutionary history of the closely related group 2 coronaviruses: porcinehemagglutinating encephalomyelitis virus, bovine coronavirus, and humancoronavirus OC43.	2006 Jul	United States	10.1128/JVI.02675-05
16809319	Comparative analysis of 22 coronavirus HKU1 genomes reveals a novel genotype andevidence of natural recombination in coronavirus HKU1.	2006 Jul	United States	10.1128/JVI.00509-06
16809289	Both spike and background genes contribute to murine coronavirus neurovirulence.	2006 Jul	United States	10.1128/JVI.00432-06
16809285	Conformational states of the severe acute respiratory syndrome coronavirus spikeprotein ectodomain.	2006 Jul	United States	10.1128/JVI.02744-05
16808902	Mechanisms of establishment of persistent SARS-CoV-infected cells.	2006 Aug 18	United States	10.1016/j.bbrc.2006.06.086
16808126	Severe acute respiratory syndrome in a naval diver.	2006 Jun	England	10.7205/milmed.171.6.491
16804448	Human coronavirus nomenclature.	2006 Jul	United States	10.1097/01.inf.0000225784.06712.8e
16804033	Severe acute respiratory syndrome (SARS): development of diagnostics andantivirals.	2006 May	United States	10.1196/annals.1354.072
16803585	Hosting the severe acute respiratory syndrome coronavirus: specific cell factorsrequired for infection.	2006 Aug	England	10.1111/j.1462-5822.2006.00744.x
16799860	NMR assignment of the protein nsp3a from SARS-CoV.	2006	Netherlands	10.1007/s10858-006-9017-x
16798980	Preparation of a chimeric armored RNA as a versatile calibrator for multiplevirus assays.	2006 Jul	England	10.1373/clinchem.2006.069971
16797548	Accelerated induction of apoptosis in insect cells by baculovirus-expressedSARS-CoV membrane protein.	2006 Jul 10	England	10.1016/j.febslet.2006.06.003
16796401	Human monoclonal antibody combination against SARS coronavirus: synergy andcoverage of escape mutants.	2006 Jul	United States	10.1371/journal.pmed.0030237
16794950	Generality of the final size formula for an epidemic of a newly invadinginfectious disease.	2006 Apr	United States	10.1007/s11538-005-9047-7
16793110	Recombinant adeno-associated virus expressing the receptor-binding domain ofsevere acute respiratory syndrome coronavirus S protein elicits neutralizingantibodies: Implication for developing SARS vaccines.	2006 Sep 15	United States	10.1016/j.virol.2006.03.049
16789928	Antiviral effects of saikosaponins on human coronavirus 229E in vitro.	2006 Jul	Australia	10.1111/j.1440-1681.2006.04415.x
16789884	A new nucleotide-composition based fingerprint of SARS-CoV with visualizationanalysis.	2005 Jan	Netherlands	10.2174/1573406053402505
16789718	Multiplex reverse transcription-PCR for rapid differential detection of porcineepidemic diarrhea virus, transmissible gastroenteritis virus, and porcine group Arotavirus.	2006 May	United States	10.1177/104063870601800309
16789312	Who owns the genome?	2006 Winter	United States	
16787316	Application of bioinformatics in search for cleavable peptides of SARS-CoV M(pro)and chemical modification of octapeptides.	2005 May	Netherlands	10.2174/1573406053765468
16781892	Long-lived effector/central memory T-cell responses to severe acute respiratorysyndrome coronavirus (SARS-CoV) S antigen in recovered SARS patients.	2006 Aug	United States	10.1016/j.clim.2006.05.002
16781713	Amino acids 15-28 in the ectodomain of SARS coronavirus 3a protein inducesneutralizing antibodies.	2006 Jul 10	England	10.1016/j.febslet.2006.06.002
16780645	[Serological analysis of SARS Coronavirus in children diagnosed clinically assevere acute respiratory syndrome cases during SARS epidemic in Beijing].	2006 Apr	China	
16777454	Whole blood cytokine profiles in cats infected by feline coronavirus and healthynon-FCoV infected specific pathogen-free cats.	2006 Dec	England	10.1016/j.jfms.2006.05.002
16776568	Novel mfgl2 antisense plasmid inhibits murine fgl2 expression and amelioratesmurine hepatitis virus type 3-induced fulminant hepatitis in BALB/cJ mice.	2006 Jun	United States	10.1089/hum.2006.17.589
16775933	[Chiroptera and zoonosis: an emerging problem on all five continents].	2006 Apr	France	
16775348	X-ray structures of the N- and C-terminal domains of a coronavirus nucleocapsidprotein: implications for nucleocapsid formation.	2006 Jul	United States	10.1128/JVI.00157-06
16772384	Identification of pulmonary Oct-4+ stem/progenitor cells and demonstration oftheir susceptibility to SARS coronavirus (SARS-CoV) infection in vitro.	2006 Jun 20	United States	10.1073/pnas.0510232103
16771611	More mysteries of HIV and SARS are revealed.	2006 Jun	England	10.1586/14787210.4.3.353
16766733	New variant of IBV in Poland.	2006 Jun 10	England	10.1136/vr.158.23.808-c
16765058	Biophysical characterization of HRC peptide analogs interaction with heptadrepeat regions of the SARS-coronavirus Spike fusion protein core.	2006 Aug	United States	10.1016/j.jsb.2006.03.024
16761881	Surveillance for febrile respiratory infections during Cobra Gold 2003.	2006 May	England	10.7205/milmed.171.5.357
16760548	Prevalence of subclinical infection and transmission of severe acute respiratorysyndrome (SARS) in a residential care home for the elderly.	2006 Jun	China	
16760398	Transcriptional profiling of acute cytopathic murine hepatitis virus infection infibroblast-like cells.	2006 Jul	England	10.1099/vir.0.81756-0
16760397	Interaction of severe acute respiratory syndrome-associated coronavirus withdendritic cells.	2006 Jul	England	10.1099/vir.0.81624-0
16759866	Is there an ideal animal model for SARS?	2006 Jul	England	10.1016/j.tim.2006.05.007
16759303	Plasma glucose levels and diabetes are independent predictors for mortality andmorbidity in patients with SARS.	2006 Jun	England	10.1111/j.1464-5491.2006.01861.x
16759112	Effect of various pyrimidines possessing the1-[(2-hydroxy-1-(hydroxymethyl)ethoxy)methyl] moiety, able to mimic natural2'-deoxyribose, on wild-type and mutant hepatitis B virus replication.	2006 Jun 15	United States	10.1021/jm060102l
16759091	Discovery of a novel family of SARS-CoV protease inhibitors by virtual screeningand 3D-QSAR studies.	2006 Jun 15	United States	10.1021/jm050852f
16759084	Isatin compounds as noncovalent SARS coronavirus 3C-like protease inhibitors.	2006 Jun 15	United States	10.1021/jm0602357
16759052	The role of viruses in the aetiology of community-acquired pneumonia in adults.	2006	England	
16757801	Identification of effective siRNA blocking the expression of SARS viral envelopeE and RDRP genes.	2006 Jun	United States	10.1385/MB:33:2:141
16757599	Coronavirus HKU1 and other coronavirus infections in Hong Kong.	2006 Jun	United States	10.1128/JCM.02614-05
16755366	Reciprocal antibody and complement responses of two chicken breeds to vaccinestrains of Newcastle disease virus, infectious bursal disease virus andinfectious bronchitis virus.	2006 Jul	Netherlands	10.1007/s11259-006-3311-7
16753150	Expression and functional characterization of the putative protein 8b of thesevere acute respiratory syndrome-associated coronavirus.	2006 Jun 26	England	10.1016/j.febslet.2006.05.051
16752365	Coronavirus phylogeny based on 2D graphical representation of DNA sequence.	2006 Aug	United States	10.1002/jcc.20439
16740197	Bats and human emerging diseases.	2006 Oct	England	10.1017/S0950268806006674
16737794	Anti-RNA virus activity of polyoxometalates.	2006 Jun	France	10.1016/j.biopha.2006.03.009
16734668	Delineation and modelling of a nucleolar retention signal in the coronavirusnucleocapsid protein.	2006 Jul	England	10.1111/j.1600-0854.2006.00424.x
16731931	Ultrastructure and origin of membrane vesicles associated with the severe acuterespiratory syndrome coronavirus replication complex.	2006 Jun	United States	10.1128/JVI.02501-05
16731916	Endosomal proteolysis by cathepsins is necessary for murine coronavirus mousehepatitis virus type 2 spike-mediated entry.	2006 Jun	United States	10.1128/JVI.00442-06
16731915	Antigenic and immunogenic characterization of recombinant baculovirus-expressedsevere acute respiratory syndrome coronavirus spike protein: implication forvaccine design.	2006 Jun	United States	10.1128/JVI.00083-06
16731004	Assembly of pseudorabies virus genome-based transfer vehicle carrying majorantigen sites of S gene of transmissible gastroenteritis virus: potentialperspective for developing live vector vaccines.	2007 Mar	England	10.1016/j.biologicals.2006.02.001
16730806	Emodin blocks the SARS coronavirus spike protein and angiotensin-convertingenzyme 2 interaction.	2007 May	Netherlands	10.1016/j.antiviral.2006.04.014
16730762	Oral efficacy of Vero cell attenuated porcine epidemic diarrhea virus DR13strain.	2007 Feb	England	10.1016/j.rvsc.2006.03.007
16725238	Identification and characterization of novel neutralizing epitopes in thereceptor-binding domain of SARS-CoV spike protein: revealing the criticalantigenic determinants in inactivated SARS-CoV vaccine.	2006 Jun 29	Netherlands	10.1016/j.vaccine.2006.04.054
16723685	Serum amyloid A is not useful in the diagnosis of severe acute respiratorysyndrome.	2006 Jun	England	10.1373/clinchem.2006.068395
16723558	Inhibition of human coronavirus NL63 infection at early stages of the replicationcycle.	2006 Jun	United States	10.1128/AAC.01598-05
16721849	Genetic variability of human coronavirus OC43-, 229E-, and NL63-like strains andtheir association with lower respiratory tract infections of hospitalized infantsand immunocompromised patients.	2006 Jul	United States	10.1002/jmv.20645
16718402	Investigation of interaction between two neutralizing monoclonal antibodies andSARS virus using biosensor based on imaging ellipsometry.	2006 Sep	United States	10.1007/s10544-006-8305-2
16716107	Efficacy of severe acute respiratory syndrome vaccine based on a nonhuman primateadenovirus in the presence of immunity against human adenovirus.	2006 May	United States	10.1089/hum.2006.17.500
16716052	Transmissible gastroenteritis virus infection: a vanishing specter.	2006 Apr	Germany	
16715412	Anti-SARS drug screening by molecular docking.	2006 Jul	Austria	10.1007/s00726-006-0361-7
16714663	Thin-Section CT 12 Months After the Diagnosis of Severe Acute RespiratorySyndrome in Pediatric Patients.	2006 Jun	United States	10.2214/AJR.05.0382
16714001	Characterization of HCoV-229E fusion core: implications for structure basis ofcoronavirus membrane fusion.	2006 Jul 7	United States	10.1016/j.bbrc.2006.04.141
16712436	Biochemical aspects of coronavirus replication and virus-host interaction.	2006	United States	10.1146/annurev.micro.60.080805.142157
16706344	[The research and development of new diagnostic gene chips for SARS coronavirus].	2006 Apr	China	
16704837	Coronavirus HKU1 infection in the United States.	2006 May	United States	10.3201/eid1205.051316
16704791	Canine coronavirus highly pathogenic for dogs.	2006 Mar	United States	10.3201/eid1203.050839
16704119	Identification of one peptide which inhibited infectivity of avian infectiousbronchitis virus in vitro.	2006 Apr	China	10.1007/s11427-006-0158-7
16698774	Model of a putative pore: the pentameric alpha-helical bundle of SARS coronavirusE protein in lipid bilayers.	2006 Aug 1	United States	10.1529/biophysj.105.080119
16698555	[Emergent viruses: SARS-associate coronavirus and H5N1 influenza virus].	2006 May-Jun	France	
16698550	Structures and polymorphic interactions of two heptad-repeat regions of the SARSvirus S2 protein.	2006 May	United States	10.1016/j.str.2006.03.007
16697680	Effect of porcine respiratory coronavirus infection on lipopolysacchariderecognition proteins and haptoglobin levels in the lungs.	2006 May	France	10.1016/j.micinf.2006.01.009
16697221	Template-based coiled-coil antigens elicit neutralizing antibodies to theSARS-coronavirus.	2006 Aug	United States	10.1016/j.jsb.2006.03.019
16697037	Infectious causes of reproductive loss in camelids.	2006 Aug	United States	10.1016/j.theriogenology.2006.04.008
16697007	From the similarity analysis of protein cavities to the functional classificationof protein families using cavbase.	2006 Jun 16	England	10.1016/j.jmb.2006.04.024
16696450	Environmental transmission of SARS at Amoy Gardens.	2006 May	United States	
16690935	Analysis of ACE2 in polarized epithelial cells: surface expression and functionas receptor for severe acute respiratory syndrome-associated coronavirus.	2006 Jun	England	10.1099/vir.0.81749-0
16690934	Feline infectious peritonitis virus-infected monocytes internalize viralmembrane-bound proteins upon antibody addition.	2006 Jun	England	10.1099/vir.0.81692-0
16690906	Nidovirus transcription: how to make sense...?	2006 Jun	England	10.1099/vir.0.81611-0
16690096	Long-lived memory T lymphocyte responses against SARS coronavirus nucleocapsidprotein in SARS-recovered patients.	2006 Aug 1	United States	10.1016/j.virol.2006.03.036
16689659	SARS-CoV virus-host interactions and comparative etiologies of acute respiratorydistress syndrome as determined by transcriptional and cytokine profiling offormalin-fixed paraffin-embedded tissues.	2006 May	United States	10.1089/jir.2006.26.309
16688706	An efficient method for the synthesis of peptide aldehyde libraries employed inthe discovery of reversible SARS coronavirus main protease (SARS-CoV Mpro)inhibitors.	2006 Jul	Germany	10.1002/cbic.200500533
16688178	A mechanical explanation of RNA pseudoknot function in programmed ribosomalframeshifting.	2006 May 11	England	10.1038/nature04735
16684538	Biochemical evidence for the presence of mixed membrane topologies of the severeacute respiratory syndrome coronavirus envelope protein expressed in mammaliancells.	2006 May 29	England	10.1016/j.febslet.2006.04.076
16682811	Mitochondrial location of severe acute respiratory syndrome coronavirus 3bprotein.	2006 Apr 30	Korea (South)	
16682490	Risk-stratified seroprevalence of severe acute respiratory syndrome coronavirusamong children in Hong Kong.	2006 Jun	United States	10.1542/peds.2005-1476
16682481	Production of an anti-severe acute respiratory syndrome (SARS) coronavirus humanmonoclonal antibody Fab fragment by using a combinatorial immunoglobulin genelibrary derived from patients who recovered from SARS.	2006 May	United States	10.1128/CVI.13.5.594-597.2006
16678878	Induction of protective immunity against severe acute respiratory syndromecoronavirus (SARS-CoV) infection using highly attenuated recombinant vacciniavirus DIs.	2006 Aug 1	United States	10.1016/j.virol.2006.03.020
16677717	A simple method for preparing synthetic controls for conventional and real-timePCR for the identification of endemic and exotic disease agents.	2006 Aug	Netherlands	10.1016/j.jviromet.2006.03.007
16675072	Structure- and oil type-based efficacy of emulsion adjuvants.	2006 Jun 29	Netherlands	10.1016/j.vaccine.2006.03.074
16675038	Inhibition of feline (FIPV) and human (SARS) coronavirus by semisyntheticderivatives of glycopeptide antibiotics.	2006 Oct	Netherlands	10.1016/j.antiviral.2006.03.005
16675037	Rhinovirus chemotherapy.	2006 Sep	Netherlands	10.1016/j.antiviral.2006.03.011
16675032	Detection of antibodies to avian infectious bronchitis virus by a recombinantnucleocapsid protein-based enzyme-linked immunosorbent assay.	2006 Aug	Netherlands	10.1016/j.jviromet.2006.03.019
16671039	Airborne severe acute respiratory syndrome coronavirus concentrations in anegative-pressure isolation room.	2006 May	United States	10.1086/504357
16671038	Hospital waste generation during an outbreak of severe acute respiratory syndromein Taiwan.	2006 May	United States	10.1086/503691
16671028	Cluster of cases of severe acute respiratory syndrome among Toronto healthcareworkers after implementation of infection control precautions: a case series.	2006 May	United States	10.1086/504363
16671027	Epidemiologic study and containment of a nosocomial outbreak of severe acuterespiratory syndrome in a medical center in Kaohsiung, Taiwan.	2006 May	United States	10.1086/504501
16670317	Cross-neutralization of human and palm civet severe acute respiratory syndromecoronaviruses by antibodies targeting the receptor-binding domain of spikeprotein.	2006 May 15	United States	10.4049/jimmunol.176.10.6085
16652313	Nasopharyngeal shedding of severe acute respiratory syndrome-associatedcoronavirus is associated with genetic polymorphisms.	2006 Jun 1	United States	10.1086/503843
16649161	Inflammation inhibitors were remarkably up-regulated in plasma of severe acuterespiratory syndrome patients at progressive phase.	2006 May	Germany	10.1002/pmic.200500638
16648962	Assembly of HCV E1 and E2 glycoproteins into coronavirus VLPs.	2006 Oct	Austria	10.1007/s00705-006-0769-0
16647871	A six-year study on respiratory viral infections in a bull testing facility.	2007 May	England	10.1016/j.tvjl.2006.02.010
16647731	Molecular diversity of coronaviruses in bats.	2006 Jul 20	United States	10.1016/j.virol.2006.02.041
16647061	Enzymatic activity of the SARS coronavirus main proteinase dimer.	2006 May 15	England	10.1016/j.febslet.2006.04.004
16641281	Receptor-independent infection of murine coronavirus: analysis by spinoculation.	2006 May	United States	10.1128/JVI.80.10.4901-4908.2006
16640347	Design and synthesis of hydroxyferroquine derivatives with antimalarial andantiviral activities.	2006 May 4	United States	10.1021/jm0601856
16638566	Kinetics and synergistic effects of siRNAs targeting structural and replicasegenes of SARS-associated coronavirus.	2006 May 1	England	10.1016/j.febslet.2006.03.066
16638531	Stable benzotriazole esters as mechanism-based inactivators of the severe acuterespiratory syndrome 3CL protease.	2006 Mar	United States	10.1016/j.chembiol.2005.12.008
16638527	Sometimes intermediates. Do the job!	2006 Mar	United States	10.1016/j.chembiol.2006.03.002
16630634	Mapping a neutralizing epitope on the SARS coronavirus spike protein:computational prediction based on affinity-selected peptides.	2006 May 26	England	10.1016/j.jmb.2006.03.008
16630549	HLA-A*0201 T-cell epitopes in severe acute respiratory syndrome (SARS)coronavirus nucleocapsid and spike proteins.	2006 May 26	United States	10.1016/j.bbrc.2006.03.152
16630025	Role of natural interferon-producing cells and T lymphocytes in porcinemonocyte-derived dendritic cell maturation.	2006 May	England	10.1111/j.1365-2567.2006.02343.x
16629982	Detection of bovine torovirus in neonatal calf diarrhoea in Lower Austria andStyria (Austria).	2006 May	Germany	10.1111/j.1439-0450.2006.00936.x
16627473	Crystal structure of the severe acute respiratory syndrome (SARS) coronavirusnucleocapsid protein dimerization domain reveals evolutionary linkage betweencorona- and arteriviridae.	2006 Jun 23	United States	10.1074/jbc.M602107200
16625834	Polymorphism of SARS-CoV genomes.	2006 Apr	China	10.1016/S0379-4172(06)60061-9
16624753	[Variability analysis of S2 gene of SARS-CoV].	2006 Apr	China	
16624149	[Expression and significance of severe acute respiratory syndrome associatedcoronavirus (SARS-CoV)-X4 protein in lungs of SARS patients].	2006 Mar	China	
16624059	[Human coronavirus-NL63 was detected in specimens from children with acuterespiratory infection in Beijing, China].	2006 Mar	China	
16621188	Immunization with SARS-CoV S DNA vaccine generates memory CD4+ and CD8+ T cellimmune responses.	2006 Jun 5	Netherlands	10.1016/j.vaccine.2006.03.058
16621037	Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenaseinhibitors, including ribavirin.	2006 Aug	Netherlands	10.1016/j.antiviral.2006.03.001
16621029	Natural feline coronavirus infection: differences in cytokine patterns inassociation with the outcome of infection.	2006 Aug 15	Netherlands	10.1016/j.vetimm.2006.02.004
16617369	[Enhanced-real time PCR: a highly sensitive method for SARS-coronavirusdetection].	2006 Apr 18	China	
16617048	Detection of feline infectious peritonitis virus-like antigen in ferrets.	2006 Apr 15	England	10.1136/vr.158.15.523-b
16616792	Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV)infectivity by peptides analogous to the viral spike protein.	2006 Sep	Netherlands	10.1016/j.virusres.2006.03.001
16615996	A single amino acid substitution (R441A) in the receptor-binding domain of SARScoronavirus spike protein disrupts the antigenic structure and binding activity.	2006 May 26	United States	10.1016/j.bbrc.2006.03.139
16611893	Identification of functionally important negatively charged residues in thecarboxy end of mouse hepatitis coronavirus A59 nucleocapsid protein.	2006 May	United States	10.1128/JVI.80.9.4344-4355.2006
16611880	Animal origins of the severe acute respiratory syndrome coronavirus: insight fromACE2-S-protein interactions.	2006 May	United States	10.1128/JVI.80.9.4211-4219.2006
16611148	Characterization and inhibition of SARS-coronavirus main protease.	2006	United Arab Emirates	10.2174/156802606776287090
16611118	Understanding helicases as a means of virus control.	2006	United Arab Emirates	10.2174/138161206776361147
16611117	Antiviral drug discovery targeting to viral proteases.	2006	United Arab Emirates	10.2174/138161206776361110
16610761	Nucleic-acid-based antiviral agents against positive single-stranded RNA viruses.	2006 Apr	England	
16608385	Nonhuman primate models for SARS.	2006 May	United States	10.1371/journal.pmed.0030194
16607445	Acute renal failure in patients with severe acute respiratory syndrome.	2005 Dec	Singapore	
16605302	Cynomolgus macaque as an animal model for severe acute respiratory syndrome.	2006 May	United States	10.1371/journal.pmed.0030149
16604443	Molecular characterization of HE, M, and E genes of winter dysentery bovinecoronavirus circulated in Korea during 2002-2003.	2006 Apr	United States	10.1007/s11262-005-6867-3
16603523	Sialic acid is a receptor determinant for infection of cells by avian Infectiousbronchitis virus.	2006 May	England	10.1099/vir.0.81651-0
16603522	Analysis of human coronavirus 229E spike and nucleoprotein genes demonstratesgenetic drift between chronologically distinct strains.	2006 May	England	10.1099/vir.0.81662-0
16600962	Rapid peptide-based screening on the substrate specificity of severe acuterespiratory syndrome (SARS) coronavirus 3C-like protease by matrix-assisted laserdesorption/ionization time-of-flight mass spectrometry.	2006 Apr	United States	10.1110/ps.052007306
16600073	Prevalence of naturally occurring viral infections, Mycoplasma pulmonis andClostridium piliforme in laboratory rodents in Western Europe screened from 2000to 2003.	2006 Apr	England	10.1258/002367706776319114
16597622	Structure of severe acute respiratory syndrome coronavirus receptor-bindingdomain complexed with neutralizing antibody.	2006 Jun 9	United States	10.1074/jbc.M600697200
16597209	Potential antivirals and antiviral strategies against SARS coronavirusinfections.	2006 Apr	England	10.1586/14787210.4.2.291
16595305	Infectious bronchitis virus S1 gene sequence comparison is a better predictor ofchallenge of immunity in chickens than serotyping by virus neutralization.	2006 Apr	England	10.1080/03079450600597865
16595304	Isolation of a coronavirus from a green-cheeked Amazon parrot (Amazonviridigenalis Cassin).	2006 Apr	England	10.1080/03079450600597733
16595297	Antigenic and molecular characterization of isolates of the Italy 02 infectiousbronchitis virus genotype.	2006 Apr	England	10.1080/03079450600597295
16586361	Anti-severe acute respiratory syndrome coronavirus immune responses: the roleplayed by V gamma 9V delta 2 T cells.	2006 May 1	United States	10.1086/502975
16586072	Early diagnosis of SARS: lessons from the Toronto SARS outbreak.	2006 Apr	Germany	10.1007/s10096-006-0127-x
16583154	Molecular analysis of Brazilian strains of bovine coronavirus (BCoV) reveals adeletion within the hypervariable region of the S1 subunit of the spikeglycoprotein also found in human coronavirus OC43.	2006 Sep	Austria	10.1007/s00705-006-0752-9
16582498	Crystallization and preliminary X-ray diffraction analysis of Nsp15 from SARScoronavirus.	2006 Apr 1	England	10.1107/S1744309106009407
16582497	Expression, purification and crystallization of the SARS-CoV macro domain.	2006 Apr 1	England	10.1107/S1744309106009274
16581910	Severe acute respiratory syndrome coronavirus papain-like protease: structure ofa viral deubiquitinating enzyme.	2006 Apr 11	United States	10.1073/pnas.0510851103
16581295	Angiotensin-converting enzyme 2 in lung diseases.	2006 Jun	England	10.1016/j.coph.2006.03.001
16580632	Severe acute respiratory syndrome coronavirus protein 7a interacts with hSGT.	2006 May 19	United States	10.1016/j.bbrc.2006.03.091
16579970	Tertiary structure prediction of SARS coronavirus helicase.	2006 May 19	United States	10.1016/j.bbrc.2006.03.069
16579755	Analysis of genetic mutations in the 7a7b open reading frame of coronavirus ofcheetahs (Acinonyx jubatus).	2006 Apr	United States	10.2460/ajvr.67.4.627
16575524	Localisation and distribution of O-acetylated N-acetylneuraminic acids, theendogenous substrates of the hemagglutinin-esterases of murine coronaviruses, inmouse tissue.	2006 Feb	United States	10.1007/s10719-006-5439-7
16575523	Structure, function and evolution of the hemagglutinin-esterase proteins ofcorona- and toroviruses.	2006 Feb	United States	10.1007/s10719-006-5438-8
16575522	Sialic acids as receptor determinants for coronaviruses.	2006 Feb	United States	10.1007/s10719-006-5437-9
16571831	Characterization of a torovirus main proteinase.	2006 Apr	United States	10.1128/JVI.80.8.4157-4167.2006
16571830	Cell cycle perturbations induced by infection with the coronavirus infectiousbronchitis virus and their effect on virus replication.	2006 Apr	United States	10.1128/JVI.80.8.4147-4156.2006
16571824	Mucosal immunization with surface-displayed severe acute respiratory syndromecoronavirus spike protein on Lactobacillus casei induces neutralizing antibodiesin mice.	2006 Apr	United States	10.1128/JVI.80.8.4079-4087.2006
16571117	Inhibition of cytokine gene expression and induction of chemokine genes innon-lymphatic cells infected with SARS coronavirus.	2006 Mar 29	England	10.1186/1743-422X-3-17
16570854	Functional diversity of chemokines and chemokine receptors in response to viralinfection of the central nervous system.	2006	Germany	10.1007/978-3-540-33397-5_1
16569847	Triaryl pyrazoline compound inhibits flavivirus RNA replication.	2006 Apr	United States	10.1128/AAC.50.4.1320-1329.2006
16566254	Diseases and pathogens associated with mortality in Ontario beef feedlots.	2006 Jan	United States	10.1177/104063870601800104
16565086	Only one protomer is active in the dimer of SARS 3C-like proteinase.	2006 May 19	United States	10.1074/jbc.M510745200
16564911	The comparative pathology of severe acute respiratory syndrome and avianinfluenza A subtype H5N1--a review.	2006 Apr	United States	10.1016/j.humpath.2006.01.015
16555552	Seroprevalence study of feline coronavirus in owned and feral cats in Sydney,Australia.	2006 Mar	England	10.1111/j.1751-0813.2006.tb12231.x
16555283	Enhanced identification of viral and atypical bacterial pathogens in lowerrespiratory tract samples with nucleic acid amplification tests.	2006 May	United States	10.1002/jmv.20595
16554722	Close relationship between SARS-coronavirus and group 2 coronavirus.	2006 Feb	Korea (South)	
16553810	Severe acute respiratory syndrome coronavirus 3C-like protease-induced apoptosis.	2006 Apr	England	10.1111/j.1574-695X.2006.00045.x
16552820	High expression level of soluble SARS spike protein mediated by adenovirus inHEK293 cells.	2006 Mar 7	United States	10.3748/wjg.v12.i9.1452
16551493	Serological prevalence of canine respiratory coronavirus.	2006 Jun 15	Netherlands	10.1016/j.vetmic.2006.02.008
16550673	SARS: are we still at risk?	2006 Mar	United States	10.1097/01720610-200603000-00007
16549795	Discovery of an RNA virus 3'->5' exoribonuclease that is critically involved incoronavirus RNA synthesis.	2006 Mar 28	United States	10.1073/pnas.0508200103
16546729	[Antigenicity analysis of nucleocapsid proteins of 3 human coronavirusesSARS-CoV, 229E and OC43 with their monoclonal antibodies].	2006 Mar	China	
16546436	Nucleocapsid protein of SARS-CoV activates the expression of cyclooxygenase-2 bybinding directly to regulatory elements for nuclear factor-kappa B andCCAAT/enhancer binding protein.	2006	Netherlands	10.1016/j.biocel.2006.02.003
16544518	SARS patients-derived human recombinant antibodies to S and M proteinsefficiently neutralize SARS-coronavirus infectivity.	2005 Dec	China	
16541132	Evolutionary implications of Avian Infectious Bronchitis Virus (AIBV) analysis.	2006 Mar	England	10.1038/sj.cr.7310041
16537637	Recovery of a neurovirulent human coronavirus OC43 from an infectious cDNA clone.	2006 Apr	United States	10.1128/JVI.80.7.3670-3674.2006
16537590	Functional characterization of heptad repeat 1 and 2 mutants of the spike proteinof severe acute respiratory syndrome coronavirus.	2006 Apr	United States	10.1128/JVI.80.7.3225-3237.2006
16537586	The avian coronavirus infectious bronchitis virus undergoes directlow-pH-dependent fusion activation during entry into host cells.	2006 Apr	United States	10.1128/JVI.80.7.3180-3188.2006
16537477	Severe acute respiratory syndrome diagnostics using a coronavirus proteinmicroarray.	2006 Mar 14	United States	10.1073/pnas.0510921103
16537157	Coronaviruses in poultry and other birds.	2005 Dec	England	10.1080/03079450500367682
16536279	[Lung pathology and pathogenesis of severe acute respiratory syndrome: a reportof six full autopsies].	2005 Oct	China	
16535860	Developments in antiviral drug design, discovery and development in 2004.	2005 Dec	Netherlands	10.2174/156800505774912893
16527322	Human coronavirus OC43 infection induces chronic encephalitis leading todisabilities in BALB/C mice.	2006 Jun 5	United States	10.1016/j.virol.2006.01.049
16522785	False-positive results in a recombinant severe acute respiratorysyndrome-associated coronavirus (SARS-CoV) nucleocapsid-based western blot assaywere rectified by the use of two subunits (S1 and S2) of spike for detection ofantibody to SARS-CoV.	2006 Mar	United States	10.1128/CVI.13.3.409-414.2006
16521129	Severe acute respiratory syndrome coronavirus entry into host cells:Opportunities for therapeutic intervention.	2006 Jul	United States	10.1002/med.20055
16519916	Furin cleavage of the SARS coronavirus spike glycoprotein enhances cell-cellfusion but does not affect virion entry.	2006 Jul 5	United States	10.1016/j.virol.2006.02.003
16518967	A human neutralizing antibody against a conformational epitope shared byoligomeric SARS S1 protein.	2006	England	
16518829	Severe acute respiratory syndrome (SARS) coronavirus: application of monoclonalantibodies and development of an effective vaccine.	2006 Mar-Apr	England	10.1002/rmv.492
16517883	Molecular epidemiology of bovine coronavirus on the basis of comparative analysesof the S gene.	2006 Mar	United States	10.1128/JCM.44.3.957-960.2006
16515044	[Biological properties of the chick infectious bronchitis virus isolated inRussia].	2006 Jan-Feb	Russia (Federation)	
16514342	Respiratory viral threats.	2006 Apr	United States	10.1097/01.qco.0000216628.51563.b1
16511823	Deciphering the biosynthetic codes for the potent anti-SARS-CoV cyclodepsipeptidevalinomycin in Streptomyces tsusimaensis ATCC 15141.	2006 Mar	Germany	10.1002/cbic.200500425
16511208	Structure of the SARS coronavirus main proteinase as an active C2crystallographic dimer.	2005 Nov 1	England	10.1107/S1744309105033257
16510164	Mouse hepatitis virus pathogenesis in the central nervous system is independentof IL-15 and natural killer cells.	2006 Jun 20	United States	10.1016/j.virol.2006.01.027
16510163	Identification of critical determinants on ACE2 for SARS-CoV entry anddevelopment of a potent entry inhibitor.	2006 Jun 20	United States	10.1016/j.virol.2006.01.029
16507895	Inhibition of interferon-gamma signaling in oligodendroglia delays coronavirusclearance without altering demyelination.	2006 Mar	United States	10.2353/ajpath.2006.050496
16507566	Solution structure of the severe acute respiratory syndrome-coronavirus heptadrepeat 2 domain in the prefusion state.	2006 Apr 28	United States	10.1074/jbc.M601174200
16507314	Biochemical and functional characterization of the membrane association andmembrane permeabilizing activity of the severe acute respiratory syndromecoronavirus envelope protein.	2006 Jun 5	United States	10.1016/j.virol.2006.01.028
16503535	[Some medical staff positive for serum SARS coronavirus antibody IgG have onlymild symptoms].	2006 Feb	China	
16502604	Going to bat.	2006 Mar	United States	10.1038/scientificamerican0306-24
16501892	Isolation of a variant infectious bronchitis virus in Australia that furtherillustrates diversity among emerging strains.	2006 Aug	Austria	10.1007/s00705-006-0726-y
16501078	Modeling the early events of severe acute respiratory syndrome coronavirusinfection in vitro.	2006 Mar	United States	10.1128/JVI.80.6.2684-2693.2006
16500894	Identification of Hepta- and Octo-Uridine stretches as sole signals forprogrammed +1 and -1 ribosomal frameshifting during translation of SARS-CoV ORF3a variants.	2006	England	10.1093/nar/gkl017
16499943	Molecular characterization of a novel coronavirus associated with epizooticcatarrhal enteritis (ECE) in ferrets.	2006 May 25	United States	10.1016/j.virol.2006.01.031
16498838	Rapid differentiation of current infectious bronchitis virus vaccine strains andfield isolates in Australia.	2006 Jan-Feb	England	10.1111/j.1751-0813.2006.tb13130.x
16498826	The relationship between the feline coronavirus antibody titre and the age,breed, gender and health status of Australian cats.	2006 Jan-Feb	England	10.1111/j.1751-0813.2006.tb13114.x
16497914	Voucher specimens for SARS-linked bats.	2006 Feb 24	United States	10.1126/science.311.5764.1099
16497913	Linking bats to emerging diseases.	2006 Feb 24	United States	10.1126/science.311.5764.1098c
16497657	Comparative study of the effects of heptameric slippery site composition on -1frameshifting among different eukaryotic systems.	2006 Apr	United States	10.1261/rna.2225206
16497416	A recombinant baculovirus-expressed S glycoprotein vaccine elicits high titers ofSARS-associated coronavirus (SARS-CoV) neutralizing antibodies in mice.	2006 Apr 24	Netherlands	10.1016/j.vaccine.2006.01.059
16496340	Targeted delivery of ribavirin improves outcome of murine viral fulminanthepatitis via enhanced anti-viral activity.	2006 Mar	United States	10.1002/hep.21072
16494977	Immunological characterizations of the nucleocapsid protein based SARS vaccinecandidates.	2006 Apr 12	Netherlands	10.1016/j.vaccine.2006.01.058
16494729	SARS-associated coronavirus replication in cell lines.	2006 Jan	United States	10.3201/eid1201.050496
16493065	Vaccine-induced memory CD8+ T cells cannot prevent central nervous system virusreactivation.	2006 Mar 1	United States	10.4049/jimmunol.176.5.3062
16491018	Comparison of 3'-end encoding regions of turkey coronavirus isolates fromIndiana, North Carolina, and Minnesota with chicken infectious bronchitiscoronavirus strains.	2006	Switzerland	10.1159/000091470
16490989	Inactivation of SARS coronavirus by means of povidone-iodine, physical conditionsand chemical reagents.	2006	Switzerland	10.1159/000089211
16490123	Seroprevalence of IgG antibodies to SARS-coronavirus in asymptomatic orsubclinical population groups.	2006 Apr	England	10.1017/S0950268805004826
16487305	Inhibition of cell proliferation by SARS-CoV infection in Vero E6 cells.	2006 Mar	England	10.1111/j.1574-695X.2005.00028.x
16485471	SARS-CoV infection in a restaurant from palm civet.	2005 Dec	United States	10.3201/eid1112.041293
16484730	Absence of infection in asymptomatic contacts of index SARS case in France.	2006	Sweden	
16482545	Cytokine regulation in SARS coronavirus infection compared to other respiratoryvirus infections.	2006 Apr	United States	10.1002/jmv.20556
16479546	Differential roles for CXCR3 in CD4+ and CD8+ T cell trafficking following viralinfection of the CNS.	2006 Mar	Germany	10.1002/eji.200535509
16479513	Two-year prospective study of the humoral immune response of patients with severeacute respiratory syndrome.	2006 Mar 15	United States	10.1086/500469
16478476	The catalysis of the SARS 3C-like protease is under extensive regulation by itsextra domain.	2006 Mar	England	10.1111/j.1742-4658.2006.05130.x
16476987	Identification of protease and ADP-ribose 1''-monophosphatase activitiesassociated with transmissible gastroenteritis virus non-structural protein 3.	2006 Mar	England	10.1099/vir.0.81596-0
16476986	Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccinecandidates in mice challenged with SARS coronavirus.	2006 Mar	England	10.1099/vir.0.81579-0
16476560	Prevalence of antibodies against feline coronavirus and Chlamydophila felis inSwedish cats.	2006 Jun	England	10.1016/j.jfms.2005.12.004
16476169	Evaluation of measures to reduce international spread of SARS.	2006 Oct	England	10.1017/S0950268806005863
16475526	Canine coronavirus-associated puppy mortality without evidence of concurrentcanine parvovirus infection.	2005 Nov	United States	10.1177/104063870501700618
16474437	Characterization of the antiviral effects of interferon-alpha against a SARS-likecoronoavirus infection in vitro.	2006 Feb	England	10.1038/sj.cr.7310030
16474157	Preferential infection of mature dendritic cells by mouse hepatitis virus strainJHM.	2006 Mar	United States	10.1128/JVI.80.5.2506-2514.2006
16474139	Glycosylation of the severe acute respiratory syndrome coronavirustriple-spanning membrane proteins 3a and M.	2006 Mar	United States	10.1128/JVI.80.5.2326-2336.2006
16474126	Bovine coronavirus 5'-proximal genomic acceptor hotspot for discontinuoustranscription is 65 nucleotides wide.	2006 Mar	United States	10.1128/JVI.80.5.2183-2193.2006
16472519	Genetic evolution of canine coronavirus and recent advances in prophylaxis.	2006 Mar-Apr	England	10.1051/vetres:2005053
16470249	Risk of ruling out severe acute respiratory syndrome by ruling in anotherdiagnosis: variable incidence of atypical bacteria coinfection based ondiagnostic assays.	2006 Jan-Feb	Egypt	10.1155/2006/862797
16470161	The widening scope of coronaviruses.	2006 Feb	United States	10.1097/01.mop.0000192520.48411.fa
16469163	Oral immunoadjuvant activity of Lactobacillus casei subsp. casei in dextran-fedlayer chickens.	2006 Feb	England	10.1079/bjn20051629
16468630	Promoter activity of SARS coronavirus 5' UTR sequence in eukaryotic cells.	2006 Jan	China	
16466783	LightUp probes in clinical diagnostics.	2006 Apr-Jun	England	10.1016/j.mam.2005.12.005
16466582	Automated extraction protocol for quantification of SARS-coronavirus RNA inserum: an evaluation study.	2006 Feb 9	England	10.1186/1471-2334-6-20
16462674	[Antiretroviral drugs in severe acute respiratory syndrome].	2006 Jan	France	10.1016/s0755-4982(06)74531-6
16462112	The prevalence of a group 2 coronavirus in dogs in Japan.	2006 Jan	Japan	10.1292/jvms.68.21
16461566	Specific epitopes of the structural and hypothetical proteins elicit variablehumoral responses in SARS patients.	2006 May	England	10.1136/jcp.2005.029868
16460352	A serological survey of selected pathogens in wild boar in Slovenia.	2006 Feb	Germany	10.1111/j.1439-0450.2006.00899.x
16458888	Regulation of p90RSK phosphorylation by SARS-CoV infection in Vero E6 cells.	2006 Feb 20	England	10.1016/j.febslet.2006.01.066
16456884	Functional peptide microarrays for specific and sensitive antibody diagnostics.	2006 Mar	Germany	10.1002/pmic.200500343
16455884	Epidemiological and genetic correlates of severe acute respiratory syndromecoronavirus infection in the hospital with the highest nosocomial infection ratein Taiwan in 2003.	2006 Feb	United States	10.1128/JCM.44.2.359-365.2006
16453264	Therapy with a severe acute respiratory syndrome-associatedcoronavirus-neutralizing human monoclonal antibody reduces disease severity andviral burden in golden Syrian hamsters.	2006 Mar 1	United States	10.1086/500143
16451084	Design and synthesis of dipeptidyl glutaminyl fluoromethyl ketones as potentsevere acute respiratory syndrome coronovirus (SARS-CoV) inhibitors.	2006 Feb 9	United States	10.1021/jm0507678
16451078	Synthesis of cyclopentenyl carbocyclic nucleosides as potential antiviral agentsagainst orthopoxviruses and SARS.	2006 Feb 9	United States	10.1021/jm0509750
16450706	Detection of canine coronaviruses genotype I and II in raised Canidae animals inChina.	2006 Jan-Feb	Germany	
16450013	Preparing the biochemistry laboratory for the next outbreak: lessons from SARS inSingapore.	2005 Aug	Australia	
16448945	Typing infectious bronchitis virus strains using reverse transcription-polymerasechain reaction and restriction fragment length polymorphism analysis to comparethe 3' 7.5 kb of their genomes.	2006 Feb	England	10.1080/03079450500465817
16447108	Detection of the new human coronavirus HKU1: a report of 6 cases.	2006 Mar 1	United States	10.1086/500136
16445811	Emerging viral diseases and infectious disease risks.	2006 Mar	England	10.1111/j.1365-2516.2006.01194.x
16443296	Patent pools and diagnostic testing.	2006 Mar	England	10.1016/j.tibtech.2006.01.002
16442106	Characterization of severe acute respiratory syndrome coronavirus membraneprotein.	2006 Feb 6	England	10.1016/j.febslet.2006.01.026
16441209	Development of human monoclonal antibodies against diseases caused by emergingand biodefense-related viruses.	2006 Feb	England	10.1586/14787210.4.1.57
16440123	Clinical and laboratory features in the early stage of severe acute respiratorysyndrome.	2006 Feb	England	
16437596	Fibrinogen-like protein 2 fibroleukin expression and its correlation with diseaseprogression in murine hepatitis virus type 3-induced fulminant hepatitis and inpatients with severe viral hepatitis B.	2005 Nov 28	United States	10.3748/wjg.v11.i44.6936
16437540	CNS viral infection diverts homing of antibody-secreting cells from lymphoidorgans to the CNS.	2006 Mar	Germany	10.1002/eji.200535123
16437080	China: open season.	2006 Jan 26	England	10.1038/439382a
16433589	Antiviral applications of RNAi for coronavirus.	2006 Feb	England	10.1517/13543784.15.2.89
16432024	Amino terminus of the SARS coronavirus protein 3a elicits strong, potentiallyprotective humoral responses in infected patients.	2006 Feb	England	10.1099/vir.0.81078-0
16431923	The nucleocapsid protein of severe acute respiratory syndrome-coronavirusinhibits the activity of cyclin-cyclin-dependent kinase complex and blocks Sphase progression in mammalian cells.	2006 Apr 21	United States	10.1074/jbc.M509233200
16424418	Colonization of severe acute respiratory syndrome-associated coronavirus amonghealth-care workers screened by nasopharyngeal swab.	2006 Jan	United States	10.1378/chest.129.1.95
16424407	Nasopharyngeal detection of severe acute respiratory syndrome-associatedcoronavirus RNA in health-care workers.	2006 Jan	United States	10.1378/chest.129.1.12
16423906	Serum proteomic fingerprints of adult patients with severe acute respiratorysyndrome.	2006 Mar	England	10.1373/clinchem.2005.061689
16423399	The expression of membrane protein augments the specific responses induced bySARS-CoV nucleocapsid DNA immunization.	2006 Apr	England	10.1016/j.molimm.2005.11.005
16423201	Longitudinal profile of antibodies against SARS-coronavirus in SARS patients andtheir clinical significance.	2006 Jan	Australia	10.1111/j.1440-1843.2006.00783.x
16422144	The effect of fostering on the genetic expression of locomotor sensitivity toalcohol.	2005 Dec	United States	
16421796	Viral pneumonia in older adults.	2006 Feb 15	United States	10.1086/499955
16420748	Assessing the genetic component of the susceptibility of mice to viralinfections.	2005 Nov	England	10.1093/bfgp/4.3.225
16419110	Impact of human metapneumovirus and human cytomegalovirus versus otherrespiratory viruses on the lower respiratory tract infections of lung transplantrecipients.	2006 Mar	United States	10.1002/jmv.20555
16418166	Significant redox insensitivity of the functions of the SARS-CoV spikeglycoprotein: comparison with HIV envelope.	2006 Apr 7	United States	10.1074/jbc.M512529200
16416820	[Detection of SARS coronavirus RNA].	2005 Dec	Japan	
16415994	[Receptor-binding ability of fragments 260-600 and 397-796 of SARS-associatedcoronavirus spike protein].	2005 Dec	China	
16415928	Coronavirus infection of the central nervous system: host-virus stand-off.	2006 Feb	England	10.1038/nrmicro1343
16415007	Important role for the transmembrane domain of severe acute respiratory syndromecoronavirus spike protein during entry.	2006 Feb	United States	10.1128/JVI.80.3.1302-1310.2006
16415005	Palmitoylations on murine coronavirus spike proteins are essential for virionassembly and infectivity.	2006 Feb	United States	10.1128/JVI.80.3.1280-1289.2006
16415002	Redirecting coronavirus to a nonnative receptor through a virus-encoded targetingadapter.	2006 Feb	United States	10.1128/JVI.80.3.1250-1260.2006
16413043	Murine encephalitis caused by HCoV-OC43, a human coronavirus with broad speciesspecificity, is partly immune-mediated.	2006 Apr 10	United States	10.1016/j.virol.2005.11.044
16411895	SARS: clinical presentation, transmission, pathogenesis and treatment options.	2006 Feb	England	10.1042/CS20050188
16409721	[A study of pulmonary inflammatory reaction induced by N-protein of SARS-CoV inrat models and effects of glucocorticoids on it].	2005 Dec	China	
16408627	[Ultrastructural changes in the cells of human embryo lung fibroblasts in thereproduction of the coronavirus HCoV/SPb/01/03].	2005 Nov-Dec	Russia (Federation)	
16405010	Data from 11 years of molecular typing infectious bronchitis virus fieldisolates.	2005 Dec	United States	10.1637/7389-052905R.1
16404996	Effect of IBV-H120 vaccination in broilers on colibacillosis susceptibility afterinfection with a virulent Massachusetts-type IBV strain.	2005 Dec	United States	10.1637/7380-051305R.1
16404989	Molecular characterization of avian infectious bronchitis virus strains isolatedin Colombia during 2003.	2005 Dec	United States	10.1637/7202-050304R.1
16397876	Novel five-membered iminocyclitol derivatives as selective and potent glycosidaseinhibitors: new structures for antivirals and osteoarthritis.	2006 Jan	Germany	10.1002/cbic.200500321
16397751	Genetic diversity of avian infectious bronchitis coronavirus strains isolated inChina between 1995 and 2004.	2006 Jun	Austria	10.1007/s00705-005-0695-6
16392175	"Re: Article by Ewens et al. entitled, ""Fluorouracil plus leucovorin inducessubmandibular salivary gland enlargement in rats""."	2005	United States	10.1080/01926230500449840
16391410	Virus safety of intravenous immunoglobulin: future challenges.	2005 Dec	United States	10.1385/CRIAI:29:3:333
16391044	Evaluation of affymetrix severe acute respiratory syndrome resequencing GeneChipsin characterization of the genomes of two strains of coronavirus infectinghumans.	2006 Jan	United States	10.1128/AEM.72.1.207-211.2006
16388880	Immunogenicity and protective efficacy in monkeys of purified inactivatedVero-cell SARS vaccine.	2006 Feb 13	Netherlands	10.1016/j.vaccine.2005.06.038
16387746	Pyridine N-oxide derivatives are inhibitory to the human SARS and felineinfectious peritonitis coronavirus in cell culture.	2006 Mar	England	10.1093/jac/dki481
16387696	Anti-HIV, anti-poxvirus, and anti-SARS activity of a nontoxic, acidic plantextract from the Trifollium species Secomet-V/anti-vac suggests that it containsa novel broad-spectrum antiviral.	2005 Nov	United States	10.1196/annals.1352.014
16387339	SARS coronavirus nucleocapsid immunodominant T-cell epitope cluster is common toboth exogenous recombinant and endogenous DNA-encoded immunogens.	2006 Mar 30	United States	10.1016/j.virol.2005.11.042
29208086	Absence of infection in asymptomatic contacts of index SARS case in France.	2006 Jan	Sweden	10.2807/esm.11.01.00593-en
16385373	Clinical manifestations and inflammatory cytokine responses in patients withsevere acute respiratory syndrome.	2005 Oct	Singapore	
16383292	[Development of infection pathology in China].	2005 Aug	China	
16379499	Time course and cellular localization of SARS-CoV nucleoprotein and RNA in lungsfrom fatal cases of SARS.	2006 Feb	United States	10.1371/journal.pmed.0030027
16378996	Monoclonal antibodies targeting the HR2 domain and the region immediatelyupstream of the HR2 of the S protein neutralize in vitro infection of severeacute respiratory syndrome coronavirus.	2006 Jan	United States	10.1128/JVI.80.2.941-950.2006
16378980	7a protein of severe acute respiratory syndrome coronavirus inhibits cellularprotein synthesis and activates p38 mitogen-activated protein kinase.	2006 Jan	United States	10.1128/JVI.80.2.785-793.2006
16378050	History and recent advances in coronavirus discovery.	2005 Nov	United States	10.1097/01.inf.0000188166.17324.60
16371863	Infections by human coronavirus-NL in hospitalized children.	2005 Dec	United States	10.1097/01.inf.0000183743.68569.c7
16369534	Homozygous L-SIGN (CLEC4M) plays a protective role in SARS coronavirus infection.	2006 Jan	United States	10.1038/ng1698
16363683	[Clinical and epidemiological review of SARS].	2005 Dec	Japan	
16363682	[SARS coronavirus].	2005 Dec	Japan	
16362992	How the SARS coronavirus causes disease: host or organism?	2006 Jan	England	10.1002/path.1897
16362893	Lack of association between infection with a novel human coronavirus (HCoV),HCoV-NH, and Kawasaki disease in Taiwan.	2006 Jan 15	United States	10.1086/498875
16361349	SARS coronavirus E protein in phospholipid bilayers: an x-ray study.	2006 Mar 15	United States	10.1529/biophysj.105.072892
16358325	Binding site-based classification of coronaviral papain-like proteases.	2006 Mar 15	United States	10.1002/prot.20802
16357284	Effects of additional milk replacer feeding on calf health, growth, and selectedblood metabolites in calves.	2006 Jan	United States	10.3168/jds.S0022-0302(06)72085-9
16352564	Role of the mitochondrial signaling pathway in murine coronavirus-inducedoligodendrocyte apoptosis.	2006 Jan	United States	10.1128/JVI.80.1.395-403.2006
16352554	Neither the RNA nor the proteins of open reading frames 3a and 3b of thecoronavirus infectious bronchitis virus are essential for replication.	2006 Jan	United States	10.1128/JVI.80.1.296-305.2006
16352545	Severe acute respiratory syndrome coronavirus 3a protein is released inmembranous structures from 3a protein-expressing cells and infected cells.	2006 Jan	United States	10.1128/JVI.80.1.210-217.2006
16350957	A practical protocol for carbohydrate microarrays.	2005	United States	10.1007/978-1-59259-948-6_17
16345017	Modelling SARS data using threshold geometric process.	2006 Jun 15	England	10.1002/sim.2376
16344618	Vasculitis and systemic infections.	2006 Jan	United States	10.1097/01.bor.0000197999.58073.2e
16343974	Severe acute respiratory syndrome coronavirus membrane protein interacts withnucleocapsid protein mostly through their carboxyl termini by electrostaticattraction.	2006	Netherlands	10.1016/j.biocel.2005.10.022
16341254	Functional and genetic analysis of coronavirus replicase-transcriptase proteins.	2005 Dec	United States	10.1371/journal.ppat.0010039
16339739	Coronavirus pathogenesis and the emerging pathogen severe acute respiratorysyndrome coronavirus.	2005 Dec	United States	10.1128/MMBR.69.4.635-664.2005
16339146	SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infectACE2-expressing cells.	2006 Feb 10	United States	10.1074/jbc.M508381200
16339072	Longitudinal analysis of Severe Acute Respiratory Syndrome (SARS)coronavirus-specific antibody in SARS patients.	2005 Dec	United States	10.1128/CDLI.12.12.1455-1457.2005
16338414	The nucleocapsid protein of coronavirus infectious bronchitis virus: crystalstructure of its N-terminal domain and multimerization properties.	2005 Dec	United States	10.1016/j.str.2005.08.021
16337697	Design and biological activities of novel inhibitory peptides for SARS-CoV spikeprotein and angiotensin-converting enzyme 2 interaction.	2006 Feb	Netherlands	10.1016/j.antiviral.2005.10.005
16335659	SARS: the new challenge to international health and travel medicine.	2004 Jul-Sep	Egypt	
16331324	Study on substrate specificity at subsites for severe acute respiratory syndromecoronavirus 3CL protease.	2005 Dec	China	10.1111/j.1745-7270.2005.00114.x
16330306	Handwashing practice and the use of personal protective equipment among medicalstudents after the SARS epidemic in Hong Kong.	2005 Dec	United States	10.1016/j.ajic.2005.05.025
16329994	The N-terminal octapeptide acts as a dimerization inhibitor of SARS coronavirus3C-like proteinase.	2006 Jan 20	United States	10.1016/j.bbrc.2005.11.102
16328780	Solution structure of the X4 protein coded by the SARS related coronavirusreveals an immunoglobulin like fold and suggests a binding activity to integrin Idomains.	2006 May	England	10.1007/s11373-005-9043-9
16328219	A virologic survey of patients admitted to a critical care unit for acutecardiorespiratory failure.	2006 Jan	United States	10.1007/s00134-005-2861-4
16325400	From genome to drug lead: identification of a small-molecule inhibitor of theSARS virus.	2006 Feb 15	England	10.1016/j.bmcl.2005.11.018
16325277	Preparation and evaluation of anti-SARS coronavirus IgY from yolks of immunizedSPF chickens.	2006 Apr	Netherlands	10.1016/j.jviromet.2005.10.027
16322745	Immunopathogenesis of coronavirus infections: implications for SARS.	2005 Dec	England	10.1038/nri1732
16318735	Social factors associated with AIDS and SARS.	2005 Nov	United States	10.3201/eid1111.050424
16318726	Respiratory infections during SARS outbreak, Hong Kong, 2003.	2005 Nov	United States	10.3201/eid1111.050729
16318725	Neutralizing antibody response and SARS severity.	2005 Nov	United States	10.3201/eid1111.040659
16317448	Rapid detection and characterisation of infectious bronchitis virus (IBV) fromNew Zealand using RT-PCR and sequence analysis.	2005 Dec	England	10.1080/00480169.2005.36592
16315087	Studying human pathogens in animal models: fine tuning the humanized mouse.	2005 Dec	Netherlands	10.1007/s11248-005-1676-y
16312970	Concentration and detection of SARS coronavirus in sewage from Xiao Tang ShanHospital and the 309th Hospital of the Chinese People's Liberation Army.	2005	England	
16312205	An overview on severe acute respiratory syndrome (SARS).	2005 Sep	Italy	10.4081/monaldi.2005.632
16310880	Programmed ribosomal frameshifting in HIV-1 and the SARS-CoV.	2006 Jul	Netherlands	10.1016/j.virusres.2005.10.008
16310783	The putative protein 6 of the severe acute respiratory syndrome-associatedcoronavirus: expression and functional characterization.	2005 Dec 19	England	10.1016/j.febslet.2005.11.007
16310778	Adenovirus-mediated expression of the C-terminal domain of SARS-CoV spike proteinis sufficient to induce apoptosis in Vero E6 cells.	2005 Dec 19	England	10.1016/j.febslet.2005.10.065
16309462	Surface ultrastructure of SARS coronavirus revealed by atomic force microscopy.	2005 Dec	England	10.1111/j.1462-5822.2005.00593.x
16308526	[Caveolar endocytosis and virus entry].	2005 Jun	Japan	10.2222/jsv.55.19
16306622	Severe acute respiratory syndrome coronavirus infection of human ciliated airwayepithelia: role of ciliated cells in viral spread in the conducting airways ofthe lungs.	2005 Dec	United States	10.1128/JVI.79.24.15511-15524.2005
16306602	Soluble receptor-mediated targeting of mouse hepatitis coronavirus to the humanepidermal growth factor receptor.	2005 Dec	United States	10.1128/JVI.79.24.15314-15322.2005
16306591	The papain-like protease from the severe acute respiratory syndrome coronavirusis a deubiquitinating enzyme.	2005 Dec	United States	10.1128/JVI.79.24.15199-15208.2005
16306590	The papain-like protease of severe acute respiratory syndrome coronavirus hasdeubiquitinating activity.	2005 Dec	United States	10.1128/JVI.79.24.15189-15198.2005
16306577	Expression of hemagglutinin esterase protein from recombinant mouse hepatitisvirus enhances neurovirulence.	2005 Dec	United States	10.1128/JVI.79.24.15064-15073.2005
16306576	Luxury at a cost? Recombinant mouse hepatitis viruses expressing the accessoryhemagglutinin esterase protein display reduced fitness in vitro.	2005 Dec	United States	10.1128/JVI.79.24.15054-15063.2005
16306572	A point mutation within the replicase gene differentially affects coronavirusgenome versus minigenome replication.	2005 Dec	United States	10.1128/JVI.79.24.15016-15026.2005
16305493	SARS: understanding the virus and development of rational therapy.	2005 Nov	Netherlands	10.2174/156652405774641124
16303160	SARS coronavirus 7a protein blocks cell cycle progression at G0/G1 phase via thecyclin D3/pRb pathway.	2006 Mar 1	United States	10.1016/j.virol.2005.10.015
16299724	Antibody responses against SARS coronavirus are correlated with disease outcomeof infected individuals.	2006 Jan	United States	10.1002/jmv.20499
16298975	Subcellular localization of the severe acute respiratory syndrome coronavirusnucleocapsid protein.	2005 Dec	England	10.1099/vir.0.81076-0
16298409	Differential localization and turnover of infectious bronchitis virus 3b proteinin mammalian versus avian cells.	2006 Feb 20	United States	10.1016/j.virol.2005.09.069
16298165	Anti-SARS-CoV immunity induced by a novel CpG oligodeoxynucleotide.	2006 Feb-Mar	United States	10.1016/j.clim.2005.09.014
16297915	Transplantation of glial-committed progenitor cells into a viral model ofmultiple sclerosis induces remyelination in the absence of an attenuatedinflammatory response.	2006 Feb	United States	10.1016/j.expneurol.2005.10.016
16297415	The 2003 SARS outbreak and its impact on infection control practices.	2006 Jan	Netherlands	10.1016/j.puhe.2005.10.002
16297347	Preparation and development of equine hyperimmune globulin F(ab')2 against severeacute respiratory syndrome coronavirus.	2005 Dec	United States	10.1111/j.1745-7254.2005.00210.x
16296262	Update on community-acquired pneumonia. New pathogens and new concepts intreatment.	2005 Oct	England	10.3810/pgm.2005.10.1699
16294000	Comparison of an enzyme-linked immunosorbent assay with serum neutralization testfor serodiagnosis of porcine epidemic diarrhea virus infection.	2005 Dec	Korea (South)	
16290276	Why are HIV-1 fusion inhibitors not effective against SARS-CoV? Biophysicalevaluation of molecular interactions.	2006 Jan	Netherlands	10.1016/j.bbagen.2005.10.001
16289934	A novel fingerprint map for detecting SARS-CoV.	2006 Apr 11	England	10.1016/j.jpba.2005.09.031
16287687	The severe acute respiratory syndrome (SARS).	2005 Oct	United States	10.1080/13550280500187724
16285739	SR-rich motif plays a pivotal role in recombinant SARS coronavirus nucleocapsidprotein multimerization.	2005 Nov 22	United States	10.1021/bi051122c
16285506	[Expression and renaturation of a novel human single-chain Fv antibody againstSARS-CoV].	2005 Sep	China	
16282944	Human coronavirus NL63 associated with lower respiratory tract symptoms in earlylife.	2005 Nov	United States	10.1097/01.inf.0000183773.80217.12
16282490	Severe acute respiratory syndrome coronavirus group-specific open reading framesencode nonessential functions for replication in cell cultures and mice.	2005 Dec	United States	10.1128/JVI.79.23.14909-14922.2005
16282461	ACE2 receptor expression and severe acute respiratory syndrome coronavirusinfection depend on differentiation of human airway epithelia.	2005 Dec	United States	10.1128/JVI.79.23.14614-14621.2005
16282457	Effect of mutations in the mouse hepatitis virus 3'(+)42 protein binding elementon RNA replication.	2005 Dec	United States	10.1128/JVI.79.23.14570-14585.2005
16278955	Neural models for predicting viral vaccine targets.	2005 Oct	Singapore	10.1142/s0219720005001466
16278351	Bats may be SARS reservoir.	2005 Nov 9	United States	10.1001/jama.294.18.2291
16275947	Serological responses in patients with severe acute respiratory syndromecoronavirus infection and cross-reactivity with human coronaviruses 229E, OC43,and NL63.	2005 Nov	United States	10.1128/CDLI.12.11.1317-1321.2005
16274510	Seroprevalence of SARS coronavirus antibody in household contacts.	2005 Dec	England	10.1017/S0950268805004541
16273643	Receptor-binding domain of SARS-Cov spike protein: soluble expression in E. coli,purification and functional characterization.	2005 Oct 21	United States	10.3748/wjg.v11.i39.6159
16272469	Development of one-step, real-time, quantitative reverse transcriptase PCR assaysfor absolute quantitation of human coronaviruses OC43 and 229E.	2005 Nov	United States	10.1128/JCM.43.11.5452-5456.2005
16271890	Structural basis of severe acute respiratory syndrome coronavirusADP-ribose-1''-phosphate dephosphorylation by a conserved domain of nsP3.	2005 Nov	United States	10.1016/j.str.2005.07.022
16271880	SARS proteomics reveals viral secrets.	2005 Nov	United States	10.1016/j.str.2005.10.004
16270262	Sensitivity of Tru-cut and fine needle aspiration biopsies of liver and kidneyfor diagnosis of feline infectious peritonitis.	2005 Dec	United States	10.1111/j.1939-165x.2005.tb00063.x
16270257	An immunoturbidimetric assay for rapid quantitative measurement of felinealpha-1-acid glycoprotein in serum and peritoneal fluid.	2005 Dec	United States	10.1111/j.1939-165x.2005.tb00058.x
16269264	Establishment of Vero E6 cell clones persistently infected with severe acuterespiratory syndrome coronavirus.	2005 Dec	France	10.1016/j.micinf.2005.05.013
16269206	Preparation and characterization of SARS in-house reference antiserum.	2005 Dec 1	Netherlands	10.1016/j.vaccine.2004.12.032
16267893	On interferon research.	2005 Sep	China	
16267760	Clinical and molecular epidemiological features of coronavirus HKU1-associatedcommunity-acquired pneumonia.	2005 Dec 1	United States	10.1086/497151
16263266	Structural insights into SARS coronavirus proteins.	2005 Dec	England	10.1016/j.sbi.2005.10.004
16263078	Cross-reactivity of antibody against SARS-coronavirus nucleocapsid protein withIL-11.	2005 Dec 23	United States	10.1016/j.bbrc.2005.10.088
16261215	[Cloning, purification, and antigenic characterization of three recombinantfragments derived from SARS-CoV S1 domain].	2005 Sep	China	
16261211	[Cloning of ACE-2 gene encoding the functional receptor for the SARS coronavirusand its expression in eukaryotic cells].	2005 Sep	China	
16261200	[A field trial of recombinant human interferon alpha-2b for nasal spray toprevent SARS and other respiratory viral infections].	2005 Sep	China	
16261199	[A field trial for evaluating the safety of recombinant human interferon alpha-2bfor nasal spray].	2005 Sep	China	
16261198	[Preventive and therapeutic effects of recombinant IFN-alpha2b nasal spray onSARS-CoV infection in Macaca mulata].	2005 Sep	China	
16258152	Molecular diagnosis of severe acute respiratory syndrome: the state of the art.	2005 Nov	United States	10.1016/S1525-1578(10)60587-9
16257260	Evidence of human coronavirus HKU1 and human bocavirus in Australian children.	2006 Jan	Netherlands	10.1016/j.jcv.2005.09.008
16256037	[Expression of SARS coronavirus nucleocapsid protein and construction of its DNAvaccine].	2005 Nov	China	
16254971	Real-time NASBA detection of SARS-associated coronavirus and comparison withreal-time reverse transcription-PCR.	2005 Dec	United States	10.1002/jmv.20498
16254381	Murine coronavirus with an extended host range uses heparan sulfate as an entryreceptor.	2005 Nov	United States	10.1128/JVI.79.22.14451-14456.2005
16254347	Acquisition of macrophage tropism during the pathogenesis of feline infectiousperitonitis is determined by mutations in the feline coronavirus spike protein.	2005 Nov	United States	10.1128/JVI.79.22.14122-14130.2005
16254327	Modulation of the immune response to the severe acute respiratory syndrome spikeglycoprotein by gene-based and inactivated virus immunization.	2005 Nov	United States	10.1128/JVI.79.22.13915-13923.2005
16254320	Assembly of severe acute respiratory syndrome coronavirus RNA packaging signalinto virus-like particles is nucleocapsid dependent.	2005 Nov	United States	10.1128/JVI.79.22.13848-13855.2005
16254175	Virology. What links bats to emerging infectious diseases?	2005 Oct 28	United States	10.1126/science.1120872
16252612	Neurological manifestations in severe acute respiratory syndrome.	2005 Sep	China (Republic : 1949- )	
16250642	A new lead for nonpeptidic active-site-directed inhibitors of the severe acuterespiratory syndrome coronavirus main protease discovered by a combination ofscreening and docking methods.	2005 Nov 3	United States	10.1021/jm0501782
16250632	Design and synthesis of peptidomimetic severe acute respiratory syndromechymotrypsin-like protease inhibitors.	2005 Nov 3	United States	10.1021/jm050548m
16250594	[Theoretical prediction of the antigenic epitopes of severe acute respiratorysyndrome (SARS-CoV) proteins and evaluation of their diagnostic value].	2005 Sep-Oct	Russia (Federation)	
16247759	Direct Fmoc/tert-Bu solid phase synthesis of octamannosyl polylysinedendrimer-peptide conjugates.	2006	United States	10.1002/bip.20403
16245877	[Construction of recombinant canine adenovirus type 2 expressing Caninecoronavirus spike glycoprotein and its immunogenicity].	2005 Aug	China	
16244476	Policy conflicts: gene patents and health care in Canada.	2005	Switzerland	10.1159/000087959
16244207	Severe acute respiratory syndrome (SARS) in neonates and children.	2005 Nov	England	10.1136/adc.2005.075309
16243257	Cathepsin enzyme provides clue to SARS infection.	2005 Nov 1	England	10.1016/S1359-6446(05)03634-2
16242214	Synthesis and activity of an octapeptide inhibitor designed for SARS coronavirusmain proteinase.	2006 Apr	United States	10.1016/j.peptides.2005.09.006
16242152	pH-dependent conformational flexibility of the SARS-CoV main proteinase (M(pro))dimer: molecular dynamics simulations and multiple X-ray structure analyses.	2005 Nov 18	England	10.1016/j.jmb.2005.09.012
16241900	Genomic classification using an information-based similarity index: applicationto the SARS coronavirus.	2005 Oct	United States	10.1089/cmb.2005.12.1103
16239054	Development of attenuated vaccines from Taiwanese infectious bronchitis virusstrains.	2006 Feb 6	Netherlands	10.1016/j.vaccine.2005.08.081
16237267	In silico analysis of ORF1ab in coronavirus HKU1 genome reveals a unique putativecleavage site of coronavirus HKU1 3C-like protease.	2005	Australia	10.1111/j.1348-0421.2005.tb03681.x
16237214	Scalable transcriptional analysis routine--multiplexed quantitative real-timepolymerase chain reaction platform for gene expression analysis and moleculardiagnostics.	2005 Oct	United States	10.1016/S1525-1578(10)60575-2
16237152	Orchitis: a complication of severe acute respiratory syndrome (SARS).	2006 Feb	United States	10.1095/biolreprod.105.044776
16236698	What Internet services would patients like from hospitals during an epidemic?Lessons from the SARS outbreak in Toronto.	2005 Aug 3	Canada	10.2196/jmir.7.4.e46
16236266	Biochemical and biophysical characterization of the transmissible gastroenteritiscoronavirus fusion core.	2005 Dec 2	United States	10.1016/j.bbrc.2005.09.189
16235604	[Apropos of the nosocomial transmission of Southeast Asian severe acuterespiratory syndrome (SARS)].	2004 May	France	10.1016/j.medmal.2004.02.001
16235175	Human coronavirus NL63 is not detected in the respiratory tracts of children withacute Kawasaki disease.	2005 Nov 15	United States	10.1086/497170
16231254	Impact of rapid detection of viral and atypical bacterial pathogens by real-timepolymerase chain reaction for patients with lower respiratory tract infection.	2005 Nov 15	United States	10.1086/497134
16229772	Molecular epidemiology of SARS-associated coronavirus, Beijing.	2005 Sep	United States	10.3201/eid1109.040773
16229749	A simple and rapid approach for screening of SARS-coronavirus genotypes: anevaluation study.	2005 Oct 18	England	10.1186/1471-2334-5-87
16229262	[Modified molecular beacon-based dual real-time PCR for detection of SARS virusand its application].	2005 Jul	China	
16229261	[Detection of SARS-coronavirus in both human and animals by RT-PCR].	2005 Jul	China	
16228284	Modular organization of SARS coronavirus nucleocapsid protein.	2006 Jan	England	10.1007/s11373-005-9035-9
16228002	Insights into SARS-CoV transcription and replication from the structure of thensp7-nsp8 hexadecamer.	2005 Nov	United States	10.1038/nsmb999
16227300	Severe acute respiratory syndrome coronavirus fails to activate cytokine-mediatedinnate immune responses in cultured human monocyte-derived dendritic cells.	2005 Nov	United States	10.1128/JVI.79.21.13800-13805.2005
16227261	The nsp2 replicase proteins of murine hepatitis virus and severe acuterespiratory syndrome coronavirus are dispensable for viral replication.	2005 Nov	United States	10.1128/JVI.79.21.13399-13411.2005
16227251	A major determinant for membrane protein interaction localizes to thecarboxy-terminal domain of the mouse coronavirus nucleocapsid protein.	2005 Nov	United States	10.1128/JVI.79.21.13285-13297.2005
16227244	Contribution of trafficking signals in the cytoplasmic tail of the infectiousbronchitis virus spike protein to virus infection.	2005 Nov	United States	10.1128/JVI.79.21.13209-13217.2005
16226257	Binding interaction of SARS coronavirus 3CL(pro) protease with vacuolar-H+ ATPaseG1 subunit.	2005 Nov 7	England	10.1016/j.febslet.2005.09.075
16225774	Cross-reaction of SARS-CoV antigen with autoantibodies in autoimmune diseases.	2004 Aug	China	
16224518	[Preparation and identification of monoclonal antibodies against SARS-CoVputative protein X4].	2005 Oct 18	China	
16224511	[Expression of SARS-CoV in various types of cells in lung tissues].	2005 Oct 18	China	
16222170	Dynamically modeling SARS and other newly emerging respiratory illnesses: past,present, and future.	2005 Nov	United States	10.1097/01.ede.0000181633.80269.4c
16221989	Risk assessment of mouse hepatitis virus infection via in vitro fertilization andembryo transfer by the use of zona-intact and laser-microdissected oocytes.	2006 Feb	United States	10.1095/biolreprod.105.045112
16219322	Crystal structures of the main peptidase from the SARS coronavirus inhibited by asubstrate-like aza-peptide epoxide.	2005 Nov 11	England	10.1016/j.jmb.2005.09.004
16219167	SARS Immunity and Vaccination.	2004 Jun	China	
16216641	Lessons from severe acute respiratory syndrome (SARS): implications for infectioncontrol.	2005 Nov-Dec	United States	10.1016/j.arcmed.2005.03.040
16216498	Screening of electrophilic compounds yields an aziridinyl peptide as newactive-site directed SARS-CoV main protease inhibitor.	2005 Dec 15	England	10.1016/j.bmcl.2005.09.012
16216269	Mutational analysis of the SARS virus Nsp15 endoribonuclease: identification ofresidues affecting hexamer formation.	2005 Nov 11	England	10.1016/j.jmb.2005.09.007
16214268	A double-inactivated whole virus candidate SARS coronavirus vaccine stimulatesneutralising and protective antibody responses.	2006 Jan 30	Netherlands	10.1016/j.vaccine.2005.08.055
16214138	The dimer interface of the SARS coronavirus nucleocapsid protein adapts a porcinerespiratory and reproductive syndrome virus-like structure.	2005 Oct 24	England	10.1016/j.febslet.2005.09.038
16213766	Natural FCoV infection: cats with FIP exhibit significantly higher viral loadsthan healthy infected cats.	2006 Feb	England	10.1016/j.jfms.2005.07.002
16212942	In vivo functional characterization of the SARS-Coronavirus 3a protein inDrosophila.	2005 Nov 18	United States	10.1016/j.bbrc.2005.09.098
16212898	Immunological responses against SARS-coronavirus infection in humans.	2004 Apr	China	
16212536	Detection of infectious bronchitis virus and specific anti- viral antibodiesusing a Concanavalin A-Sandwich-ELISA.	2005	United States	10.1089/vim.2005.18.569
16212442	Prediction of functional class of the SARS coronavirus proteins by a statisticallearning method.	2005 Sep-Oct	United States	10.1021/pr050110a
16211506	Enhanced expression and purification of membrane proteins by SUMO fusion inEscherichia coli.	2005	Netherlands	10.1007/s10969-005-2664-4
16211163	Managing severe acute respiratory syndrome (SARS) intellectual property rights:the possible role of patent pooling.	2005 Sep	Switzerland	
16210748	Persevering through a difficult time during the SARS outbreak in Toronto.	2005 Oct	United States	10.1177/0894318405280353
16210485	Feline coronavirus serotypes 1 and 2: seroprevalence and association with diseasein Switzerland.	2005 Oct	United States	10.1128/CDLI.12.10.1209-1215.2005
16205703	Crossing the species barrier.	2005 Oct	United States	10.1038/nsmb1005-831
16201478	[Molecular cloning and expression of the severe acute respiratorysyndrome-associated coronavirus nucleocapsid protein and its clinicalapplication].	2005 Mar	China	
16197706	Experience with mouse hepatitis virus sanitation in three transplantable murinetumour lines.	2005 Oct	England	10.1258/002367705774286358
16195440	Virology. Researchers tie deadly SARS virus to bats.	2005 Sep 30	United States	10.1126/science.309.5744.2154
16195424	Bats are natural reservoirs of SARS-like coronaviruses.	2005 Oct 28	United States	10.1126/science.1118391
16194584	Influence of intron and exon splicing enhancers on mammalian cell expression of atruncated spike protein of SARS-CoV and its implication for subunit vaccinedevelopment.	2006 Feb 20	Netherlands	10.1016/j.vaccine.2005.09.011
16191709	A comparison of methods of inducing lachrymation and tear collection in chickensfor detection of virus-specific immuoglobulins after infection with infectiousbronchitis virus.	2005 Jun	England	10.1080/03079450500112344
16191702	S1 gene characteristics and efficacy of vaccination against infectious bronchitisvirus field isolates from the United States and Israel (1996 to 2000).	2005 Jun	England	10.1080/03079450500096539
16191455	Obstacles and advances in SARS vaccine development.	2006 Feb 13	Netherlands	10.1016/j.vaccine.2005.08.102
16191415	SARS vaccine: progress and challenge.	2005 Apr	China	
16189379	Use of dual TaqMan probes to increase the sensitivity of 1-step quantitativereverse transcription-PCR: application to the detection of SARS coronavirus.	2005 Oct	England	10.1373/clinchem.2005.054106
16188992	Structural genomics of the severe acute respiratory syndrome coronavirus: nuclearmagnetic resonance structure of the protein nsP7.	2005 Oct	United States	10.1128/JVI.79.20.12905-12913.2005
16188977	Coronaviruses as vectors: stability of foreign gene expression.	2005 Oct	United States	10.1128/JVI.79.20.12742-12751.2005
16188975	"ADP-ribose-1""-monophosphatase: a conserved coronavirus enzyme that is dispensablefor viral replication in tissue culture."	2005 Oct	United States	10.1128/JVI.79.20.12721-12731.2005
16186991	Evaluation of serum- and animal protein-free media for the production ofinfectious bronchitis virus (M41) strain in a continuous cell line.	2005	Germany	
16185324	Influence of FcgammaRIIA and MBL polymorphisms on severe acute respiratorysyndrome.	2005 Oct	England	10.1111/j.1399-0039.2005.00476.x
16183666	Experience of using convalescent plasma for severe acute respiratory syndromeamong healthcare workers in a Taiwan hospital.	2005 Nov	England	10.1093/jac/dki346
16183217	Cellular composition and interferon-gamma expression of the local inflammatoryresponse in feline infectious peritonitis (FIP).	2005 Nov 30	Netherlands	10.1016/j.vetmic.2005.07.017
16182383	Improved detection of bovine coronavirus N gene in faeces of calves infectednaturally by a semi-nested PCR assay and an internal control.	2006 Feb	Netherlands	10.1016/j.jviromet.2005.08.005
16181227	Post-SARS sickness syndrome manifestations and endocrinopathy: how, why, and sowhat?	2005 Oct	England	10.1111/j.1365-2265.2005.02361.x
16178983	Rhabdomyolysis associated with acute renal failure in patients with severe acuterespiratory syndrome.	2005 Oct	England	10.1111/j.1368-5031.2005.00540.x
16176106	[Expression of SARS spike gene in Shizomycete pombe].	2005 Jul	China	
16176089	[Expression of the recombinant SARS coronavirus nucleocapsid protein in Pichiapastoris and identification of its bioactivity].	2005 Jul	China	
16174563	Expression of synthetic neutralizing epitope of porcine epidemic diarrhea virusfused with synthetic B subunit of Escherichia coli heat-labile enterotoxin intobacco plants.	2006 Mar	United States	10.1016/j.pep.2005.07.026
16174304	Molecular signature of clinical severity in recovering patients with severe acuterespiratory syndrome coronavirus (SARS-CoV).	2005 Sep 21	England	10.1186/1471-2164-6-132
16174089	Similarities of immune reactions between hepatitis C and severe acute respiratorysyndrome-associated coronavirus infections.	2005 Oct	Australia	10.1111/j.1440-1746.2005.03850.x
16173783	Properties of isonucleotide-incorporated oligodeoxynucleotides and inhibition ofthe expression of spike protein of SARS-CoV.	2005 Sep-Oct	United States	10.1021/bc049769h
16173022	False positive antibody results against human T-cell lymphotropic virus inpatients with severe acute respiratory syndrome.	2005 Nov	United States	10.1002/jmv.20460
16171519	Generation of human antibody fragments recognizing distinct epitopes of thenucleocapsid (N) SARS-CoV protein using a phage display approach.	2005 Sep 19	England	10.1186/1471-2334-5-73
16171460	Real-time reverse transcription PCR (qRT-PCR) and its potential use in clinicaldiagnosis.	2005 Oct	England	10.1042/CS20050086
16170752	Association between mannose-binding lectin gene polymorphisms and susceptibilityto severe acute respiratory syndrome coronavirus infection.	2005 Oct 15	United States	10.1086/491479
16169905	Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoebats.	2005 Sep 27	United States	10.1073/pnas.0506735102
16166518	Structure of SARS coronavirus spike receptor-binding domain complexed withreceptor.	2005 Sep 16	United States	10.1126/science.1116480
16166506	Structural biology. Adaptation of SARS coronavirus to humans.	2005 Sep 16	United States	10.1126/science.1118817
16164833	T-Cell response profiling to biological threat agents including the SARScoronavirus.	2005 Jul-Sep	England	10.1177/039463200501800312
16163626	Detection of severe acute respiratory syndrome coronavirus in the brain:potential role of the chemokine mig in pathogenesis.	2005 Oct 15	United States	10.1086/444461
16160171	Stem-loop IV in the 5' untranslated region is a cis-acting element in bovinecoronavirus defective interfering RNA replication.	2005 Oct	United States	10.1128/JVI.79.19.12434-12446.2005
16159544	[SARS, avian influenza, and human metapneumovirus infection].	2005 Aug-Sep	Spain	10.1157/13078803
16157265	The interaction of the SARS coronavirus non-structural protein 10 with thecellular oxido-reductase system causes an extensive cytopathic effect.	2005 Oct	Netherlands	10.1016/j.jcv.2004.12.019
16157050	Severe acute respiratory syndrome: vaccine on the way.	2005 Sep 5	China	
16156956	Direct template matching reveals a host subcellular membrane gyroid cubicstructure that is associated with SARS virus.	2005	England	10.1179/135100005X57373
16156097	Sensitive detection of SARS coronavirus RNA by a novel asymmetric multiplexnested RT-PCR amplification coupled with oligonucleotide microarrayhybridization.	2005	United States	10.1385/1-59259-923-0:59
16155806	Bcl-2 inhibits the caspase-dependent apoptosis induced by SARS-CoV withoutaffecting virus replication kinetics.	2006 Feb	Austria	10.1007/s00705-005-0632-8
16153744	Using an integrated infection control strategy during outbreak control tominimize nosocomial infection of severe acute respiratory syndrome amonghealthcare workers.	2006 Feb	England	10.1016/j.jhin.2005.02.011
16153058	Screening and identification of linear B-cell epitopes and entry-blocking peptideof severe acute respiratory syndrome (SARS)-associated coronavirus usingsynthetic overlapping peptide library.	2005 Sep-Oct	United States	10.1021/cc0500607
16152762	Protection of mammalian cells from severe acute respiratory syndrome coronavirusinfection by equine neutralizing antibody.	2005	England	
16145108	Human coronavirus NL-63 infections in children: a 1-year study.	2005 Sep	United States	10.1128/JCM.43.9.4567-4573.2005
16144805	Optimal word sizes for dissimilarity measures and estimation of the degree ofdissimilarity between DNA sequences.	2005 Nov 15	England	10.1093/bioinformatics/bti658
16144519	SARS-CoV genome polymorphism: a bioinformatics study.	2005 Feb	China	10.1016/s1672-0229(05)03004-4
16143815	Activation of NF-kappaB by the full-length nucleocapsid protein of the SARScoronavirus.	2005 Sep	China	10.1111/j.1745-7270.2005.00082.x
16142653	Survival of severe acute respiratory syndrome coronavirus.	2005 Oct 1	United States	10.1086/433186
16140765	Molecular evolution analysis and geographic investigation of severe acuterespiratory syndrome coronavirus-like virus in palm civets at an animal marketand on farms.	2005 Sep	United States	10.1128/JVI.79.18.11892-11900.2005
16140741	Single amino acid substitutions in the severe acute respiratory syndromecoronavirus spike glycoprotein determine viral entry and immunogenicity of amajor neutralizing domain.	2005 Sep	United States	10.1128/JVI.79.18.11638-11646.2005
16139595	Molecular interactions in the assembly of coronaviruses.	2005	United States	10.1016/S0065-3527(05)64006-7
16137782	The complete sequence of the bovine torovirus genome.	2006 Jan	Netherlands	10.1016/j.virusres.2005.07.005
16137773	Differential detection of turkey coronavirus, infectious bronchitis virus, andbovine coronavirus by a multiplex polymerase chain reaction.	2006 Jan	Netherlands	10.1016/j.jviromet.2005.07.007
16137658	Selection of and recombination between minor variants lead to the adaptation ofan avian coronavirus to primate cells.	2005 Oct 21	United States	10.1016/j.bbrc.2005.08.105
16133409	Double-antigen sandwich ELISA for detection of antibodies to SARS-associatedcoronavirus in human serum.	2005 Aug	Germany	10.1007/s10096-005-1378-7
16132115	Characterization of neutralizing monoclonal antibodies recognizing a 15-residuesepitope on the spike protein HR2 region of severe acute respiratory syndromecoronavirus (SARS-CoV).	2005 Oct	England	10.1007/s11373-005-9004-3
16131092	Selective immobilization of fusion proteins on poly(hydroxyalkanoate) microbeads.	2005 Sep 1	United States	10.1021/ac0505223
16131020	Efficient and quick inactivation of SARS coronavirus and other microbes exposedto the surfaces of some metal catalysts.	2005 Jun	China	
16129616	A probable role for IFN-gamma in the development of a lung immunopathology inSARS.	2005 Oct 7	England	10.1016/j.cyto.2005.07.007
16129340	Rational monoclonal antibody development to emerging pathogens, biothreat agentsand agents of foreign animal disease: The antigen scale.	2005 Sep	England	10.1016/j.tvjl.2004.04.021
16128623	Design of wide-spectrum inhibitors targeting coronavirus main proteases.	2005 Oct	United States	10.1371/journal.pbio.0030324
16125443	Recent highlights in the development of new antiviral drugs.	2005 Oct	England	10.1016/j.mib.2005.08.010
16122388	The SARS coronavirus S glycoprotein receptor binding domain: fine mapping andfunctional characterization.	2005 Aug 25	England	10.1186/1743-422X-2-73
16121382	Replication of respiratory viruses, particularly influenza virus, rhinovirus, andcoronavirus in HuH7 hepatocarcinoma cell line.	2005 Oct	United States	10.1002/jmv.20449
16121380	Respiratory disease caused by a species B2 adenovirus in a military camp inTurkey.	2005 Oct	United States	10.1002/jmv.20441
16121372	Rapid and sensitive detection of multiple genes from the SARS-coronavirus usingquantitative RT-PCR with dual systems.	2005 Oct	United States	10.1002/jmv.20432
16121363	A serological survey on neutralizing antibody titer of SARS convalescent sera.	2005 Oct	United States	10.1002/jmv.20431
16120590	[A preliminary study of the structure prediction and expression of SARS-CoV spikeprotein].	2005 Jul	China	
16118891	Severe acute respiratory syndrome coronavirus infection in children.	2005 Aug	Australia	10.1111/j.1442-200x.2005.02092.x
16118271	Cloning of a human parvovirus by molecular screening of respiratory tractsamples.	2005 Sep 6	United States	10.1073/pnas.0504666102
16116432	Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus inRhesus macaque.	2005 Sep	United States	10.1038/nm1280
16116101	Protease-mediated enhancement of severe acute respiratory syndrome coronavirusinfection.	2005 Aug 30	United States	10.1073/pnas.0503203102
16115693	Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root andplant-derived phenolic compounds.	2005 Oct	Netherlands	10.1016/j.antiviral.2005.07.002
16115318	Chloroquine is a potent inhibitor of SARS coronavirus infection and spread.	2005 Aug 22	England	10.1186/1743-422X-2-69
16112670	Molecular evolution and multilocus sequence typing of 145 strains of SARS-CoV.	2005 Sep 12	England	10.1016/j.febslet.2005.07.075
16112641	Characterization and application of monoclonal antibodies against N protein ofSARS-coronavirus.	2005 Oct 14	United States	10.1016/j.bbrc.2005.08.032
16112612	Anti-SARS-CoV IgG response in relation to disease severity of severe acuterespiratory syndrome.	2006 Feb	Netherlands	10.1016/j.jcv.2005.07.005
16111269	[Diagnostic tests: SARS-Corona virus].	2005 Jul	Japan	
16111268	[Diagnostic tests: Corona virus].	2005 Jul	Japan	
16110580	SARS vaccine protective in mice.	2005 Aug	United States	10.3201/eid1108.041003
16107980	Characterization of viral agents causing acute respiratory infection in a SanFrancisco University Medical Center Clinic during the influenza season.	2005 Sep 15	United States	10.1086/432800
16107979	Biosafety level 3 laboratory for autopsies of patients with severe acuterespiratory syndrome: principles, practices, and prospects.	2005 Sep 15	United States	10.1086/432720
16107218	G0/G1 arrest and apoptosis induced by SARS-CoV 3b protein in transfected cells.	2005 Aug 17	England	10.1186/1743-422X-2-66
16104827	Croup is associated with the novel coronavirus NL63.	2005 Aug	United States	10.1371/journal.pmed.0020240
16103615	Outbreak of severe acute respiratory syndrome in southern Taiwan, 2003.	2005 Aug	United States	
16103202	Intracellular localization of the severe acute respiratory syndrome coronavirusnucleocapsid protein: absence of nucleolar accumulation during infection andafter expression as a recombinant protein in vero cells.	2005 Sep	United States	10.1128/JVI.79.17.11507-11512.2005
16103198	The severe acute respiratory syndrome coronavirus nucleocapsid protein isphosphorylated and localizes in the cytoplasm by 14-3-3-mediated translocation.	2005 Sep	United States	10.1128/JVI.79.17.11476-11486.2005
16103185	A severe acute respiratory syndrome-associated coronavirus-specific proteinenhances virulence of an attenuated murine coronavirus.	2005 Sep	United States	10.1128/JVI.79.17.11335-11342.2005
16102649	The clinical presentation and outcomes of children infected with newly identifiedrespiratory tract viruses.	2005 Sep	United States	10.1016/j.idc.2005.05.009
16102324	Posttraumatic stress after SARS.	2005 Aug	United States	10.3201/eid1108.041083
16102311	Human coronavirus NL63, France.	2005 Aug	United States	10.3201/eid1108.050110
16101804	Amotosalen photochemical inactivation of severe acute respiratory syndromecoronavirus in human platelet concentrates.	2005 Aug	England	10.1111/j.0958-7578.2005.00588.x
16101496	Synthesis of novel test compounds for antiviral chemotherapy of severe acuterespiratory syndrome (SARS).	2005	United Arab Emirates	10.2174/0929867054637644
16101351	Profiles of IgG antibodies to nucleocapsid and spike proteins of theSARS-associated coronavirus in SARS patients.	2005 Aug	United States	10.1089/dna.2005.24.521
16101350	Construction of a eukaryotic expression plasmid encoding partial S gene fragmentsof the SARS-CoV and its potential utility as a DNA vaccine.	2005 Aug	United States	10.1089/dna.2005.24.516
16101349	Elicitation of immunity in mice after immunization with the S2 subunit of thesevere acute respiratory syndrome coronavirus.	2005 Aug	United States	10.1089/dna.2005.24.510
16101348	Identification and antigenic epitope mapping of immunodominant region aminoresidues 510 to 672 on the spike protein of the severe acute respiratory syndromecoronavirus.	2005 Aug	United States	10.1089/dna.2005.24.503
16101347	Apoptosis induced by the SARS-associated coronavirus in Vero cells isreplication-dependent and involves caspase.	2005 Aug	United States	10.1089/dna.2005.24.496
16101345	Pathology of guinea pigs experimentally infected with a novel reovirus andcoronavirus isolated from SARS patients.	2005 Aug	United States	10.1089/dna.2005.24.485
16101344	Development of a method for concentrating and purifying SARS coronavirus RNA by amagnetic bead capture system.	2005 Aug	United States	10.1089/dna.2005.24.479
16099010	Genetic analysis of the SARS-coronavirus spike glycoprotein functional domainsinvolved in cell-surface expression and cell-to-cell fusion.	2005 Oct 25	United States	10.1016/j.virol.2005.06.046
16095942	Effects of severe acute respiratory syndrome (SARS) coronavirus infection onperipheral blood lymphocytes and their subsets.	2005 Nov	Canada	10.1016/j.ijid.2004.07.014
16095648	Coordinate induction of IFN-alpha and -gamma by SARS-CoV also in the absence ofvirus replication.	2005 Oct 10	United States	10.1016/j.virol.2005.07.015
16091881	Expression and purification of N and E proteins from severe acute respiratorysyndrome (SARS)-associated coronavirus: a comparative study.	2005 Jul	Netherlands	10.1007/s10529-005-7176-6
16087120	First external quality assurance of antibody diagnostic for SARS-new coronavirus.	2005 Sep	Netherlands	10.1016/j.jcv.2005.01.004
16081995	Performance of single-step gel-based reverse transcription-PCR (RT-PCR) assaysequivalent to that of real-time RT-PCR assays for detection of the severe acuterespiratory syndrome-associated coronavirus.	2005 Aug	United States	10.1128/JCM.43.8.4262-4265.2005
16081901	Identification of immunodominant epitopes on the membrane protein of the severeacute respiratory syndrome-associated coronavirus.	2005 Aug	United States	10.1128/JCM.43.8.3718-3726.2005
16081529	Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirusentry.	2005 Aug 16	United States	10.1073/pnas.0505577102
16081124	Serine-scanning mutagenesis studies of the C-terminal heptad repeats in the SARScoronavirus S glycoprotein highlight the important role of the short helicalregion.	2005 Oct 10	United States	10.1016/j.virol.2005.07.005
16079870	Good ACE, bad ACE do battle in lung injury, SARS.	2005 Aug	United States	10.1038/nm0805-821
16077248	Current perspectives on Kawasaki disease.	2005 Jul	India	10.1007/bf02724189
16077216	Quality assurance for the diagnostics of viral diseases to enhance the emergencypreparedness in Europe.	2005 Jun	Sweden	
16060914	Hypocortisolism in survivors of severe acute respiratory syndrome (SARS).	2005 Aug	England	10.1111/j.1365-2265.2005.02325.x
16055920	An atypical RNA pseudoknot stimulator and an upstream attenuation signal for -1ribosomal frameshifting of SARS coronavirus.	2005	England	10.1093/nar/gki731
16055009	Cutaneous lesions associated with coronavirus-induced vasculitis in a cat withfeline infectious peritonitis and concurrent feline immunodeficiency virusinfection.	2005 Aug	England	10.1016/j.jfms.2004.12.001
16054014	Membrane-associated zinc peptidase families: comparing ACE and ACE2.	2005 Aug 1	Netherlands	10.1016/j.bbapap.2004.10.010
16053703	Peptide domain involved in the interaction between membrane protein andnucleocapsid protein of SARS-associated coronavirus.	2005 Jul 31	Korea (South)	10.5483/bmbrep.2005.38.4.381
16052283	Replication of feline coronaviruses in peripheral blood monocytes.	2005 Dec	Austria	10.1007/s00705-005-0598-6
16051304	LSECtin interacts with filovirus glycoproteins and the spike protein of SARScoronavirus.	2005 Sep 30	United States	10.1016/j.virol.2005.06.026
16051301	Mutagenesis of the murine hepatitis virus nsp1-coding region identifies residuesimportant for protein processing, viral RNA synthesis, and viral replication.	2005 Sep 30	United States	10.1016/j.virol.2005.06.035
16050150	Emerging infectious agents.	2005	Switzerland	
16049331	Pneumonitis and multi-organ system disease in common marmosets (Callithrixjacchus) infected with the severe acute respiratory syndrome-associatedcoronavirus.	2005 Aug	United States	10.1016/S0002-9440(10)62989-6
16048439	Bcl-xL inhibits T-cell apoptosis induced by expression of SARS coronavirus Eprotein in the absence of growth factors.	2005 Nov 15	England	10.1042/BJ20050698
16046244	Nucleolar localization of non-structural protein 3b, a protein specificallyencoded by the severe acute respiratory syndrome coronavirus.	2005 Dec	Netherlands	10.1016/j.virusres.2005.06.001
16046238	Hematopoietic prostaglandin D2 synthase in the chicken Harderian gland.	2005 Dec 15	Netherlands	10.1016/j.vetimm.2005.06.008
16045996	Proposal for vaccination against SARS coronavirus using avian infectiousbronchitis virus strain H from The Netherlands.	2005 Oct	England	10.1016/j.jinf.2005.04.010
16045740	Antibody to severe acute respiratory syndrome (SARS)-associated coronavirus spikeprotein domain 2 cross-reacts with lung epithelial cells and causes cytotoxicity.	2005 Sep	England	10.1111/j.1365-2249.2005.02864.x
16043521	Multiple organ infection and the pathogenesis of SARS.	2005 Aug 1	United States	10.1084/jem.20050828
16043204	Long-term protection from SARS coronavirus infection conferred by a singleimmunization with an attenuated VSV-based vaccine.	2005 Sep 30	United States	10.1016/j.virol.2005.06.016
16042412	Papain-like protease 2 (PLP2) from severe acute respiratory syndrome coronavirus(SARS-CoV): expression, purification, characterization, and inhibition.	2005 Aug 2	United States	10.1021/bi0504761
16041067	High-resolution structure of HLA-A*1101 in complex with SARS nucleocapsidpeptide.	2005 Aug	United States	10.1107/S0907444905013090
16039725	Retinal degeneration in experimental coronavirus retinopathy (ECOR) is associatedwith increased TNF-alpha, soluble TNFR2 and altered TNF-alpha signaling.	2005 Sep	Netherlands	10.1016/j.jneuroim.2005.05.018
16038478	Inhibition of replication and infection of severe acute respiratorysyndrome-associated coronavirus with plasmid-mediated interference RNA.	2005	England	
16038039	Excretion and detection of SARS coronavirus and its nucleic acid from digestivesystem.	2005 Jul 28	United States	10.3748/wjg.v11.i28.4390
16035944	Vaccine design for severe acute respiratory syndrome coronavirus.	2005	United States	10.1089/vim.2005.18.327
16035257	Identification of a feline coronavirus type I strain from a cat with felineinfectious peritonitis by RT-pCR and phylogenetic analysis.	2005 Apr	Italy	
16033974	Vesicular stomatitis virus pseudotyped with severe acute respiratory syndromecoronavirus spike protein.	2005 Aug	England	10.1099/vir.0.80955-0
16033973	Phosphorylation and subcellular localization of transmissible gastroenteritisvirus nucleocapsid protein in infected cells.	2005 Aug	England	10.1099/vir.0.80975-0
16033972	Genomic RNA sequence of Feline coronavirus strain FIPV WSU-79/1146.	2005 Aug	England	10.1099/vir.0.80985-0
16032747	Autoantibodies against human epithelial cells and endothelial cells after severeacute respiratory syndrome (SARS)-associated coronavirus infection.	2005 Sep	United States	10.1002/jmv.20407
16032339	An update on aspects of viral gastrointestinal diseases of dogs and cats.	2003 Dec	England	10.1080/00480169.2003.36379
16028157	A case-control study of acute respiratory tract infection in general practicepatients in The Netherlands.	2005 Aug 15	United States	10.1086/431982
16027791	[Determination of SARS-CoV by simplified nested fluorescent RT-PCR].	2005 Jun	China	
16027779	[Conditions for SARS-CoV cultivation and inactivation].	2005 Jun	China	
16027775	[Detection of autoimmune parameter of SARS patients].	2005 Jun	China	
16026862	Yeast expression and characterization of SARS-CoV N protein.	2005 Dec	Netherlands	10.1016/j.jviromet.2005.06.010
16025480	Novel rapid immunochromatographic test based on an enzyme immunoassay fordetecting nucleocapsid antigen in SARS-associated coronavirus.	2005	United States	10.1002/jcla.20070
16025240	Variations in the nucleocapsid protein gene of infectious bronchitis virusesisolated in Korea.	2005 Oct	United States	10.1007/s11262-005-1788-8
16024100	Genotype-specific fluorogenic RT-PCR assays for the detection and quantitation ofcanine coronavirus type I and type II RNA in faecal samples of dogs.	2005 Dec	Netherlands	10.1016/j.jviromet.2005.06.005
16024098	Detection of the nucleocapsid protein of severe acute respiratory syndromecoronavirus in serum: comparison with results of other viral markers.	2005 Dec	Netherlands	10.1016/j.jviromet.2005.06.001
16023880	Viral load quantitation of SARS-coronavirus RNA using a one-step real-timeRT-PCR.	2006 Jan	Canada	10.1016/j.ijid.2005.02.003
16023741	Thermal aggregation of SARS-CoV membrane protein.	2005 Nov	Netherlands	10.1016/j.jviromet.2005.05.022
16023411	Detection and pathogenicity of human metapneumovirus respiratory infection inpediatric Italian patients during a winter--spring season.	2006 Jan	Netherlands	10.1016/j.jcv.2005.05.010
16022898	Adenoviral expression of a truncated S1 subunit of SARS-CoV spike protein resultsin specific humoral immune responses against SARS-CoV in rats.	2005 Sep	Netherlands	10.1016/j.virusres.2005.02.009
16022801	Asymptomatic SARS coronavirus infection among healthcare workers, Singapore.	2005 Jul	United States	10.3201/eid1107.041165
16022791	SARS coronavirus detection methods.	2005 Jul	United States	10.3201/eid1107.041045
16022774	SARS vaccine development.	2005 Jul	United States	10.3201/1107.050219
16019455	Thrombocytopenia in patients with severe acute respiratory syndrome (review).	2005 Apr	England	10.1080/10245330400026170
16018568	Detection of coronavirus in cases of tracheobronchitis in dogs: a retrospectivestudy from 1971 to 2003.	2005 May	Canada	
16014971	The severe acute respiratory syndrome coronavirus 3a protein up-regulatesexpression of fibrinogen in lung epithelial cells.	2005 Aug	United States	10.1128/JVI.79.15.10083-10087.2005
16014947	Murine coronavirus requires lipid rafts for virus entry and cell-cell fusion butnot for virus release.	2005 Aug	United States	10.1128/JVI.79.15.9862-9871.2005
16014928	Inhibition, escape, and attenuated growth of severe acute respiratory syndromecoronavirus treated with antisense morpholino oligomers.	2005 Aug	United States	10.1128/JVI.79.15.9665-9676.2005
16014910	Apical entry and release of severe acute respiratory syndrome-associatedcoronavirus in polarized Calu-3 lung epithelial cells.	2005 Aug	United States	10.1128/JVI.79.15.9470-9479.2005
16014902	Important roles for gamma interferon and NKG2D in gammadelta T-cell-induceddemyelination in T-cell receptor beta-deficient mice infected with a coronavirus.	2005 Aug	United States	10.1128/JVI.79.15.9388-9396.2005
16014825	Rapid awareness and transmission of severe acute respiratory syndrome in HanoiFrench Hospital, Vietnam.	2005 Jul	United States	
16013477	[Development of monoclonal antibodies against SARS-CoV and identification ofantigenic epitopes].	2005 Mar	China	
16013037	The estimation of SARS incubation distribution from serial interval data using aconvolution likelihood.	2005 Aug 30	England	10.1002/sim.2123
16012012	Low prevalence of subclinical severe acute respiratory syndrome-associatedcoronavirus infection among hospital healthcare workers in Hong Kong.	2005	England	10.1080/00365540510033645
16009768	Myopathic changes associated with severe acute respiratory syndrome: a postmortemcase series.	2005 Jul	United States	10.1001/archneur.62.7.1113
16008226	Epidemiologic evaluation of diarrhea in dogs in an animal shelter.	2005 Jun	United States	10.2460/ajvr.2005.66.1018
16007933	Protecting human and ecological health under viral threats in Asia.	2005	England	
16007097	A crucial role of angiotensin converting enzyme 2 (ACE2) in SARScoronavirus-induced lung injury.	2005 Aug	United States	10.1038/nm1267
16005746	Augmentation of immune responses to SARS coronavirus by a combination of DNA andwhole killed virus vaccines.	2005 Aug 15	Netherlands	10.1016/j.vaccine.2005.04.011
16002945	Adverse effects of ribavirin and outcome in severe acute respiratory syndrome:experience in two medical centers.	2005 Jul	United States	10.1378/chest.128.1.263
16002634	Evaluation of inapparent nosocomial severe acute respiratory syndrome coronavirusinfection in Vietnam by use of highly specific recombinant truncated nucleocapsidprotein-based enzyme-linked immunosorbent assay.	2005 Jul	United States	10.1128/CDLI.12.7.848-854.2005
16001071	Angiotensin-converting enzyme 2 protects from severe acute lung failure.	2005 Jul 7	England	10.1038/nature03712
16000477	Evaluation of real-time reverse transcriptase PCR and real-time loop-mediatedamplification assays for severe acute respiratory syndrome coronavirus detection.	2005 Jul	United States	10.1128/JCM.43.7.3457-3459.2005
16000415	Differential sensitivities of severe acute respiratory syndrome (SARS)coronavirus spike polypeptide enzyme-linked immunosorbent assay (ELISA) and SARScoronavirus nucleocapsid protein ELISA for serodiagnosis of SARS coronaviruspneumonia.	2005 Jul	United States	10.1128/JCM.43.7.3054-3058.2005
15999634	[Field study of the prevalence and diagnosis of diarrhea-causing agents in thenewborn calf in a Swiss veterinary practice area].	2005 May	Switzerland	10.1024/0036-7281.147.6.245
15999208	Sequence analysis and structural prediction of the severe acute respiratorysyndrome coronavirus nsp5.	2005 Jul	China	10.1111/j.1745-7270.2005.00066.x
15999010	Detection of human coronavirus-NL63 in children in Japan.	2005 Jul	United States	10.1097/01.inf.0000168846.71517.ee
15996256	Clinical impact of community-acquired respiratory viruses on bronchiolitisobliterans after lung transplant.	2005 Aug	United States	10.1111/j.1600-6143.2005.00971.x
15994805	Contributions of the viral genetic background and a single amino acidsubstitution in an immunodominant CD8+ T-cell epitope to murine coronavirusneurovirulence.	2005 Jul	United States	10.1128/JVI.79.14.9108-9118.2005
15994104	Prevalence of feline infectious peritonitis in specific cat breeds.	2006 Feb	England	10.1016/j.jfms.2005.04.003
15994085	Inhibition of the severe acute respiratory syndrome 3CL protease bypeptidomimetic alpha,beta-unsaturated esters.	2005 Sep 1	England	10.1016/j.bmc.2005.05.065
15994050	Comparison of 9 different PCR primers for the rapid detection of severe acuterespiratory syndrome coronavirus using 2 RNA extraction methods.	2005 Sep	United States	10.1016/j.diagmicrobio.2005.03.007
15993989	SARS coronavirus spike polypeptide DNA vaccine priming with recombinant spikepolypeptide from Escherichia coli as booster induces high titer of neutralizingantibody against SARS coronavirus.	2005 Oct 10	Netherlands	10.1016/j.vaccine.2005.05.023
15993669	Reduced bone mineral density in male Severe Acute Respiratory Syndrome (SARS)patients in Hong Kong.	2005 Sep	United States	10.1016/j.bone.2005.04.018
15992957	Nuclear/nucleolar localization properties of C-terminal nucleocapsid protein ofSARS coronavirus.	2005 Dec	Netherlands	10.1016/j.virusres.2005.05.007
15992768	Susceptibility of human and rat neural cell lines to infection bySARS-coronavirus.	2005 Aug 19	United States	10.1016/j.bbrc.2005.06.061
15989788	[Construction of a large human scFv library against SARS virus].	2005 Jul	China	
15989769	Immune response in Balb/c mice induced by recombinant spike protein of severeacute respiratory syndrome coronavirus.	2005 May 20	China	
15989282	[Two genotypes of Canine coronavirus simultaneously detected in the fecal samplesof healthy foxes and raccoon dogs].	2005 Apr	China	
15987362	Purification of severe acute respiratory syndrome hyperimmune globulins forintravenous injection from convalescent plasma.	2005 Jul	United States	10.1111/j.1537-2995.2005.00179.x
15986492	Cross-species transfer of viruses: implications for the use of viral vectors inbiomedical research, gene therapy and as live-virus vaccines.	2005 Oct	England	10.1002/jgm.794
15986174	Phylogenetic and recombination analysis of coronavirus HKU1, a novel coronavirusfrom patients with pneumonia.	2005 Nov	Austria	10.1007/s00705-005-0573-2
15984332	Commercialization of plant-based vaccines from research and development tomanufacturing.	2004 Dec	England	10.1079/ahr200476
15984322	Bovine torovirus (Breda virus) revisited.	2004 Dec	England	10.1079/ahr200498
15983030	Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomainshedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV)receptor, angiotensin-converting enzyme-2 (ACE2).	2005 Aug 26	United States	10.1074/jbc.M505111200
15980414	Identification of two critical amino acid residues of the severe acuterespiratory syndrome coronavirus spike protein for its variation in zoonotictropism transition via a double substitution strategy.	2005 Aug 19	United States	10.1074/jbc.M500662200
15979680	The virion N protein of infectious bronchitis virus is more phosphorylated thanthe N protein from infected cell lysates.	2005 Aug 15	United States	10.1016/j.virol.2005.04.029
15979045	A molecular docking model of SARS-CoV S1 protein in complex with its receptor,human ACE2.	2005 Jun	England	10.1016/j.compbiolchem.2005.04.008
15979041	Structural analysis of inhibition mechanisms of aurintricarboxylic acid onSARS-CoV polymerase and other proteins.	2005 Jun	England	10.1016/j.compbiolchem.2005.04.006
15977301	The probability of failing in detecting an infectious disease at entry pointsinto a country.	2005 Sep 15	England	10.1002/sim.2131
15977248	Recurrent mutations associated with isolation and passage of SARS coronavirus incells from non-human primates.	2005 Aug	United States	10.1002/jmv.20379
15976093	Comprehensive antibody epitope mapping of the nucleocapsid protein of severeacute respiratory syndrome (SARS) coronavirus: insight into the humoral immunityof SARS.	2005 Aug	England	10.1373/clinchem.2005.051045
15974598	Discovery of potent anilide inhibitors against the severe acute respiratorysyndrome 3CL protease.	2005 Jun 30	United States	10.1021/jm050184y
15972696	Response of memory CD8+ T cells to severe acute respiratory syndrome (SARS)coronavirus in recovered SARS patients and healthy individuals.	2005 Jul 1	United States	10.4049/jimmunol.175.1.591
15970619	A case-control study of SARS versus community acquired pneumonia.	2005 Jul	England	10.1136/adc.2004.063446
15970094	[Study of laboratory characteristic of 4 patients with sporadic severe acuterespiratory syndrome in 2004].	2005 Jun	China	
15969052	[Over-expression in Escherichia coli and purification of nucleocaspid andmembrane protein of SARS coronavirus].	2003 Jul	China	
15968975	[RNase III-prepared short interfering RNAs induce degradation of SARS-coronavirusmRNAs in human cells].	2004 Jul	China	
15968766	[Asymptomatic forms of the Severe Acute Respiratory Syndrome (SARS)].	2005 Feb	France	10.1016/s0761-8425(05)85444-0
15965603	Using DNA shuffling to create novel infectious bronchitis virus S1 genes:implications for S1 gene recombination.	2005 Aug	United States	10.1007/s11262-004-2194-3
15964242	Longitudinal alteration of circulating dendritic cell subsets and its correlationwith steroid treatment in patients with severe acute respiratory syndrome.	2005 Sep	United States	10.1016/j.clim.2005.04.015
15964082	Concentration and detection of SARS coronavirus in sewage from Xiao Tang ShanHospital and the 309th Hospital.	2005 Sep	Netherlands	10.1016/j.jviromet.2005.03.022
15963987	Viroporin activity of murine hepatitis virus E protein.	2005 Jul 4	England	10.1016/j.febslet.2005.05.046
15963240	Genetic lesions within the 3a gene of SARS-CoV.	2005 Jun 20	England	10.1186/1743-422X-2-51
15962234	Kawasaki disease and human coronavirus.	2005 Jul 15	United States	10.1086/431609
15962233	Lack of association between New Haven coronavirus and Kawasaki disease.	2005 Jul 15	United States	10.1086/430797
15962232	Questions concerning the New Haven coronavirus.	2005 Jul 15	United States	10.1086/430795
15961624	Appropriate use of personal protective equipment among healthcare workers inpublic sector hospitals and primary healthcare polyclinics during the SARSoutbreak in Singapore.	2005 Jul	England	10.1136/oem.2004.015024
15961169	Development of a homogeneous screening assay for automated detection of antiviralagents active against severe acute respiratory syndrome-associated coronavirus.	2005 Oct	Netherlands	10.1016/j.jviromet.2005.05.010
15958670	The 3a protein of severe acute respiratory syndrome-associated coronavirusinduces apoptosis in Vero E6 cells.	2005 Jul	England	10.1099/vir.0.80813-0
15956552	Gene 5 of the avian coronavirus infectious bronchitis virus is not essential forreplication.	2005 Jul	United States	10.1128/JVI.79.13.8065-8078.2005
15956182	Severe acute respiratory syndrome (SARS) S protein production in plants:development of recombinant vaccine.	2005 Jun 21	United States	10.1073/pnas.0503760102
15953191	Mouse hepatitis virus 3 binding to macrophages correlates with resistance toexperimental infection.	2005 Jul	England	10.1111/j.1365-3083.2005.01616.x
15951805	Multiplexed detection of pathogen DNA with DNA-based fluorescence nanobarcodes.	2005 Jul	United States	10.1038/nbt1106
15950449	Pathogenesis of severe acute respiratory syndrome.	2005 Aug	England	10.1016/j.coi.2005.05.009
15950190	Screening of drugs by FRET analysis identifies inhibitors of SARS-CoV 3CLprotease.	2005 Jul 22	United States	10.1016/j.bbrc.2005.05.095
15949361	[An immunofluorescence assay for the detection of SARS associated coronavirusantibody based on recombinant nucleocapsid antigen and its application].	2005 Mar 9	China	
15949331	[Specific antibodies against the nucleocapsid protein and S1 domain of spikeglycoprotein in patients with severe acute respiratory syndrome].	2005 Mar 2	China	
15947329	Follow-up study on pulmonary function and lung radiographic changes inrehabilitating severe acute respiratory syndrome patients after discharge.	2005 Jun	United States	10.1378/chest.127.6.2119
15944304	Severe acute respiratory syndrome and the innate immune responses: modulation ofeffector cell function without productive infection.	2005 Jun 15	United States	10.4049/jimmunol.174.12.7977
15942907	Antibody avidity maturation during severe acute respiratory syndrome-associatedcoronavirus infection.	2005 Jul 1	United States	10.1086/430615
15941537	[Development and application of triple antibodies-based sandwich ELISA fordetecting nucleocapsid protein of SARS-associated coronavirus].	2005 Apr	China	
15941510	[Study on the RNA of severe acute respiratory syndrome (SARS) associatedcoronavirus in the blood and excretion of convalescent patients with SARS].	2005 Mar	China	
15941507	[Study on the dynamics of IgG antibody in 311 patients with severe acuterespiratory syndrome].	2005 Mar	China	
15941360	Pseudoknots: RNA structures with diverse functions.	2005 Jun	United States	10.1371/journal.pbio.0030213
15939399	A human SARS-CoV neutralizing antibody against epitope on S2 protein.	2005 Jul 22	United States	10.1016/j.bbrc.2005.05.089
15939295	Expression and purification of SARS coronavirus proteins using SUMO-fusions.	2005 Jul	United States	10.1016/j.pep.2005.02.004
15939287	SARS-coronavirus (SARS-CoV) and the safety of a solvent/detergent (S/D) treatedimmunoglobulin preparation.	2005 Jun	England	10.1016/j.biologicals.2005.01.003
15937940	Identification of an alternative 5'-untranslated exon and new polymorphisms ofangiotensin-converting enzyme 2 gene: lack of association with SARS in theVietnamese population.	2005 Jul 1	United States	10.1002/ajmg.a.30779
15935325	The interaction between severe acute respiratory syndrome coronavirus 3C-likeproteinase and a dimeric inhibitor by capillary electrophoresis.	2005 Aug 1	United States	10.1016/j.ab.2005.04.027
15933575	Clinical, virologic and immunologic profiles of a young infant with severe acuterespiratory syndrome.	2005 Jun	United States	10.1097/01.inf.0000164703.61282.3b
15928078	Humanized mice develop coronavirus respiratory disease.	2005 Jun 7	United States	10.1073/pnas.0503091102
15923564	Evidence of circulation of a Chinese strain of infectious bronchitis virus(QXIBV) in Italy.	2005 May 28	England	10.1136/vr.156.22.720
15923059	Efficacy of various disinfectants against SARS coronavirus.	2005 Oct	England	10.1016/j.jhin.2004.12.023
15921605	[Surveillance on severe acute respiratory syndrome associated coronavirus inanimals at a live animal market of Guangzhou in 2004].	2005 Feb	China	
15921591	[Hypothesis on generating and tracer gas study regarding transmission of severeacute respiratory syndrome through ventilation system in a general hospital].	2005 Jan	China	
15921587	[The effects of 4 laboratory test kits in early detecting of severe acuterespiratory syndrome coronavirus].	2005 Jan	China	
29183474	Quality assurance for the diagnostics of viral diseases to enhance the emergencypreparedness in Europe.	2005 Jun	Sweden	10.2807/esm.10.06.00545-en
23674957	Seroepidemiological Study on SARS-CoV IgG Antibodies of Different Populationsfrom Several Areas.	2005 Jun	United States	
15920543	Coronaviral hypothetical and structural proteins were found in the intestinalsurface enterocytes and pneumocytes of severe acute respiratory syndrome (SARS).	2005 Nov	United States	10.1038/modpathol.3800439
15919935	Cytokine responses in severe acute respiratory syndrome coronavirus-infectedmacrophages in vitro: possible relevance to pathogenesis.	2005 Jun	United States	10.1128/JVI.79.12.7819-7826.2005
15919915	Murine coronavirus evolution in vivo: functional compensation of a detrimentalamino acid substitution in the receptor binding domain of the spike glycoprotein.	2005 Jun	United States	10.1128/JVI.79.12.7629-7640.2005
15919828	Development of a transgenic mouse model susceptible to human coronavirus 229E.	2005 Jun 7	United States	10.1073/pnas.0408589102
15918782	Overview of antiviral and anti-inflammatory treatment for severe acuterespiratory syndrome.	2005 Apr	England	10.1586/14787210.3.2.251
15918330	Synthetic peptides outside the spike protein heptad repeat regions as potentinhibitors of SARS-associated coronavirus.	2005	England	
15916886	JNK and PI3k/Akt signaling pathways are required for establishing persistentSARS-CoV infection in Vero E6 cells.	2005 Jun 30	Netherlands	10.1016/j.bbadis.2005.04.004
15915382	[Emerging respiratory infections caused by pneumotropic viruses].	2005 Jun 3	Germany	10.1055/s-2005-868739
15915178	[Tuberculosis as an occupational disease].	2005	Spain	
15914837	Molecular identification and characterization of novel coronaviruses infectinggraylag geese (Anser anser), feral pigeons (Columbia livia) and mallards (Anasplatyrhynchos).	2005 Jun	England	10.1099/vir.0.80927-0
15914223	Circulation of genetically distinct contemporary human coronavirus OC43 strains.	2005 Jun 20	United States	10.1016/j.virol.2005.04.010
15911427	The design and application of DNA chips for early detection of SARS-CoV fromclinical samples.	2005 Jun	Netherlands	10.1016/j.jcv.2004.10.019
15911031	Inhibitory effect of mizoribine and ribavirin on the replication of severe acuterespiratory syndrome (SARS)-associated coronavirus.	2005 Jun	Netherlands	10.1016/j.antiviral.2005.01.003
15911026	Interferon alfacon1 is an inhibitor of SARS-corona virus in cell-based models.	2005 Jun	Netherlands	10.1016/j.antiviral.2005.01.002
15909257	Human coronavirus NL63 infection and other coronavirus infections in childrenhospitalized with acute respiratory disease in Hong Kong, China.	2005 Jun 15	United States	10.1086/430301
15906671	A deficient public health system as a contributing cause of Severe AcuteRespiratory Syndrome (SARS) epidemic in mainland China.	2005 Jan	Thailand	
15906480	[Characteristics and distribution of serum antibodies of SARS virus in populationof Shanxi].	2004 Aug	China	
15906479	[Seroepidemiology of SARS in Taiyuan City].	2004 Aug	China	
15899131	Potent and specific inhibition of SARS-CoV antigen expression by RNAinterference.	2005 May 5	China	
15899130	Variation analysis of the severe acute respiratory syndrome coronavirus putativenon-structural protein 2 gene and construction of three-dimensional model.	2005 May 5	China	
15897988	Antigenic cross-reactivity between severe acute respiratory syndrome-associatedcoronavirus and human coronaviruses 229E and OC43.	2005 Jun 15	United States	10.1086/430355
15897467	Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirusreceptor for cellular entry.	2005 May 31	United States	10.1073/pnas.0409465102
15896959	Synthesis and evaluation of isatin derivatives as effective SARS coronavirus 3CLprotease inhibitors.	2005 Jun 15	England	10.1016/j.bmcl.2005.04.027
15894731	Efficacy of live infectious bronchitis vaccines against a novel Europeangenotype, Italy 02.	2005 May 14	England	10.1136/vr.156.20.646
15894326	Assays for the assessment of neutralizing antibody activities against SevereAcute Respiratory Syndrome (SARS) associated coronavirus (SCV).	2005 Jun	Netherlands	10.1016/j.jim.2005.03.008
15893956	Expanding the frontiers of existing antiviral drugs: possible effects of HIV-1protease inhibitors against SARS and avian influenza.	2005 Nov	Netherlands	10.1016/j.jcv.2005.03.005
15893826	Production of a monoclonal antibody against SARS-CoV spike protein with singleintrasplenic immunization of plasmid DNA.	2005 Sep 15	Netherlands	10.1016/j.imlet.2005.03.015
15893565	Characterization of monoclonal antibody against SARS coronavirus nucleocapsidantigen and development of an antigen capture ELISA.	2005 Jul	Netherlands	10.1016/j.jviromet.2005.03.004
15892690	Development in lipid drugs.	2005 May	Netherlands	10.2174/1389557053765574
15892035	An animal model of SARS produced by infection of Macaca mulatta with SARScoronavirus.	2005 Jul	England	10.1002/path.1769
15890958	Identification and characterization of the putative fusion peptide of the severeacute respiratory syndrome-associated coronavirus spike protein.	2005 Jun	United States	10.1128/JVI.79.11.7195-7206.2005
15890951	Viral expression of CCL2 is sufficient to induce demyelination in RAG1-/- miceinfected with a neurotropic coronavirus.	2005 Jun	United States	10.1128/JVI.79.11.7113-7120.2005
15890949	Cinanserin is an inhibitor of the 3C-like proteinase of severe acute respiratorysyndrome coronavirus and strongly reduces virus replication in vitro.	2005 Jun	United States	10.1128/JVI.79.11.7095-7103.2005
15890900	Selective replication of coronavirus genomes that express nucleocapsid protein.	2005 Jun	United States	10.1128/JVI.79.11.6620-6630.2005
15890535	Coronavirus phylogeny based on a geometric approach.	2005 Aug	United States	10.1016/j.ympev.2005.03.030
15889535	A throat lozenge containing amyl meta cresol and dichlorobenzyl alcohol has adirect virucidal effect on respiratory syncytial virus, influenza A and SARS-CoV.	2005	England	10.1177/095632020501600205
15888207	Persistence of lung inflammation and lung cytokines with high-resolution CTabnormalities during recovery from SARS.	2005 May 11	England	10.1186/1465-9921-6-42
15887978	Real-time quantitative fluorescent reverse transcriptase-PCR for detection ofsevere acute respiratory syndrome-associated coronavirus RNA.	2004	United States	10.1007/bf03260067
15885816	Identification of natural compounds with antiviral activities againstSARS-associated coronavirus.	2005 Jul	Netherlands	10.1016/j.antiviral.2005.02.007
15885812	Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): identificationof neutralizing and antibodies reactive to S, N, M and E viral proteins.	2005 Sep	Netherlands	10.1016/j.jviromet.2005.03.021
15884978	A three-stemmed mRNA pseudoknot in the SARS coronavirus frameshift signal.	2005 Jun	United States	10.1371/journal.pbio.0030172
15883050	Mutational and inhibitive analysis of SARS coronavirus 3C-like protease byfluorescence resonance energy transfer-based assays.	2005 Jun 17	United States	10.1016/j.bbrc.2005.04.072
15881341	[The advances in basal research of SARS CoV].	2005 Jan	China	
15878786	Development of antiviral therapy for severe acute respiratory syndrome.	2005 Jun	Netherlands	10.1016/j.antiviral.2005.03.002
15878679	Antibody responses to individual proteins of SARS coronavirus and theirneutralization activities.	2005 May	France	10.1016/j.micinf.2005.02.006
15877099	Precautions in ophthalmic practice in a hospital with a major acute SARSoutbreak: an experience from Hong Kong.	2006 Mar	England	10.1038/sj.eye.6701885
15876221	Use of monoclonal antibodies in blocking ELISA detection of transmissiblegastroenteritis virus in faeces of piglets.	2005 Apr	Germany	10.1111/j.1439-0450.2005.00829.x
15872378	Morphologic features and development of granulomatous vasculitis in felineinfectious peritonitis.	2005 May	United States	10.1354/vp.42-3-321
15872279	Immunofluorescence assay for detection of the nucleocapsid antigen of the severeacute respiratory syndrome (SARS)-associated coronavirus in cells derived fromthroat wash samples of patients with SARS.	2005 May	United States	10.1128/JCM.43.5.2444-2448.2005
15872263	Rapid and sensitive detection of severe acute respiratory syndrome coronavirus byrolling circle amplification.	2005 May	United States	10.1128/JCM.43.5.2339-2344.2005
15872219	Development and evaluation of a multitarget real-time Taqman reversetranscription-PCR assay for detection of the severe acute respiratorysyndrome-associated coronavirus and surveillance for an apparently relatedcoronavirus found in masked palm civets.	2005 May	United States	10.1128/JCM.43.5.2041-2046.2005
15868786	Study of SARS transmission via liquid droplets in air.	2005 Feb	United States	10.1115/1.1835350
15868095	Identification of previously unknown antigenic epitopes on the S and N proteinsof avian infectious bronchitis virus.	2005 Sep	Austria	10.1007/s00705-005-0541-x
15866725	Cloning and sequence analysis of the Korean strain of spike gene of porcineepidemic diarrhea virus and expression of its neutralizing epitope in plants.	2005 Jun	United States	10.1016/j.pep.2005.02.018
15866708	Molecular cloning, expression, and purification of SARS-CoV nsp13.	2005 Jun	United States	10.1016/j.pep.2004.08.003
15865221	Dynamic changes in clinical features and cytokine/chemokine responses in SARSpatients treated with interferon alfacon-1 plus corticosteroids.	2005	England	
15864739	Development of immunoglobulin G enzyme-linked immunosorbent assay for theserodiagnosis of severe acute respiratory syndrome.	2005	England	10.1007/s11373-004-8184-6
15862300	The nucleocapsid protein of SARS coronavirus has a high binding affinity to thehuman cellular heterogeneous nuclear ribonucleoprotein A1.	2005 May 9	England	10.1016/j.febslet.2005.03.080
15860669	Chemokine up-regulation in SARS-coronavirus-infected, monocyte-derived humandendritic cells.	2005 Oct 1	United States	10.1182/blood-2004-10-4166
15858286	Immunological detection of severe acute respiratory syndrome coronavirus bymonoclonal antibodies.	2005 Apr	Japan	
15858003	Comparative host gene transcription by microarray analysis early after infectionof the Huh7 cell line by severe acute respiratory syndrome coronavirus and humancoronavirus 229E.	2005 May	United States	10.1128/JVI.79.10.6180-6193.2005
15857999	Infectious bronchitis virus 3a protein localizes to a novel domain of the smoothendoplasmic reticulum.	2005 May	United States	10.1128/JVI.79.10.6142-6151.2005
15857995	Receptor-independent spread of a highly neurotropic murine coronavirus JHMVstrain from initially infected microglial cells in mixed neural cultures.	2005 May	United States	10.1128/JVI.79.10.6102-6110.2005
15857975	Evaluation of human monoclonal antibody 80R for immunoprophylaxis of severe acuterespiratory syndrome by an animal study, epitope mapping, and analysis of spikevariants.	2005 May	United States	10.1128/JVI.79.10.5900-5906.2005
15851378	Association of RANTES with the replication of severe acute respiratory syndromecoronavirus in THP-1 cells.	2005 Mar 29	England	
15849874	Meeting report: Part II. Notes from the Twentieth Annual Clinical VirologySymposium.	2005 Apr	Netherlands	10.1016/j.jcv.2004.11.005
15849181	Recombinant severe acute respiratory syndrome (SARS) coronavirus nucleocapsidprotein forms a dimer through its C-terminal domain.	2005 Jun 17	United States	10.1074/jbc.M501015200
15848298	Spectrum of antiviral activity of o-(acetoxyphenyl)hept-2-ynyl sulphide (APHS).	2005 May	Netherlands	10.1016/j.ijantimicag.2004.11.011
15848179	Small interfering RNA inhibits SARS-CoV nucleocapsid gene expression in culturedcells and mouse muscles.	2005 Apr 25	England	10.1016/j.febslet.2005.02.080
15848177	Sumoylation of the nucleocapsid protein of severe acute respiratory syndromecoronavirus.	2005 Apr 25	England	10.1016/j.febslet.2005.03.039
15847934	Study on the resistance of severe acute respiratory syndrome-associatedcoronavirus.	2005 Jun	Netherlands	10.1016/j.jviromet.2005.02.005
15847923	Effects of cold storage on detection of avian infectious bronchitis virus inchicken carcasses and local antibodies in tracheal washes.	2005 Jun	Netherlands	10.1016/j.jviromet.2005.01.024
15847919	Development of three multiplex RT-PCR assays for the detection of 12 respiratoryRNA viruses.	2005 Jun	Netherlands	10.1016/j.jviromet.2005.01.020
15845254	Transcriptional analysis of avian embryonic tissues following infection withavian infectious bronchitis virus.	2005 Jun	Netherlands	10.1016/j.virusres.2005.01.006
15844623	Human monoclonal antibodies to the S glycoprotein and related proteins aspotential therapeutics for SARS.	2005 Apr	England	
15843851	Severe acute respiratory syndrome epidemic in Taiwan, 2003.	2005 Apr	England	
15843808	Targeting non-human coronaviruses to human cancer cells using a bispecificsingle-chain antibody.	2005 Sep	England	10.1038/sj.gt.3302535
15842838	[Detection of severe acute respiratory syndrome probable patients' virus RNA inHangzhou by using a two loci and a modified nested real-time reversetranscription polymerase chain reaction].	2005 Mar	China	
15841339	Investigation into the causes of canine infectious respiratory disease: antibodyresponses to canine respiratory coronavirus and canine herpesvirus in twokennelled dog populations.	2005 Aug	Austria	10.1007/s00705-005-0533-x
15840526	Central ions and lateral asparagine/glutamine zippers stabilize the post-fusionhairpin conformation of the SARS coronavirus spike glycoprotein.	2005 May 10	United States	10.1016/j.virol.2005.02.022
15840518	Cells of human aminopeptidase N (CD13) transgenic mice are infected by humancoronavirus-229E in vitro, but not in vivo.	2005 May 10	United States	10.1016/j.virol.2005.02.023
15840516	Expression, purification, and characterization of SARS coronavirus RNApolymerase.	2005 May 10	United States	10.1016/j.virol.2005.02.017
15839432	In vitro analysis of a hammerhead ribozyme targeted to infectious bronchitisvirus nucleocapsid mRNA.	2005 Mar	United States	10.1637/7259-081104R
15839418	Multiplex real-time reverse transcription-polymerase chain reaction for thedetection of three viruses associated with poult enteritis complex: turkeyastrovirus, turkey coronavirus, and turkey reovirus.	2005 Mar	United States	10.1637/7265-082304R
15839408	Molecular detection and serotyping of infectious bronchitis virus from FTA filterpaper.	2005 Mar	United States	10.1637/7220
15838797	Mannose-binding lectin in severe acute respiratory syndrome coronavirusinfection.	2005 May 15	United States	10.1086/429631
15837647	[Detection of SARS-associated coronavirus N protein by time-resolvedfluoroimmunoassay].	2005 Apr	China	
15837368	rOv-ASP-1, a recombinant secreted protein of the helminth Onchocercavolvulus, isa potent adjuvant for inducing antibodies to ovalbumin, HIV-1 polypeptide andSARS-CoV peptide antigens.	2005 May 16	Netherlands	10.1016/j.vaccine.2005.01.098
15837221	Immunogenicity, safety, and protective efficacy of an inactivated SARS-associatedcoronavirus vaccine in rhesus monkeys.	2005 May 2	Netherlands	10.1016/j.vaccine.2004.11.075
15837220	Immune responses in Balb/c mice induced by a candidate SARS-CoV inactivatedvaccine prepared from F69 strain.	2005 May 2	Netherlands	10.1016/j.vaccine.2004.11.073
15834986	Are SARS superspreaders cloud adults?	2005 Apr	United States	10.3201/eid1104.040639
15834868	Recombinant protein-based ELISA and immuno-cytochemical assay for the diagnosisof SARS.	2005 Jun	United States	10.1002/jmv.20338
15833360	Transcriptome profile within the mouse central nervous system and activation ofmyelin-reactive T cells following murine coronavirus infection.	2005 May	Netherlands	10.1016/j.jneuroim.2005.01.007
15833113	Molecular advances in the cell biology of SARS-CoV and current disease preventionstrategies.	2005 Apr 15	England	10.1186/1743-422X-2-35
15831955	A single immunization with a rhabdovirus-based vector expressing severe acuterespiratory syndrome coronavirus (SARS-CoV) S protein results in the productionof high levels of SARS-CoV-neutralizing antibodies.	2005 May	England	10.1099/vir.0.80844-0
15831954	Differential maturation and subcellular localization of severe acute respiratorysyndrome coronavirus surface proteins S, M and E.	2005 May	England	10.1099/vir.0.80671-0
15831489	Critical assessment of important regions in the subunit association and catalyticaction of the severe acute respiratory syndrome coronavirus main protease.	2005 Jun 17	United States	10.1074/jbc.M502556200
15830791	[Severe acute respiratory syndrome. The public health laboratory in a globalemergency].	2005	Argentina	
15830158	Molecular cloning and phylogenetic analysis of ORF7 region of chinese isolateTH-98 from transmissible gastroenteritis virus.	2005 May	United States	10.1007/s11262-004-6783-y
15827211	Epizootiologic investigations of selected infectious disease agents infree-ranging Eurasian lynx from Sweden.	2005 Jan	United States	10.7589/0090-3558-41.1.58
15827197	Aged BALB/c mice as a model for increased severity of severe acute respiratorysyndrome in elderly humans.	2005 May	United States	10.1128/JVI.79.9.5833-5838.2005
15827143	Identification of novel subgenomic RNAs and noncanonical transcription initiationsignals of severe acute respiratory syndrome coronavirus.	2005 May	United States	10.1128/JVI.79.9.5288-5295.2005
15823604	Identification of murine CD8 T cell epitopes in codon-optimized SARS-associatedcoronavirus spike protein.	2005 Apr 25	United States	10.1016/j.virol.2005.01.050
15819995	Absence of association between angiotensin converting enzyme polymorphism anddevelopment of adult respiratory distress syndrome in patients with severe acuterespiratory syndrome: a case control study.	2005 Apr 9	England	10.1186/1471-2334-5-26
15818427	Immunohistochemical study of severe acute respiratory syndrome-associatedcoronavirus in tissue sections of patients.	2005 Mar	Singapore	
15818183	Community-acquired pneumonia in children.	2005 May	United States	10.1097/01.mcp.0000159831.82529.85
15818145	Hepatobiliary pathology.	2005 May	United States	10.1097/01.mog.0000159820.78532.68
15817766	Retrospective serological investigation of severe acute respiratory syndromecoronavirus antibodies in recruits from mainland China.	2005 Apr	United States	10.1128/CDLI.12.4.552-554.2005
15817564	Species-independent detection of RNA virus by representational differenceanalysis using non-ribosomal hexanucleotides for reverse transcription.	2005 Apr 7	England	10.1093/nar/gni064
15816152	Human coronavirus OC43 causes influenza-like illness in residents and staff ofaged-care facilities in Melbourne, Australia.	2005 Apr	England	10.1017/s0950268804003346
15815038	Development and application of a Saccharomyces cerevisiae-expressed nucleocapsidprotein-based enzyme-linked immunosorbent assay for detection of antibodiesagainst infectious bronchitis virus.	2005 Apr	United States	10.1128/JCM.43.4.1982-1984.2005
15814718	Receptor-binding domain of severe acute respiratory syndrome coronavirus spikeprotein contains multiple conformation-dependent epitopes that induce highlypotent neutralizing antibodies.	2005 Apr 15	United States	10.4049/jimmunol.174.8.4908
15813661	Severe acute respiratory syndrome: pertinent clinical characteristics andtherapy.	2005	United States	10.2165/00151829-200504020-00003
15813242	Clinical findings, treatment and prognosis in patients with severe acuterespiratory syndrome (SARS).	2005 Mar	Netherlands	10.1016/S1726-4901(09)70229-1
15812185	SARS-CoV infection was from at least two origins in the Taiwan area.	2005	Switzerland	10.1159/000081739
15811330	Synthetic peptides derived from SARS coronavirus S protein with diagnostic andtherapeutic potential.	2005 Apr 11	England	10.1016/j.febslet.2005.02.070
15810082	Clinical significance of hepatic derangement in severe acute respiratorysyndrome.	2005 Apr 14	United States	10.3748/wjg.v11.i14.2148
15809907	Molecular epidemiology of severe acute respiratory syndrome-associatedcoronavirus infections in Taiwan.	2005 May 1	United States	10.1086/428591
15809906	Detection of airborne severe acute respiratory syndrome (SARS) coronavirus andenvironmental contamination in SARS outbreak units.	2005 May 1	United States	10.1086/429634
15809896	Airborne severe acute respiratory syndrome coronavirus and its implications.	2005 May 1	United States	10.1086/429637
15802960	Maintenance of CD8+ T cells during acute viral infection of the central nervoussystem requires CD4+ T cells but not interleukin-2.	2005	United States	10.1089/vim.2005.18.162
15797903	Mining SARS-CoV protease cleavage data using non-orthogonal decision trees: anovel method for decisive template selection.	2005 Jun 1	England	10.1093/bioinformatics/bti404
15797361	Clinical evaluation of real-time PCR assays for rapid diagnosis of SARScoronavirus during outbreak and post-epidemic periods.	2005 May	Netherlands	10.1016/j.jcv.2004.09.029
15797360	Development and evaluation of an enzyme-linked immunosorbent assay for detectionof antibodies against the spike protein of SARS-coronavirus.	2005 May	Netherlands	10.1016/j.jcv.2004.09.024
15797323	Genosensor on gold films with enzymatic electrochemical detection of a SARS virussequence.	2005 May 15	England	10.1016/j.bios.2004.10.019
15797214	The adamantane-derived bananins are potent inhibitors of the helicase activitiesand replication of SARS coronavirus.	2005 Mar	United States	10.1016/j.chembiol.2005.01.006
15796872	[Gene detection: an impact on the development of pathology].	2005 Jan	China	
15795262	Expression of matrix metalloproteinases and their tissue inhibitor during viralencephalitis.	2005 Apr	United States	10.1128/JVI.79.8.4764-4773.2005
15795256	Virus-specific and bystander CD8 T cells recruited during virus-inducedencephalomyelitis.	2005 Apr	United States	10.1128/JVI.79.8.4700-4708.2005
15794988	Recombinant nucleocapsid protein-based IgG enzyme-linked immunosorbent assay forthe serological diagnosis of SARS.	2005 May	Netherlands	10.1016/j.jviromet.2005.01.028
15791576	Immunohistochemical, in situ hybridization, and ultrastructural localization ofSARS-associated coronavirus in lung of a fatal case of severe acute respiratorysyndrome in Taiwan.	2005 Mar	United States	10.1016/j.humpath.2004.11.006
15791205	Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2.	2005 Apr 20	England	10.1038/sj.emboj.7600640
15789222	Persistent shedding of viable SARS-CoV in urine and stool of SARS patients duringthe convalescent phase.	2005 Mar	Germany	10.1007/s10096-005-1299-5
15788388	Mechanism of the maturation process of SARS-CoV 3CL protease.	2005 Sep 2	United States	10.1074/jbc.M502577200
15788131	Antiviral activity of cepharanthine against severe acute respiratory syndromecoronavirus in vitro.	2005 Mar 20	China	
15788125	Severe acute respiratory syndrome coronavirus persistence in Vero cells.	2005 Mar 20	China	
15788124	Evaluation by indirect immunofluorescent assay and enzyme linked immunosorbentassay of the dynamic changes of serum antibody responses against severe acuterespiratory syndrome coronavirus.	2005 Mar 20	China	
15788123	Interpreting serological studies on severe acute respiratory syndrome: definingthe reference.	2005 Mar 20	China	
15784933	Quantitative analysis of severe acute respiratory syndrome (SARS)-associatedcoronavirus-infected cells using proteomic approaches: implications for cellularresponses to virus infection.	2005 Jul	United States	10.1074/mcp.M400112-MCP200
15784184	Th2 predominance and CD8+ memory T cell depletion in patients with severe acuterespiratory syndrome.	2005 Mar	France	10.1016/j.micinf.2004.11.017
15782666	Detection of respiratory and enteric shedding of bovine coronaviruses in cattlein Northwestern Turkey.	2005	Hungary	10.1556/AVet.53.2005.1.13
15782539	[Severe acute respiratory syndrome (SARS). Lesson and challenges].	2005 Mar	Venezuela	
15781262	The severe acute respiratory syndrome coronavirus 3a is a novel structuralprotein.	2005 Apr 29	United States	10.1016/j.bbrc.2005.02.153
15781229	Design of recombinant protein-based SARS-CoV entry inhibitors targeting theheptad-repeat regions of the spike protein S2 domain.	2005 Apr 29	United States	10.1016/j.bbrc.2005.02.117
15780881	Spike protein assembly into the coronavirion: exploring the limits of itssequence requirements.	2005 Apr 10	United States	10.1016/j.virol.2005.02.001
15780866	Neutralizing antibody and protective immunity to SARS coronavirus infection ofmice induced by a soluble recombinant polypeptide containing an N-terminalsegment of the spike glycoprotein.	2005 Apr 10	United States	10.1016/j.virol.2005.01.042
15780182	Inhibition of genes expression of SARS coronavirus by synthetic small interferingRNAs.	2005 Mar	England	10.1038/sj.cr.7290286
15778027	Mixed infections in vitro with different Chlamydiaceae strains and a cell cultureadapted porcine epidemic diarrhea virus.	2005 Apr 10	Netherlands	10.1016/j.vetmic.2004.10.023
15777647	Microarray and real-time RT-PCR analyses of differential human gene expressionpatterns induced by severe acute respiratory syndrome (SARS) coronavirusinfection of Vero cells.	2005 Feb	France	10.1016/j.micinf.2004.11.004
15776156	Screening of specific antigens for SARS clinical diagnosis using a proteinmicroarray.	2005 Apr	England	10.1039/b415888a
15774192	[Advances in vaccine research of severe acute respiratory syndrome].	2005 Jan	China	
15772689	siRNA targeting the leader sequence of SARS-CoV inhibits virus replication.	2005 May	England	10.1038/sj.gt.3302479
15771947	Epidemiologic evaluation of multiple respiratory pathogens in cats in animalshelters.	2005 Apr	England	10.1016/j.jfms.2004.07.004
15769316	[Analysis on the characteristics of blood serum Ab-IgG detective result of severeacute respiratory syndrome patients in Guangzhou, China].	2004 Nov	China	
15767458	Deubiquitination, a new function of the severe acute respiratory syndromecoronavirus papain-like protease?	2005 Apr	United States	10.1128/JVI.79.7.4550-4551.2005
15767437	Viral induction of central nervous system innate immune responses.	2005 Apr	United States	10.1128/JVI.79.7.4369-4381.2005
15766649	Treatment and vaccines for severe acute respiratory syndrome.	2005 Mar	United States	10.1016/S1473-3099(05)01307-1
15765160	Evolution of pulmonary pathology in severe acute respiratory syndrome.	2005 Feb	Singapore	
15764169	In vitro inhibition of SARS virus replication by human interferons.	2004	England	10.1080/00365540410021144
15763735	Variation in the spike protein of the 793/B type of infectious bronchitis virus,in the field and during alternate passage in chickens and embryonated eggs.	2005 Feb	England	10.1080/03079450400025414
15763730	Retrospective evidence that the MHC (B haplotype) of chickens influences geneticresistance to attenuated infectious bronchitis vaccine strains in chickens.	2004 Dec	England	10.1080/03079450400013147
15763728	Aerosol-induced Mycoplasma synoviae arthritis: the synergistic effect ofinfectious bronchitis virus infection.	2004 Dec	England	10.1080/03079450400013170
15763721	Development and use of the H strain of avian infectious bronchitis virus from theNetherlands as a vaccine: a review.	2004 Dec	England	10.1080/03079450400013154
15763150	Subcellular localization and membrane association of SARS-CoV 3a protein.	2005 May	Netherlands	10.1016/j.virusres.2005.01.001
15759346	SARS control and psychological effects of quarantine, Toronto, Canada.	2005 Feb	United States	10.3201/eid1102.040760
15759315	Biochemical and immunological studies of nucleocapsid proteins of severe acuterespiratory syndrome and 229E human coronaviruses.	2005 Mar	Germany	10.1002/pmic.200401204
15757562	SARS-associated coronavirus transmitted from human to pig.	2005 Mar	United States	10.3201/eid1103.040824
15757556	Longitudinally profiling neutralizing antibody response to SARS coronavirus withpseudotypes.	2005 Mar	United States	10.3201/eid1103.040906
15757550	Rapid identification of emerging pathogens: coronavirus.	2005 Mar	United States	10.3201/eid1103.040629
15756729	[Kawasaki syndrome: a coronavirus infection?].	2005 Feb 18	Germany	
15755610	Evaluation of modified vaccinia virus Ankara based recombinant SARS vaccine inferrets.	2005 Mar 18	Netherlands	10.1016/j.vaccine.2005.01.033
15755609	The development of vaccines against SARS corona virus in mice and SCID-PBL/humice.	2005 Mar 18	Netherlands	10.1016/j.vaccine.2005.01.036
15753261	Use of the COOH portion of the nucleocapsid protein in an antigen-capturingenzyme-linked immunosorbent assay for specific and sensitive detection of severeacute respiratory syndrome coronavirus.	2005 Mar	United States	10.1128/CDLI.12.3.474-476.2005
15752773	Growth kinetics of SARS-coronavirus in Vero E6 cells.	2005 Apr 15	United States	10.1016/j.bbrc.2005.02.085
15752746	The substrate specificity of SARS coronavirus 3C-like proteinase.	2005 Apr 15	United States	10.1016/j.bbrc.2005.02.061
15752456	Late recognition of SARS in nosocomial outbreak, Toronto.	2005 Feb	United States	10.3201/eid1102.040607
15752447	Quarantine for SARS, Taiwan.	2005 Feb	United States	10.3201/eid1102.040190
15751577	Detection of the Italy O2 strain of infectious bronchitis virus in the UK.	2005 Feb 19	England	
15750316	Detection and isolation of winter dysentery bovine coronavirus circulated inKorea during 2002-2004.	2005 Feb	Japan	10.1292/jvms.67.187
15749283	From genome to antivirals: SARS as a test tube.	2005 Mar 1	England	10.1016/S1359-6446(04)03320-3
15749129	Epitope mapping and biological function analysis of antibodies produced byimmunization of mice with an inactivated Chinese isolate of severe acuterespiratory syndrome-associated coronavirus (SARS-CoV).	2005 Mar 30	United States	10.1016/j.virol.2005.01.035
15749126	Substitutions of conserved amino acids in the receptor-binding domain of thespike glycoprotein affect utilization of murine CEACAM1a by the murinecoronavirus MHV-A59.	2005 Mar 30	United States	10.1016/j.virol.2005.01.016
15749124	Identification of a critical neutralization determinant of severe acuterespiratory syndrome (SARS)-associated coronavirus: importance for designing SARSvaccines.	2005 Mar 30	United States	10.1016/j.virol.2005.01.034
15748730	Controlling emerging infectious diseases like SARS.	2005 Feb	United States	10.1016/j.mbs.2004.07.006
15744567	Isolation of virus from a SARS patient and genome-wide analysis of geneticmutations related to pathogenesis and epidemiology from 47 SARS-CoV isolates.	2005 Jan	United States	10.1007/s11262-004-4586-9
15744564	Cloning and sequence analysis of the M gene of porcine epidemic diarrhea virusLJB/03.	2005 Jan	United States	10.1007/s11262-004-4583-z
15743792	Virus-specific antibody, in the absence of T cells, mediates demyelination inmice infected with a neurotropic coronavirus.	2005 Mar	United States	10.1016/S0002-9440(10)62301-2
15742624	Animal coronavirus vaccines: lessons for SARS.	2004	Switzerland	
15740663	The protein X4 of severe acute respiratory syndrome-associated coronavirus isexpressed on both virus-infected cells and lung tissue of severe acuterespiratory syndrome patients and inhibits growth of Balb/c 3T3 cell line.	2005 Feb 20	China	
15739619	Current status of anti-SARS agents.	2005	England	10.1177/095632020501600103
15739618	New antiviral drugs, vaccines and classic public health interventions againstSARS coronavirus.	2005	England	10.1177/095632020501600102
15737918	Phylogenetic analysis and sequence comparisons of structural and non-structuralSARS coronavirus proteins in Taiwan.	2005 Apr	Netherlands	10.1016/j.meegid.2004.08.005
15737606	Identification of single-chain antibody fragments specific againstSARS-associated coronavirus from phage-displayed antibody library.	2005 Apr 8	United States	10.1016/j.bbrc.2005.02.003
15737482	Persistence of Mycoplasma gallisepticum in chickens after treatment withenrofloxacin without development of resistance.	2005 Mar 20	Netherlands	10.1016/j.vetmic.2004.11.016
15736999	SARS transmission pattern in Singapore reassessed by viral sequence variationanalysis.	2005 Feb	United States	10.1371/journal.pmed.0020043
15735418	Newer respiratory virus infections: human metapneumovirus, avian influenza virus,and human coronaviruses.	2005 Apr	United States	10.1097/01.qco.0000160903.56566.84
15735160	Development of a quantitative assay for SARS coronavirus and correlation of GAPDHmRNA with SARS coronavirus in clinical specimens.	2005 Mar	England	10.1136/jcp.2004.016592
15731278	Exogenous ACE2 expression allows refractory cell lines to support severe acuterespiratory syndrome coronavirus replication.	2005 Mar	United States	10.1128/JVI.79.6.3846-3850.2005
15731234	B-cell responses in patients who have recovered from severe acute respiratorysyndrome target a dominant site in the S2 domain of the surface spikeglycoprotein.	2005 Mar	United States	10.1128/JVI.79.6.3401-3408.2005
15731233	Single-amino-acid substitutions in open reading frame (ORF) 1b-nsp14 and ORF 2aproteins of the coronavirus mouse hepatitis virus are attenuating in mice.	2005 Mar	United States	10.1128/JVI.79.6.3391-3400.2005
15731231	Increased epitope-specific CD8+ T cells prevent murine coronavirus spread to thespinal cord and subsequent demyelination.	2005 Mar	United States	10.1128/JVI.79.6.3370-3381.2005
15731223	Amino acids 1055 to 1192 in the S2 region of severe acute respiratory syndromecoronavirus S protein induce neutralizing antibodies: implications for thedevelopment of vaccines and antiviral agents.	2005 Mar	United States	10.1128/JVI.79.6.3289-3296.2005
15731213	Using evolutionary Expectation Maximization to estimate indel rates.	2005 May 15	England	10.1093/bioinformatics/bti177
15731211	Object-oriented biological system integration: a SARS coronavirus example.	2005 May 15	England	10.1093/bioinformatics/bti344
15730921	Clinical characteristics and mechanism of liver damage in patients with severeacute respiratory syndrome.	2005 Feb	Singapore	
15727223	[Study on mice hepatitis virus].	2004 Oct	China	
15726228	Infectious respiratory illnesses and their impact on healthcare workers: areview.	2005 Jan	Singapore	
15725684	Health surveillance of specific pathogen-free and conventionally-housed mice andrats in Korea.	2005 Jan	Japan	10.1538/expanim.54.85
15722532	Isolation of avian infectious bronchitis coronavirus from domestic peafowl (Pavocristatus) and teal (Anas).	2005 Mar	England	10.1099/vir.0.80546-0
15722333	The severe acute respiratory syndrome coronavirus in tears.	2005 Mar	England	10.1136/bjo.2004.054130
15719959	Is thermal scanner losing its bite in mass screening of fever due to SARS?	2005 Jan	United States	10.1118/1.1819532
15715493	Antiviral activity of glycyrrhizic acid derivatives against SARS-coronavirus.	2005 Feb 24	United States	10.1021/jm0493008
15714661	Tracing SARS-coronavirus variant with large genomic deletion.	2005 Jan	United States	10.3201/eid1101.040544
15714660	Occupational health response to SARS.	2005 Jan	United States	10.3201/eid1101.040637
15714659	SARS-CoV sampling from 3 portals.	2005 Jan	United States	10.3201/eid1101.040645
15713601	The transmembrane oligomers of coronavirus protein E.	2005 Feb	United States	10.1529/biophysj.104.051730
15712093	Outbreak of methicillin-resistant Staphylococcus aureus infection associated withan outbreak of severe acute respiratory syndrome.	2005 Feb 15	United States	10.1086/427151
15709046	Genetic variability of human respiratory coronavirus OC43.	2005 Mar	United States	10.1128/JVI.79.5.3223-3225.2005
15709039	Severe acute respiratory syndrome coronavirus 3a protein is a viral structuralprotein.	2005 Mar	United States	10.1128/JVI.79.5.3182-3186.2005
15709029	Recombinant mouse hepatitis virus strain A59 from cloned, full-length cDNAreplicates to high titers in vitro and is fully pathogenic in vivo.	2005 Mar	United States	10.1128/JVI.79.5.3097-3106.2005
15708987	Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein ofsevere acute respiratory syndrome coronavirus induces protective neutralizingantibodies primarily targeting the receptor binding region.	2005 Mar	United States	10.1128/JVI.79.5.2678-2688.2005
15708633	Characterization of viral proteins encoded by the SARS-coronavirus genome.	2005 Feb	Netherlands	10.1016/j.antiviral.2004.10.001
15707076	SARS: the flying death.	2003 Jul-Sep	Lebanon	
15705339	SARS clinical features, United States, 2003.	2005 Jan	United States	10.3201/eid1101.040585
15705328	Anti-SARS-CoV immunoglobulin G in healthcare workers, Guangzhou, China.	2005 Jan	United States	10.3201/eid1101.040138
15705315	Border screening for SARS.	2005 Jan	United States	10.3201/eid1101.040835
15705200	Reference gene selection for quantitative real-time PCR analysis in virusinfected cells: SARS corona virus, Yellow fever virus, Human Herpesvirus-6,Camelpox virus and Cytomegalovirus infections.	2005 Feb 10	England	10.1186/1743-422X-2-7
15703131	Differentiation of mouse hepatitis virus genotypes by restriction fragment lengthpolymorphism analysis.	2005 Jan	England	10.1258/0023677052886574
15703085	The Severe Acute Respiratory Syndrome (SARS)-coronavirus 3a protein may functionas a modulator of the trafficking properties of the spike protein.	2005 Feb 10	England	10.1186/1743-422X-2-5
15702757	Severe acute respiratory syndrome (SARS) and healthcare workers.	2004 Oct-Dec	England	10.1179/oeh.2004.10.4.421
15702725	Animal coronaviruses: what can they teach us about the severe acute respiratorysyndrome?	2004 Aug	France	10.20506/rst.23.2.1513
15700108	Using cellular automata to generate image representation for biologicalsequences.	2005 Feb	Austria	10.1007/s00726-004-0154-9
15699428	Novel immunofluorescence assay using recombinant nucleocapsid-spike fusionprotein as antigen to detect antibodies against severe acute respiratory syndromecoronavirus.	2005 Feb	United States	10.1128/CDLI.12.2.321-328.2005
15695719	Detection of severe acute respiratory syndrome coronavirus RNA in plasma duringthe course of infection.	2005 Feb	United States	10.1128/JCM.43.2.962-965.2005
15695705	Emergence of a nephropathogenic avian infectious bronchitis virus with a novelgenotype in India.	2005 Feb	United States	10.1128/JCM.43.2.916-918.2005
15695582	Cross-host evolution of severe acute respiratory syndrome coronavirus in palmcivet and human.	2005 Feb 15	United States	10.1073/pnas.0409608102
15693056	SARS-CoV protease inhibitors design using virtual screening method from naturalproducts libraries.	2005 Apr 15	United States	10.1002/jcc.20186
15692748	1H, 13C, and 15N resonance assignments of the N-terminal domain of the SARS CoVnucleocapsid protein.	2005 Jan	Netherlands	10.1007/s10858-004-6890-z
15692623	Protective effect of vaccination in chicks with local infectious bronchitisviruses against field virus challenge.	2005 Feb	England	
15691506	Molecular modeling and chemical modification for finding peptide inhibitoragainst severe acute respiratory syndrome coronavirus main proteinase.	2005 Feb 15	United States	10.1016/j.ab.2004.10.003
15690947	Myositis, lameness, and recumbency after use of water-in-oil adjuvanted vaccinesin near-term beef cattle.	2005 Jan	United States	10.1177/104063870501700106
15690493	Three-dimensional model of a substrate-bound SARS chymotrypsin-like cysteineproteinase predicted by multiple molecular dynamics simulations: catalyticefficiency regulated by substrate binding.	2004 Dec 1	United States	10.1002/prot.20249
15689078	Development and comparison of the real-time amplification basedmethods--NASBA-Beacon, RT-PCR taqman and RT-PCR hybridization probe assays--forthe qualitative detection of sars coronavirus.	2004 Sep	Thailand	
15688292	Function of HAb18G/CD147 in invasion of host cells by severe acute respiratorysyndrome coronavirus.	2005 Mar 1	United States	10.1086/427811
